{
  "meta": {
    "title": "21_Mission_Neetpg_Inicet_Gt_-_12",
    "url": "https://brainandscalpel.vercel.app/21-mission-neetpg-inicet-gt-12-eda334bd.html",
    "scrapedAt": "2025-11-29T17:23:27.631Z"
  },
  "questions": [
    {
      "id": 38526,
      "choices": [
        {
          "id": 153847,
          "text": "<p><span style=\"font-size:14.0pt;\">Intracellular accumulation of Ca<sup>2+</sup></span></p>"
        },
        {
          "id": 153848,
          "text": "<p><span style=\"font-size:14.0pt;\">Mitochondrial dysfunction</span></p>"
        },
        {
          "id": 153849,
          "text": "<p><span style=\"font-size:14.0pt;\">Membrane damage</span></p>"
        },
        {
          "id": 153850,
          "text": "<p><span style=\"font-size:14.0pt;\">Release of lysosomal (hydrolytic) enzymes</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 55-year-old man with a history of chronic heart failure is admitted to the hospital following an episode of acute chest pain. On examination, his heart rate is elevated, and an ECG shows signs consistent with myocardial ischemia. Laboratory findings indicate elevated cardiac enzymes. The patient's condition leads to a discussion among the medical team about the cellular mechanisms of injury in myocardial ischemia. One of the team members mentions that a diminished supply of ATP is a critical factor in the pathophysiology of this condition. Which of the following leads to diminished ATP in the context of cellular injury during myocardial ischemia?</span></p>",
      "unique_key": "Q6739225",
      "question_audio": null,
      "question_video": null,
      "map_id": 3733905,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Ans. B) Mitochondrial dysfunction</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Mitochondrial dysfunction leads to diminished ATP production within cells.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">The mitochondria are the primary site of ATP production through oxidative phosphorylation in aerobic conditions.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">In the context of myocardial ischemia, as described in the patient's scenario, reduced oxygen supply leads to impaired mitochondrial function.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">This impairment limits the electron transport chain's ability to produce ATP, directly linking diminished ATP levels to mitochondrial dysfunction.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option A. Intracellular accumulation of Ca<sup>2+</sup></strong> does occur in the setting of cellular injury, often as a secondary effect due to the dysfunction of ATP-dependent ion pumps. However, it is not the most direct consequence of diminished ATP related to mitochondrial dysfunction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Membrane damage</strong> is a significant result of cellular injury and can be exacerbated by ATP depletion. However, it typically follows mitochondrial dysfunction and is more of a downstream effect of the initial energy crisis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option D. The release of lysosomal (hydrolytic) enzymes</strong> is a consequence of severe cellular injury and necrosis, which might follow mitochondrial dysfunction and membrane damage but is not the primary consequence of diminished ATP.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">The educational objective is to recognize the role of mitochondrial dysfunction as a primary and direct consequence of diminished ATP production in the setting of cellular injury, such as in myocardial ischemia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Mitochondria are crucial for ATP synthesis, and their dysfunction underlies many pathophysiological processes associated with ischemic conditions.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\">Summary:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_akOFxLW.png\" width=\"1393\" height=\"387\"></span></p>",
      "correct_choice_id": 153848,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38730,
      "choices": [
        {
          "id": 154663,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patient must be started on anti-gas gangrene serum therapy</span></span></span></span></p>"
        },
        {
          "id": 154664,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a mixed flora aerobic and anaerobic infection</span></span></span></span></p>"
        },
        {
          "id": 154665,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral orchidectomy is generally performed</span></span></span></span></p>"
        },
        {
          "id": 154666,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Compulsory urinary diversion is performed</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 67-year-old male patient visits the emergency department due to rapidly worsening pain and swelling in the genital and perianal regions, with signs of necrotizing infection as shown below upon examination. The patient has a history of alcohol abuse and poorly controlled diabetes, and laboratory tests reveal leukocytosis and elevated blood glucose levels. What is the accurate statement about the condition presented by the patient? </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132352.JPG\" style=\"height:223px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q3181829",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756926,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) It is a mixed flora aerobic and anaerobic infection</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image provided suggests Fournier&#39;s gangrene, which is a mixed aerobic and anaerobic infection and a surgical emergency.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fournier&#39;s gangrene is a rapidly progressive infection of the genitalia and perineum caused by mixed bacterial flora, often associated with diabetes, cancer, malnutrition, recent urogenital or colorectal instrumentation, or trauma.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms of Fournier&#39;s gangrene include erythema, swelling, pain, and blister formation with ultimately foul-smelling necrotic lesions.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Patient must be started on anti-gas gangrene serum therapy. </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Anti-gas gangrene serum therapy is typically used for the treatment of gas gangrene caused by the bacterium Clostridium perfringens. While C. perfringens can sometimes be a part of the mixed bacterial flora in Fournier&#39;s gangrene, the condition itself is not specifically gas gangrene, and thus anti-gas gangrene serum therapy is not the primary treatment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Bilateral orchidectomy is generally performed. </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. A bilateral orchidectomy, or the removal of both testes, is not a standard treatment for Fournier&#39;s gangrene. Testes are typically spared in Fournier&rsquo;s gangrene.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Compulsory urinary diversion is performed. </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. While urinary diversion might be considered in some cases where the urethra is compromised or if there&#39;s significant involvement of the urogenital structures, it&#39;s not a compulsory or routine part of the management of Fournier&#39;s gangrene.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fournier&#39;s gangrene, is a mixed aerobic and anaerobic infection and is a surgical emergency.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38381,
      "choices": [
        {
          "id": 153279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Bedaquiline</span></span></span></p>"
        },
        {
          "id": 153280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Linezolid</span></span></span></p>"
        },
        {
          "id": 153281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Fluconazole</span></span></span></p>"
        },
        {
          "id": 153282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Liposomal amphotericin B</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 50-year-old man presents with a week-long history of fever, abdominal distention, and loss of appetite. His condition has not improved despite treatment with antibiotics and antimalarials. Laboratory tests, including a negative Widal test, have ruled out typhoid fever. However, the RK39 dipstick test, used for the diagnosis of visceral leishmaniasis (kala-azar), returns positive. Considering the diagnosis and the need for effective treatment, which of the following drugs is most appropriate for this patient?</span></span></span></p>",
      "unique_key": "Q2941775",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717182,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Liposomal amphotericin B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Liposomal amphotericin B is the drug of choice for the treatment of visceral leishmaniasis, also known as <strong>kala-azar</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This formulation of amphotericin B is preferred due to its improved safety profile and efficacy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It targets the fungal cell membrane, causing cell death, and is effective against the protozoa responsible for leishmaniasis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Bedaquiline</span></strong><span style=\"font-size:14.0pt\"> is an anti-mycobacterial agent used primarily in the treatment of multidrug-resistant tuberculosis and is not effective against the parasites causing leishmaniasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Linezolid</span></strong><span style=\"font-size:14.0pt\"> is an antibiotic that belongs to the oxazolidinone class and is used to treat infections caused by gram-positive bacteria, including resistant strains like MRSA. It is not used in the treatment of leishmaniasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Fluconazole</span></strong><span style=\"font-size:14.0pt\"> is an antifungal medication used to treat a variety of fungal infections, including candidiasis and cryptococcal meningitis. It is not effective against the protozoan parasites that cause leishmaniasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question is designed to assess the knowledge of the appropriate pharmacological treatment for visceral leishmaniasis, emphasizing the use of liposomal amphotericin B. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of choosing the correct treatment based on the specific causative agent and the clinical presentation of the disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38591,
      "choices": [
        {
          "id": 154107,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Everyone is given the Diphtheria vaccine</span></span></span></p>"
        },
        {
          "id": 154108,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Everyone is given Tetanus toxoid</span></span></span></p>"
        },
        {
          "id": 154109,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Everyone is given the Cholera vaccine</span></span></span></p>"
        },
        {
          "id": 154110,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Only the health workers are given Cholera, Typhoid, and Tetanus toxoid vaccines</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the aftermath of a disaster, public health officials must implement a vaccine protocol to prevent the outbreak of diseases among the affected population. Which of the following protocols is typically followed after a disaster situation?</span></span></span></p>",
      "unique_key": "Q2565280",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739280,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Only the health workers are given Cholera, Typhoid, and Tetanus toxoid vaccines</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Following a disaster, the risk of communicable diseases may increase due to a lack of clean water, sanitation, and the disruption of regular health services. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Health workers are often at the highest risk as they are directly involved in the care of affected individuals. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Consequently, they may be prioritized for vaccination against diseases like Cholera, Typhoid, and Tetanus, which can be more prevalent in such settings. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The general population may not be universally vaccinated for these diseases immediately post-disaster unless there is an identified risk or outbreak that necessitates such an intervention.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">WHO does not recommend Typhoid, Cholera and Tetanus Toxoid vaccinations in routine use in endemic areas post-disaster. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, these vaccinations are recommended for health workers</span></span></li>\r\n</ul>",
      "correct_choice_id": 154110,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38313,
      "choices": [
        {
          "id": 153011,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Statement A is correct, and Statement B is incorrect.</span></span></span></p>"
        },
        {
          "id": 153012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Statement A is incorrect, and Statement B is correct.</span></span></span></p>"
        },
        {
          "id": 153013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Both Statement A and Statement B are correct.</span></span></span></p>"
        },
        {
          "id": 153014,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Both Statement A and Statement B are incorrect.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In the context of cancer metastasis, which of the following statements regarding the role of adhesion molecules is accurate?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement A:</span></strong><span style=\"font-size:14.0pt\"> E-cadherin downregulation is often observed in tumor cells, allowing them to detach from primary tumors and invade surrounding tissues.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement B:</span></strong><span style=\"font-size:14.0pt\"> Integrins play a crucial role in mediating the attachment of circulating tumor cells to endothelial cells in distant organs, facilitating metastatic spread.</span></span></span></p>",
      "unique_key": "Q2617038",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715164,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Both Statement A and Statement B are correct</span></strong><span style=\"font-size:14.0pt\">.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement A:</span></strong><span style=\"font-size:14.0pt\"> <strong>E-cadherin downregulation is often observed in tumor cells, allowing them to detach from primary tumors and invade surrounding tissues.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">E-cadherin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> is an <strong>adhesion molecule</strong> commonly found in <strong>epithelial tissues</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Its <strong>downregulation</strong> is associated with <strong>Epithelial-Mesenchymal Transition (EMT)</strong>, a process in which <strong>epithelial cells</strong> acquire characteristics that enable them to detach from <strong>primary tumors</strong> and <strong>invade surrounding tissues</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is a <strong>crucial step</strong> in <strong>cancer metastasis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement B:</span></strong><span style=\"font-size:14.0pt\"> <strong>Integrins play a crucial role in mediating the attachment of circulating tumor cells to endothelial cells in distant organs, facilitating metastatic spread.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Integrins are a family of <strong>cell adhesion receptors</strong> that facilitate <strong>cell-cell</strong> and <strong>cell-matrix interactions</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In cancer metastasis, <strong>integrins</strong> on the <strong>surface</strong> of <strong>circulating tumor cells</strong> can bind to <strong>adhesion molecules</strong> on <strong>endothelial cells</strong> within distant organs, aiding the <strong>attachment</strong> and <strong>extravasation</strong> of <strong>tumor cells</strong> during <strong>metastatic spread</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question assesses the understanding of the <strong>roles of adhesion molecules</strong>, specifically <strong>E-cadherin</strong> and <strong>integrins</strong>, in <strong>cancer metastasis</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It highlights the importance of these molecules in <strong>tumor invasion</strong> and <strong>distant organ colonization</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Extra-edge</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">There are four broad families of cell adhesion molecules:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Integrins</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: <strong>Heterodimers</strong> &ndash; <strong>mediate</strong> the interactions <strong>between</strong> the <strong>extracellular matrix</strong> and the <strong>cytoskeletal framework</strong> of the cells.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cadherins</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: depend on <strong>calcium ions</strong> &ndash; involved in the <strong>formation </strong>of <strong>adherens junctions</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ig superfamily</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: include <strong>vascular (VCAM)</strong> and <strong>neural cell adhesion molecules (NCAM)</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Selectins</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: with <strong>lectin-like domains</strong> <strong>binding carbohydrates</strong> &ndash; involved in <strong>inflammation</strong> and <strong>immune reactions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-164623.JPG\" style=\"height:244px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ref: Ganong&rsquo;s Review of Medical physiology, 25<sup>th</sup> edition, page no. 40</span></strong></span></span></p>",
      "correct_choice_id": 153013,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38556,
      "choices": [
        {
          "id": 153967,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eumycetoma is caused by bacteria.</span></span></span></p>"
        },
        {
          "id": 153968,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Surgery is an important component of treatment.</span></span></span></p>"
        },
        {
          "id": 153969,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The condition is usually painless.</span></span></span></p>"
        },
        {
          "id": 153970,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diagnosis can be made by examination of the lesion.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old farmer from a tropical region presents to the clinic with a chronic, swollen foot with multiple draining sinuses. The sinuses are exuding grains of black material. The patient reports that the foot has been slowly enlarging over several years. The medical team suspects mycetoma based on the clinical presentation. In discussing the case, various statements are made about mycetoma. Which of the following statements is INCORRECT regarding this patient&#39;s most likely diagnosis of mycetoma?</span></span></span></span></p>",
      "unique_key": "Q6806880",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736128,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A)</span></strong><strong><span style=\"font-size:14.0pt\"> Eumycetoma is caused by bacteria.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The incorrect statement is that eumycetoma is caused by bacteria. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eumycetoma, also known as &quot;<strong>fungal mycetoma</strong>,&quot; is caused by fungi, not bacteria. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The term &quot;mycetoma&quot; refers to a chronic granulomatous infection of the skin and subcutaneous tissues, which can be caused by various species of fungi (eumycetoma) or bacteria (actinomycetoma).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Surgery is an important component of treatment</span></strong><span style=\"font-size:14.0pt\">. This is a correct statement. Surgery can be an essential part of treatment for mycetoma, particularly in advanced cases or when there is a need to remove diseased tissue to reduce the load of infection and improve the efficacy of medical therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The condition is usually painless</span></strong><span style=\"font-size:14.0pt\">. This is a correct statement. Mycetoma often progresses slowly and is usually painless, which can delay the patient seeking medical attention, leading to more extensive disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Diagnosis can be made by examination of the lesion</span></strong><span style=\"font-size:14.0pt\">. This is a correct statement. Clinical examination of the characteristic lesions, especially when grains are present in the discharge, is important for diagnosis. Further confirmation can be obtained through histopathological examination and culture of the grains.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-115930.JPG\" style=\"height:694px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Difference between Eumycetoma and Actinomycetoma:</span></strong></span></span></p>",
      "correct_choice_id": 153967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38312,
      "choices": [
        {
          "id": 153007,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ophthalmic nerve (V1)</span></span></span></p>"
        },
        {
          "id": 153008,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Maxillary nerve (V2)</span></span></span></p>"
        },
        {
          "id": 153009,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Mandibular nerve (V3)</span></span></span></p>"
        },
        {
          "id": 153010,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Facial nerve (VII)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 33-year-old male presents to the clinic with numbness and tingling in the upper cheek, upper lip, and upper gingiva. He reports that the symptoms started a few days after a traumatic injury to the face. Physical examination reveals decreased sensation in the aforementioned areas. The physician suspects an injury to a specific branch of the trigeminal nerve given the distribution of the sensory loss. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Which of the following nerves is most likely involved in this patient&#39;s symptoms?</span></span></span></p>",
      "unique_key": "Q5337408",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714983,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Maxillary nerve (V2)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Maxillary nerve (V2) is the second branch of the trigeminal nerve (cranial nerve V) and is primarily responsible for providing sensory innervation to the middle third of the face. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This includes the upper cheek, upper lip, lower eyelids, and upper gingiva, as well as the maxillary sinuses and the nasopharynx. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The symptoms described by the patient, such as numbness and tingling in the upper cheek, upper lip, and upper gingiva, are consistent with an injury to the maxillary nerve, likely as a result of the traumatic facial injury.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Ophthalmic nerve (V1).</span></strong><span style=\"font-size:14.0pt\"> The ophthalmic nerve provides sensory innervation to the upper third of the face, including the forehead, scalp, and upper eyelid. It does not innervate the areas described by the patient&#39;s symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mandibular nerve (V3).</span></strong><span style=\"font-size:14.0pt\"> The mandibular nerve provides motor innervation to the muscles of mastication and sensory innervation to the lower third of the face, including the lower lip, lower gingiva, and chin. The distribution does not match the patient&#39;s symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Facial nerve (VII).</span></strong><span style=\"font-size:14.0pt\"> The facial nerve primarily provides motor innervation to the muscles of facial expression, taste sensation to the anterior two-thirds of the tongue, and some parasympathetic functions. It does not provide general sensory innervation to the face, thus not matching the patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective of this question is to understand the sensory innervation of the face provided by the branches of the trigeminal nerve, with a focus on the maxillary nerve (V2). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing the distribution of sensory innervation is crucial for localizing nerve injuries based on clinical presentations and for guiding appropriate diagnostic and therapeutic interventions. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This knowledge is essential for the differential diagnosis of facial sensory loss and for planning surgical or other interventions in the region of the face.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38565,
      "choices": [
        {
          "id": 154003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neutrophil</span></span></span></p>"
        },
        {
          "id": 154004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Macrophage</span></span></span></p>"
        },
        {
          "id": 154005,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lymphocyte</span></span></span></p>"
        },
        {
          "id": 154006,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Antibody</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a clinical immunology seminar focusing on the mechanisms of autoimmune diseases, a group of medical students presents a case study of a 45-year-old woman diagnosed with rheumatoid arthritis (RA). They detail her symptoms, including joint pain, stiffness, and swelling, and discuss the laboratory findings, including elevated inflammatory markers and the presence of specific autoantibodies. As part of their presentation, they explore the immune system components implicated in the pathogenesis of RA. Based on current understanding of RA&#39;s immunopathology, which of the following immune components is least involved in the initiation and progression of rheumatoid arthritis?</span></span></span></p>",
      "unique_key": "Q5237064",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736361,
      "difficulty_level": "difficult",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A)</span></strong><strong><span style=\"font-size:14.0pt\"> Neutrophil</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the context of rheumatoid arthritis, neutrophils are present in the inflamed synovial fluid and contribute to the inflammatory milieu; however, they are not considered central to the disease&#39;s initiation and progression. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RA is primarily driven by an autoimmune process involving lymphocytes (B cells and T cells), which leads to the production of autoantibodies (such as rheumatoid factor and anti-citrullinated protein antibodies), and macrophages, which secrete pro-inflammatory cytokines.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Macrophage</span></strong><span style=\"font-size:14.0pt\">. Macrophages are key players in RA, involved in the secretion of pro-inflammatory cytokines that contribute to joint inflammation and damage.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Lymphocyte</span></strong><span style=\"font-size:14.0pt\">. Lymphocytes, including both T cells and B cells, are central to the autoimmune response in RA, with T cells helping to activate B cells, which in turn produce autoantibodies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Antibody</span></strong><span style=\"font-size:14.0pt\">. Autoantibodies, such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA), are hallmark features of RA and play a significant role in its pathogenesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Bottom of Form</span></strong><strong><span style=\"font-size:14.0pt\">Rheumatoid arthritis (RA):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Group of auto-antibodies against the host IgG antibodies are produced called RA factor.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is an IgM antibody directed against the Fc region of IgG.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Women (40&ndash;60 years of age) affected.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Autoantibodies bind to circulating IgG, forming IgM-IgG complexes that are deposited in the joints and can activate the complement cascade.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Major symptoms:</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Main feature</span></strong><span style=\"font-size:14.0pt\">: Arthritis (chronic inflammation of the joints, begins at synovium; most common joints involved are-small joints of the hands, feet and cervical spine)</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other features</span></strong><span style=\"font-size:14.0pt\">: Hematologic, cardiovascular, and respiratory systems are also frequently affected</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 154003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38707,
      "choices": [
        {
          "id": 154571,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Total capacity</span></span></span></p>"
        },
        {
          "id": 154572,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Forced Expiratory Volume in 1 second (FEV1)</span></span></span></p>"
        },
        {
          "id": 154573,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Forced Vital Capacity (FVC)</span></span></span></p>"
        },
        {
          "id": 154574,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Flow-volume loop</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Which of the following parameters cannot be obtained by using the following instrument?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-121538.JPG\" style=\"height:297px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5750994",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755233,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Total capacity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The instrument shown in the image is a <strong>spirometer</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is used to measure various parameters of lung function, most notably those involving the movement of air in and out of the lungs under specific conditions and time constraints. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Total lung capacity (TLC) cannot be measured directly by a spirometer because it includes the residual volume (RV), which is the amount of air remaining in the lungs after a full, forceful exhalation and cannot be measured by forced expiration. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To measure TLC, additional techniques such as body plethysmography or gas dilution are required.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>FEV1.</strong> Forced Expiratory Volume in 1 second can be measured by a spirometer. It reflects the volume of air that can be forcefully blown out in one second, after full inspiration, and is a critical measure for assessing conditions like asthma and COPD.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>FVC.</strong> Forced Vital Capacity can be measured by a spirometer and represents the total volume of air that can be forcefully exhaled after full inspiration. It is used to evaluate lung function and to identify obstructive versus restrictive lung disease patterns.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Flow-volume loop.</strong> This graphical representation depicts the rate of airflow (on the y-axis) versus the total volume of air exhaled (on the x-axis) during a forceful respiratory maneuver. Spirometers are capable of generating flow-volume loops, which help in the diagnosis and assessment of lung diseases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The spirometry can measure dynamic lung volumes and capacities such as FEV1, FVC, and provide a flow-volume loop, which are essential for the diagnosis and management of respiratory diseases. </span></span></li>\r\n</ul>",
      "correct_choice_id": 154571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38320,
      "choices": [
        {
          "id": 153039,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased Phosphate Levels</span></span></span></p>"
        },
        {
          "id": 153040,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Raised Calcitonin Levels</span></span></span></p>"
        },
        {
          "id": 153041,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased Parathyroid Hormone Secretion</span></span></span></p>"
        },
        {
          "id": 153042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Activation of 24&ndash;25 dihydroxycholecalciferol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 54-year-old female patient presents to her primary care physician for a routine check-up. She has no significant medical history but mentions that she has been following a diet low in calcium for several months due to personal preferences. Concerned about the potential effects of prolonged low calcium intake on her bone health and calcium metabolism, the physician decides to order a series of laboratory tests. Based on the patient&#39;s dietary history and the body&#39;s physiological response to low calcium levels, which of the following laboratory findings would be most expected in this patient?</span></span></span></p>",
      "unique_key": "Q8974751",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715351,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Increased Parathyroid Hormone Secretion</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In response to low dietary calcium intake, the body increases the secretion of parathyroid hormone (PTH) to maintain normal serum calcium levels. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">PTH acts to increased calcium levels by stimulating bone resorption (releasing calcium into the bloodstream), increasing renal reabsorption of calcium, and enhancing the conversion of 25-hydroxyvitamin D to its active form, 1, 25-dihydroxyvitamin D (calcitriol), in the kidneys. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Calcitriol then acts to increase dietary calcium absorption from the intestine. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Therefore, in the setting of prolonged low calcium intake, one would expect to find increased PTH secretion as the body attempts to compensate for the reduced dietary calcium.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Increased Phosphate Levels.</span></strong><span style=\"font-size:14.0pt\"> This option is incorrect because increased PTH secretion typically leads to decreased phosphate reabsorption in the kidneys, resulting in lower serum phosphate levels.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Raised Calcitonin Levels.</span></strong><span style=\"font-size:14.0pt\"> Calcitonin is a hormone that lowers blood calcium levels, but its role in day-to-day calcium homeostasis is less significant than PTH and calcitriol. It is not typically raised in response to low dietary calcium intake.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Activation of 24&ndash;25 dihydroxycholecalciferol.</span></strong><span style=\"font-size:14.0pt\"> This is incorrect because the active form of vitamin D relevant to calcium homeostasis is 1, 25-dihydroxycholecalciferol (calcitriol), not 24&ndash;25 dihydroxycholecalciferol. Increased PTH secretion would lead to increased activation of calcitriol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The educational objective is to understand the body&#39;s physiological response to low dietary calcium intake, emphasizing the central role of parathyroid hormone in maintaining calcium homeostasis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased PTH secretion in response to low calcium intake highlights the interconnectedness of bone resorption, renal calcium reabsorption, and vitamin D activation in managing serum calcium levels.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153041,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38306,
      "choices": [
        {
          "id": 152983,
          "text": "<p><span style=\"font-size:14.0pt;\">Fracture of scaphoid has a low incidence of non-union</span></p>"
        },
        {
          "id": 152984,
          "text": "<p><span style=\"font-size:14.0pt;\">Scaphoid bone articulates with five bones totally</span></p>"
        },
        {
          "id": 152985,
          "text": "<p><span style=\"font-size:14.0pt;\">Scaphoid bone can be easily immobilized</span></p>"
        },
        {
          "id": 152986,
          "text": "<p><span style=\"font-size:14.0pt;\">Fracture line on the scaphoid bone may deprive the distal fragment of its arterial supply</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A&nbsp; 22-year-old male was referred to the emergency room after a fall from height on an outstretched left wrist. Pain and tenderness were noticed in the region of the anatomical snuff box of her left hand. X-ray showed fracture of scaphoid bone. Identify the correct statement.</span></p>",
      "unique_key": "Q6285778",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714637,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Ans. B) Scaphoid bone articulates with five bones totally</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Scaphoid bone articulates with <strong>Radius</strong> (<strong>proximally</strong>), <strong>Trapezium</strong> &amp; <strong>Trapezoid</strong> (<strong>distally</strong>), <strong>Lunate</strong> and <strong>Head of Capitate</strong> (<strong>medially</strong>).</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-161321.JPG\" alt=\"\" width=\"400\" height=\"392\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option A. Fracture of scaphoid has a low incidence of non-union.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Scaphoid fractures</strong> actually have a <strong>relatively high incidence</strong> of <strong>non-union</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">This is due to the <strong>peculiar blood supply</strong> of the <strong>scaphoid</strong>, where the <strong>blood</strong> enters the <strong>bone distally</strong> and <strong>travels proximally</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-161332.JPG\" alt=\"\" width=\"400\" height=\"350\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">In case of a <strong>fracture</strong>, especially in the <strong>proximal part</strong>, this can lead to <strong>avascular necrosis</strong> and <strong>non-union</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Common sites of avascular necrosis:</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-161405.JPG\" alt=\"\" width=\"1000\" height=\"415\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Scaphoid bone can be easily immobilized.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Immobilization</strong> of the <strong>scaphoid bone</strong> can be <strong>challenging </strong>due to its <strong>location</strong> and the <strong>range of movements</strong> in the <strong>wrist</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Proper healing</strong> often requires a <strong>specific type of cast</strong> or <strong>splint</strong> known as <strong>GLASS HOLDING CAST</strong> that <strong>immobilizes not just the wrist</strong> but also the <strong>thumb</strong>, as movement of the thumb can <strong>disturb the scaphoid</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-161415.JPG\" alt=\"\" width=\"300\" height=\"144\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Fracture line on the scaphoid bone may deprive the distal fragment of its arterial supply.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">In scaphoid fractures, it is typically the <strong>proximal fragment</strong> that is at <strong>risk</strong> of <strong>losing</strong> its <strong>blood supply</strong>, not the distal fragment.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">This is because the <strong>blood supply</strong> to the <strong>scaphoid</strong> enters <strong>distally</strong> and <strong>travels proximally</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">If there is a fracture, &nbsp;dividing the bone into proximal and distal fragments, it can <strong>compromise</strong> the <strong>blood flow</strong> to the <strong>proximal fragment</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Scaphoid Bone Articulates with Five Bones Totally</strong>: The scaphoid bone, <strong>one</strong> of the <strong>carpal bones</strong> in the <strong>wrist</strong>, articulates with <strong>five other bones</strong>: the radius proximally; the trapezium distally on the thumb side; and the lunate, capitate, and trapezoid on its ulnar side.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Ref: Grays Anatomy, 41<sup>st</sup> edition, page no. 868</strong></span></p>",
      "correct_choice_id": 152984,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38406,
      "choices": [
        {
          "id": 153379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Blood clots in the endometrial cavity</span></span></span></p>"
        },
        {
          "id": 153380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Heteroechoic contents seen in the uterine cavity</span></span></span></p>"
        },
        {
          "id": 153381,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Normal endometrial lining</span></span></span></p>"
        },
        {
          "id": 153382,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The gestational sac seen low down in the uterine cavity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 25-year-old woman with a history of two previous live births presents with symptoms suggestive of a complete abortion. She reports having experienced heavy bleeding, cramping, and the passage of tissue. To evaluate her current status and ensure that the abortion was complete, an ultrasound is performed. Which of the following findings would most likely be expected on ultrasound in the case of a complete abortion?</span></span></span></p>",
      "unique_key": "Q9796825",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718498,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Normal endometrial lining</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In the case of a complete abortion, the expected ultrasound finding would be a normal endometrial lining, indicating that all products of conception have been expelled from the uterus. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The absence of any retained tissue or abnormal masses suggests that the abortion process has concluded, and the uterus is returning to its pre-pregnancy state.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Blood clots in the endometrial cavity</span></strong><span style=\"font-size:14.0pt\">. While blood clots may be present during or immediately after an abortion, their presence on an ultrasound following the resolution of symptoms might suggest retained products of conception rather than a complete abortion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Heteroechoic contents seen in the uterine cavity</span></strong><span style=\"font-size:14.0pt\">. Heteroechoic (mixed echogenicity) contents in the uterine cavity may indicate retained products of conception or other material that has not been expelled, inconsistent with a complete abortion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. The gestational sac seen low down in the uterine cavity</span></strong><span style=\"font-size:14.0pt\">. The presence of a gestational sac, especially low in the uterine cavity, might suggest an incomplete abortion or an ongoing pregnancy, rather than a complete abortion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question assesses the understanding of ultrasound findings in the context of a complete abortion. Recognizing a normal endometrial lining as an indication of a complete abortion is crucial for the management of patients presenting with symptoms of abortion. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identifying the presence of blood clots, heteroechoic contents, or a gestational sac would suggest incomplete abortion and potentially necessitate further medical intervention.</span></span></li>\r\n</ul>",
      "correct_choice_id": 153381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38346,
      "choices": [
        {
          "id": 153143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Amantadine</span></span></span></p>"
        },
        {
          "id": 153144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Rotigotine</span></span></span></p>"
        },
        {
          "id": 153145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Tolcapone</span></span></span></p>"
        },
        {
          "id": 153146,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Selegiline</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 62-year-old man with a 5-year history of Parkinson&#39;s disease is seen in the clinic for a follow-up visit. He has been on levodopa/carbidopa therapy but reports increasing periods of immobility. His neurologist is considering adding another medication to help reduce these off periods. Which of the following medications, working by inhibiting the enzyme catechol-O-methyltransferase, would be most appropriate to add to this patient&#39;s regimen?</span></span></span></p>",
      "unique_key": "Q6943572",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716086,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Tolcapone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tolcapone is a medication used in the management of Parkinson&#39;s disease as an adjunct to levodopa/carbidopa therapy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works by inhibiting the enzyme catechol-O-methyltransferase (COMT), which metabolizes levodopa in the periphery, thereby increasing the availability of levodopa in the brain and prolonging its effects. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This can be particularly beneficial in reducing &quot;off&quot; periods in patients with advancing Parkinson&#39;s disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Amantadine.</strong> This drug is an antiviral that also has anti-Parkinsonian properties. It is thought to work by releasing dopamine from existing stores in the nerve terminals and possibly by blocking the reuptake of dopamine into the nerve endings. It does not inhibit catechol-O-methyltransferase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Rotigotine.</strong> Rotigotine is a dopamine agonist that mimics the action of dopamine in the brain. It is used in the treatment of Parkinson&#39;s disease and is administered via a transdermal patch. It does not act by inhibiting catechol-O-methyltransferase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Selegiline.</strong> Selegiline is a selective monoamine oxidase B (MAO-B) inhibitor used in the treatment of Parkinson&#39;s disease. It helps to increase and extend the effects of levodopa by inhibiting the breakdown of dopamine in the brain. It does not inhibit catechol-O-methyltransferase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The key educational objective is to understand the pharmacological management of Parkinson&#39;s disease, particularly the role of tolcapone. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor used to increase the bioavailability of levodopa in the brain, thereby reducing &quot;off&quot; periods in patients with Parkinson&#39;s disease. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is important to differentiate between the mechanisms of action of various drugs used in Parkinson&#39;s disease treatment, such as COMT inhibitors (like tolcapone), MAO-B inhibitors (like selegiline), dopamine agonists (like rotigotine), and others (like amantadine).<strong> </strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153145,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38604,
      "choices": [
        {
          "id": 154159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CONSORT &ndash; Randomized Controlled Trials</span></span></span></p>"
        },
        {
          "id": 154160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MOOSE &ndash; Meta-analysis of Observational Studies</span></span></span></p>"
        },
        {
          "id": 154161,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CARE &ndash; Randomized Controlled Trials</span></span></span></p>"
        },
        {
          "id": 154162,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PRISMA &ndash; Systematic Review and Meta-analysis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the realm of academic research, specific guidelines are established to standardize the reporting of various types of studies, ensuring clarity, transparency, and reproducibility. Each set of guidelines is tailored to a particular study design, ranging from randomized controlled trials to case reports. Given the following options, identify which pair incorrectly matches a set of guidelines with the corresponding study design.</span></span></p>",
      "unique_key": "Q1042976",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739663,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) CARE &ndash; Randomized Controlled Trials</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The CARE (Case Reports) guidelines are specifically designed for the reporting of case reports, not Randomized Controlled Trials (RCTs). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They aim to standardize the reporting of clinical cases to improve the quality of published case reports and ensure valuable information is not omitted.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. CONSORT&ndash; Randomized Controlled Trials</span></strong><span style=\"font-size:14.0pt\">. Correctly matched, as it provides a checklist and flow diagram for reporting Randomized Controlled Trials.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. MOOSE&ndash; Meta-analysis of Observational Studies</span></strong><span style=\"font-size:14.0pt\">. Appropriately matched with the Meta-analysis of Observational Studies, offering a comprehensive checklist for reporting these types of studies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. PRISMA&ndash; Systematic Review and Meta-analysis</span></strong><span style=\"font-size:14.0pt\">. Correctly paired with Systematic Review and Meta-analysis, offering guidance for reporting systematic reviews, particularly those that assess the benefits and harms of healthcare interventions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CONSORT for RCTs, MOOSE for observational study meta-analyses, CARE for case reports, and PRISMA for systematic reviews and meta-analysis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38816,
      "choices": [
        {
          "id": 155003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">A mixed-device bomb</span></span></span></p>"
        },
        {
          "id": 155004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">A simple petrol bomb thrown by hand</span></span></span></p>"
        },
        {
          "id": 155005,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">Named after the Molotov, a foreign minister of Russia, who died after consuming a cocktail</span></span></span></p>"
        },
        {
          "id": 155006,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">A type of tank</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">A forensic expert is lecturing at a medical college on the types of injuries commonly seen in victims of civil unrest. One topic of discussion is the &quot;Molotov cocktail,&quot; a term that appears in both medical and legal investigations involving improvised incendiary devices. Based on the forensic context, how is a &quot;Molotov cocktail&quot; best characterized?</span></span></span></p>",
      "unique_key": "Q9599956",
      "question_audio": null,
      "question_video": null,
      "map_id": 3775902,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) A simple petrol bomb thrown by hand</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">In this scenario, the explosive device used is a Molotov cocktail, which is a simple petrol bomb typically thrown by hand. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">It consists of a glass bottle filled with a flammable liquid, usually petrol/gasoline, and a cloth wick that is lit before throwing. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\">Its use is associated with irregular warfare or civil unrest situations.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\">Note</span></strong><span style=\"font-size:14.0pt\">: Incendiary bombs, e.g. napalm bombs primarily cause burns. Usually, phosphorus and magnesium are added. Temperature of 1000C is produced.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. A mixed device bomb</span></strong><span style=\"font-size:14.0pt\">. Incorrect. A &quot;Molotov cocktail&quot; is not a bomb in the traditional sense but rather an improvised incendiary device.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Named after the Molotov, a foreign minister of Russia, who died after consuming a cocktail</span></strong><span style=\"font-size:14.0pt\">. Molotov, foreign minister of Russia, died after having the cocktail: Incorrect. The term &quot;Molotov cocktail&quot; does not refer to an actual cocktail or the manner of death of Molotov, a Soviet politician. The name is derived from Vyacheslav Molotov, a Soviet foreign minister, but it&#39;s used symbolically for the device.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. A type of tank</span></strong><span style=\"font-size:14.0pt\">. Incorrect. A &quot;Molotov cocktail&quot; has no relation to tanks or armored vehicles.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Aptos&quot;,sans-serif\">&ldquo;Molotov cocktail&quot; is a simple hand-thrown petrol bomb used as an improvised incendiary weapon, distinct from conventional bombs or other military equipment.</span></span></p>",
      "correct_choice_id": 155004,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38738,
      "choices": [
        {
          "id": 154695,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duhamel surgery</span></span></span></span></p>"
        },
        {
          "id": 154696,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kasai procedure</span></span></span></span></p>"
        },
        {
          "id": 154697,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kimura surgery</span></span></span></span></p>"
        },
        {
          "id": 154698,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conservative management</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 1-month old baby boy presents with progressive, persistent jaundice after birth. The baby is breastfed exclusively and has been feeding well. On examination, there is yellowish discoloration of skin, mildly distended abdomen, and hepatomegaly. Technetium-99m iminodiacetic acid scan shows radionuclide that is concentrated in the liver but not excreted into the intestine. What is the treatment of choice in this patient?</span></span></p>",
      "unique_key": "Q2444851",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Kasai procedure</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The condition mentioned above is Biliary atresia.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Japanese and Anglo-Saxon classification describes <strong>three main types</strong> (Kasai):</span></span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: atresia restricted to the CBD</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: atresia of the common hepatic duct </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IIa</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: a patent gallbladder and a patent CBD are present</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IIb</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: the gallbladder, cystic duct and CBD are also obliterated</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type III</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: atresia of the right and left hepatic ducts and the entire extrahepatic biliary tree</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">About one-third of patients are jaundiced at birth; in all affected babies, jaundice is present by the end of the first week and deepens progressively. </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The meconium may be a little bile-stained, but later the stools are pale and the urine is dark. </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pruritus is severe. </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clubbing and skin xanthomas, probably related to raised serum cholesterol, may be present</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associations</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polysplenia, situs inversus, absent vena cava and preduodenal portal vein</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fasting USG is the gold standard when biliary atresia is suspected. </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A shrunken gallbladder, a hyperechogenic liver hilum (&lsquo;triangular cord sign&lsquo;) or a cyst at the liver hilum without bile duct dilatation with associated anomalies support the diagnosis. </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatobiliary scintigraphy may reveal the diagnosis but <strong>MRCP is highly sensitive and specific in the diagnosis.</strong> </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory cells, a fibrotic liver parenchyma exhibiting signs of cholestasis and biliary neoductal structures establishes <strong>the definite diagnosis on liver biopsy.</strong></span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Kasai hepatico-portoenterostomy</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the majority of cases in which the proximal hepatic ducts are either very small (type II) or atretic (type III) are treated by the Kasai procedure, in which radical excision of all bile duct tissue up to the liver capsule is performed. </span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Roux-en-Y loop of jejunum is anastomosed to the exposed area of liver capsule above the bifurcation of the portal vein, creating a portoenterostomy.</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I lesions</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A direct Roux-en-Y hepaticojejunostomy</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The treatment of choice in Biliary atresia is Kasai procedure.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Bailey and Love&rsquo;s short practice of surgery, 28<sup>th</sup> edition, page no. 1240-41</span></span></strong></span></span></p>",
      "correct_choice_id": 154696,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38358,
      "choices": [
        {
          "id": 153187,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Avelumab</span></span></span></p>"
        },
        {
          "id": 153188,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Atezolizumab</span></span></span></p>"
        },
        {
          "id": 153189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Cetuximab</span></span></span></p>"
        },
        {
          "id": 153190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Durvalumab</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 62-year-old woman with a history of smoking is diagnosed with advanced non-small cell lung cancer (NSCLC). Her tumor testing shows high PD-L1 expression without any EGFR or ALK mutations. You discuss treatment options with her, focusing on targeted immunotherapy that can enhance her immune system&#39;s ability to fight cancer. You consider prescribing a PD-L1 inhibitor, which blocks the interaction between PD-1 on T cells and PD-L1 on tumor cells, thereby preventing the inhibition of the immune response against the tumor. All of the following medications are PD-L1 inhibitors used in the treatment of various cancers, including NSCLC, except:</span></span></span></p>",
      "unique_key": "Q5608217",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716530,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Cetuximab</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on the surface of cancer cells, not PD-L1. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is used in the treatment of certain types of colorectal cancer and head and neck cancer. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cetuximab works by inhibiting the EGFR pathway, which is involved in cell growth and survival, thereby inhibiting the growth of cancer cells.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Avelumab</span></strong><span style=\"font-size:14.0pt\"> is a PD-L1 inhibitor that binds to PD-L1 and blocks its interaction with PD-1, enabling the immune system to recognize and attack tumor cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Atezolizumab</span></strong><span style=\"font-size:14.0pt\"> is another PD-L1 inhibitor used in the treatment of various cancers, including NSCLC, by preventing PD-L1 from binding to PD-1 and B7.1 on the surface of T cells and antigen-presenting cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Durvalumab</span></strong><span style=\"font-size:14.0pt\"> is a PD-L1 inhibitor that works similarly to avelumab and atezolizumab by blocking the interaction of PD-L1 with PD-1, enhancing the immune system&#39;s ability to attack tumor cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the mechanism of action of different immunotherapeutic agents used in cancer treatment, particularly PD-L1 inhibitors versus EGFR inhibitors. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of targeted therapy in oncology, based on specific molecular markers, and the need for precision medicine in the management of cancer.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38388,
      "choices": [
        {
          "id": 153307,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Basal Cell Carcinoma is the most common Skin Malignancy</span></span></span></span></p>"
        },
        {
          "id": 153308,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous Cell Carcinoma occurs in Sun Exposed and also over Sun protected sites including Mucosae</span></span></span></span></p>"
        },
        {
          "id": 153309,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous Cell Carcinoma is Most Common in Transplant Recipients</span></span></span></span></p>"
        },
        {
          "id": 153310,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous Cell Carcinoma has Pearly Rolled Edges</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the FALSE statement among the following options.</span></span></span></span></p>",
      "unique_key": "Q7519983",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717454,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Squamous Cell Carcinoma has Pearly Rolled Edges</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The description of &quot;<strong>pearly rolled edges</strong>&quot; typically refers to <strong>Basal Cell Carcinoma</strong>, not Squamous Cell Carcinoma. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SCC often presents as a <strong>scaly </strong>or<strong> crusted lesion</strong> with a potential for <strong>ulceration</strong>, rather than with the <strong>pearly appearance</strong> associated with BCC.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Basal Cell Carcinoma is the most common skin malignancy</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Basal Cell Carcinoma (BCC) is indeed the <strong>most common form</strong> of <strong>skin</strong> <strong>cancer</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Squamous Cell Carcinoma occurs in sun exposed and also over sun protected sites including mucosae</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous Cell Carcinoma (SCC) can occur on <strong>sun-exposed skin</strong>, such as the <strong>head</strong>, <strong>neck</strong>, and <strong>arms</strong>, as well as in <strong>sun-protected</strong> <strong>areas</strong> and <strong>mucosal surfaces</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Squamous Cell Carcinoma is Most common in Transplant recipients</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. SCC is more common in transplant <strong>recipients</strong> due to <strong>immunosuppression</strong>, which <strong>increases</strong> the <strong>risk</strong> of <strong>various skin cancers</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The edges of a lesion can provide critical diagnostic clues; in the case of <strong>Basal Cell Carcinoma, &quot;pearly rolled edges</strong>&quot; are characteristic, whereas Squamous Cell Carcinoma typically does not present with such a feature.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Rooks&rsquo; Textbook of Dermatology, 9<sup>th</sup> Edition, Page No. 141.8, 142.25</span></span></strong></p>",
      "correct_choice_id": 153310,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38321,
      "choices": [
        {
          "id": 153043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">S Cells</span></span></span></p>"
        },
        {
          "id": 153044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">H Cells</span></span></span></p>"
        },
        {
          "id": 153045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Peptic Cells</span></span></span></p>"
        },
        {
          "id": 153046,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">G Cells</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In a 57-year-old patient with chronic acid reflux and peptic ulcer symptoms, which type of gastric mucosal cells is primarily responsible for secreting a substance that stimulates the production of hydrochloric acid in the stomach, potentially contributing to the patient&#39;s digestive issues?</span></span></span></p>",
      "unique_key": "Q8528181",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715352,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. D) G Cells</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">G cells, located in the <strong>stomach lining</strong>, <strong>secrete gastrin</strong>, which <strong>stimulates</strong> the <strong>production</strong> of <strong>hydrochloric acid</strong> by <strong>parietal cells.</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Different cells secreting hormones are:</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-164726.JPG\" style=\"height:567px; width:497px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. </span></strong><strong><span style=\"font-size:14.0pt\">S cells</span></strong><span style=\"font-size:14.0pt\">, located in the <strong>intestine</strong>, <strong>secrete secretin</strong>, which <strong>regulates water homeostasis</strong> in the <strong>body</strong>, not hydrochloric acid secretion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. </span></strong><strong><span style=\"font-size:14.0pt\">H cells</span></strong><span style=\"font-size:14.0pt\"> are not a recognized cell type involved in the <strong>regulation</strong> of <strong>gastric secretions</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. </span></strong><strong><span style=\"font-size:14.0pt\">Peptic cells</span></strong><span style=\"font-size:14.0pt\">, or <strong>chief cells</strong>, are primarily <strong>responsible</strong> for <strong>secreting pepsinogen</strong>, an <strong>enzyme precursor</strong>, not a stimulant for hydrochloric acid.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understand that <strong>G cells</strong> in the <strong>stomach lining</strong> secrete <strong>gastrin</strong>, a hormone that stimulates the <strong>production</strong> of <strong>hydrochloric acid</strong>, playing a <strong>crucial role</strong> in <strong>digestive processes</strong> and contributing to conditions like <strong>acid reflux</strong> and <strong>peptic ulcers</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ganong&rsquo;s Review of Medical physiology, 25<sup>th</sup> edition, page no. 468, 471</span></span></strong></p>",
      "correct_choice_id": 153046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38447,
      "choices": [
        {
          "id": 153539,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Leakage of fluid into the peritoneal cavity leading to peritonitis</span></span></span></p>"
        },
        {
          "id": 153540,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluid wetting the surgeon</span></span></span></span></p>"
        },
        {
          "id": 153541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fluids running out during the procedure</span></span></span></p>"
        },
        {
          "id": 153542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Electrolyte imbalance in the patient</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a hysteroscopy, a surgeon is performing a diagnostic evaluation on a 35-year-old woman for abnormal uterine bleeding. The procedure involves the introduction of fluid into the uterine cavity to expand it and improve visibility. The surgeon is mindful of the volume and type of fluid used, as well as the patient&#39;s fluid balance. Understanding the significance of fluid management during this procedure, which of the following is the most critical reason for careful fluid monitoring during hysteroscopy?</span></span></span></p>",
      "unique_key": "Q2470760",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719878,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Electrolyte imbalance in the patient</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The most critical reason for careful fluid management during hysteroscopy is to prevent electrolyte imbalance in the patient. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">During hysteroscopy, fluid is used to distend the uterine cavity, which can sometimes be absorbed into the patient&#39;s bloodstream. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This can lead to a condition known as <strong>fluid overload</strong> or, depending on the type of fluid used, specific imbalances like hyponatremia if hypotonic solutions are absorbed in significant quantities. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Managing the volume and type of fluid used is crucial to prevent these potentially serious complications.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Leakage of fluid into the peritoneal cavity leading to peritonitis</span></strong><span style=\"font-size:14.0pt\">. While fluid can inadvertently enter the peritoneal cavity during procedures, it typically does not lead to peritonitis unless the fluid is contaminated, which is a rare occurrence with proper sterile techniques.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Fluid from wetting the surgeon</span></strong><span style=\"font-size:14.0pt\">. While maintaining a dry surgical field is important for the comfort of the surgical team and the integrity of the procedure, it is not the most critical reason for fluid management during hysteroscopy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Fluids running out during the procedure</span></strong><span style=\"font-size:14.0pt\">. Preventing fluid loss is important for maintaining visibility and distension of the uterine cavity during hysteroscopy, but it is not as critical as preventing electrolyte imbalances in the patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The primary objective of careful fluid management during hysteroscopy is to prevent electrolyte imbalances in the patient, such as hyponatremia, which can occur due to the absorption of irrigation fluids into the bloodstream. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding the implications of fluid absorption and the potential for fluid overload is essential for the safe conduct of hysteroscopic procedures.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153542,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38619,
      "choices": [
        {
          "id": 154219,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Optic disc pit </span></span></span></p>"
        },
        {
          "id": 154220,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Posterior staphyloma </span></span></span></p>"
        },
        {
          "id": 154221,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Morning glory syndrome </span></span></span></p>"
        },
        {
          "id": 154222,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Advanced glaucomatous cupping </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Identify the abnormality. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-163432.JPG\" style=\"height:295px; width:300px\" /></p>",
      "unique_key": "Q9606409",
      "question_audio": null,
      "question_video": null,
      "map_id": 3740198,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Morning glory syndrome </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">The given image shows:</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>large disc</strong> with a <strong>funnel-shaped excavation</strong> <strong>surrounded</strong> by a <strong>ring-shaped chorioretinal disturbance</strong>. </span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Blood vessels emerge from the rim of excavation radially</span></strong><span style=\"font-size:14.0pt\">, like <strong>spokes</strong> of a <strong>wheel</strong>. </span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Veins and arteries are difficult to distinguish. </span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Persistent hyaloid vascular remnants</span></strong><span style=\"font-size:14.0pt\"> are seen as a white tuft of glial tissue overlying the centre.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">All these features make the optic disc look like a morning glory flower, hence the name.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-163513.JPG\" style=\"height:228px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Morning glory anomaly</span></strong><span style=\"font-size:14.0pt\"> may be <strong>unilateral and sporadic</strong> condition or <strong>bilateral and hereditary</strong> (rarer).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">PAX6 gene mutation</span></strong><span style=\"font-size:14.0pt\"> may be present.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most important systemic association is frontonasal dysplasia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Optic Disc Pit. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An optic disc pit is a <strong>congenital anomaly characterized by a small, round or oval, greyish depression in the optic nerve head</strong>, often associated with potential complications like serous macular detachment.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-163607.JPG\" style=\"height:376px; width:400px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Posterior staphyloma. </span></strong><span style=\"font-size:14.0pt\">Posterior staphyloma is a <strong>localized protrusion or bulging of the sclera</strong> (the white outer layer of the eye) at the <strong>back of the eye</strong>, often <strong>associated with severe myopia</strong> (near-sightedness) and thinning of the scleral tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-163644.JPG\" style=\"height:524px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Advanced glaucomatous cupping. </span></strong><span style=\"font-size:14.0pt\">Advanced glaucomatous cupping refers to the <strong>deepening and enlargement of the optic cup in the optic nerve head</strong>, a sign of <strong>progressive damage caused by glaucoma</strong>, leading to a distinctive cup-to-disc ratio increase and corresponding vision loss.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-163721.JPG\" style=\"height:227px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Morning Glory Syndrome</span></strong><span style=\"font-size:14.0pt\"> is a <strong>congenital, enlarged, funnel-shaped optic disc anomaly.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38398,
      "choices": [
        {
          "id": 153347,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fibrosarcoma</span></span></span></p>"
        },
        {
          "id": 153348,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Osteosarcoma</span></span></span></p>"
        },
        {
          "id": 153349,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Undifferentiated sarcoma</span></span></span></p>"
        },
        {
          "id": 153350,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Malignant peripheral nerve sheath tumor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 50-year-old woman presents to her primary care physician with complaints of bone pain and muscle weakness that have progressively worsened over the past year. She also reports frequent urination and a recent history of kidney stones. Physical examination reveals diffuse bone tenderness and decreased muscle tone. Laboratory tests show low serum calcium, high serum phosphate, and elevated alkaline phosphatase levels. Urinalysis reveals increased phosphate excretion. A bone density scan indicates decreased bone density consistent with osteomalacia. Based on the patient&#39;s clinical presentation and laboratory findings, which of the following conditions is most likely responsible for her symptoms?</span></span></span></p>",
      "unique_key": "Q8165294",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717921,
      "difficulty_level": "difficult",
      "subjects_id": [
        15
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Fibrosarcoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation of bone pain, muscle weakness, phosphaturia, osteomalacia, and the laboratory findings of low serum calcium, high serum phosphate, and elevated alkaline phosphatase are indicative of oncogenic osteomalacia, also known as tumor-induced osteomalacia (TIO). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">TIO is most commonly associated with mesenchymal tumors such as fibrosarcoma. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These tumors produce fibroblast growth factor 23 (FGF23), which leads to phosphaturia and subsequent osteomalacia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Osteosarcoma.</strong> This is a type of bone cancer that typically presents with localized bone pain and swelling. It is not typically associated with metabolic conditions like phosphaturia and osteomalacia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Undifferentiated sarcoma.</strong> This term refers to a group of sarcomas that cannot be more specifically categorized. While they can cause local bone destruction, they are not typically associated with systemic metabolic effects like phosphaturia and osteomalacia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Malignant peripheral nerve sheath tumor.</strong> These are rare soft tissue sarcomas that arise from the peripheral nerves. They typically present with a palpable mass and pain or neurological deficits, not with systemic metabolic disturbances like phosphaturia and osteomalacia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective is to recognize the clinical and laboratory findings associated with oncogenic osteomalacia (tumor-induced osteomalacia), including phosphaturia, osteomalacia, low serum calcium, high serum phosphate, and elevated alkaline phosphatase levels, and to understand its association with mesenchymal tumors such as fibrosarcoma that produce fibroblast growth factor 23 (FGF23).</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153347,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38465,
      "choices": [
        {
          "id": 153611,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Estimation of time since death</span></span></span></p>"
        },
        {
          "id": 153612,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Deciding the cause of death</span></span></span></p>"
        },
        {
          "id": 153613,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Determining the manner of death</span></span></span></p>"
        },
        {
          "id": 153614,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Assessing the liquification of tissues</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a District hospital, a casualty medical officer was faced with a peculiar case. A group of hikers had discovered a body in a densely wooded area on the outskirts of the city. The body was in an advanced state of decomposition. Given the outdoor setting and variable environmental conditions, the medical officer decided to utilize Casper&#39;s dictum to potentially assist in the ongoing police investigation. In this context, what is the primary application of Casper&#39;s dictum by the medical officer?</span></span></span></p>",
      "unique_key": "Q4902613",
      "question_audio": null,
      "question_video": null,
      "map_id": 3720296,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Estimation of time since death</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Casper&#39;s dictum is a principle used in forensic medicine that provides a comparative rate of decomposition under different conditions, aiding in the estimation of the post-mortem interval or time since death. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is based on the observation that a body decomposes twice as fast in air than in water and eight times as fast as in earth, given similar conditions. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This guideline is particularly useful in outdoor scenarios, where environmental factors play a significant role in the rate of decomposition.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Deciding the cause of death</span></strong><span style=\"font-size:14.0pt\">. This involves a thorough investigation including autopsy, toxicology, and histology, which is not directly related to Casper&#39;s dictum.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Determining the manner of death</span></strong><span style=\"font-size:14.0pt\">. This categorizes the death as natural, accidental, suicidal, or homicidal, which is beyond the scope of Casper&#39;s dictum.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Assessing the liquification of tissues</span></strong><span style=\"font-size:14.0pt\">. While Casper&#39;s dictum involves understanding the decomposition process, its primary use is not to assess tissue liquification but rather to estimate the time since death.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Casper&#39;s dictum is a rule used to <strong>estimate the time since death </strong>by comparing the rates of decomposition in air, water, and soil. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The rate of putrefaction is faster in air (e.g.- 8 hrs) followed by water (e.g.- 2 hrs) and least in soil or earth (e.g.- 1 hr).</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38731,
      "choices": [
        {
          "id": 154667,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stapled hemorroidopexy</span></span></span></span></p>"
        },
        {
          "id": 154668,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Well&#39;s procedure</span></span></span></span></p>"
        },
        {
          "id": 154669,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiersch stitch</span></span></span></span></p>"
        },
        {
          "id": 154670,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Altemeier repair</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male underwent surgery for rectal prolapse, and a postoperative image was obtained. Can you identify the procedure that was most likely performed on the patient from the given image?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132404.JPG\" style=\"height:306px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q3114959",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757027,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Thiersch stitch </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The postoperative image suggests the use of Thiersch wiring for rectal prolapse.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiersch&#39;s wiring involves placing a steel wire or a silastic/nylon tape around the anal canal. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is now rarely done due to post-operative problems such as chronic perineal sepsis, anal stenosis, and obstructed defecation.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:&nbsp; </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stapled hemorrhoidopexy.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A minimally invasive surgical technique used to treat internal hemorrhoids by repositioning prolapsed tissue back to its normal anatomical position with a circular stapling device. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Well&#39;s procedure.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An abdominal procedure for rectal prolapse that involves repositioning and attaching the rectum to the sacrum using sutures, often reinforced with mesh.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Altemeier repair.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A perineal approach to resect and anastomose the prolapsed rectum.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiersch&#39;s wiring involves placing a steel wire or a silastic/nylon tape around the anal canal for rectal prolapse.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38325,
      "choices": [
        {
          "id": 153059,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The active site is the same as the allosteric site in enzymes.</span></span></span></p>"
        },
        {
          "id": 153060,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">All allosteric enzymes exhibit positive cooperativity.</span></span></span></p>"
        },
        {
          "id": 153061,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An allosteric inhibitor is not a structural analogue of the substrate.</span></span></span></p>"
        },
        {
          "id": 153062,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The activity of allosteric enzymes is described by the Michaelis-Menten equation.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a biochemistry lecture on enzyme regulation, a medical instructor discusses the unique properties of allosteric enzymes and their significance in metabolic pathways. One student asks about the distinction between the active and allosteric sites of these enzymes and their implications for enzyme kinetics and regulation. The instructor decides to use this opportunity to test the students&#39; understanding by asking which of the following statements about allosteric enzymes is correct?</span></span></span></p>",
      "unique_key": "Q4804050",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715395,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) An allosteric inhibitor is not a structural analogue of the substrate.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Allosteric inhibitors bind to sites on an enzyme that are distinct from the active site, known as <strong>allosteric sites</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The binding of an allosteric inhibitor to an enzyme induces a conformational change that reduces the enzyme&#39;s activity but does not involve structural mimicry of the enzyme&#39;s substrate. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This distinguishes allosteric regulation from competitive inhibition, where the inhibitor is often a structural analogue of the substrate and competes for binding at the active site.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>The active site is the same as the allosteric site in enzymes.</strong> This statement is incorrect because the active site is where substrate binding and catalysis occur, whereas the allosteric site is a separate site where regulatory molecules bind, influencing the enzyme&#39;s activity through conformational changes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>All allosteric enzymes exhibit positive cooperativity.</strong> Not all allosteric enzymes display positive cooperativity. Allosteric enzymes can show either positive or negative cooperativity, or none at all, depending on how the binding of a ligand at one site affects the binding of additional ligands at other sites.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D)</span></strong><span style=\"font-size:14.0pt\"> <strong>The activity of allosteric enzymes is described by the Michaelis-Menten equation.</strong> Allosteric enzymes do not typically follow Michaelis-Menten kinetics because their activity is not described by a simple hyperbolic relationship between enzyme activity and substrate concentration. Instead, their kinetics often exhibit a sigmoidal (S-shaped) curve due to cooperative binding effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question aims to clarify the concepts related to allosteric enzymes, focusing on the distinction between active and allosteric sites, the nature of allosteric regulation, and the kinetic properties of these enzymes. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding these principles is crucial for comprehending the regulation of metabolic pathways and the mechanisms of action of certain pharmaceuticals that target allosteric sites.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38414,
      "choices": [
        {
          "id": 153411,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pack the cervix and remove the pack after 4-6 hours</span></span></span></p>"
        },
        {
          "id": 153412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Suture the cervical tear vaginally</span></span></span></p>"
        },
        {
          "id": 153413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Laparotomy and suture the cervical tear from above</span></span></span></p>"
        },
        {
          "id": 153414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Administer anti-fibrinolytics</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 24-year-old woman delivers a 3.4 kg baby at 38 weeks&rsquo; gestation using outlet forceps due to a prolonged second stage of labor. Following the successful delivery of the baby and the complete delivery of the placenta, she experiences profuse bleeding. The uterus is found to be well-contracted upon examination. Further examination of the vagina and cervix reveals a cervical tear. Given this scenario, what would be the most appropriate next step in management?</span></span></span></p>",
      "unique_key": "Q8937477",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719027,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Suture the cervical tear vaginally</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In the case of a cervical tear following delivery, the most appropriate management is direct suturing of the tear vaginally, especially if the tear is accessible and the bleeding is significant. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This approach allows for immediate control of the hemorrhage and repair of the injury. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cervical tears can be a source of significant postpartum hemorrhage, and timely intervention is crucial to prevent excessive blood loss.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Pack the cervix and remove the pack after 4-6 hours</span></strong><span style=\"font-size:14.0pt\">. Cervical packing is a more conservative approach and might be considered in cases where bleeding is minimal or when immediate surgical intervention is not possible. However, it does not directly address the repair of the tear and can be associated with infection or continued bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Laparotomy and suture the cervical tear from above</span></strong><span style=\"font-size:14.0pt\">. Laparotomy for suturing a cervical tear is highly invasive and generally not indicated unless there are additional intra-abdominal injuries or complications that cannot be managed vaginally.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Administer anti-fibrinolytics</span></strong><span style=\"font-size:14.0pt\">. While anti-fibrinolytics like tranexamic acid can be useful in managing postpartum hemorrhage, they do not directly address the mechanical cause of bleeding, such as a cervical tear. This option might be used adjunctively but not as the primary intervention for a cervical tear.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question highlights the importance of promptly identifying and managing cervical tears following delivery, especially when they are the source of significant postpartum hemorrhage. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Direct suturing of the tear via a vaginal approach is often the most appropriate and effective intervention. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other management strategies, such as cervical packing or the use of anti-fibrinolytics, may have a role in specific contexts but are not the primary treatment for a cervical tear. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Laparotomy is generally reserved for more complex cases where vaginal access is not sufficient or other intra-abdominal injuries are suspected.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153412,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38303,
      "choices": [
        {
          "id": 152971,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Derivative of First Pharyngeal Pouch</span></span></span></p>"
        },
        {
          "id": 152972,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Develops from Second Pharyngeal Pouch</span></span></span></p>"
        },
        {
          "id": 152973,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Develops from Third Pharyngeal Pouch</span></span></span></p>"
        },
        {
          "id": 152974,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Derivative of Fourth Pharyngeal Pouch</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 6-year-old child presents to the clinic with a sore throat, fever, and difficulty swallowing for the past two days. On examination, the child appears irritable, with enlarged and erythematous tonsils, each displaying a white exudate. No rash is observed. The child&#39;s mother reports that the child has had similar episodes in the past. Considering the anatomical origin of the affected structure, where do the tonsils develop from?</span></span></span></p>",
      "unique_key": "Q5419968",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714444,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Develops from Second Pharyngeal Pouch</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical scenario describes a typical case of <strong>acute tonsillitis</strong>, commonly seen in <strong>pediatric patients</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>tonsils</strong>, which are <strong>lymphoid tissues</strong>, play a role in the <strong>immune response</strong> to <strong>oral pathogens</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Embryologically,</span></strong><span style=\"font-size:14.0pt\"> the <strong>palatine tonsils</strong>, which are <strong>most commonly involved</strong> in <strong>tonsillitis</strong>, develop from the <strong>second pharyngeal pouch</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelial lining</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of <strong>tonsil</strong> and <strong>tonsillar crypts</strong> is formed from the <strong>endoderm</strong> of the <strong>ventral part</strong> of the <strong>second pharyngeal pouch</strong>. </span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/capture.JPG\" style=\"height:414px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Lymphatic follicles</span></strong><span style=\"font-size:14.0pt\"> of tonsil are derived from <strong>mesoderm</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Neural crest cells</span></strong><span style=\"font-size:14.0pt\"> also <strong>migrate</strong> into <strong>developing pharyngeal arches</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Intratonsillar cleft</span></strong><span style=\"font-size:14.0pt\">/<strong>Crypta magna</strong> represents <strong>non-obliterated </strong>part of <strong>second pharyngeal pouch</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Derivative of First Pharyngeal Pouch. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The first pharyngeal pouch gives rise to structures like the <strong>middle ear cavity</strong>, <strong>Eustachian tube</strong>, and the <strong>inner layer</strong> of the <strong>tympanic membrane</strong>, not the tonsils. Therefore, this option is <strong>incorrect</strong> for the origin of the tonsils.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Develops from Third Pharyngeal Pouch. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The third pharyngeal pouch is responsible for the <strong>development</strong> of the <strong>inferior parathyroid glands</strong> and the <strong>thymus</strong>. It does not contribute to the formation of the tonsils.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Derivative of Fourth Pharyngeal Pouch. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The fourth pharyngeal pouch primarily contributes to the <strong>formation</strong> of the <strong>superior parathyroid glands</strong> and, in part, the <strong>ultimobranchial body</strong> which contributes to the <strong>thyroid gland</strong>. It does not give rise to the tonsils.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The palatine tonsils, develop from the <strong>second pharyngeal pouch</strong>.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The <strong>epithelial lining</strong> of this pouch <strong>proliferates</strong> and <strong>invaginates</strong>, forming the <strong>crypts</strong> of the <strong>tonsils</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lymphoid tissue then <strong>infiltrates</strong> these crypts <strong>during later development</strong>.Top of Form</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ref: Textbook of Human Embryology, First Edition, Yogesh Sontakke, Page no. 104</span></strong></span></span></p>",
      "correct_choice_id": 152972,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38307,
      "choices": [
        {
          "id": 152987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Tibio-navicular part</span></span></span></p>"
        },
        {
          "id": 152988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Tibio-calcaneal part</span></span></span></p>"
        },
        {
          "id": 152989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anterior tibio-talar part</span></span></span></p>"
        },
        {
          "id": 152990,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Posterior tibio-talar part</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A 26-year-old professional soccer player presents to the clinic with acute ankle pain following a severe inversion injury during a match. Physical examination reveals significant tenderness and swelling over the medial aspect of the ankle. Radiographic imaging is negative for fractures but suggests a ligamentous injury. The physician suspects injury to a specific component of the medial (deltoid) ligament complex, which is crucial for resisting valgus stress and providing stability to the medial side of the ankle. Which part of the deltoid ligament is most likely involved in this patient&#39;s injury?</span></span></span></p>",
      "unique_key": "Q9019670",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714868,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Tibio-calcaneal part</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The tibio-calcaneal part of the deltoid ligament is a significant component of the medial ligamentous support of the ankle. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It extends from the medial malleolus of the tibia to the sustentaculum tali of the calcaneus. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This part of the deltoid ligament is crucial for providing stability against valgus forces and preventing excessive eversion of the foot. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In the case of a severe inversion injury, as described for the soccer player, the medial ligament complex, particularly the tibio-calcaneal part, is prone to injury due to the forceful overstretching and potential tearing of the ligament fibers.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-161429.JPG\" style=\"height:310px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A) Tibio-navicular part</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. This component of the deltoid ligament extends from the medial malleolus to the navicular bone. It plays a role in stabilizing the medial side of the ankle but is less likely to be isolatedly involved in an inversion injury, which typically affects the ligaments on the lateral side of the ankle or the deeper components of the medial side.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C) Anterior tibio-talar part</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. This part of the deltoid ligament stretches from the medial malleolus to the talus. It is involved in resisting anterior translation of the talus and internal rotation but is less likely to be the primary site of injury in an inversion sprain.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D) Posterior tibio-talar part.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Extending from the medial malleolus to the talus, this part of the deltoid ligament helps stabilize the ankle against posterior translation of the talus. While it contributes to the overall stability of the ankle, it is less commonly injured compared to the tibio-calcaneal part in inversion injuries.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question aims to assess the learner&#39;s understanding of the anatomy and function of the deltoid ligament, particularly the tibio-calcaneal part, in providing medial ankle stability. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Recognizing the specific components of the deltoid ligament and their roles in ankle stability is crucial for diagnosing ligamentous injuries and guiding appropriate treatment, especially in athletes who sustain inversion injuries of the ankle. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the mechanism of injury and the anatomical structures involved is essential for accurate diagnosis, management, and prevention of further injury in clinical practice.</span></span></li>\r\n</ul>",
      "correct_choice_id": 152988,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38364,
      "choices": [
        {
          "id": 153211,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sumatriptan</span></span></span></p>"
        },
        {
          "id": 153212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Valproate</span></span></span></p>"
        },
        {
          "id": 153213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Propranolol</span></span></span></p>"
        },
        {
          "id": 153214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Topiramate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 30-year-old woman presents to the clinic with a history of recurrent, debilitating headaches characterized by unilateral throbbing pain, nausea, and photophobia. These episodes occur approximately 4 times per month and significantly impair her ability to work. After a thorough evaluation, you diagnose her with migraine without aura and discuss treatment options. Given the frequency and severity of her migraines, you consider starting prophylactic therapy to reduce the frequency, severity, and duration of her migraine episodes. Which of the following medications is NOT typically used for the prophylaxis of migraines?</span></span></span></p>",
      "unique_key": "Q6900694",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716633,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Sumatriptan</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sumatriptan is a serotonin receptor agonist (specifically, a 5-HT1 agonist) that is used for the acute treatment of migraine attacks but is not used for migraine prophylaxis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works by constricting blood vessels in the brain and blocking pain pathways in the brain, which helps to relieve the symptoms of a migraine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Valproate</span></strong><span style=\"font-size:14.0pt\">, an anticonvulsant medication, is effective in reducing the frequency and intensity of migraines and is used for migraine prophylaxis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Propranolol</span></strong><span style=\"font-size:14.0pt\">, a beta-blocker, is commonly used for migraine prophylaxis. It is thought to work by blocking beta-adrenergic receptors, which may be involved in the generation of migraines.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Topiramate</span></strong><span style=\"font-size:14.0pt\">, another anticonvulsant, is also used for the prophylactic treatment of migraines. Its mechanism in migraine prevention is not entirely understood but is thought to involve the modulation of neurotransmitter pathways that are implicated in migraine pathogenesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of migraine prophylaxis and the differentiation between prophylactic and acute treatment options for migraine. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of choosing the appropriate medication based on the treatment goal, whether it is to prevent future migraine episodes or to treat acute migraine symptoms.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38711,
      "choices": [
        {
          "id": 154587,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Otitis Externa</span></span></span></p>"
        },
        {
          "id": 154588,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute Otitis Media with perforation</span></span></span></p>"
        },
        {
          "id": 154589,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cholesteatoma</span></span></span></p>"
        },
        {
          "id": 154590,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vestibular Schwannoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old man presents with a chronic foul-smelling discharge from his right ear, hearing loss, and occasional dizziness. On examination, there is a white mass visible behind the tympanic membrane, and the membrane appears retracted in attic with a pocket formation. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q4430426",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755607,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Cholesteatoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A cholesteatoma is an <strong>abnormal growth</strong> of <strong>keratinizing squamous epithelium</strong> in the <strong>middle ear</strong> and <strong>mastoid process</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It presents with <strong>chronic foul-smelling discharge</strong>, <strong>hearing loss</strong>, and can cause <strong>dizziness</strong> if it <strong>affects</strong> the <strong>inner ear structures</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of a <strong>white mass</strong> in an <strong>attic retraction pocket</strong> is <strong>highly suggestive</strong> of <strong>cholesteatoma.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A</span></strong><span style=\"font-size:14.0pt\">. <strong>Otitis externa</strong>, or &quot;<strong>swimmer&#39;s ear</strong>,&quot; typically presents with <strong>pain</strong>, especially with <strong>manipulation of the pinna</strong> or <strong>tragus</strong>, and can have <strong>discharge</strong>, but it does not usually present with a <strong>visible mass</strong> behind the <strong>tympanic membrane</strong> or <strong>cause chronic symptoms</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B</span></strong><span style=\"font-size:14.0pt\">. <strong>Acute otitis media</strong> <strong>with perforation</strong> can lead to <strong>discharge</strong> and <strong>hearing loss</strong>, but it is unlikely to <strong>present</strong> with a <strong>white mass</strong> <strong>behind the tympanic membrane</strong>. Perforation usually results in a <strong>visible defect</strong> in the <strong>tympanic membrane</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. A <strong>vestibular schwannoma</strong>, also known as an <strong>acoustic neuroma</strong>, is a <strong>benign tumor</strong> of the <strong>vestibulocochlear nerve</strong>. It typically presents with <strong>unilateral sensorineural hearing loss</strong>, <strong>tinnitus</strong>, and <strong>balance disturbances</strong>. It would not be visible behind the tympanic membrane nor present with ear discharge.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective of this question is to <strong>recognize the clinical presentation</strong> of a <strong>cholesteatoma</strong>, which typically <strong>includes chronic</strong> <strong>foul-smelling ear discharge</strong>, <strong>hearing loss</strong>, and the <strong>presence</strong> of a <strong>white mass</strong> behind an <strong>intact tympanic membrane</strong>.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38567,
      "choices": [
        {
          "id": 154011,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Herpes Simplex Virus (HSV)</span></span></span></p>"
        },
        {
          "id": 154012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Trichomonas vaginalis</span></span></span></p>"
        },
        {
          "id": 154013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Haemophilus influenza</span></span></span></p>"
        },
        {
          "id": 154014,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neisseria gonorrhoeae</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 28-year-old woman presents to the clinic with a history of recurrent genital infections. She reports having multiple sexual partners over the past year and admits to inconsistent use of condoms and other protective measures. Her medical history is significant for similar episodes in the past, which temporarily resolved with treatment but recurred upon re-exposure. Given the pattern of transient colonization and the patient&#39;s sexual history, which of the following organisms is most likely responsible for her recurrent genital infections?</span></span></span></p>",
      "unique_key": "Q4978800",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736382,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Neisseria gonorrhoeae</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neisseria gonorrhoeae, the causative agent of gonorrhea, is a common sexually transmitted infection that can lead to recurrent genital infections, especially in individuals with multiple sexual partners and inconsistent use of protection. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gonorrhea can be effectively treated with antibiotics, but reinfection can occur with subsequent exposures, leading to a pattern of transient colonization and recurrent infections.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Herpes Simplex Virus (HSV)</span></strong><span style=\"font-size:14.0pt\">. HSV causes genital herpes, which is characterized by recurrent painful lesions. Unlike transient colonization, HSV establishes lifelong latency in the host&#39;s nerve cells and can reactivate periodically.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Trichomonas vaginalis</span></strong><span style=\"font-size:14.0pt\">. This protozoan parasite causes trichomoniasis, a sexually transmitted infection. While it can be recurrent, it is due to reinfection rather than transient colonization.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Haemophilus influenza</span></strong><span style=\"font-size:14.0pt\">. This bacterium is primarily associated with respiratory infections and is not commonly linked to recurrent genital infections or sexual transmission.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neisseria gonorrhoeae is known for causing transient colonization, particularly in the genital tract. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a common sexually transmitted bacterium that can lead to infections like gonorrhea.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154014,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38467,
      "choices": [
        {
          "id": 153619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 3</span></span></span></p>"
        },
        {
          "id": 153620,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3, 4</span></span></span></p>"
        },
        {
          "id": 153621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 2</span></span></span></p>"
        },
        {
          "id": 153622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2, 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a rural health camp, a medical officer is educating the community about the risks associated with snakebites, particularly from venomous species. The officer emphasizes the importance of recognizing features of poisonous snakes for early identification and management. Which of the following characteristics is NOT typically associated with venomous snakes?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are primarily nocturnal in habit.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They have a compressed tail.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They possess solid and stout fangs.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They exhibit large scales on their head.</span></span></span></li>\r\n</ol>",
      "unique_key": "Q3689928",
      "question_audio": null,
      "question_video": null,
      "map_id": 3720438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 3, 4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Poisonous snakes, particularly those belonging to the viper and elapid families, typically have hollow fangs that act as channels for injecting venom, contradicting <strong>statement 3</strong>, which suggests solid fangs. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, many venomous snakes have smaller, more numerous head scales rather than large ones, making <strong>statement 4</strong> incorrect.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-194055.JPG\" style=\"height:289px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Nocturnal in habit</span></strong><span style=\"font-size:14.0pt\">: This is a common characteristic of many poisonous snakes, allowing them to hunt and avoid predators under the cover of darkness.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Have compressed tail</span></strong><span style=\"font-size:14.0pt\">: While some venomous snakes may exhibit a compressed tail, this feature is not a definitive indicator of venomous species and varies among different snake families.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Poisonous Vs non-poisonous snakes:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-194232.JPG\" style=\"height:798px; width:983px\" /></span></strong></span></span></p>",
      "correct_choice_id": 153620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38416,
      "choices": [
        {
          "id": 153419,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Testicular feminizing syndrome</span></span></span></p>"
        },
        {
          "id": 153420,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gonadal dysgenesis</span></span></span></p>"
        },
        {
          "id": 153421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kallmann syndrome</span></span></span></p>"
        },
        {
          "id": 153422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Turner syndrome</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A 16-year-old girl with primary amenorrhea has the following features. What is the most probable diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Normal stature</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Thelarche &ndash; absent</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">FSH, LH &ndash; high</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Karyotype &ndash; 46 XX</span></span></span></li>\r\n</ul>",
      "unique_key": "Q2811580",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719229,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Gonadal dysgenesis </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The probable diagnosis, in this case, is pure gonadal dysgenesis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Whenever secondary sexual characters are ABSENT, think of ovarian or hypothalamic/pituitary causes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If FSH/ LH is low, think of hypothalamic or pituitary causes (Hypogonadotrophic hypogonadism)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If FSH/ LH is high, think of ovarian cause (hypergonadotropic hypogonadism)</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">46 XX</span></strong><span style=\"font-size:14.0pt\"> &ndash; gonadal dysgenesis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">46 XY</span></strong><span style=\"font-size:14.0pt\"> &ndash; Swyer syndrome</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Testicular Feminization Syndrome/Androgen Insensitivity Syndrome.&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">&nbsp;</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">46 XY</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Uterus and ovaries absent</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Secondary sexual development (especially breast development +) due to peripheral production of estrogens. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Kallman Syndrome.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">&nbsp;</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is a cause of Hypogonadotrophic hypogonadism leading to primary amenorrhoea</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Associated with anosmia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Absent secondary sexual characters</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">FSH and LH Low</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Turner Syndrome.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">&nbsp;</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">45 XO</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Streak ovaries leading to low estrogen and absent secondary sexual characters</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">FSH and LH are high</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Very important feature</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: Short stature</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ref: DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition, Page no. 454</span></strong></span></span></p>",
      "correct_choice_id": 153420,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38590,
      "choices": [
        {
          "id": 154103,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a-2, b-4, c-3, d-1</span></span></p>"
        },
        {
          "id": 154104,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-1, b-4, c-2, d-3</span></span></span></p>"
        },
        {
          "id": 154105,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a-4, b-3, c-2, d-1</span></span></p>"
        },
        {
          "id": 154106,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a-4, b-2, c-3, d-1</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A healthcare facility is training its staff on the Biomedical Waste Management (BMW) Guidelines for the proper segregation of waste products. The staff is presented with a list of items and a set of coloured dustbins where each colour is designated for a specific type of waste. Match the following items with the correct coloured dustbins according to the BMW Guidelines.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-131352.JPG\" style=\"height:324px; width:700px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Using the information provided, select the appropriate colour for each item from the list.</span></span></span></p>",
      "unique_key": "Q5031027",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739259,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) a-4, b-3, c-2, d-1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-131655.JPG\" style=\"height:837px; width:700px\" /></span></strong></span></span></p>",
      "correct_choice_id": 154105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38401,
      "choices": [
        {
          "id": 153359,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Gastrograffin</span></span></span></p>"
        },
        {
          "id": 153360,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Bromium</span></span></span></p>"
        },
        {
          "id": 153361,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Gadolinium</span></span></span></p>"
        },
        {
          "id": 153362,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Barium sulfate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old male patient presents to the emergency department with sudden onset of severe chest pain, dysphagia, and subcutaneous emphysema after a forceful episode of vomiting. The clinical suspicion is high for esophageal perforation. To confirm the diagnosis, an imaging study using a contrast agent is planned. Which of the following contrast agents is most appropriate for diagnosing esophageal perforation in this patient?</span></span></span></p>",
      "unique_key": "Q5107618",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718144,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Gastrograffin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gastrograffin (water-soluble contrast medium) is the preferred initial contrast agent for suspected esophageal perforation due to its lower risk of causing a severe inflammatory response if it leaks into the mediastinum or pleural space compared to barium. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While Gastrograffin can still cause an inflammatory response, it is less severe than that caused by barium sulfate. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If Gastrograffin does not show clear evidence of perforation and clinical suspicion remains high, a follow-up study with barium might be considered, as barium provides better anatomic detail.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>B. Bromium.</strong> Bromium is not used as a contrast agent</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>C. Gadolinium.</strong> Gadolinium is a contrast agent used in magnetic resonance imaging (MRI) and is not appropriate for imaging the esophagus in the context of suspected perforation due to its use in a different imaging modality and potential for severe side effects if used outside the vascular system.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>D. Barium sulfate.</strong> Barium sulfate provides excellent anatomic detail and is the contrast agent of choice for many gastrointestinal studies. However, in the case of esophageal perforation, barium can cause a severe chemical mediastinitis if it leaks into the mediastinum, making it a less preferred option for initial evaluation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to test the knowledge of the appropriate use of contrast agents in the diagnosis of gastrointestinal perforations, particularly esophageal perforations. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It emphasizes the importance of choosing a contrast agent that minimizes patient risk while providing sufficient diagnostic information. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the properties and appropriate clinical use of various contrast agents, such as Gastrograffin, gadolinium, and barium sulfate, is crucial for safe and effective patient care in radiologic evaluations.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153359,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38400,
      "choices": [
        {
          "id": 153355,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute pyelonephritis</span></span></span></p>"
        },
        {
          "id": 153356,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Emphysematous pyelonephritis</span></span></span></p>"
        },
        {
          "id": 153357,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Perinephric abscess</span></span></span></p>"
        },
        {
          "id": 153358,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Renal abscess</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old patient with a history of diabetes mellitus presents to the emergency department with acute onset of high fever, chills, and painful urination. The patient also complains of flank pain and nausea. Urinalysis reveals significant leukocyturia and glycosuria. Given the patient&#39;s diabetic status and the acute presentation, a CT scan of the abdomen is performed to further evaluate the cause of these symptoms. Based on the clinical presentation and the patient&#39;s background, which of the following is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-183846.JPG\" style=\"height:217px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5366848",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718123,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Emphysematous pyelonephritis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Emphysematous pyelonephritis is a severe, necrotizing infection of the renal parenchyma and surrounding tissues that typically occurs in patients with diabetes mellitus. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is characterized by the production of gas within the renal parenchyma, calices, and perinephric tissues, often identifiable on imaging studies such as CT scans. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of gas makes this condition distinct from other forms of kidney infections. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The acute onset of fever, dysuria, and the patient&#39;s diabetic status significantly increase the likelihood of this diagnosis, particularly if the CT scan shows gas formation within or around the kidneys.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>A. Acute pyelonephritis.</strong> This is a bacterial infection that causes the kidneys to swell. While it presents with symptoms similar to those described, the absence of gas formation on the CT scan would make emphysematous pyelonephritis a more likely diagnosis in a diabetic patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>C. Perinephric abscess.</strong> This is a collection of pus around the kidney, often secondary to pyelonephritis. Although it can occur in diabetic patients, the presence of gas on a CT scan is more indicative of emphysematous pyelonephritis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>D. Renal abscess</strong>. A renal abscess is a localized collection of pus within the renal parenchyma. It might present similarly to the other options but lacks the characteristic gas formation seen in emphysematous pyelonephritis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question is designed to test the ability to recognize and differentiate between severe urinary tract infections in diabetic patients, particularly focusing on emphysematous pyelonephritis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It underscores the importance of considering this life-threatening condition when a diabetic patient presents with symptoms of a UTI and emphasizes the role of imaging, such as a CT scan, in diagnosing emphysematous pyelonephritis by identifying gas within the renal tissues. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the distinctions between acute pyelonephritis, perinephric abscess, and renal abscess is essential for accurate diagnosis and effective management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153356,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38412,
      "choices": [
        {
          "id": 153403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Position of the cervix</span></span></span></p>"
        },
        {
          "id": 153404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cervical consistency</span></span></span></p>"
        },
        {
          "id": 153405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Station of the fetal head</span></span></span></p>"
        },
        {
          "id": 153406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Position of the fetal head</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Modified Bishop score is a pre-labor scoring system used to predict the likelihood of successful labor induction and assess the cervix&#39;s readiness for labor. It takes into account various cervical and fetal factors. Which of the following is NOT a component of the Modified Bishop score?</span></span></span></p>",
      "unique_key": "Q9629632",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719001,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Position of the fetal head</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The position of the fetal head is not a component of the Modified Bishop score. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The Bishop score assesses cervical readiness for labor by evaluating factors such as cervical dilation, effacement, consistency, and position, as well as the station of the fetal head in relation to the ischial spines. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The position of the fetal head (e.g., whether the fetus is facing anterior, posterior, or transverse) does not contribute to this scoring system.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Position of the cervix</span></strong><span style=\"font-size:14.0pt\">. This refers to whether the cervix is positioned anteriorly or posteriorly in the vagina, which can indicate how advanced labor is. A more anterior position is favourable for labor induction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Cervical consistency</span></strong><span style=\"font-size:14.0pt\">. This assesses whether the cervix feels soft, medium, or firm. A softer cervix is more favourable for labor induction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Station of the fetal head</span></strong><span style=\"font-size:14.0pt\">. This indicates the level of the fetal head in relation to the ischial spines of the pelvis, measured in centimetres. The higher the station, the less engaged the fetal head is, and a lower station indicates that the fetal head is more engaged in the pelvis, which is favourable for labor.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question aims to clarify the components of the Modified Bishop score, which is used to evaluate cervical readiness for labor and the likelihood of successful labor induction. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding the components of this score is essential for obstetric management, particularly when deciding on the timing and method of labor induction. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The position of the fetal head, while important for other aspects of labor management, is not included in this scoring system.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153406,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38422,
      "choices": [
        {
          "id": 153443,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Severe continuous abdominal pain</span></span></span></p>"
        },
        {
          "id": 153444,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fetal distress</span></span></span></p>"
        },
        {
          "id": 153445,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fresh vaginal bleeding</span></span></span></p>"
        },
        {
          "id": 153446,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Maternal tachycardia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 29-year-old woman, gravida 2 para 1, who previously underwent an uncomplicated lower segment cesarean section, is currently in labor and has been deemed a candidate for a trial of labor after cesarean (TOLAC). The medical team is closely monitoring for any signs of complications, particularly uterine scar rupture, due to her history of cesarean delivery. In this scenario, which of the following is considered the earliest warning sign of uterine scar rupture?</span></span></span></p>",
      "unique_key": "Q3337101",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719349,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Fetal distress</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the context of TOLAC, fetal distress can be an early indicator of uterine scar rupture. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fetal heart rate abnormalities may reflect the compromised blood flow or oxygenation associated with the beginning of a scar rupture, making it one of the earliest detectable signs through continuous fetal monitoring.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Severe continuous abdominal pain</span></strong><span style=\"font-size:14.0pt\">. While this can be a sign of uterine rupture, it may not always precede fetal distress. In some cases, the pain may not be as pronounced or may be mistaken for normal labor pain.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Fresh vaginal bleeding</span></strong><span style=\"font-size:14.0pt\">. This sign, although potentially associated with uterine rupture, is not as early or specific as fetal distress and can result from various other obstetric complications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Maternal tachycardia</span></strong><span style=\"font-size:14.0pt\">. This can be a secondary sign related to pain, hemorrhage, or maternal distress but is not the earliest indicator of uterine rupture.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The earliest warning sign of uterine scar rupture during a trial of labor after cesarean (TOLAC) is often fetal distress, detected as abnormal fetal heart rate patterns. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Continuous fetal monitoring is essential in TOLAC to detect such changes promptly, allowing for immediate evaluation and intervention to ensure the safety of both mother and fetus. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other signs like severe abdominal pain, vaginal bleeding, and maternal tachycardia, while important, may manifest later or be less specific to uterine rupture.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38360,
      "choices": [
        {
          "id": 153195,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prostaglandin analogues</span></span></span></p>"
        },
        {
          "id": 153196,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alpha agonist</span></span></span></p>"
        },
        {
          "id": 153197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pilocarpine</span></span></span></p>"
        },
        {
          "id": 153198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beta blocker</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 54-year-old male with a long-standing history of insulin-dependent diabetes mellitus presents to the ophthalmology clinic with complaints of gradually worsening vision in both eyes. His medical history is significant for diabetic retinopathy, and on examination, macular edema is noted. Additionally, intraocular pressure (IOP) measurements reveal elevated levels consistent with glaucoma. Considering the patient&#39;s background of diabetes and existing macular edema, you deliberate on the most suitable anti-glaucoma medication to prescribe. Which of the following anti-glaucoma drugs should be avoided in this patient due to the potential exacerbation of macular edema?</span></span></span></p>",
      "unique_key": "Q6905036",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716531,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prostaglandin analogues, while effective in reducing intraocular pressure by increasing the outflow of aqueous humor, have been associated with the potential side effect of worsening or inducing macular edema, particularly in patients with pre-existing conditions such as diabetic retinopathy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with insulin-dependent diabetes and existing macular edema, caution is advised when considering prostaglandin analogues due to this risk.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Alpha agonists</span></strong><span style=\"font-size:14.0pt\">, such as brimonidine, decrease aqueous humor production and increase uveoscleral outflow, and are not primarily associated with worsening macular edema.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Pilocarpine</span></strong><span style=\"font-size:14.0pt\">, a miotic agent, works by constricting the pupil and opening the trabecular meshwork to facilitate aqueous humor outflow. It is not contraindicated in patients with macular edema.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Beta blockers</span></strong><span style=\"font-size:14.0pt\">, such as timolol, decrease aqueous humor production and are a common choice for glaucoma treatment without a direct link to worsening macular edema.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the pharmacological management of glaucoma in patients with concurrent ocular conditions such as diabetic macular edema. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It emphasizes the importance of considering potential drug side effects and contraindications in the context of a patient&#39;s overall clinical picture, particularly in complex cases involving multiple comorbidities.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153195,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38316,
      "choices": [
        {
          "id": 153023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Free form</span></span></span></p>"
        },
        {
          "id": 153024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Dissolved form</span></span></span></p>"
        },
        {
          "id": 153025,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oxyhemoglobin</span></span></span></p>"
        },
        {
          "id": 153026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Carbonic acid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old man with a history of chronic obstructive pulmonary disease (COPD) is brought to the emergency department due to an exacerbation characterized by increased shortness of breath and wheezing. On examination, his oxygen saturation is noted to be 88% on room air, and he is promptly placed on supplemental oxygen. The attending physician explains to the medical students that oxygen transport in the blood can occur in various forms. He poses a question regarding the predominant mode of transport of oxygen in the blood. Which of the following will be the predominant mode of transport of oxygen in the blood?</span></span></span></p>",
      "unique_key": "Q2386871",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715187,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Oxyhemoglobin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oxyhemoglobin is the predominant mode of transport of oxygen in the blood. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oxygen binds reversibly to the heme component of hemoglobin in red blood cells, forming oxyhemoglobin. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This allows for efficient transport of large quantities of oxygen, with each hemoglobin molecule capable of carrying up to four oxygen molecules. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This binding is influenced by factors such as pH, temperature, and the partial pressure of carbon dioxide and oxygen, described by the oxygen-hemoglobin dissociation curve.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Free form.</span></strong><span style=\"font-size:14.0pt\"> Only a very small percentage of oxygen is transported in the free form dissolved in the plasma. This amount is insufficient for the body&#39;s metabolic needs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Dissolved form.</span></strong><span style=\"font-size:14.0pt\"> Similar to the free form, the dissolved form of oxygen in plasma accounts for a very small fraction of oxygen transport and is not the predominant mode of transport.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Carbonic acid.</span></strong><span style=\"font-size:14.0pt\"> Carbon dioxide is more commonly transported in the blood as bicarbonate ions, which form carbonic acid in combination with water. This process is facilitated by the enzyme carbonic anhydrase but is relevant to carbon dioxide transport rather than oxygen.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The educational objective is to understand the various modes of oxygen transport in the blood, with a focus on the primary role of hemoglobin in oxygen binding and transport as oxyhemoglobin. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This understanding is crucial for the management of patients with respiratory conditions and for optimizing oxygen delivery in clinical settings.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38601,
      "choices": [
        {
          "id": 154147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HPV 31, 33</span></span></span></p>"
        },
        {
          "id": 154148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HPV 6, 11</span></span></span></p>"
        },
        {
          "id": 154149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HPV 16, 18</span></span></span></p>"
        },
        {
          "id": 154150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HPV 31, 45</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In India, cervical cancer remains a significant public health concern. Identifying the most common causative agents is crucial for targeted prevention and treatment strategies. Among the human papillomavirus (HPV) types listed below, which is most commonly associated with cervical cancer in India?</span></span></p>",
      "unique_key": "Q8358868",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739620,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) HPV 16, 18</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Globally, HPV types 16 and 18 are the most common high-risk HPV types associated with cervical cancer, accounting for approximately 70% of cases. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This trend is also reflected in India, where these two HPV types are predominantly responsible for the majority of cervical cancer cases. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Targeted vaccines against these HPV types offer significant potential in reducing the incidence of cervical cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. HPV 31, 33</span></strong><span style=\"font-size:14.0pt\">. While these are high-risk HPV types, they are less commonly associated with cervical cancer compared to HPV 16 and 18.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. HPV 6, 11</span></strong><span style=\"font-size:14.0pt\">. These HPV types are most commonly associated with benign conditions like genital warts and have a low risk for cervical cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. HPV 31, 45</span></strong><span style=\"font-size:14.0pt\">. These types do contribute to cervical cancer risk but are less prevalent than HPV 16 and 18 in causing the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">CERVICAL CANCER</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">MC in World</span></strong><span style=\"font-size:14.0pt\">: HPV 16, 18, 45, 31</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">MC in India</span></strong><span style=\"font-size:14.0pt\">: HPV 16, 18 (76% of all cases)</span></span></span></li>\r\n\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single MCC in India</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: HPV 16 (59% of total cases)</span></span></li>\r\n</ul>",
      "correct_choice_id": 154149,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38378,
      "choices": [
        {
          "id": 153267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Low molecular weight heparin (LMWH)</span></span></span></p>"
        },
        {
          "id": 153268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-thrombin III inhibitors</span></span></span></p>"
        },
        {
          "id": 153269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Direct Xa inhibitors</span></span></span></p>"
        },
        {
          "id": 153270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Warfarin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 60-year-old woman with a recent diagnosis of pancreatic cancer presents to the clinic with complaints of swelling, pain, and redness in her left lower extremity. Her medical history is significant for hypertension and type 2 diabetes mellitus. On examination, her left leg is warm to the touch, with palpable cords and a positive Homan&#39;s sign. A Doppler ultrasound confirms the presence of a deep vein thrombosis (DVT). Given her cancer diagnosis, you consider the most appropriate anticoagulation therapy to manage her thromboembolism. Which of the following drugs is commonly used in the treatment of cancer-associated thromboembolism?</span></span></span></p>",
      "unique_key": "Q3211446",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717161,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Low molecular weight heparin (LMWH)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Low molecular weight heparin (LMWH) is the preferred choice for the initial and long-term treatment of cancer-associated thromboembolism. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">LMWH has been shown to be more effective than vitamin K antagonists, like warfarin, in preventing recurrent thrombosis in cancer patients without increasing the risk of bleeding. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Its use is supported by clinical guidelines for cancer patients with acute venous thromboembolism (VTE) due to its favourable benefit-risk profile, ease of use, and no need for routine monitoring of anticoagulation levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Anti-thrombin III inhibitors</span></strong><span style=\"font-size:14.0pt\"> are not typically used as first-line agents for the treatment of cancer-associated thromboembolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Direct Xa inhibitors</span></strong><span style=\"font-size:14.0pt\"> are a newer class of anticoagulants that have been gaining acceptance for various indications, including the treatment of VTE. However, LMWH remains the preferred choice in cancer-associated thromboembolism, although Direct Xa inhibitors may be considered in some cases based on recent studies and evolving guidelines.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Warfarin</span></strong><span style=\"font-size:14.0pt\">, a vitamin K antagonist, has traditionally been used for the treatment of VTE, but it is not the preferred agent in cancer-associated thromboembolism due to a higher risk of recurrent thrombosis and more challenging management involving frequent monitoring and dose adjustments.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the knowledge of the appropriate management of cancer-associated thromboembolism, emphasizing the preferred use of low molecular weight heparin (LMWH) over other anticoagulation options due to its effectiveness, safety profile, and practical advantages in this patient population.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38717,
      "choices": [
        {
          "id": 154611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth weight below &lt;90<sup>th</sup> percentile</span></span></span></span></p>"
        },
        {
          "id": 154612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth weight below &lt;10<sup>th</sup> per centile</span></span></span></span></p>"
        },
        {
          "id": 154613,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth weight below &lt;20<sup>th</sup> percentile </span></span></span></span></p>"
        },
        {
          "id": 154614,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth weight below &lt; 50<sup>th</sup> percentile </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newborn preterm baby is classified as small for gestational age (SGA). Which of the following best defines an SGA infant?</span></span></span></span></p>",
      "unique_key": "Q1192655",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756173,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Birth weight below &lt;10<sup>th</sup> per centile</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGA is defined as a birth weight below the 10th percentile for the infant&#39;s gestational age, indicating the baby weighs less than the majority of infants at the same number of weeks of gestation.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small for gestational age is weight for age &lt; 10<sup>th</sup> centile.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Appropriate for gestational age is weight for age between 10<sup>th</sup> &amp; 90<sup>th</sup> centile.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large for gestational age is weight for age &gt; 90<sup>th</sup> centile.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth weight below &lt;90<sup>th</sup> percentile</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option describes large for gestational age (LGA) infants, not SGA. LGA infants have a birth weight above the 90th percentile for their gestational age.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Birth weight below the 20th percentile</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> may indicate a smaller infant but does not meet the standard definition for SGA.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth weight below &lt; 50<sup>th</sup> percentile</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The 50th percentile is the median weight for gestational age, so being below this does not necessarily indicate SGA.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small for gestational age is defined as a birth weight below the 10th percentile for the infant&#39;s gestational age.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-125414.JPG\" style=\"height:326px; width:500px\" /></span></span></span></span></p>",
      "correct_choice_id": 154612,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38386,
      "choices": [
        {
          "id": 153299,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is more common in Girls</span></span></span></span></p>"
        },
        {
          "id": 153300,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lesions follow Blaschko&#39;s Lines</span></span></span></span></p>"
        },
        {
          "id": 153301,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutation in IKBKG Gene </span></span></span></span></p>"
        },
        {
          "id": 153302,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peg-Shaped Teeth are seen</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old girl is brought to the clinic by her parents due to skin lesions that have been present since birth. The lesions initially appeared as blisters on her trunk and limbs as shown below, then evolved into wart-like rashes that followed a linear pattern. Currently, they have a swirled hyperpigmentation. The child&#39;s growth and development have been otherwise normal. The parents are concerned about the progression and the appearance of the skin lesions. Which of the following statement is INCORRECT about this disease? </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-181027.JPG\" style=\"height:273px; width:200px\" /></p>",
      "unique_key": "Q3946947",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717433,
      "difficulty_level": "difficult",
      "subjects_id": [
        18
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Peg-Shaped Teeth are seen</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peg-shaped teeth with a notch in biting edge of incisors are seen in <strong>congenital syphilis.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-181043.JPG\" style=\"height:206px; width:300px\" /></strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is more common in girls</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incontinentia pigmenti (IP) is indeed more common in girls due to its <strong>X-linked dominant </strong>inheritance pattern, which is often <strong>lethal </strong>in utero for <strong>males</strong>, leading to a <strong>predominance</strong> of the condition in <strong>females</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lesions follow Blaschko&#39;s lines</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. In IP, the skin lesions typically follow Blaschko&#39;s lines, which are patterns of <strong>skin development</strong> that are <strong>invisible</strong> <strong>except</strong> when <strong>revealed </strong>by certain<strong> skin conditions</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mutation in IKBKG gene. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IP is caused by <strong>mutations</strong> in the <strong>IKBKG gene</strong> (also known as <strong>NEMO</strong>), which is involved in the <strong>regulation </strong>of<strong> immune responses</strong> and <strong>protection against cell death</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Peg-shaped teeth</strong> are an associated feature of <strong>congenital syphilis,&nbsp;</strong>NOT&nbsp;<strong>incontinentia pigmenti.</strong>&nbsp;I<strong>ncontinentia pigmenti</strong>&nbsp;presents with <strong>skin lesions</strong> that follow<strong> Blaschko&#39;s</strong> lines and is <strong>more common in girls</strong> due to its <strong>X-linked dominant </strong>inheritance pattern.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Rook&rsquo;s Textbook of Dermatology, 9<sup>th</sup> Edition, Page No. 70.11</span></span></strong></span></span></p>",
      "correct_choice_id": 153302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38608,
      "choices": [
        {
          "id": 154175,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Caudal Anaesthesia</span></span></span></p>"
        },
        {
          "id": 154176,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Spinal Anaesthesia</span></span></span></p>"
        },
        {
          "id": 154177,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Epidural Anesthesia</span></span></span></p>"
        },
        {
          "id": 154178,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Saddle Anesthesia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 3-month-old child is undergoing surgical repair of umbilical hernia under general anesthesia. Identify the procedure performed in the picture below.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-160847.JPG\" style=\"height:175px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q2130205",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739957,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Caudal Anaesthesia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Caudal anesthesiais a common <strong>regional anesthetic technique</strong> used in <strong>children</strong> for surgeries <strong>below</strong> the <strong>umbilicus</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The procedure involves <strong>inserting</strong> a <strong>needle</strong> through the <strong>sacral hiatus</strong> to <strong>access</strong> the <strong>epidural space</strong> at the <strong>caudal end</strong> of the <strong>spinal column</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This matches the <strong>procedure depicted</strong> in the <strong>image</strong>, where the <strong>landmarks</strong> of the <strong>sacral cornua</strong> are used to <strong>guide needle insertion</strong>.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The above image shows a <strong>caudal block </strong>which is a type of <strong>central neuraxial block</strong>, most commonly used in <strong>pediatrics</strong> to <strong>provide analgesia</strong> for <strong>surgeries</strong> up to the <strong>umbilicus</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Spinal anesthesia</strong> involves the <strong>injection</strong> of <strong>anesthetic</strong> into the <strong>subarachnoid space</strong> and is <strong>typically performed</strong> at <strong>higher levels</strong> of the <strong>spine</strong>, not at the sacral hiatus. Spinal anesthesia is not commonly used in infants due to the risks associated with administering a spinal block at such a young age.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Epidural anesthesia. </span></strong><span style=\"font-size:14.0pt\">Similar to caudal anesthesia, Epidural anesthesia technique involves the <strong>injection</strong> of <strong>anesthetic</strong> into the <strong>epidural space</strong>, but it is usually <strong>performed</strong> at <strong>higher vertebral levels</strong>. While the <strong>caudal block</strong> is a <strong>type</strong> of <strong>epidural anesthesia</strong>, the term &quot;<strong>epidural anesthesia</strong>&quot; alone usually refers to <strong>lumbar</strong> or <strong>thoracic epidural injections</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Saddle anesthesia</strong> is a <strong>specific type</strong> of <strong>spinal anesthesia</strong> that <strong>affects</strong> only the <strong>lower extremities</strong> and <strong>perineal area</strong>, resembling the <strong>area</strong> where a <strong>saddle</strong> would be. This type of block is not depicted in the image, as it would not be performed in the sacral area for an umbilical hernia repair.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Caudal anesthesia</span></strong><span style=\"font-size:14.0pt\"> is a <strong>form</strong> of <strong>regional anesthesia</strong> used <strong>primarily</strong> in the <strong>pediatric population</strong> for <strong>procedures below</strong> the <strong>umbilicus</strong>, <strong>utilizing</strong> the <strong>sacral hiatus</strong> as the <strong>entry point</strong> for the <strong>anesthetic</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is <strong>commonly used</strong> due to its <strong>safety</strong> and <strong>effectiveness</strong> for <strong>sub-umbilical surgical procedures</strong> in <strong>children</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38709,
      "choices": [
        {
          "id": 154579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">CD4+ T cell count</span></span></span></p>"
        },
        {
          "id": 154580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Viral load</span></span></span></p>"
        },
        {
          "id": 154581,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">p24 antigen</span></span></span></p>"
        },
        {
          "id": 154582,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Viral serotype</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy?</span></span></p>",
      "unique_key": "Q8558268",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755385,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Viral load</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">NACO recommends Viral load monitoring every 6,12 months and then every 12 months.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Virological suppression = &le;1000 copies after 6 months of ART initiation with &ge;95% ART adherence.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. CD4+ T cell count. </span></strong><span style=\"font-size:14.0pt\">CD4 count monitoring recommended every 6 months only in patients on 1st line ART.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. p24 antigen. </span></strong><span style=\"font-size:14.0pt\">p24 capture is not recommended for following and used in the diagnosis during window period.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Viral serotype. </span></strong><span style=\"font-size:14.0pt\">Viral serotyping is not recommended to monitor efficacy of treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-122150.JPG\" style=\"height:249px; width:400px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Earliest to detect failure is viral load &rarr; CD4 count &rarr; Clinical parameters.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ref: NACO 2021 guidelines</span></strong></span></span></p>",
      "correct_choice_id": 154580,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38537,
      "choices": [
        {
          "id": 153891,
          "text": "<p><span style=\"font-size:14.0pt;\">Anaplastic carcinoma</span></p>"
        },
        {
          "id": 153892,
          "text": "<p><span style=\"font-size:14.0pt;\">Medullary carcinoma</span></p>"
        },
        {
          "id": 153893,
          "text": "<p><span style=\"font-size:14.0pt;\">Papillary thyroid carcinoma</span></p>"
        },
        {
          "id": 153894,
          "text": "<p><span style=\"font-size:14.0pt;\">Metastatic renal cell carcinoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 40-year-old woman has noted enlargement of her anterior neck region over the past 8 months. On physical examination, her vital signs include Temperature of 36.8C, Pulse rate of 64/minute, RR of 16/minute, and BP of 155/105 mm Hg. There is diffuse, symmetrical thyroid enlargement without tenderness. A chest radiograph is normal. Fine needle aspiration of the thyroid yields cells consistent with a neoplasm. She is taken to surgery and frozen sections of several thyroid masses show a malignant neoplasm composed of polygonal cells in nests. A thyroidectomy is performed. Immunostaining for calcitonin of the permanent sections is positive, and the neoplasm has an amyloid stroma with Congo red staining. Which of the following neoplasms is she most likely to have?</span></p>",
      "unique_key": "Q8487809",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734686,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Ans. B) Medullary carcinoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">The patient's clinical findings, including diffuse symmetrical thyroid enlargement, euthyroid status, elevated serum ionized calcium, and the histological features of polygonal cells in nests with positive calcitonin immunostaining and amyloid stroma, are characteristic of medullary thyroid carcinoma (MTC).</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">MTC arises from the parafollicular C cells of the thyroid, which produce calcitonin. The presence of amyloid (which stains with Congo red) in the stroma of the tumor is a classic finding for MTC.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Elevated levels of calcitonin can also lead to hypercalcemia, which is noted in the patient's lab findings.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Option A. Anaplastic carcinoma.</strong> This is a highly aggressive form of thyroid cancer that typically presents in older patients and has a rapid, painful enlargement of the neck. Histologically, it would not show the features described, such as calcitonin positivity or amyloid stroma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Option C. Papillary thyroid carcinoma.</strong> This is the most common type of thyroid cancer and often presents with a solitary thyroid nodule rather than diffuse enlargement. Histologically, it is characterized by papillary structures with orphan Annie eye nuclei, psammoma bodies, and is not associated with amyloid stroma or elevated calcitonin levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Option D. Metastatic renal cell carcinoma.</strong> Metastasis to the thyroid can occur, but it is relatively rare and would not typically present with the described histological findings. Also, renal cell carcinoma would not cause elevated calcitonin levels.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">The diagnosis of medullary thyroid carcinoma is supported by the clinical presentation of a thyroid mass, the histological findings of polygonal cells arranged in nests with amyloid stroma, positive calcitonin immunostaining, and associated hypercalcemia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Medullary thyroid carcinoma is a distinct entity from other forms of thyroid cancer, with unique clinical, histological, and biochemical profiles.</span></p></li><li><span style=\"font-size:18px;\">Although calcitonin physiologically lowers calcium levels, in MTC:</span><ul><li><span style=\"font-size:18px;\">The amount of calcitonin produced is not enough to overcome other factors</span></li><li><span style=\"font-size:18px;\">In some cases, hypercalcemia is due to co-secretion of PTH-related peptide (PTHrP) or other paraneoplastic mechanisms</span></li></ul></li><li><span style=\"font-size:18px;\">Rarely, hypercalcemia may result from:</span><ul><li><span style=\"font-size:18px;\">Bone metastases causing local bone resorption</span></li><li><span style=\"font-size:18px;\">Other neuroendocrine peptides altering calcium homeostasis</span></li><li><span style=\"font-size:18px;\">So, even though calcitonin is secreted, paradoxical hypercalcemia can occur in some MTC patients.</span></li></ul></li></ul>",
      "correct_choice_id": 153892,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38528,
      "choices": [
        {
          "id": 153855,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Miliary tuberculosis </span></span></span></p>"
        },
        {
          "id": 153856,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Metastatic carcinoma </span></span></span></p>"
        },
        {
          "id": 153857,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic renal failure </span></span></span></p>"
        },
        {
          "id": 153858,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Congestive heart failure</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 60-year-old man has had increasing lethargy for the past year. On physical examination, he has an audible friction rub. He is afebrile. An echocardiogram shows normal valvular motion. The pericardial cavity has been opened here to reveal the epicardial surface representative of this man&#39;s disease. Which of the following underlying conditions would you most strongly suspect contributed to the appearance of the process shown here? </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-110251.JPG\" style=\"height:285px; width:200px\" /></p>",
      "unique_key": "Q9710036",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734047,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Chronic renal failure</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This fibrinous pericarditis results from inflammation with exudation of fibrin to form the grossly shaggy appearance. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Renal failure with uremia is the most likely cause for fibrinous pericarditis in hospitalized persons. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the context of a 60-year-old man presenting with increasing lethargy, an audible friction rub, and normal valvular motion on an echocardiogram, the finding of changes in the epicardial surface upon opening the pericardial cavity is highly suggestive of uremic pericarditis, which is associated with chronic renal failure. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uremic pericarditis occurs due to the accumulation of uremic toxins as a result of inadequate renal filtration. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition can lead to an inflammatory process in the pericardium, presenting as a friction rub due to the pericardial layers&#39; inflammation and resultant fibrinous exudate. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The absence of fever and the chronicity of the symptoms further support chronic renal failure as the underlying cause, given that uremic pericarditis can occur in the absence of overt signs of infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. </span></strong><strong><span style=\"font-size:14.0pt\">Miliary tuberculosis</span></strong><span style=\"font-size:14.0pt\"> could cause pericarditis as part of a disseminated infection. However, this would more likely present with systemic symptoms of tuberculosis, such as fever, night sweats, and weight loss, which are not highlighted in this scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. </span></strong><strong><span style=\"font-size:14.0pt\">Metastatic carcinoma </span></strong><span style=\"font-size:14.0pt\">can lead to pericardial involvement and pericarditis, but it would typically be accompanied by other signs or symptoms suggestive of malignancy, such as significant weight loss, night sweats, or a known primary cancer, which are not mentioned in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. </span></strong><strong><span style=\"font-size:14.0pt\">Congestive heart failure </span></strong><span style=\"font-size:14.0pt\">might lead to pericardial effusion, potentially causing a friction rub if the effusion is exudative. However, the echocardiogram findings in congestive heart failure typically include evidence of cardiac dysfunction, such as ventricular dilation or valvular abnormalities, which were not observed in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question emphasizes the recognition of uremic pericarditis as a complication of chronic renal failure. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of considering the patient&#39;s systemic symptoms, the absence of other typical symptoms of pericarditis causes, and the echocardiographic findings in making a differential diagnosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the link between chronic renal failure and uremic pericarditis is crucial for appropriate diagnosis and management, including the potential need for dialysis in advanced cases to remove uremic toxins and reduce inflammation.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153857,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38736,
      "choices": [
        {
          "id": 154687,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Femoropopliteal obstruction</span></span>&nbsp;</span></span></p>"
        },
        {
          "id": 154688,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortoiliac obstruction</span></span>&nbsp;</span></span></p>"
        },
        {
          "id": 154689,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iliac obstruction</span></span></span></span></p>"
        },
        {
          "id": 154690,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior</span></span><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> tibial obstruction</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient was being examined for suspected Peripheral Arterial Disease. On history, he had complaints of claudication in right calf. On examination, his right-sided femoral pulse was present but all pulses distal to that were absent. Left side was normal on examination.&nbsp;What is the most likely site of obstruction?</span></span></p>",
      "unique_key": "Q6488297",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757182,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)</span></span></strong><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Femoropopliteal obstruction</span></span></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sites of obstruction and their respective clinical findings:</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132619.JPG\" style=\"height:576px; width:1000px\" /></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical findings in this patient with peripheral arterial disease suggest an obstruction between the femoral artery and the branches that supply the lower leg, given the presence of femoral pulse and absence of pulses distal to the femoral artery on the affected side.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Bailey and Love&rsquo;s Short Practice of Surgery, 28th Edition, Page no. 998-1000</span></span></strong></span></span></p>",
      "correct_choice_id": 154687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38309,
      "choices": [
        {
          "id": 152995,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a transverse section of upper medulla</span></span></span></p>"
        },
        {
          "id": 152996,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The pointed structure is inferior olivary nucleus</span></span></span></p>"
        },
        {
          "id": 152997,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Efferents from inferior olivary nucleus form the parolivocerebellar fibres</span></span></span></p>"
        },
        {
          "id": 152998,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The efferents from inferior olivary nucleus reach the cerebellum through inferior cerebellar peduncle</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Which of the following statements is not true about the image below?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-161520.JPG\" style=\"height:224px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5483900",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714910,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Efferents from inferior olivary nucleus form the parolivocerebellar fibres</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The characteristic feature to identify the <strong>transverse section</strong> of <strong>upper medulla</strong> is the <strong>presence of inferior olivary nucleus</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inferior olivary nuclear complex consists of &ndash; <strong>principal inferior olivary nucleus</strong> (<strong>crumbled bag appearance</strong>), <strong>Medial</strong> &amp; <strong>dorsal accessory olivary nucleus</strong>, <strong>Efferents</strong> from <strong>principal inferior olivary nucleus</strong> forms the <strong>olivocerebellar fibres</strong> and <strong>Efferents from Medial</strong> &amp; <strong>dorsal accessory olivary nucleus</strong> forms the <strong>parolivocerebellar fibres</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A.</span></strong> <strong><span style=\"font-size:14.0pt\">It is a transverse section of upper medulla</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. Transverse section of Upper Medulla is commonly studied in <strong>neuroanatomy</strong> to understand the <strong>arrangement of various nuclei</strong> and <strong>fiber tracts</strong> at this level of the brainstem.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. </span><strong><span style=\"font-size:14.0pt\">The pointed structure is inferior olivary nucleus</span></strong><span style=\"font-size:14.0pt\">.</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> If the image shows a <strong>prominent</strong>, <strong>convoluted structure</strong> on <strong>either side</strong> of the <strong>midline</strong>, it is likely the <strong>inferior olivary nucleus</strong>. This nucleus is a <strong>distinctive feature</strong> in the <strong>medulla&#39;s cross section</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D.</span></strong> <strong><span style=\"font-size:14.0pt\">The efferents from inferior olivary nucleus reach the cerebellum through inferior cerebellar peduncle.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> The olivocerebellar fibers, originating from the inferior olivary nucleus, indeed <strong>cross over</strong> and <strong>ascend</strong> to the <strong>cerebellum</strong> via the <strong>inferior cerebellar peduncle</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Efferents from inferior olivary nucleus form the parolivocerebellar fibres: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The critical aspect to remember regarding the <strong>upper medulla</strong> is that the <strong>efferents</strong> from the <strong>inferior olivary nucleus</strong>, known as <strong>olivocerebellar fibers</strong>, project to the <strong>cerebellum</strong> through the <strong>inferior cerebellar peduncle</strong> and are <strong>vital</strong> for <strong>motor coordination</strong> and <strong>learning</strong>, not &quot;<strong>parolivocerebellar fibers</strong>&quot;.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ref: Vishram Singh, Textbook of Clinical Neuroanatomy, 2<sup>nd</sup> edition, page no. 76-77</span></strong></span></span></p>",
      "correct_choice_id": 152997,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38588,
      "choices": [
        {
          "id": 154095,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Critical path method</span></span></span></p>"
        },
        {
          "id": 154096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Program evaluation and review technique</span></span></span></p>"
        },
        {
          "id": 154097,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Management by objectives</span></span></span></p>"
        },
        {
          "id": 154098,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Total Quality management</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In health management, cost-benefit analysis (CBA) is a systematic approach to estimate the strengths and weaknesses of alternatives used to determine options that provide the best approach to achieve benefits while preserving savings. It is an example of which of the following management techniques?</span></span></span></p>",
      "unique_key": "Q4071957",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739067,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Total Quality management</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cost-benefit analysis is not an exclusive tool of Total Quality Management (TQM); however, it is often used within TQM frameworks. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">TQM is a management approach that seeks to improve quality and performance which will meet or exceed customer expectations. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It involves the continuous improvement of organizational processes, resulting in high-quality products and services. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cost-benefit analysis can be an essential part of the TQM process as it helps in making decisions that aim to maximize the value and quality for stakeholders while minimizing costs.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Critical path method</span></strong><span style=\"font-size:14.0pt\">. This is incorrect because the critical path method is a project management tool used to schedule project activities.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Program evaluation and review technique</span></strong><span style=\"font-size:14.0pt\">. This is also a project management tool that is used for scheduling, organizing, and coordinating tasks within a project.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Management by objectives</span></strong><span style=\"font-size:14.0pt\">. This is a performance management approach in which managers and employees work together to set, record, and monitor goals for a specific period.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cost-benefit analysis is a tool that can be utilized within a TQM framework to evaluate the potential costs and benefits associated with a project or initiative, helping to ensure high-quality outcomes and efficient use of resources.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38536,
      "choices": [
        {
          "id": 153887,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Poorly controlled diabetes mellitus</span></span></span></p>"
        },
        {
          "id": 153888,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pharyngitis three weeks ago</span></span></span></p>"
        },
        {
          "id": 153889,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">100 pack year history of smoking</span></span></span></p>"
        },
        {
          "id": 153890,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recent hemoptysis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 26-year-old man has the onset of nausea and lethargy over the past 3 days. On physical examination, his blood pressure is 146/94 mm Hg. His serum creatinine is 4.4 mg/dL. Urinalysis shows hematuria and proteinuria. He has anti-glomerular basement membrane antibody. A renal biopsy is performed and the microscopic appearance with H&amp;E stain is shown here. Which of the following historical findings is this patient most likely to provide?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-110352.JPG\" style=\"height:241px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8175589",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Recent hemoptysis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The biopsy image shown is characteristic of anti-glomerular basement membrane disease, also known as <strong>Goodpasture syndrome</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The epithelial crescents in Bowman&#39;s space shown here are indicative of a rapidly progressive (crescentic) glomerulonephritis (RPGN). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">One form of RPGN is Goodpasture syndrome, caused by anti-glomerular basement membrane antibodies, and the lungs can be affected, leading to acute pulmonary hemorrhage and hemoptysis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is characterized by the presence of anti-glomerular basement membrane antibodies that attack the basement membrane in the kidneys and lungs. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of nausea and lethargy is consistent with renal failure, which is reflected in the elevated serum creatinine level. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hematuria and proteinuria are indicative of kidney damage. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of these antibodies and the acute onset of symptoms suggest an autoimmune process rather than a chronic disease like diabetes or a post-infectious condition like post-streptococcal glomerulonephritis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The fact that the patient has experienced recent hemoptysis is significant and characteristic for Goodpasture syndrome, which often presents with pulmonary hemorrhage, as well as renal failure.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Poorly controlled diabetes mellitus.</span></strong><span style=\"font-size:14.0pt\"> While diabetes can lead to kidney damage and end-organ disease, the biopsy does not show the nodular glomerulosclerosis typical of diabetic nephropathy. Moreover, diabetes does not typically present with anti-glomerular basement membrane antibody or hemoptysis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Pharyngitis three weeks ago.</span></strong><span style=\"font-size:14.0pt\"> A history of pharyngitis followed by kidney problems could suggest post-streptococcal glomerulonephritis. However, the presence of anti-glomerular basement membrane antibody and the renal biopsy findings are not characteristic of post-streptococcal glomerulonephritis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. 100 pack year history of smoking.</span></strong><span style=\"font-size:14.0pt\"> While smoking is a risk factor for many diseases, including those affecting the lungs and kidneys, it does not cause the production of anti-glomerular basement membrane antibodies, nor is it associated with the specific biopsy findings shown.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image provided is indicative of anti-glomerular basement membrane disease, also known as <strong>Goodpasture syndrome</strong>, which often presents with both renal and pulmonary symptoms, including hemoptysis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is characterized by the presence of anti-glomerular basement membrane antibodies and the associated clinical findings of renal failure (elevated creatinine, hematuria, and proteinuria). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The diagnosis can be confirmed with a renal biopsy showing characteristic histological findings.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153890,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38597,
      "choices": [
        {
          "id": 154131,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Infant Mortality Rate (IMR)</span></span></span></p>"
        },
        {
          "id": 154132,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Child mortality</span></span></span></p>"
        },
        {
          "id": 154133,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Child undernourishment</span></span></span></p>"
        },
        {
          "id": 154134,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Child underweight</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A health policy analyst is examining the components used by the International Food Policy Research Institute to calculate the Global Hunger Index (GHI) for a country. The GHI is a tool that measures and tracks hunger globally, using specific indicators to assess the state of hunger in countries. Given the following parameters for a country:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Proportion of undernourished population: 27%</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prevalence of underweight children: 25%</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mortality rate of children under 5 years: 29%</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Infant mortality rate (IMR): 20%</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Which of the following indicators is NOT utilized in the calculation of the Global Hunger Index?</span></span></span></p>",
      "unique_key": "Q6919264",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739526,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Infant Mortality Rate (IMR)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Global Hunger Index primarily focuses on undernourishment and its direct impact on children, specifically considering the prevalence of underweight children and child mortality (under-5 mortality rate) as key components. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Infant Mortality Rate (IMR), while an important indicator of overall child health and healthcare quality, is not directly included in the GHI calculation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Child mortality.</span></strong><span style=\"font-size:14.0pt\"> This is included as one of the key components in calculating the GHI, reflecting the mortality rate of children under 5 years.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Child undernourishment.</span></strong><span style=\"font-size:14.0pt\"> The proportion of the undernourished population, including children, is a critical component in assessing the overall hunger situation in the GHI.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Child underweight.</span></strong><span style=\"font-size:14.0pt\"> The prevalence of underweight children under the age of five is another essential indicator used in the GHI to assess malnutrition and hunger.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To capture the multidimensional nature of hunger, GHI scores are based on the <strong>following indicators</strong>:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-132121.JPG\" style=\"height:375px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 154131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38690,
      "choices": [
        {
          "id": 154503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Cystic medial necrosis</span></span></span></p>"
        },
        {
          "id": 154504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Smoking</span></span></span></p>"
        },
        {
          "id": 154505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Aortitis</span></span></span></p>"
        },
        {
          "id": 154506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Atherosclerotic inflammation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 34-year-old male with Marfan syndrome presents with acute chest pain, worsening with deep breathing, and recent fatigue. Vital signs include blood pressure of 130/85 mmHg, heart rate of 102 bpm, and oxygen saturation of 94%. Considering his background and symptoms, what is the most likely cause?</span></span></span></p>",
      "unique_key": "Q3227806",
      "question_audio": null,
      "question_video": null,
      "map_id": 3752486,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Cystic medial necrosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Cystic medial necrosis is a degenerative condition of the connective tissue in the aorta, leading to weakening of the aortic wall. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">In patients with Marfan syndrome, there is an increased predisposition to cystic medial necrosis due to the underlying defect in fibrillin-1, a protein essential for the integrity of connective tissue. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">This condition can lead to aortic dilatation, dissection, or rupture, which could present as acute chest pain and tightness, especially in the context of Marfan syndrome. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">The acute presentation and the patient&#39;s background strongly suggest an aortic complication, likely stemming from cystic medial necrosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Smoking</span></strong><span style=\"font-size:14.0pt\"> is a risk factor for many cardiovascular diseases, including coronary artery disease, but it is less likely to be the immediate cause of acute chest pain in a young patient with Marfan syndrome and no history of smoking.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Aortitis&nbsp;</span></strong><span style=\"font-size:14.0pt\">inflammation of the aorta, can cause chest pain but is more commonly associated with infectious or inflammatory diseases such as Takayasu arteritis or giant cell arteritis, neither of which is indicated by this patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Atherosclerotic inflammation</span></strong><span style=\"font-size:14.0pt\"> is a leading cause of ischemic heart disease; however, it is less common in young individuals without significant risk factors such as hyperlipidemia, diabetes, or a long history of smoking. Furthermore, the clinical scenario is more suggestive of a structural complication related to Marfan syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">In patients with Marfan syndrome, there is an increased predisposition to cystic medial necrosis due to the underlying defect in fibrillin-1, a protein essential for the integrity of connective tissue.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38596,
      "choices": [
        {
          "id": 154127,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">More than 80% of the meal&#39;s caloric content should come from fat</span></span></span></p>"
        },
        {
          "id": 154128,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The meal should contain more than 2000 kcal from fat</span></span></span></p>"
        },
        {
          "id": 154129,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The meal should provide 400 kcal from carbohydrates</span></span></span></p>"
        },
        {
          "id": 154130,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The total caloric content of the meal should range between 800 and 1000 kcal</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of dietary guidelines for specific health conditions, the FDA has outlined the composition of an approved high-fat meal. When considering the caloric distribution and content of such a meal, which of the following statements accurately reflects the FDA&#39;s standards?</span></span></p>",
      "unique_key": "Q3951195",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739375,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) The total caloric content of the meal should range between 800 and 1000 kcal</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The FDA-approved high-fat meal guidelines specify that the total caloric content should be within the range of 800 to 1000 kcal. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is designed to ensure a controlled intake while providing adequate nutrients, including proteins, carbohydrates, and fats. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The meal is structured to cater to specific dietary needs, possibly for medical purposes, with a substantial but controlled fat content.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. More than 80% of the meal&#39;s caloric content should come from fat</span></strong><span style=\"font-size:14.0pt\">. This is incorrect as the FDA guidelines specify that the percent calories from fat should be more than 50%, not 80%.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. The meal should contain more than 2000 kcal from fat</span></strong><span style=\"font-size:14.0pt\">. This is not aligned with the guidelines, as the total caloric content of the meal is meant to be between 800 and 1000 kcal, with 500-600 kcal from fat.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The meal should provide 400 kcal from carbohydrates</span></strong><span style=\"font-size:14.0pt\">. This exceeds the specified amount in the guidelines, which is 250 kcal from carbohydrates.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Composition of a High-Fat Meal (FDA):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Total Calories</span></strong><span style=\"font-size:14.0pt\">: 800-1000</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Calories from Protein</span></strong><span style=\"font-size:14.0pt\">: 150 kcal</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Calories from Carbohydrates</span></strong><span style=\"font-size:14.0pt\">: 250 kcal</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Calories from Fat</span></strong><span style=\"font-size:14.0pt\">: 500-600 kcal</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Percent Calories from Fat</span></strong><span style=\"font-size:14.0pt\">: &gt;50%</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154130,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38612,
      "choices": [
        {
          "id": 154191,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Unconsciousness</span></span></span></p>"
        },
        {
          "id": 154192,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Pain Relief</span></span></span></p>"
        },
        {
          "id": 154193,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Loss of Reflexes </span></span></span></p>"
        },
        {
          "id": 154194,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Muscle Relaxation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Which of these is NOT a property of volatile anaesthetic agents?</span></span></span></p>",
      "unique_key": "Q4754347",
      "question_audio": null,
      "question_video": null,
      "map_id": 3740121,
      "difficulty_level": "difficult",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Ans. B) Pain Relief </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is generally <strong>not considered</strong> a <strong>primary property</strong> of <strong>volatile anaesthetic agents</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While they can <strong>contribute</strong> to <strong>overall anesthesia</strong>, they <strong>do not provide</strong> significant <strong>analgesia</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The main analgesic inhalational agents are <strong>nitrous oxide </strong>and<strong> xenon</strong>.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Properties of volatile anaesthetic agents:</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Amnesia </span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Muscle relaxation</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Loss of reflexes </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A</span></strong><span style=\"font-size:14.0pt\">. <strong>Unconsciousness.</strong> <strong>Volatile anaesthetic agents</strong> are known to induce a <strong>reversible loss of consciousness</strong>, making them <strong>essential for general anesthesia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C</span></strong><span style=\"font-size:14.0pt\">. <strong>Loss of Reflexes.</strong> <strong>Volatile anaesthetics</strong> can <strong>diminish or abolish reflexes</strong>, which is <strong>important</strong> during <strong>surgical procedures</strong> to <strong>prevent</strong> <strong>spontaneous movements</strong> and <strong>potential injury</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Muscle Relaxation.</strong> These agents also contribute to <strong>muscle relaxation</strong>, which is necessary for some types of <strong>surgical procedures</strong>, though often, <strong>additional muscle relaxants</strong> are used to <strong>achieve adequate relaxation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Volatile anaesthetic agents are used in general anesthesia for their <strong>ability to induce unconsciousness</strong>, <strong>muscle relaxation</strong>, and <strong>suppression of reflexes</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They <strong>do not provide</strong> significant <strong>pain relief</strong>, which is why additional analgesic agents, such as <strong>opioids</strong>, <strong>are often administered</strong> <strong>concurrently</strong> during surgery. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Nitrous oxide</span></strong><span style=\"font-size:14.0pt\"> and <strong>xenon</strong> are unique among inhalational agents in that they also have analgesic properties.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38423,
      "choices": [
        {
          "id": 153447,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Menarche</span></span></span></p>"
        },
        {
          "id": 153448,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pubarche</span></span></span></p>"
        },
        {
          "id": 153449,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thelarche</span></span></span></p>"
        },
        {
          "id": 153450,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Growth spurt</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 12-year-old girl presents to the pediatric clinic with her mother for a routine health check-up. Her mother expresses concern that her daughter has not yet started menstruating, whereas some of her classmates have. The pediatrician explains the sequence of events in female puberty to reassure the mother and daughter about the normal progression of puberty. Which of the following generally occurs first among the major developmental events of female puberty?</span></span></span></p>",
      "unique_key": "Q4399754",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719450,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Thelarche</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thelarche, the onset of breast development, is generally the first sign of puberty in females and typically occurs between the ages of 8 and 13. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It marks the beginning of pubertal development and is followed by other pubertal milestones. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thelarche is the result of estrogen stimulation of breast tissue and is considered the initial physical sign of puberty in most girls.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Menarche</span></strong><span style=\"font-size:14.0pt\">. Menarche, the first occurrence of menstruation, typically occurs later in the pubertal process, usually around 2 to 2.5 years after the onset of thelarche, and is one of the later signs of puberty in females.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Pubarche</span></strong><span style=\"font-size:14.0pt\">. Pubarche, the development of pubic and axillary hair, occurs due to the increased production of adrenal androgens and often follows thelarche but can sometimes occur concurrently. It is not typically the first sign of puberty.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Growth spurt</span></strong><span style=\"font-size:14.0pt\">. The growth spurt in females usually occurs after thelarche and just before or around the time of peak pubertal changes, including menarche. While it is a significant pubertal event, it does not usually occur first.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the typical sequence of pubertal events in females is crucial for assessing normal development and identifying potential developmental disorders. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thelarche, or the onset of breast development, generally marks the beginning of puberty in females and is followed by other events such as pubarche, the growth spurt, and menarche. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing the normal progression of these milestones allows for the timely identification and management of any deviations from expected developmental patterns.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38692,
      "choices": [
        {
          "id": 154511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Metabolic alkalosis</span></span></span></p>"
        },
        {
          "id": 154512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Metabolic acidosis</span></span></span></p>"
        },
        {
          "id": 154513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Respiratory alkalosis</span></span></span></p>"
        },
        {
          "id": 154514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Respiratory acidosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">A 55-year-old male presented with tachypnea and mental confusion. His blood sugar is 350 mg/dL, pH is 7.2, HCO<sub>3</sub><sup></sup> is 10 mEq/L, and pCO<sub>2</sub> is 25 mmHg. What is the metabolic abnormality?</span></span></span></p>",
      "unique_key": "Q9316704",
      "question_audio": null,
      "question_video": null,
      "map_id": 3752558,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Metabolic acidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Steps:</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">pH is on acidic side.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">HCO<sub>3</sub><sup>-</sup> in on acidic side (&lt; 24 mEq/L), while pCO<sub>2</sub> is on basic side (&lt; 35 mmHg).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Therefore, Metabolic acidosis is the main metabolic abnormality which was compensated by respiratory system via decreasing pCO<sub>2</sub> values.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38462,
      "choices": [
        {
          "id": 153599,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serotonin syndrome</span></span></span></p>"
        },
        {
          "id": 153600,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neuroleptic malignant syndrome (NMS)</span></span></span></p>"
        },
        {
          "id": 153601,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Heat stroke</span></span></span></p>"
        },
        {
          "id": 153602,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Malignant hyperthermia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old male with a history of bipolar disorder is brought to the emergency department by his family due to altered mental status, fever, and muscle rigidity. His family notes that he was recently started on a new medication for his psychiatric condition. On examination, the patient is febrile with a temperature of 39.2&deg;C (102.5&deg;F), has marked muscle rigidity, and is diaphoretic. His blood pressure is 160/90 mmHg, and his heart rate is 110 bpm. Laboratory tests reveal elevated creatine kinase levels. The patient&#39;s mental status is fluctuating, and he seems confused. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q4912107",
      "question_audio": null,
      "question_video": null,
      "map_id": 3720073,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Neuroleptic malignant syndrome (NMS)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neuroleptic malignant syndrome (NMS) is a life-threatening reaction to neuroleptic or antipsychotic drugs, characterized by fever, altered mental status, muscle rigidity, autonomic dysregulation (such as hypertension and tachycardia), and elevated creatine kinase levels. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s recent initiation of a psychiatric medication, likely an antipsychotic, combined with the clinical presentation, strongly suggests NMS. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Management includes immediate cessation of the offending agent and supportive care, which may include hydration, cooling measures, and administration of medications like dantrolene or bromocriptine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Serotonin syndrome.</span></strong><span style=\"font-size:14.0pt\"> This condition is caused by excessive serotonergic activity and presents with symptoms such as agitation, confusion, rapid heart rate, dilated pupils, muscle rigidity, and in severe cases, seizures. It is more commonly associated with the use of serotonergic drugs, like SSRIs, and the clinical presentation can overlap with NMS, but the rapid onset after medication change and prominent gastrointestinal symptoms can help differentiate it.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Heat stroke.</span></strong><span style=\"font-size:14.0pt\"> This is a form of hyperthermia associated with a systemic inflammatory response leading to a syndrome of multi-organ dysfunction. It occurs due to environmental heat exposure or strenuous physical activity and not due to medication. Key features include a core body temperature above 40&deg;C (104&deg;F) and central nervous system dysfunction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Malignant hyperthermia.</span></strong><span style=\"font-size:14.0pt\"> This is a rare but severe reaction to certain general anesthetics and neuromuscular blocking drugs, characterized by rapid onset of high fever, severe muscle contractions, and a high heart rate. It is genetically inherited and not triggered by antipsychotic medications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neuroleptic malignant syndrome is a severe adverse reaction to antipsychotic medications, characterized by fever, altered mental status, muscle rigidity, autonomic dysregulation, and elevated creatine kinase levels. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153600,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38722,
      "choices": [
        {
          "id": 154631,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marasmus </span></span></span></span></p>"
        },
        {
          "id": 154632,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kwashiorkor </span></span></span></span></p>"
        },
        {
          "id": 154633,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indian childhood cirrhosis </span></span></span></span></p>"
        },
        {
          "id": 154634,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatric patient who has a diet consisting solely of rice presents with stunted growth and a clinical picture that includes edema. Laboratory tests reveal a total protein of 5 mg/dL and albumin of 2.5 mg/dL. Which of the following is the most likely diagnosis?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-125456.JPG\" style=\"height:392px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q7291410",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756398,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Kwashiorkar</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kwashiorkor is a protein deficiency malnutrition, typically presenting with edema, poor growth, an enlarged liver, and other signs such as dermatosis and hair changes. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of edema, in this case, suggests this diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Marasmus</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a form of severe malnutrition characterized by energy deficiency; affected children typically present with muscle wasting and lack subcutaneous fat but do not generally exhibit edema.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Indian childhood cirrhosis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a condition primarily affecting the liver, leading to cirrhosis. While malnutrition can be a concern with cirrhosis, the primary clinical presentation would be liver-related symptoms, not just the growth retardation and edema.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Iron deficiency anemia</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> may cause growth retardation, but it does not typically result in the edema or the specific changes in serum protein and albumin seen here.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kwashiorkor is characterized by protein deficiency, leading to low total protein and albumin levels, with clinical features including edema and retarded growth.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154632,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38532,
      "choices": [
        {
          "id": 153871,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Low serum testosterone levels</span></span></span></p>"
        },
        {
          "id": 153872,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Positive family history of benign prostatic hyperplasia (BPH)</span></span></span></p>"
        },
        {
          "id": 153873,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High Gleason score</span></span></span></p>"
        },
        {
          "id": 153874,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated serum alkaline phosphatase levels</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 65-year-old man presents to the urology clinic with urinary hesitancy, frequency, and nocturia. Digital rectal examination reveals a firm, non-tender prostate with asymmetry and palpable nodules. Serum prostate-specific antigen (PSA) levels are significantly elevated. Transrectal ultrasound-guided biopsy is also suggestive of a malignancy. Which of the following factors is most strongly associated with an increased risk of aggressive disease and poor prognosis in prostate cancer?</span></span></span></p>",
      "unique_key": "Q1587326",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734321,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) High Gleason score</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gleason score is used to assess the aggressiveness of prostate cancer based on the microscopic appearance of cancer cells. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A high Gleason score (usually 8-10) indicates poorly differentiated and more aggressive cancer. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A higher Gleason score is associated with an increased risk of disease progression and poorer prognosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, a high Gleason score is a crucial factor in determining the aggressiveness of prostate cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Low serum testosterone levels</span></strong><span style=\"font-size:14.0pt\">. Low serum testosterone levels are not associated with an increased risk of aggressive prostate cancer. In fact, there is evidence to suggest that low levels of testosterone may be associated with a decreased risk of prostate cancer. Androgen deprivation therapy, which aims to lower testosterone levels, is sometimes used in the treatment of advanced prostate cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Positive family history of benign prostatic hyperplasia (BPH)</span></strong><span style=\"font-size:14.0pt\">. While a positive family history of prostate cancer is considered a risk factor for developing the disease, a family history of benign prostatic hyperplasia (BPH) specifically is not strongly associated with an increased risk of aggressive prostate cancer. Genetic factors play a role in prostate cancer risk, and having a first-degree relative with prostate cancer may slightly elevate the risk.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Elevated serum alkaline phosphatase levels</span></strong><span style=\"font-size:14.0pt\">. Elevated serum alkaline phosphatase levels are indicative of bone involvement in prostate cancer. Prostate cancer commonly metastasizes to bones, and elevated alkaline phosphatase is a marker of bone turnover. While this finding suggests advanced disease and bone metastasis, it is not directly associated with the aggressiveness of the primary tumor in the prostate. However, bone metastasis itself is a poor prognostic factor</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Gleason score is a grading system used to assess the aggressiveness of prostate cancer based on the microscopic appearance of cancer cells. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A high Gleason score (usually 8-10) indicates poorly differentiated and more aggressive cancer. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A higher Gleason score is associated with an increased risk of disease progression and poorer prognosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, a high Gleason score is a crucial factor in determining the aggressiveness of prostate cancer.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153873,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38318,
      "choices": [
        {
          "id": 153031,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">PAH is completely reabsorbed in the proximal tubule.</span></span></span></p>"
        },
        {
          "id": 153032,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">PAH is neither secreted nor reabsorbed, making it a perfect marker for glomerular filtration rate (GFR).</span></span></span></p>"
        },
        {
          "id": 153033,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Nearly all the PAH entering the kidneys is excreted in the urine, making it an excellent marker for renal plasma flow.</span></span></span></p>"
        },
        {
          "id": 153034,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">PAH is actively secreted in the distal tubule.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 28-year-old man participates in a renal function study where Para-Amino-Hippuric Acid (PAH) clearance is measured. He has no known health issues and is not on any medication. The study aims to assess his renal plasma flow (RPF) as part of a comprehensive renal function evaluation. PAH is known to be both filtered and secreted by the renal tubules, making it an effective compound for measuring RPF. Based on your understanding of renal physiology and the handling of PAH by the kidneys, which of the following statements best describes the renal handling of PAH?</span></span></span></p>",
      "unique_key": "Q8282797",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715209,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Nearly all the PAH entering the kidneys is excreted in the urine, making it an excellent marker for renal plasma flow.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">PAH is used in clinical settings to estimate renal plasma flow because it is both filtered by the glomerulus and actively secreted by the proximal tubule cells into the tubular lumen. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Almost all (about 90%) of the PAH entering the kidneys is cleared from the plasma in a single pass through the kidneys, making it an ideal substance for measuring the effective renal plasma flow (ERPF). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This high clearance rate is due to the fact that PAH is efficiently removed from the blood by the kidneys and excreted into the urine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. PAH is completely reabsorbed in the proximal tubule.</span></strong><span style=\"font-size:14.0pt\"> This is incorrect because PAH is primarily secreted by the proximal tubule cells into the tubular lumen, not reabsorbed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. PAH is neither secreted nor reabsorbed, making it a perfect marker for glomerular filtration rate (GFR).</span></strong><span style=\"font-size:14.0pt\"> This statement is incorrect because PAH is actively secreted by renal tubules, and it is used to measure renal plasma flow, not GFR. Inulin or creatinine clearance is more commonly used to estimate GFR.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. PAH is actively secreted in the distal tubule.</span></strong><span style=\"font-size:14.0pt\"> This is incorrect as PAH is actively secreted primarily by the proximal tubule cells, not the distal tubule.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The educational objective is to understand the role of PAH (Para-Amino-Hippuric Acid) in measuring renal plasma flow. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">PAH clearance is a valuable tool in assessing renal function because it is both filtered and actively secreted by the kidneys, with nearly all the PAH entering the kidneys being excreted in the urine. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This makes PAH clearance an excellent marker for estimating effective renal plasma flow, a crucial parameter in evaluating renal health and function.</span></span></li>\r\n</ul>",
      "correct_choice_id": 153033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38708,
      "choices": [
        {
          "id": 154575,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Mitral stenosis (MS)</span></span></span></p>"
        },
        {
          "id": 154576,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Tricuspid stenosis (TS)</span></span></span></p>"
        },
        {
          "id": 154577,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Mitral regurgitation (MR)</span></span></span></p>"
        },
        {
          "id": 154578,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Tricuspid regurgitation (TR)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Evaluation of a patient revealed the presence of a mid-diastolic murmur. JVP showed a prominent a-waves. What is the likely diagnosis?</span></span></span></p>",
      "unique_key": "Q3232529",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755334,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Tricuspid stenosis (TS)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Prominent a-waves suggest increase Right Atrium pressure and in the presence of MDM, suggest Tricuspid stenosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Mitral stenosis (MS). MS is associated with MDM</span></strong><span style=\"font-size:14.0pt\">; however prominent a wave is not common as these patients develop AF which causes absent a waves.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mitral regurgitation (MR). </span></strong><span style=\"font-size:14.0pt\">MR is associated with functional TR on the JVP.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Tricuspid regurgitation (TR). </span></strong><span style=\"font-size:14.0pt\">TR causes loss of x-descent causing CV-waves aka lancisi&rsquo;s sign.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-121913.JPG\" style=\"height:722px; width:940px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ref: Harrison&rsquo;s, Cardiology, Basics of CVS, Chapter - 239</span></strong></span></span></p>",
      "correct_choice_id": 154576,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38599,
      "choices": [
        {
          "id": 154139,
          "text": "<p><span style=\"font-size:14.0pt;\">Mala N</span></p>"
        },
        {
          "id": 154140,
          "text": "<p><span style=\"font-size:14.0pt;\">Progestasert</span></p>"
        },
        {
          "id": 154141,
          "text": "<p><span style=\"font-size:14.0pt;\">CuT 380 A</span></p>"
        },
        {
          "id": 154142,
          "text": "<p><span style=\"font-size:14.0pt;\">Depot formulation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 24-year-old female, currently breastfeeding an 18-month-old baby, presents with heavy and irregular menstrual bleeding. In considering the most appropriate contraceptive method for her, which of the following options would be the best recommendation?</span></p>",
      "unique_key": "Q9534897",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Mala N&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mala N:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Among the given options, Mala N, a combined oral contraceptive pill, is the contraceptive of choice for this lactating woman. It will help regulate her cycles and reduce the menstrual flow.</span></li><li><span style=\"font-size:14.0pt;\">Combined oral contraceptive pills (COCs) are contraindicated in breastfeeding mothers for the first 6 months postpartum due to potential effects on milk production. However, after 6 months, they can be safely used.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Progestasert</strong>: Progestasert is a progesterone-releasing intrauterine device. Progesterone-containing contraceptives can cause irregular bleeding, which is not desirable for this patient who already has irregular and heavy bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. CuT 380A</strong>: Copper-T 380A is a non-hormonal intrauterine device that may exacerbate heavy menstrual bleeding and would not be suitable for a patient already experiencing heavy bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Depot formulation:</strong> Refers to depot medroxyprogesterone acetate (DMPA), a hormonal contraceptive injection that is safe during breastfeeding and has minimal effects on milk supply. However, it may cause irregular bleeding patterns and delay the return of fertility after discontinuation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For a lactating woman with a history of irregular and heavy menstrual bleeding, a combined oral contraceptive pill (COC) like Mala N is the preferred choice after the first 6 months postpartum as it helps regulate menstrual cycles and reduce menstrual flow.</span></p>",
      "correct_choice_id": 154139,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38632,
      "choices": [
        {
          "id": 154271,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Retinitis Pigmentosa </span></span></span></p>"
        },
        {
          "id": 154272,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Diabetic Retinopathy </span></span></span></p>"
        },
        {
          "id": 154273,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Central Retinal Vein Occlusion </span></span></span></p>"
        },
        {
          "id": 154274,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Age-related Macular Degeneration</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Fenretinide is a new agent under trial for which of the following conditions?</span></span></span></p>",
      "unique_key": "Q7270026",
      "question_audio": null,
      "question_video": null,
      "map_id": 3740551,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Ans. D) Age-related Macular Degeneration</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Fenretinide</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"> is a <strong>new drug</strong> under <strong>clinical trial</strong> in <strong>ARMD</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\">Visual cycle modulation</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:14.0pt\"> occurs by <strong>ameliorating</strong> the <strong>formation</strong> of <strong>cytotoxic products</strong> by <strong>reducing</strong> the <strong>rate</strong> of <strong>vitamin A processing</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Fenretinide</span></span></span></strong><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">&nbsp;is a synthetic&nbsp;</span></span></span><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">retinoid</span></span></span><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">&nbsp;derivative. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Retinoids are substances related to vitamin A. </span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">It has been investigated for potential use in the treatment of&nbsp;</span></span></span><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">cancer</span></span></span><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">, as well as in the treatment of&nbsp;</span></span></span><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">cystic fibrosis</span></span></span><span style=\"font-size:14.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">,<sup> </sup>rheumatoid arthritis, acne, psoriasis, and has been found to also slow the production and accumulation of a toxin that leads to vision loss in Stargardt&#39;s patients.<sup> </sup></span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fenretinide competes with retinol and binds to retinol-binding protein (RBP). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The formation of the RBP-Fenretinide complex results in the reduction in retinol delivery and decreased accumulation of toxic visual cycle byproducts. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A phase II study which administered different doses of oral Fenretinide in Geographic Atrophy (a type of Dry ARMD) patients established that there was a reduction in Geographic Atrophy lesion growth rate and neovascularization (Wet ARMD) in treated subjects.</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug is under trial for controlling the DRY ARMD and preventing it from becoming WET ARMD which is more vision threatening. </span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-165909.JPG\" style=\"height:421px; width:700px\" /></span></span></p>",
      "correct_choice_id": 154274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38333,
      "choices": [
        {
          "id": 153091,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Addition of a 5&#39; cap</span></span></span></p>"
        },
        {
          "id": 153092,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Removal of introns via the spliceosome</span></span></span></p>"
        },
        {
          "id": 153093,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Incorporation of uracil in place of thymine</span></span></span></p>"
        },
        {
          "id": 153094,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Replication of the 3&#39; poly-A tail</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 26-year-old graduate student is conducting research on gene expression and is particularly interested in the processes that occur between transcription and translation in eukaryotic cells. She is focusing on how mRNA molecules are modified after transcription but before translation, which can affect the stability, localization, and translational efficiency of the mRNA. Which of the following best describes a common post-transcriptional modification in eukaryotic cells?</span></span></span></p>",
      "unique_key": "Q5128910",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Removal of introns via the spliceosome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The removal of introns via the spliceosome is a key post-transcriptional modification process in eukaryotic cells. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This process, known as <strong>RNA splicing</strong>, involves the spliceosome complex recognizing and excising introns (non-coding regions) from the pre-mRNA transcript and ligating the exons (coding regions) together. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This modification is crucial for generating a mature mRNA molecule that can be translated into a protein. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RNA splicing not only ensures the removal of non-coding sequences but also allows for alternative splicing, which can produce different mRNA variants from the same gene, leading to the synthesis of diverse proteins.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>A. Addition of a 5&#39; cap.</strong> This modification occurs co-transcriptionally, meaning it happens simultaneously with transcription, not after it. The 5&#39; cap is added to the 5&#39; end of the mRNA and plays a role in mRNA stability and initiation of translation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>C. Incorporation of uracil in place of thymine.</strong> This is not a post-transcriptional modification but rather a fundamental difference between DNA and RNA nucleotides, where RNA contains uracil instead of thymine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>D. Replication of the 3&#39; poly-A tail.</strong> The term &quot;<strong>replication</strong>&quot; is misleading in this context. The addition of a poly-A tail to the 3&#39; end of an mRNA molecule is a post-transcriptional modification, but it is not replicated. The polyadenylation process involves the enzymatic addition of adenine nucleotides to form a poly-A tail, which is important for mRNA stability and nuclear export.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to enhance understanding of post-transcriptional modifications in eukaryotic cells, focusing on the significance of RNA splicing mediated by the spliceosome. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This modification is crucial for the removal of non-coding introns from pre-mRNA, allowing for the production of mature mRNA that can be translated into functional proteins. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It also highlights the complexity of gene expression regulation and the role of alternative splicing in generating protein diversity.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38589,
      "choices": [
        {
          "id": 154099,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A panel of 4-8 experts discussing topics in front of an audience.</span></span></span></p>"
        },
        {
          "id": 154100,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An interactive discussion between 6-12 members focusing on a specific case.</span></span></span></p>"
        },
        {
          "id": 154101,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A series of four or more meetings designed for hands-on learning and discussion.</span></span></span></p>"
        },
        {
          "id": 154102,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A sequence of lectures on emergency medicine topics by various speakers.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A medical education director is planning a series of educational sessions focused on enhancing the practical skills of healthcare professionals in emergency medicine. The director intends to structure this as an interactive format, encouraging active participation and collaboration over several scheduled gatherings. In planning these sessions, which of the following best describes the format that the director is proposing?</span></span></span></p>",
      "unique_key": "Q3244764",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739168,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) A series of four or more meetings designed for hands-on learning and discussion.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The scenario describes an educational initiative aimed at enhancing practical skills through interactive and participatory sessions. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This format aligns with the description of a workshop, which is traditionally a series of meetings allowing for in-depth discussion, hands-on activities, and the development of specific competencies among participants. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Workshops are characterized by their interactive format and often extend over multiple sessions to allow for comprehensive coverage of the subject matter and the consolidation of learning through practice.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. A panel of 4-8 experts discussing topics in front of an audience</span></strong><span style=\"font-size:14.0pt\">. This option describes a panel discussion, which is more about experts presenting to an audience rather than engaging in hands-on learning.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. An interactive discussion between 6-12 members focusing on a specific case</span></strong><span style=\"font-size:14.0pt\">. This is indicative of small group learning but does not necessarily encompass the series of meetings or the hands-on component typical of a workshop.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. A sequence of lectures on emergency medicine topics by various speakers</span></strong><span style=\"font-size:14.0pt\">. This option outlines a lecture series, which typically involves passive learning through presentations and speeches rather than interactive, skill-based sessions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Workshop</span></strong><span style=\"font-size:14.0pt\">: Series of meetings usually &gt;4 with emphasis on individual work within the group to impart training.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Advantages of workshop</span></strong><span style=\"font-size:14.0pt\">: Learning takes place in a friendly, happy and democratic atmosphere, under expert guidance</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Disadvantages of workshop</span></strong><span style=\"font-size:14.0pt\">: Needs a lot of baseline ground work, Benefits a small no. of people</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38715,
      "choices": [
        {
          "id": 154603,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">70-90% from the vaccine alone and an additional 10-30% from HBIG </span></span></span></span></p>"
        },
        {
          "id": 154604,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">70-100% from the vaccine alone and an additional 10-30% from HBIG </span></span></span></span></p>"
        },
        {
          "id": 154605,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">70-90% from the vaccine alone and an additional 12-30% from HBIG </span></span></span></span></p>"
        },
        {
          "id": 154606,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">70-90% from the vaccine alone and an additional 10-40% from HBIG</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a neonate born to a mother who is hepatitis B surface antigen (HBsAg) positive, the administration of hepatitis B vaccine in conjunction with hepatitis B immunoglobulin (HBIG) confers what percentage of active immunity?</span></span></span></span></p>",
      "unique_key": "Q8150651",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755971,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 70-90% from the vaccine alone and an additional 10-30% from HBIG</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The hepatitis B vaccine alone provides 70-90% of active immunity. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When given in conjunction with HBIG, it is assumed to cover the remaining percentage up to 100%, so the additional immunity provided by HBIG would be in the range of 10-30%.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The hepatitis B vaccine provides 70-90% active immunity, and administration of hepatitis B immunoglobulin within 48-72 hours of life provides additional active immunity, which could potentially cover the gap up to 100% in a neonate born to a hepatitis B-positive mother.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38374,
      "choices": [
        {
          "id": 153251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alcohol</span></span></span></p>"
        },
        {
          "id": 153252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phenytoin</span></span></span></p>"
        },
        {
          "id": 153253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chloroquine</span></span></span></p>"
        },
        {
          "id": 153254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sulfasalazine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 48-year-old woman with a history of rheumatoid arthritis is being evaluated for new-onset fatigue and pallor. Laboratory tests reveal macrocytic anemia, suggesting megaloblastic anemia. Her dietary history is adequate, but further questioning reveals a subclinical folate deficiency. Given her medical history, you review her medications to identify potential contributors to her anemia. Among her current medications, which of the following is least likely to precipitate megaloblastic anemia in the context of her subclinical folate deficiency?</span></span></span></p>",
      "unique_key": "Q3606421",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716969,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Chloroquine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chloroquine, an antimalarial drug also used in the treatment of autoimmune diseases, has not been commonly associated with the induction of megaloblastic anemia through folate metabolism interference. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While it can have other hematological side effects, it is less likely than the other options to precipitate megaloblastic anemia in a patient with subclinical folate deficiency.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Alcohol</span></strong><span style=\"font-size:14.0pt\"> consumption can interfere with folate absorption and metabolism, potentially exacerbating folate deficiency and contributing to the development of megaloblastic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Phenytoin</span></strong><span style=\"font-size:14.0pt\">, an antiepileptic medication, can interfere with folate absorption and metabolism, leading to a decrease in serum folate levels and potentially precipitating megaloblastic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Sulfasalazine</span></strong><span style=\"font-size:14.0pt\">, used in the treatment of inflammatory bowel disease and rheumatoid arthritis, can also interfere with folate absorption and contribute to the development of megaloblastic anemia, especially in individuals with underlying folate deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the impact of certain medications on folate metabolism and their potential to precipitate megaloblastic anemia, especially in patients with underlying folate deficiency. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It underscores the importance of considering medication side effects in the differential diagnosis of macrocytic anemia and the need for careful medication review in patients with subclinical nutrient deficiencies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38716,
      "choices": [
        {
          "id": 154607,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left upper limb</span></span></span></span></p>"
        },
        {
          "id": 154608,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left lower limb </span></span></span></span></p>"
        },
        {
          "id": 154609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right upper limb </span></span></span></span></p>"
        },
        {
          "id": 154610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right lower limb </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a 3-minute-old preterm infant diagnosed with patent ductus arteriosus (PDA), to accurately assess pre-ductal oxygen saturation, the measurement should be taken from which limb?</span></span></span></span></p>",
      "unique_key": "Q3750633",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756072,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Right upper limb </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The right upper limb receives blood directly from the aorta via the brachiocephalic artery before the blood passes through the ductus arteriosus. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, it is the preferred site to measure pre-ductal oxygen saturation.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Left upper limb</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The left upper limb receives blood that has circulated through the aorta after the branching of the brachiocephalic artery; therefore, oxygen saturation in this limb would not represent pre-ductal saturation in the setting of a PDA.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Left lower limb</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The left lower limb receives post-ductal circulation, which includes blood that has mixed in the aorta due to the PDA, thus not providing an accurate pre-ductal saturation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Right lower limb</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Similar to the left lower limb, the right lower limb receives post-ductal circulation; hence, saturation here would not represent pre-ductal saturation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a newborn with PDA, pre-ductal oxygen saturation should be measured in the right upper limb, as it reflects the oxygen saturation of blood before it passes through the ductus arteriosus.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-125401.JPG\" style=\"height:357px; width:500px\" /></span></span></span></span></p>",
      "correct_choice_id": 154609,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38732,
      "choices": [
        {
          "id": 154671,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bulbar urethra</span></span></span></span></p>"
        },
        {
          "id": 154672,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extraperitoneal bladder rupture</span></span></span></span></p>"
        },
        {
          "id": 154673,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous urethra</span></span></span></span></p>"
        },
        {
          "id": 154674,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penile urethra</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male patient is brought to the emergency room after being involved in a motor vehicle accident. Upon examination, it is found that the patient is unable to pass urine and there is visible blood at the meatus. A retrograde urethrogram was performed as shown below. What is the most likely site of urethral injury? </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132415.JPG\" style=\"height:252px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q6358461",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757028,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Membranous urethra</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given the presentation of the patient &ndash; specifically the inability to pass urine, visible blood at the meatus after a motor vehicle accident and the RGU appearance &ndash; the membranous urethra is the most likely site of injury. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is because it is closely associated with pelvic fractures, which are common in such accidents. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management includes a retrograde urethrogram to confirm the injury, followed by the insertion of a suprapubic catheter to bypass the injured segment and allow for healing.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous urethral rupture is typically associated with pelvic fractures and presents with urinary retention, blood at the meatus, and a high-riding prostate on digital examination. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bruising may also be visible over the pubic area, scrotum, and penis. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine extravasates in perivesical space.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bulbar Urethra. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It&#39;s a common site of injury due to straddle injuries (like falling onto a bicycle crossbar) because of its exposed location. It would typically result in a perineal hematoma.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Extraperitoneal bladder rupture. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This occurs due to blow to pelvis, however no blood is seen at urethral meatus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Membranous Urethra. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The membranous urethra is the shortest and narrowest part of the male urethra and passes through the urogenital diaphragm. This segment is particularly vulnerable in cases of pelvic fractures, often seen in motor vehicle accidents. Clinical features, such as blood at the meatus and urinary retention as seen in the case, often point to an injury in this region. On rectal examination, a high-riding prostate may be palpated, indicating disruption of the urethra below the prostate. This choice aligns with the given scenario and is the correct answer.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Penile Urethra. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This portion is within the shaft of the penis, encased within the corpus spongiosum. Trauma to the penile urethra usually results from direct trauma to the penis, such as in the context of a penile fracture.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The inability to pass urine, visible blood at the meatus after a motor vehicle accident and the RGU appearance suggest that the membranous urethra is the most likely site of injury in the above case.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154673,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38701,
      "choices": [
        {
          "id": 154547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Headaches</span></span></span></p>"
        },
        {
          "id": 154548,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psychosis</span></span></span></p>"
        },
        {
          "id": 154549,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cognitive dysfunction</span></span></span></p>"
        },
        {
          "id": 154550,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Seizures</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 35-year-old female with well-controlled systemic lupus erythematosus (SLE) presents with memory lapses, difficulty concentrating, and confusion, with no history of psychiatric disorders or seizures. Considering her lupus background, what is the most common manifestation of diffuse CNS involvement in this condition?</span></span></span></p>",
      "unique_key": "Q1381273",
      "question_audio": null,
      "question_video": null,
      "map_id": 3754587,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Cognitive dysfunction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cognitive dysfunction is a common neuropsychiatric manifestation of SLE, affecting a significant proportion of patients with the disease. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It can range from mild cognitive impairment, including difficulties with memory, attention, executive function, and processing speed, to more severe forms of dysfunction. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cognitive dysfunction in SLE can occur even in the absence of other CNS manifestations of the disease and can significantly impact the quality of life.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Headaches</span></strong><span style=\"font-size:14.0pt\">. While headaches are common in the general population and can be seen in patients with SLE, they are not considered the most specific or predominant manifestation of diffuse CNS involvement in lupus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Psychosis</span></strong><span style=\"font-size:14.0pt\">, including hallucinations and delusions, can occur in SLE but is less common than cognitive dysfunction as a presenting feature of CNS involvement.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Seizures</span></strong><span style=\"font-size:14.0pt\"> are a recognized manifestation of CNS lupus but are not as frequent as cognitive changes when considering the spectrum of neuropsychiatric symptoms associated with SLE.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cognitive dysfunction is the most common manifestation of diffuse CNS involvement in systemic lupus erythematosus. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154549,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38696,
      "choices": [
        {
          "id": 154527,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-small-cell lung cancer</span></span></span></p>"
        },
        {
          "id": 154528,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Small-cell lung cancer</span></span></span></p>"
        },
        {
          "id": 154529,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thymoma</span></span></span></p>"
        },
        {
          "id": 154530,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Breast cancer</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 60-year-old male smoker with proximal muscle weakness improving with use, dry mouth, erectile dysfunction, and decreased reflexes suggestive of Lambert-Eaton Myasthenic Syndrome (LEMS), prompts a search for an underlying cancer. Which cancer is most commonly linked to LEMS in this patient?</span></span></span></p>",
      "unique_key": "Q4944572",
      "question_audio": null,
      "question_video": null,
      "map_id": 3752852,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Small-cell lung cancer</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lambert-Eaton Myasthenic Syndrome (LEMS) is a paraneoplastic syndrome characterized by muscle weakness, autonomic dysfunction, and a unique improvement in strength with repeated muscle use. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is most commonly associated with small-cell lung cancer (SCLC), a connection that is thought to be due to an autoimmune reaction where the body&#39;s immune response against the tumor also attacks components of the neuromuscular junction. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Approximately 50-60% of LEMS cases are associated with an underlying malignancy, most frequently SCLC.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Non-small-cell lung cancer</span></strong><span style=\"font-size:14.0pt\"> (NSCLC) is the most common type of lung cancer but is not typically associated with LEMS. LEMS is more specifically linked to SCLC due to its neuroendocrine characteristics.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Thymoma</span></strong><span style=\"font-size:14.0pt\"> is associated with another autoimmune neuromuscular disorder, Myasthenia Gravis (MG), rather than LEMS. Although both MG and LEMS affect the neuromuscular junction, they have different pathophysiological mechanisms and associated tumors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Breast cancer</span></strong><span style=\"font-size:14.0pt\">, while a common malignancy, is not commonly associated with LEMS. Paraneoplastic neurological syndromes associated with breast cancer typically involve different mechanisms and presentations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lambert-Eaton Myasthenic Syndrome (LEMS) is most commonly associated with small-cell lung cancer (SCLC), a connection that is thought to be due to an autoimmune reaction where the body&#39;s immune response against the tumor also attacks components of the neuromuscular junction.</span></span></li>\r\n</ul>",
      "correct_choice_id": 154528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38710,
      "choices": [
        {
          "id": 154583,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The pars flaccida</span></span></span></p>"
        },
        {
          "id": 154584,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The umbo</span></span></span></p>"
        },
        {
          "id": 154585,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The cone of light</span></span></span></p>"
        },
        {
          "id": 154586,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The pars tensa</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During an otoscopic examination, a medical student observes the tympanic membrane (TM) of a patient. The attending physician asks the student to identify the structure that appears as a triangular, light-reflecting area on the TM. Which part of the tympanic membrane does this describe?</span></span></span></p>",
      "unique_key": "Q7789232",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755606,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) The cone of light</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The cone of light is a <strong>triangular</strong>, <strong>light-reflecting area</strong> on the <strong>TM</strong> seen during <strong>otoscopic examination</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is caused by <strong>light</strong> from the <strong>otoscope</strong> <strong>reflecting off the surface</strong> of the <strong>TM</strong>, typically seen <strong>radiating anteriorly</strong> and <strong>downward</strong> from the <strong>umbo</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-123916.JPG\" style=\"height:396px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A</span></strong><span style=\"font-size:14.0pt\">. <strong>The pars flaccida</strong> is a <strong>small, slack, superior section</strong> of the TM, located above the <strong>lateral process of the malleus</strong>. It is not typically associated with light reflection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B</span></strong><span style=\"font-size:14.0pt\">. <strong>The umbo</strong> is the <strong>central point</strong> of the TM where the <strong>tip of the handle of malleus is present</strong>. It is the most <strong>inward part</strong> of the TM, but it is not specifically known for light reflection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>The pars tensa</strong> comprises the <strong>majority of the TM</strong> and is a <strong>tightly stretched portion</strong> below the <strong>lateral process</strong> of the malleus. While it is the main part of the TM, it is <strong>not specifically</strong> described as the light-reflecting area.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective of this question is to <strong>identify the cone of light</strong> as the <strong>light-reflecting area</strong> seen on the anteroinferior quadrant of tympanic membrane during otoscopic examination, which helps in orienting the examiner to the TM&#39;s anatomy.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154585,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38554,
      "choices": [
        {
          "id": 153959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rhinosporidiosis</span></span></span></p>"
        },
        {
          "id": 153960,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Invasive candidiasis</span></span></span></p>"
        },
        {
          "id": 153961,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mucormycosis</span></span></span></p>"
        },
        {
          "id": 153962,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cryptococcal meningitis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a long-standing history of uncontrolled diabetes mellitus is admitted to the hospital with a two-day history of high-grade fever, chills, and a sudden onset of visual disturbances. He is notably disoriented and complains of headache along with his visual symptoms. The clinical team is concerned about a possible systemic infection due to his immunocompromised state. Empirical antifungal therapy is started immediately after blood cultures are drawn. The subsequent laboratory report reveals a positive (1,3)-&beta;-D-Glucan assay. Considering the patient&#39;s predisposing condition, clinical presentation, and the laboratory findings, which fungal infection is most likely affecting this patient?</span></span></p>",
      "unique_key": "Q1400220",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736077,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Invasive candidiasis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The positive (1,3)-&beta;-D-Glucan assay is indicative of a fungal infection, and in the context of the patient&#39;s clinical presentation and risk factors, invasive candidiasis is the most likely diagnosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This test detects components of the fungal cell wall that are released during invasive infection. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Invasive candidiasis can cause a wide spectrum of disease, particularly in immunocompromised individuals, and is commonly associated with fever and multi-organ dysfunction.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Rhinosporidiosis</span></strong><span style=\"font-size:14.0pt\">. This infection is caused by Rhinosporidium seeberi and typically presents with nasal or ocular manifestations, not systemic symptoms, and it would not cause a positive (1,3)-&beta;-D-Glucan assay.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mucormycosis</span></strong><span style=\"font-size:14.0pt\">. While patients with diabetes, particularly those with ketoacidosis, are at increased risk for mucormycosis, this infection is not typically associated with a positive (1,3)-&beta;-D-Glucan assay.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Cryptococcal meningitis</span></strong><span style=\"font-size:14.0pt\">. This is a fungal infection of the central nervous system caused by Cryptococcus neoformans. Diagnosis is usually made by cryptococcal antigen testing rather than (1,3)-&beta;-D-Glucan assay.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The (1,3)-&beta;-D-Glucan test in the diagnosis of invasive fungal infections, particularly invasive candidiasis, and to differentiate it from other fungal diseases that do not elevate this biomarker.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153960,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38603,
      "choices": [
        {
          "id": 154155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 2, 3</span></span></span></p>"
        },
        {
          "id": 154156,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 5</span></span></span></p>"
        },
        {
          "id": 154157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3, 4, 5</span></span></span></p>"
        },
        {
          "id": 154158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4, 5</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Among the listed vaccines, which are contraindicated during pregnancy due to potential risks to the fetus or the pregnant individual?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rubella</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diphtheria</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tetanus</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatitis B</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Varicella</span></span></li>\r\n</ol>",
      "unique_key": "Q1975048",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739622,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 1, 5</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rubella and Varicella vaccines are contraindicated during pregnancy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Both vaccines are live attenuated vaccines, which carry a theoretical risk to the fetus, including congenital rubella syndrome from the Rubella vaccine and congenital varicella syndrome from the Varicella vaccine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">2. Diphtheria</span></strong><span style=\"font-size:14.0pt\">. The diphtheria component of the Tdap (tetanus, diphtheria, and pertussis) vaccine is actually recommended during pregnancy to protect the newborn from pertussis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">3. Tetanus</span></strong><span style=\"font-size:14.0pt\">. Tetanus vaccination is recommended during pregnancy to prevent neonatal tetanus, especially in areas where maternal and neonatal tetanus is a concern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">4. Hepatitis B</span></strong><span style=\"font-size:14.0pt\">. The Hepatitis B vaccine is considered safe and is recommended during pregnancy if the pregnant individual is at risk for hepatitis B virus infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Vaccines contraindicated in Pregnancy</span></strong><span style=\"font-size:14.0pt\">: ALL LIVE VACCINES (barring Yellow Fever Vaccine) and MENINGOCOCCAL VACCINE. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">BCG</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">OPV</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Yellow fever</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Measles vaccine, MMR (Measles, Mumps &amp; Rubella)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oral Typhoid (Ty 21a)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Varicella</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Live Plague vaccine</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">LAIV (Live attenuated Influenza viral vaccine)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Varicella vaccine</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Meningococcal Vaccine</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38531,
      "choices": [
        {
          "id": 153867,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute rheumatic fever </span></span></span></p>"
        },
        {
          "id": 153868,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mitral valve insufficiency </span></span></span></p>"
        },
        {
          "id": 153869,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Atherosclerotic aortic aneurysm </span></span></span></p>"
        },
        {
          "id": 153870,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcific aortic stenosis </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 72-year-old woman has had no major illnesses throughout her life. She has had 3 syncopal episodes during the past 2 weeks. Over the past 2 days, she has developed shortness of breath and a cough with production of frothy white sputum. On physical examination, she is afebrile. Her blood pressure is 135/90 mm Hg. She has no peripheral edema. A chest radiograph reveals a prominent left heart border in the region of the left ventricle, but the other chambers do not appear to be prominent. There is marked pulmonary edema. Laboratory studies show total serum cholesterol of 170 mg/dL. Which of the following is the most likely diagnosis? </span></span></span></p>",
      "unique_key": "Q2958773",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734250,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Calcific aortic stenosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s age, the absence of major illnesses, syncopal episodes, and the acute onset of dyspnea with a cough producing frothy white sputum are indicative of heart failure secondary to an acute cardiac event. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The chest radiograph findings of a prominent left heart border and marked pulmonary edema, along with no signs of peripheral edema, suggest left ventricular failure. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcific aortic stenosis is a common condition in the elderly due to progressive calcification of the aortic valve, which can lead to left ventricular hypertrophy and subsequent heart failure. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Syncope can occur due to fixed cardiac output despite increased demand during exertion. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The normal cholesterol level makes atherosclerotic causes less likely.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. </span></strong><strong><span style=\"font-size:14.0pt\">Acute rheumatic fever </span></strong><span style=\"font-size:14.0pt\">is unlikely given the patient&#39;s age and absence of a preceding streptococcal infection or fever. It more commonly affects children and young adults.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. </span></strong><strong><span style=\"font-size:14.0pt\">Mitral valve insufficiency </span></strong><span style=\"font-size:14.0pt\">could cause pulmonary edema and heart failure but is less likely to cause syncope. Additionally, the radiograph would typically show enlargement of the left atrium and possibly the left ventricle, which is not noted here.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. </span></strong><strong><span style=\"font-size:14.0pt\">Atherosclerotic aortic aneurysm </span></strong><span style=\"font-size:14.0pt\">would not directly lead to pulmonary edema or syncope and is usually asymptomatic until rupture or dissection occurs. It would also likely be accompanied by other signs of vascular disease and atherosclerosis, which are not indicated.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to identify the clinical presentation and complications of calcific aortic stenosis, particularly in elderly patients. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It distinguishes between various cardiac conditions that can lead to heart failure and emphasizes the importance of considering valve pathology as a cause of acute decompensation in a patient with a history of no major illnesses. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing the signs and symptoms of left ventricular failure and understanding the pathophysiology behind syncopal episodes in the context of aortic stenosis are important for diagnosis and management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153870,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38349,
      "choices": [
        {
          "id": 153155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated circulating IgE levels and allergen sensitivity</span></span></span></p>"
        },
        {
          "id": 153156,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Predominance of neutrophilic inflammation</span></span></span></p>"
        },
        {
          "id": 153157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beta-agonist receptor downregulation</span></span></span></p>"
        },
        {
          "id": 153158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Corticosteroid-resistant airway smooth muscle hypertrophy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 40-year-old man with a long-standing history of severe persistent asthma, inadequately controlled with high-dose inhaled corticosteroids and long-acting beta-agonists, presents to the clinic for a follow-up. Despite adherence to his current regimen, he reports frequent nocturnal awakenings and limitations in his daily activities due to asthma symptoms. His recent spirometry showed an FEV1 of 60% predicted, and he has had two hospitalizations for asthma exacerbations in the past year. Given his uncontrolled asthma and the need for additional therapy, you consider adding Omalizumab to his treatment plan. Omalizumab is most appropriately indicated for patients with asthma characterized by which of the following?</span></span></span></p>",
      "unique_key": "Q4995861",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716207,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Elevated circulating IgE levels and allergen sensitivity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Omalizumab is a monoclonal antibody that selectively binds to free human immunoglobulin E (IgE). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By binding to IgE, Omalizumab prevents IgE from attaching to mast cells and basophils, which in turn inhibits the release of inflammatory mediators that contribute to asthma symptoms and exacerbations. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Omalizumab is particularly indicated for patients with severe allergic asthma characterized by elevated circulating levels of IgE and sensitivity to perennial aeroallergens. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is typically used in patients who remain uncontrolled despite high-dose inhaled corticosteroids and long-acting beta-agonists.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Predominance of neutrophilic inflammation</span></strong><span style=\"font-size:14.0pt\"> is often associated with severe asthma subtypes that might not respond as well to Omalizumab, as it specifically targets IgE-mediated pathways.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Beta-agonist receptor downregulation</span></strong><span style=\"font-size:14.0pt\"> is a phenomenon that can occur with overuse of beta-agonist medications but is not directly targeted by Omalizumab therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Corticosteroid-resistant airway smooth muscle hypertrophy</span></strong><span style=\"font-size:14.0pt\"> is a feature of severe asthma, but Omalizumab&#39;s mechanism of action is not directly aimed at reducing smooth muscle hypertrophy; instead, it targets the IgE-mediated allergic pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the indication and mechanism of action of Omalizumab in the treatment of severe persistent asthma. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Omalizumab is specifically indicated for patients with asthma that is characterized by elevated levels of circulating IgE and allergen sensitivity, highlighting the importance of targeted therapy in managing specific asthma phenotypes for optimal control.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153155,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38331,
      "choices": [
        {
          "id": 153083,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Primarily lowers LDL cholesterol</span></span></span></p>"
        },
        {
          "id": 153084,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Primarily raises HDL cholesterol</span></span></span></p>"
        },
        {
          "id": 153085,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Primarily lowers triglycerides</span></span></span></p>"
        },
        {
          "id": 153086,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Primarily lowers blood glucose</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old man with a history of hyperlipidemia and intolerance to statins due to myopathy presents to the clinic for a follow-up visit. His current lipid profile shows total cholesterol of 240 mg/dL, LDL cholesterol of 150 mg/dL, HDL cholesterol of 35 mg/dL, and triglycerides of 300 mg/dL. Considering his statin intolerance and the need to address his comprehensive lipid abnormalities, you decide to initiate niacin therapy. Which of the following is the most important benefit of adding niacin to his treatment regimen?</span></span></span></p>",
      "unique_key": "Q9803303",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715540,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Primarily raises HDL cholesterol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Niacin, also known as <strong>nicotinic acid</strong>, is a water-soluble B vitamin that, at pharmacological doses, has lipid-modifying effects. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">One of the most significant effects of niacin therapy in the context of dyslipidemia is its ability to raise HDL cholesterol levels. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is particularly beneficial for patients with low HDL cholesterol, as seen in this patient. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, niacin can lower triglycerides and LDL cholesterol to some extent, but its most notable and unique benefit in lipid therapy is its capacity to significantly increase HDL cholesterol levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>A. Primarily lowers LDL cholesterol.</strong> While niacin can lower LDL cholesterol, this is not its most significant lipid-modifying effect, especially when compared to statins or other lipid-lowering agents.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>C. Primarily lowers triglycerides.</strong> Niacin does lower triglycerides, and it can be beneficial for patients with high triglyceride levels. However, the most distinctive benefit of niacin in the context of lipid management is its ability to raise HDL cholesterol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>D. Primarily lowers blood glucose.</strong> Niacin can actually have a detrimental effect on blood glucose levels by increasing insulin resistance, making it a less favorable option for patients with diabetes or impaired glucose tolerance.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective of this question is to understand the role of niacin therapy in the management of dyslipidemia, particularly in patients with low HDL cholesterol levels or those who are intolerant to statins. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It emphasizes niacin&#39;s unique ability to increase HDL cholesterol, in addition to its effects on lowering LDL cholesterol and triglycerides, highlighting its utility in comprehensive lipid management, especially for patients with specific lipid abnormalities.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38733,
      "choices": [
        {
          "id": 154675,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FESS (functional endoscopic sinus surgery)</span></span></span></span></p>"
        },
        {
          "id": 154676,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Needle aspiration</span></span></span></span></p>"
        },
        {
          "id": 154677,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT angiogram </span></span></span></span></p>"
        },
        {
          "id": 154678,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous antibiotics for 7 days</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with a tender pulsatile mass as shown in the image below. What is the next step?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132427.JPG\" style=\"height:346px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2489292",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757079,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) CT angiogram</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cirsoid aneurysm is a rare type of vascular malformation that involves the dilation of multiple blood vessels and their adjacent tissue, resulting in a tangled mass of blood vessels resembling a &quot;<strong>bag of worms</strong>&quot;.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These aneurysms are most commonly found in the scalp, face, and neck regions, but can occur in other parts of the body as well.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms may include visible swelling, throbbing or pulsating sensation, pain, and potential for bleeding or rupture.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis of cissoid aneurysm is typically made through imaging tests such as USG Doppler, CT, MRI, or angiography. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the pulsatile mass is suspected to be a vascular lesion or aneurysm, a CT angiogram would be a suitable choice as it provides detailed visualization of the blood vessels, and can help define the anatomy and blood supply of the lesion. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It aids in planning therapeutic interventions.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A needle aspiration is contraindicated due to risk of bleeding.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment for cissoid aneurysm may involve embolization, which involves blocking off the affected blood vessels using coils or other materials, or surgical resection, which involves removing the aneurysm and affected blood vessels. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment is typically tailored to the individual patient&#39;s condition and symptoms.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cirsoid aneurysm is a rare type of vascular malformation that involves the dilation of multiple blood vessels and their adjacent tissue, resulting in a tangled mass of blood vessels resembling a &quot;bag of worms&quot;. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT angiogram would be a suitable choice as it provides detailed visualization of the blood vessels, and can help define the anatomy and blood supply of the lesion.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38818,
      "choices": [
        {
          "id": 155011,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lenegre&#39;s disease</span></span></span></span></p>"
        },
        {
          "id": 155012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lyme disease</span></span></span></span></p>"
        },
        {
          "id": 155013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chagas disease</span></span></span></span></p>"
        },
        {
          "id": 155014,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyloidosis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old male with controlled hypertension presents with recurrent dizziness and syncope, showing bradycardia at 48 bpm and third-degree AV block on ECG. Normal thyroid and electrolytes were there, with no evidence of infiltrative diseases on cardiac imaging. What is the most likely cause of conduction system degeneration?</span></span></span></span></p>",
      "unique_key": "Q8459910",
      "question_audio": null,
      "question_video": null,
      "map_id": 3776254,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Lenegre&#39;s disease</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lenegre&#39;s disease, also known as <strong>progressive cardiac conduction defect (PCCD)</strong>, is a primary degenerative disease of the cardiac conduction system, particularly affecting the His-Purkinje system. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by the progressive fibrosis and calcification of the conduction system, leading to varying degrees of AV block and bradycardia. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is more prevalent in the elderly and can present with symptoms such as dizziness, fatigue, syncope, or even sudden cardiac death. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The absence of other systemic symptoms or signs makes Lenegre&#39;s disease a likely diagnosis in this patient.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lyme disease</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can cause various cardiac manifestations, including myocarditis and AV blocks, typically within weeks to months after the initial tick bite. However, the absence of a history of tick exposure, erythema migrans, or other systemic symptoms makes this diagnosis less likely.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chagas disease</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, caused by the Trypanosoma cruzi parasite, is endemic to Latin America and can lead to chronic cardiomyopathy, including conduction abnormalities. However, without a history of travel to endemic areas or other manifestations of Chagas disease, this option is less plausible.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Amyloidosis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can lead to cardiac involvement by the deposition of amyloid fibrils in the heart, potentially causing conduction disturbances, heart failure, and other cardiac abnormalities. While it could present with similar cardiac findings, the lack of systemic symptoms or other organ involvement (e.g., nephrotic syndrome, neuropathy) makes this diagnosis less likely in the absence of further evidence.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lenegre&#39;s disease is characterized by the progressive fibrosis and calcification of the conduction system, leading to varying degrees of AV block and bradycardia.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 155011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38600,
      "choices": [
        {
          "id": 154143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Achieving a 95% reduction in deaths due to TB by 2035</span></span></span></p>"
        },
        {
          "id": 154144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Attaining a 90% reduction in the incidence of TB by 2035</span></span></span></p>"
        },
        {
          "id": 154145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ensuring 0% of TB-affected families face catastrophic costs due to TB</span></span></span></p>"
        },
        {
          "id": 154146,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reducing the HIV-TB coinfection rate to 0%</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The End TB Strategy, spanning from 2016 to 2035, aims to significantly reduce the global burden of tuberculosis (TB) with ambitious goals and milestones. Among the following options, which one is NOT a targeted outcome specifically outlined in the End TB Strategy?</span></span></p>",
      "unique_key": "Q5068522",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739569,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Reducing the HIV-TB coinfection rate to 0%</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The End TB Strategy includes several key targets, such as significant reductions in TB deaths and incidence rates, and eliminating catastrophic costs for TB-affected families. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, it does not specifically mandate a 0% HIV-TB coinfection rate. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While reducing HIV-TB coinfections is critical in the fight against TB, the strategy&#39;s outlined targets focus on TB death reduction, incidence rate reduction, and financial protection for affected families rather than setting a specific target for HIV-TB coinfection rates.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">The End TB Strategy 2016-2035</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-132335.JPG\" style=\"height:622px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 154146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38429,
      "choices": [
        {
          "id": 153471,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pelvic ultrasound</span></span></span></p>"
        },
        {
          "id": 153472,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hysterosalpingography (HSG)</span></span></span></p>"
        },
        {
          "id": 153473,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Examination of the male partner</span></span></span></p>"
        },
        {
          "id": 153474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Explanation of the fertile period</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 23-year-old woman presents to the outpatient department accompanied by her anxious mother-in-law, concerned about the inability to conceive since her marriage 8 months ago. The patient reports having regular menstrual cycles and a coital frequency of approximately three times per week. Given this information, what is the next best step in managing this patient&#39;s concerns?</span></span></span></p>",
      "unique_key": "Q4191386",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719604,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Explanation of the fertile period</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most appropriate next step is to provide education on the fertile period. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The couple has only been attempting conception for 8 months, and infertility is typically defined as the inability to conceive after 12 months of regular, unprotected intercourse. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given the regular menstrual cycles and adequate coital frequency, it&#39;s crucial to ensure that the couple is well-informed about the timing of the fertile window, which is the period during a woman&#39;s cycle when conception is most likely to occur. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This usually spans 5 days before and includes the day of ovulation, typically around the 14th day of a 28-day menstrual cycle.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Pelvic ultrasound</span></strong><span style=\"font-size:14.0pt\">. While a pelvic ultrasound is a useful diagnostic tool for assessing the uterus and ovaries, it may be premature in this case since the couple has not been trying to conceive for at least 12 months without success.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hysterosalpingography (HSG)</span></strong><span style=\"font-size:14.0pt\">. HSG is a radiographic procedure to evaluate the uterine cavity and fallopian tubes and is typically reserved for further evaluation after an initial period of 12 months of unsuccessful attempts at conception, unless there are other indications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Examination of the male partner</span></strong><span style=\"font-size:14.0pt\">. While evaluating the male partner is an essential component of a fertility assessment, initial advice regarding the timing of intercourse to coincide with the fertile window is a less invasive and cost-effective first step.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective is to understand the initial approach to a couple concerned about infertility. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Before proceeding with invasive tests and examinations, it is essential to provide education on the fertile period to optimize the timing of intercourse for conception. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This approach is particularly relevant when the duration of attempting conception is less than 12 months and there are no immediate indications of underlying fertility issues.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38815,
      "choices": [
        {
          "id": 154999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylcholine</span></span></span></span></p>"
        },
        {
          "id": 155000,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin</span></span></span></span></p>"
        },
        {
          "id": 155001,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylinositol</span></span></span></span></p>"
        },
        {
          "id": 155002,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sphingomyelin</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male with a history of heart failure is undergoing an evaluation for a potential cardiac transplant. During his workup, a detailed analysis of his heart tissue reveals abnormalities in the mitochondrial membranes, particularly with a phospholipid identified to play a crucial role in the mitochondrial inner membrane&#39;s structure and function. This phospholipid is also known to be involved in the apoptosis process and is integral to the function of the electron transport chain. Based on this information, which of the following phospholipids is most likely being described?</span></span></span></span></p>",
      "unique_key": "Q2406381",
      "question_audio": null,
      "question_video": null,
      "map_id": 3775881,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) Cardiolipin</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin is a unique phospholipid that resides predominantly in the mitochondrial inner membrane. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It plays a pivotal role in the optimal functioning of several key enzymes involved in mitochondrial energy metabolism, including those of the electron transport chain. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin&#39;s presence and functionality are critical for maintaining mitochondrial integrity and facilitating the process of apoptosis, particularly in response to cellular stress or damage. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The abnormalities in cardiolipin can contribute to mitochondrial dysfunction, which is a common feature in various forms of heart disease, including heart failure. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, in the context of a patient with heart failure undergoing cardiac evaluation, the described abnormalities in mitochondrial membranes are most likely related to cardiolipin.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>A. Phosphatidylcholine.</strong> This is the most common phospholipid in cell membranes but is not specifically associated with the mitochondrial inner membrane or the functions described in the question.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>C. Phosphatidylinositol.</strong> This phospholipid plays a role in cell signalling pathways and is a component of cell membranes, but it is not particularly noted for its role in mitochondrial function or the electron transport chain.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>D. Sphingomyelin.</strong> Found primarily in the plasma membrane, sphingomyelin is involved in cell signalling and apoptosis but is not a key component of the mitochondrial inner membrane or directly involved in the electron transport chain.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The question aims to assess the understanding of the role of cardiolipin in the mitochondrial inner membrane and its importance in mitochondrial function, particularly in the context of heart disease. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin is crucial for the optimal operation of the electron transport chain and is implicated in the process of apoptosis, which is relevant in the pathology of heart failure. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the specific roles of different phospholipids in cellular structures and functions is essential for medical professionals, especially when considering the pathophysiology of diseases and their treatments.</span></span></li>\r\n</ul>",
      "correct_choice_id": 155000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38592,
      "choices": [
        {
          "id": 154111,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anthracosis</span></span></span></p>"
        },
        {
          "id": 154112,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Silicosis</span></span></span></p>"
        },
        {
          "id": 154113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Byssinosis</span></span></span></p>"
        },
        {
          "id": 154114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bagassosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents to a community health clinic in a rural area of India with a history of progressive shortness of breath and a non-productive cough for the past 6 months. He has worked for over 20 years in a local stone quarry where he was exposed to large amounts of dust without adequate respiratory protection. On physical examination, his oxygen saturation is 93% on room air, and lung auscultation reveals bilateral fine crackles at the lung bases. A chest X-ray is performed, showing a diffuse &quot;snow-storm&quot; appearance predominantly in the upper lobes. Given this patient&#39;s occupational history and radiographic findings, which of the following conditions is most likely?</span></span></p>",
      "unique_key": "Q8759580",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739301,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Silicosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Silicosis is an occupational lung disease caused by inhalation of crystalline silica dust, leading to inflammation and scarring in the form of nodular lesions in the upper lobes of the lungs. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &quot;snow-storm&quot; appearance on a chest X-ray, characterized by numerous small, dense nodules distributed throughout the lung fields, is a classic finding in silicosis, particularly in its chronic form. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This patient&#39;s long-term exposure to silica dust in a stone quarry without proper respiratory protection and the radiographic findings are highly suggestive of silicosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Anthracosis</span></strong><span style=\"font-size:14.0pt\">. Often called &quot;<strong>coal worker&#39;s pneumoconiosis</strong>,&quot; it is caused by inhalation of coal dust. The X-ray findings usually show diffuse, finely granular mottling but do not typically present a &quot;snow-storm&quot; pattern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Byssinosis</span></strong><span style=\"font-size:14.0pt\">. This is an occupational lung disease among workers exposed to cotton dust in textile factories, not associated with a &quot;snow-storm&quot; appearance on X-ray but rather with obstructive airway changes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Bagassosis</span></strong><span style=\"font-size:14.0pt\">. A lung disease caused by inhalation of bagasse (sugar cane dust) particles. The radiographic findings might show diffuse fibrosis, but they are not typically described as a &quot;snow-storm&quot; appearance.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-132018.JPG\" style=\"height:736px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 154112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38543,
      "choices": [
        {
          "id": 153915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">TCBS (Thiosulfate-citrate-bile salts-sucrose agar)</span></span></span></p>"
        },
        {
          "id": 153916,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stuart&#39;s transport medium</span></span></span></p>"
        },
        {
          "id": 153917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Skirrow&rsquo;s medium</span></span></span></p>"
        },
        {
          "id": 153918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MYPA (mannitol-yeast extract-potassium tellurite-peptone agar)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A laboratory technician is tasked with isolating and identifying Vibrio species from a stool sample of a patient presenting with symptoms of severe diarrhea after consuming raw seafood. Given the need to selectively isolate Vibrio species, which of the following culture media should the technician employ to enhance the likelihood of successfully identifying the organism?</span></span></span></p>",
      "unique_key": "Q5737916",
      "question_audio": null,
      "question_video": null,
      "map_id": 3735982,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) TCBS (Thiosulfate-citrate-bile salts-sucrose agar)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thiosulfate-citrate-bile salts-sucrose (TCBS) agar is a selective and differential medium designed to isolate Vibrio species, especially Vibrio cholerae. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Its high pH (8.6) selects for Vibrio by inhibiting the growth of most enteric bacteria, while the sucrose allows for differentiation based on sucrose fermentation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">V. cholerae can ferment sucrose and therefore produce large yellow colonies. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is widely used at present.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-115740.JPG\" style=\"height:301px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Stuart&#39;s transport medium</span></strong><span style=\"font-size:14.0pt\">. This is a non-nutritive medium used for the transport of specimens, not for the selective isolation of bacteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Skirrow&rsquo;s medium</span></strong><span style=\"font-size:14.0pt\">. Skirrow&#39;s medium is used for the selective isolation of Campylobacter species, not Vibrio species.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. MYPA (mannitol-yeast extract-potassium tellurite-peptone agar)</span></strong><span style=\"font-size:14.0pt\">. MYPA agar is used for the isolation of Corynebacterium diphtheriae, not Vibrio species.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-115755.JPG\" style=\"height:349px; width:700px\" /></span></span></strong></p>",
      "correct_choice_id": 153915,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38362,
      "choices": [
        {
          "id": 153203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alpha-1 agonist action leading to peripheral vasoconstriction</span></span></span></p>"
        },
        {
          "id": 153204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increase in renal perfusion due to agonist action on D1 receptors</span></span></span></p>"
        },
        {
          "id": 153205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Releases noradrenaline and causes positive inotropic effect</span></span></span></p>"
        },
        {
          "id": 153206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Direct action on heart via beta-1 receptors</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with a history of chronic heart failure is brought to the emergency department in a state of acute shock. He is hypotensive, tachycardic, and has cold, clammy skin. Initial management includes fluid resuscitation and monitoring of vital signs. As part of his pharmacological management, you consider the use of dopamine to stabilize his hemodynamic status. Dopamine has multiple actions at different dosages, contributing to its efficacy in shock management. Which of the following properties of dopamine is NOT directly beneficial in the management of acute shock in this patient?</span></span></p>",
      "unique_key": "Q5915432",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716632,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Increase in renal perfusion due to agonist action on D1 receptors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While the increase in renal perfusion due to agonist action on D1 receptors is a known effect of dopamine and can be beneficial in certain clinical scenarios by potentially improving renal function and urine output, it is not directly helpful in the acute management of shock. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The primary goal in shock is to stabilize hemodynamics and improve tissue perfusion, for which properties like alpha-1 agonist-induced vasoconstriction (to increase systemic vascular resistance) and positive inotropic effects (to improve cardiac output) are more immediately relevant.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Alpha-1 agonist action leading to peripheral vasoconstriction</span></strong><span style=\"font-size:14.0pt\"> helps increase systemic vascular resistance, which can be beneficial in certain types of shock by improving blood pressure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Releases noradrenaline and causes positive inotropic effect</span></strong><span style=\"font-size:14.0pt\">. The release of noradrenaline and the resultant positive inotropic effect directly increase cardiac output, which is crucial in the management of shock to ensure adequate tissue perfusion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Direct action on the heart via beta-1 receptors</span></strong><span style=\"font-size:14.0pt\"> increases heart rate and contractility, which is beneficial in shock by improving cardiac output and systemic perfusion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the pharmacological effects of dopamine and their relevance in the acute management of shock. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It emphasizes the importance of choosing appropriate pharmacological interventions based on their primary mechanisms of action and the immediate clinical goals in emergency situations.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38330,
      "choices": [
        {
          "id": 153079,
          "text": "<p><span style=\"font-size:14.0pt;\">Gilbert's Syndrome</span></p>"
        },
        {
          "id": 153080,
          "text": "<p><span style=\"font-size:14.0pt;\">Crigler-Najjar Syndrome Type I</span></p>"
        },
        {
          "id": 153081,
          "text": "<p><span style=\"font-size:14.0pt;\">Dubin-Johnson Syndrome</span></p>"
        },
        {
          "id": 153082,
          "text": "<p><span style=\"font-size:14.0pt;\">Rotor Syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\">A 30-year-old female presents to the clinic with complaints of intermittent jaundice that seems to worsen during periods of illness or stress. She reports no pain, pruritus, or changes in stool or urine colour. Her family history is notable for similar symptoms in her mother. Laboratory tests reveal a mild elevation in total and direct bilirubin, with normal liver enzymes and no evidence of hemolysis. An abdominal ultrasound shows no abnormalities in the liver or bile ducts. Histological examination shows deposition of brown-black melanin-like pigment in the hepatocyte. Based on her clinical presentation, which of the following is the most likely diagnosis?</p>",
      "unique_key": "Q7966023",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715539,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Ans. C) Dubin-Johnson Syndrome</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li>The patient's presentation of <strong>intermittent jaundice worsening during periods of illness or stress</strong>, combined with <strong>mild elevation in total and direct bilirubin</strong>, aligns with Dubin-Johnson Syndrome. This condition is described as a <strong>benign autosomal recessive disorder that results in conjugated hyperbilirubinemia</strong>, typically manifesting in childhood or adulthood.</li><li>The fact that her <strong>mother exhibited similar symptoms</strong> supports the inherited nature of the disorder.</li><li>The patient's <strong>normal liver enzymes</strong> and <strong>absence of hemolysis</strong> are consistent with Dubin-Johnson, as it primarily involves a defect in the <strong>secretion of conjugated bilirubin into bile</strong>, rather than widespread liver damage or red blood cell destruction.</li><li>The <strong>abdominal ultrasound showing no abnormalities in the liver or bile ducts</strong> further supports a functional defect in bilirubin excretion rather than a structural obstruction.</li><li>Crucially, the histological examination revealed <strong>deposition of brown-black melanin-like pigment in the hepatocyte</strong>. While the provided sources do not explicitly describe this pigment in the text for Dubin-Johnson Syndrome, this is a distinct histological feature commonly associated with the condition in clinical practice, indicating impaired biliary excretion.</li></ul><p>&nbsp;</p><p><strong>Other options:</strong></p><p>&nbsp;</p><p><strong>Option</strong> <strong>A. Gilbert's Syndrome:</strong> This syndrome is characterized by <strong>unconjugated hyperbilirubinemia</strong>. The patient's laboratory results indicate a <strong>mild elevation in direct bilirubin</strong>, which is a form of conjugated bilirubin, making Gilbert's Syndrome an unlikely diagnosis.</p><p>&nbsp;</p><p><strong>Option</strong> <strong>B. Crigler-Najjar Syndrome Type I:</strong> This is a severe form of jaundice, typically presenting as <strong>severe congenital jaundice (bilirubin levels over 20 mg/dL)</strong> with a <strong>complete absence of hepatic UDP-glucuronosyltransferase activity</strong>. It often leads to brain damage (kernicterus) and is frequently <strong>fatal within the first 15 months of life</strong>. The patient's age (30 years old), the intermittent and mild nature of her jaundice, and the absence of severe neurological symptoms rule out this diagnosis. This condition is also primarily associated with <strong>unconjugated hyperbilirubinemia</strong>.</p><p>&nbsp;</p><p><strong>Option</strong> <strong>D. Rotor Syndrome:</strong><br>While this also causes conjugated hyperbilirubinemia like Dubin-Johnson Syndrome, it does <strong>not</strong> have the characteristic pigment deposition in hepatocytes. The liver appears normal on histological examination. Both conditions have similar clinical presentations, but the pigment deposition distinguishes Dubin-Johnson from Rotor Syndrome.</p>",
      "correct_choice_id": 153081,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38569,
      "choices": [
        {
          "id": 154019,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Urinary Tract Infections (UTIs)</span></span></span></p>"
        },
        {
          "id": 154020,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Surgical Site Infections</span></span></span></p>"
        },
        {
          "id": 154021,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lower Respiratory Tract Infections</span></span></span></p>"
        },
        {
          "id": 154022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Skin and Soft Tissue Infections</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a hospital administration meeting focused on infection control, the topic of nosocomial infections and their prevalence in healthcare settings is discussed. The committee reviews recent data on hospital-acquired infections to identify target areas for improving patient care and reducing infection rates. Based on the patterns observed in hospitals globally, which of the following types of infections is most commonly acquired within hospital settings?</span></span></span></p>",
      "unique_key": "Q9733411",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736383,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Urinary Tract Infections (UTIs)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Urinary Tract Infections (UTIs) are the most common nosocomial infections in hospitals, often associated with the use of urinary catheters. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Catheter-associated urinary tract infections (CAUTIs) account for a significant proportion of all hospital-acquired infections, prompting numerous infection control initiatives focused on catheter use, including guidelines for catheter insertion, maintenance, and timely removal.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Surgical Site Infections</span></strong><span style=\"font-size:14.0pt\">. While surgical site infections are a significant concern, especially in postoperative patients, they are not the most common type of nosocomial infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Lower Respiratory Tract Infections</span></strong><span style=\"font-size:14.0pt\">. These include hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), which are critical issues in intensive care units but overall less frequent than UTIs in general hospital settings.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Skin and Soft Tissue Infections</span></strong><span style=\"font-size:14.0pt\">. These infections occur in hospital settings but are less common compared to UTIs, especially those associated with medical devices like catheters.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Urinary tract infections (UTIs) are recognized as the most common type of nosocomial infection, largely attributed to the widespread use of urinary catheters in hospitalized patients.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38704,
      "choices": [
        {
          "id": 154559,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IV methylprednisolone 125mg/day</span></span></span></p>"
        },
        {
          "id": 154560,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IV dexamethasone 16mg/day</span></span></span></p>"
        },
        {
          "id": 154561,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IV methylprednisolone 32mg/day</span></span></span></p>"
        },
        {
          "id": 154562,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IV dexamethasone 24mg/day</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 52-year-old male with chronic alcohol abuse history, presenting with jaundice, abdominal distention, altered mental status, and repeated admissions for acute alcoholic hepatitis, is considered for IV corticosteroid therapy due to severe presentation and oral medication intolerance. What is the most appropriate IV corticosteroid regimen for severe alcoholic hepatitis in this patient?</span></span></span></p>",
      "unique_key": "Q7573631",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755160,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) IV methylprednisolone 32mg/day</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For patients with severe alcoholic hepatitis who are unable to take oral medications, IV methylprednisolone at a dose of 32mg/day is a preferred option. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This regimen is equivalent to the commonly used oral prednisolone dose of 40mg/day, taking into account the potency and bioavailability differences between methylprednisolone and prednisolone. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methylprednisolone is preferred in this setting due to its lower mineralocorticoid activity compared to prednisolone, which can be beneficial in patients at risk for fluid retention and hypertension.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>IV methylprednisolone 125mg/day.</strong> This dose is significantly higher than the standard and could increase the risk of adverse effects without providing additional benefit in the treatment of alcoholic hepatitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>IV dexamethasone 16mg/day.</strong> Dexamethasone is not typically used in the management of alcoholic hepatitis. Its long half-life and potent glucocorticoid activity could potentially lead to more severe side effects, including immunosuppression.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>IV dexamethasone 24mg/day.</strong> Like the 16mg/day dose, this regimen is not standard for alcoholic hepatitis and carries a high risk of adverse effects due to the potent glucocorticoid activity of dexamethasone.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IV methylprednisolone at a dose of 32mg/day is the preferred choice, providing an equivalent effect to the standard oral prednisolone dose used in this setting. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38551,
      "choices": [
        {
          "id": 153947,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Direct spread by blood/urine is the main mode of transmission</span></span></span></p>"
        },
        {
          "id": 153948,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The cerebellum is the most common site of brain involvement</span></span></span></p>"
        },
        {
          "id": 153949,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Isolation of the parasite from blood is very easy</span></span></span></p>"
        },
        {
          "id": 153950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laboratory tests are useful for making a diagnosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a clinical case conference, a 55-year-old woman&#39;s case is discussed. She has a history of rheumatoid arthritis for which she has been receiving methotrexate and prednisone. Recently, she presented with symptoms including confusion, fever, and headache. A Brain MRI revealed multiple ring-enhancing lesions, raising concerns for a central nervous system infection. Subsequent serology tests returned positive for Toxoplasma gondii. Given these findings and the patient&#39;s immunocompromised state, which of the following statements about Toxoplasma gondii infection in this context is true?</span></span></span></p>",
      "unique_key": "Q5865433",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736076,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Laboratory tests are useful for making a diagnosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the context of a patient with multiple ring-enhancing lesions on MRI and a positive serology for Toxoplasma gondii, laboratory tests (such as serology) are crucial for making the diagnosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serological tests can detect antibodies (IgG and IgM) to Toxoplasma, indicating either acute or past infection. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In immunocompromised patients, such as those on immunosuppressive therapy for rheumatoid arthritis, serology along with clinical presentation and imaging findings can be key to diagnosing toxoplasmosis, particularly cerebral toxoplasmosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Direct spread by blood/urine is the main mode of transmission</span></strong><span style=\"font-size:14.0pt\">. This is incorrect. The main modes of transmission for Toxoplasma gondii include ingestion of undercooked, contaminated meat, exposure to cat feces, and congenital transmission. Direct spread via blood or urine is not a typical mode of transmission.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. The cerebellum is the most common site of brain involvement</span></strong><span style=\"font-size:14.0pt\">. This is incorrect. Toxoplasma encephalitis typically affects the basal ganglia and the corticomedullary junction. The cerebellum is not the most common site of brain involvement.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Isolation of the parasite from blood is very easy</span></strong><span style=\"font-size:14.0pt\">. This is incorrect. Isolating Toxoplasma gondii from blood is challenging, especially in immunocompetent individuals. In immunocompromised patients, while the parasite may be more likely to be found due to higher parasitemia, it still requires specialized laboratory techniques and is not considered &quot;very easy.&quot;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In immunocompromised individuals, such as those on immunosuppressive therapy, Toxoplasma gondii infection can be severe and progressive, leading to neurological symptoms consistent with cerebral toxoplasmosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laboratory tests are crucial for diagnosis, and serological procedures are commonly used for this purpose. while, direct spread by blood/urine, the involvement of the cerebellum, and parasite isolation not relevant for the diagnosis and severity assessment of cerebral toxoplasmosis in immunocompromised individuals.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153950,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38389,
      "choices": [
        {
          "id": 153311,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5% Permethrin Below Neck Application</span></span></span></span></p>"
        },
        {
          "id": 153312,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1% Permethrin Whole Body Application</span></span></span></span></p>"
        },
        {
          "id": 153313,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disinfection of Clothing</span></span></span></span></p>"
        },
        {
          "id": 153314,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clotrimazole </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the Most Effective Treatment of Vagabond&rsquo;s Disease?</span></span></span></span></p>",
      "unique_key": "Q1777439",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717565,
      "difficulty_level": "difficult",
      "subjects_id": [
        18
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Disinfection of Clothing</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagabond&#39;s disease, or <strong>pediculosis corporis</strong>, is best treated by addressing the <strong>primary habitat of the lice</strong>, which is the <strong>clothing</strong>. </span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-181104.JPG\" style=\"height:206px; width:300px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disinfection can be achieved by <strong>washing clothes </strong>in <strong>hot water, ironing</strong>, or using <strong>insecticides</strong> specifically for clothing.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 5% Permethrin below neck application</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. While permethrin is an <strong>effective treatment</strong> for <strong>lice</strong>, <strong>5% permethrin </strong>is typically used for the treatment of <strong>scabies. </strong>For <strong>pediculosis corporis</strong> (<strong>body lice</strong> or <strong>Vagabond&#39;s disease</strong>), the concentration used is different, and the <strong>focus</strong> is on <strong>clothing disinfection</strong> because <strong>body lice live</strong> in <strong>clothing</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 1% Permethrin whole body application. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although <strong>1% permethrin</strong> is used for <strong>head lice</strong>, it is not the most effective treatment for Vagabond&#39;s disease, where <strong>lice infestation</strong> is primarily in the <strong>clothes</strong>, not on the body itself.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Clotrimazole. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clotrimazole is an <strong>antifungal</strong> <strong>medication</strong> and would not be effective against lice, as it does not have pediculicidal properties.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>most effective </strong>treatment for <strong>Vagabond&#39;s disease (pediculosis corporis</strong>) is <strong>disinfection of clothing</strong>, as the body louse lives and <strong>lays eggs on clothing</strong>, not on the body itself.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rook&rsquo;s Textbook of Dermatology, 9<sup>th</sup> Edition, Page No. 34.21; </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bolognia Textbook of Dermatology, 4<sup>th</sup> edition, Page No. 1511</span></span></strong></span></span></p>",
      "correct_choice_id": 153313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38606,
      "choices": [
        {
          "id": 154167,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ketamine</span></span></span></p>"
        },
        {
          "id": 154168,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Propofol</span></span></span></p>"
        },
        {
          "id": 154169,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thiopentone</span></span></span></p>"
        },
        {
          "id": 154170,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Etomidate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is the most alkaline induction agent in Anesthesia? </span></span></p>",
      "unique_key": "Q6365469",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739795,
      "difficulty_level": "difficult",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Thiopentone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thiopentone (<strong>thiopental</strong>) is the <strong>most alkaline induction agent</strong> in anesthesia. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a <strong>barbiturate anesthetic</strong> that is prepared as a <strong>sodium salt</strong> with an <strong>alkaline pH</strong>, <strong>typically greater than 10</strong> when dissolved. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This <strong>alkaline property</strong> helps <strong>maintain the drug&#39;s potency</strong> when reconstituted with <strong>water, glucose, or normal saline</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Ketamine.</strong> Ketamine is <strong>not the most alkaline induction agent</strong> in anesthesia. Ketamine is a <strong>dissociative anesthetic</strong> that is <strong>chemically</strong> classified as an <strong>arylcyclohexylamine</strong>. It is <strong>not an alkaline agent</strong>; instead, it has a <strong>pH close to neutral</strong>. Ketamine induces <strong>anesthesia</strong> by <strong>antagonizing the N-Methyl-D-Aspartate (NMDA) receptor</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><strong><span style=\"font-size:14.0pt\"> Propofol.</span></strong><span style=\"font-size:14.0pt\"> Propofol is <strong>not the most alkaline induction agent either</strong>. Propofol is an <strong>intravenous anesthetic agent</strong> with a <strong>pH of around 7.0 to 8.5</strong>. It is an <strong>emulsion of soybean</strong> <strong>oil, glycerol, </strong>and<strong> egg lecithin</strong> and is <strong>not considered alkaline</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Etomidate.</strong> Etomidate is also <strong>not the most alkaline induction agent</strong>. Etomidate is an <strong>intravenous anesthetic</strong> that has a <strong>pH in the range of 6.0 to 7.0</strong>. It is <strong>not alkaline in nature</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>most alkaline induction agent</strong> in anesthesia is <strong>Thiopentone (Thiopental)</strong>, which is a <strong>barbiturate anesthetic prepared</strong> as a <strong>sodium salt</strong> with a <strong>high alkaline pH</strong>, helping to maintain its <strong>potency</strong> when <strong>reconstituted with various solutions</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154169,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38713,
      "choices": [
        {
          "id": 154595,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vocal Cord Nodules&nbsp; </span></span></span></p>"
        },
        {
          "id": 154596,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laryngeal Papillomatosis&nbsp; </span></span></span></p>"
        },
        {
          "id": 154597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reinke&#39;s Edema&nbsp; </span></span></span></p>"
        },
        {
          "id": 154598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laryngeal Carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old woman presents to the clinic with a 6-month history of a gradually worsening hoarse voice. She has a 30-year history of smoking one pack of cigarettes per day and drinks alcohol socially. On examination, her voice is noticeably hoarse. Laryngoscopy reveals bilateral, non-tender, swollen lesions in the superficial lamina propria of the vocal cords. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q5483103",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755799,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Reinke&#39;s Edema</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reinke&#39;s edema is strongly associated with <strong>smoking</strong> and presents with <strong>swollen</strong>, <strong>fluid-filled lesions</strong> in the <strong>superficial layer</strong> of the <strong>vocal cords</strong>, leading to a <strong>hoarse voice</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s <strong>long history</strong> of <strong>smoking</strong> and the <strong>appearance</strong> of the <strong>lesions</strong> on <strong>laryngoscopy</strong> support this diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">REINKE&#39;S EDEMA or POLYPOID DEGENERATION OF VOCAL CORDS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral symmetrical swelling</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of the whole membranous part of the vocal cords, most often seen in <strong>middle-aged men</strong> and <strong>women</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>due</strong> to <strong>oedema</strong> of the <strong>subepithelial space</strong> (<strong>Reinke&#39;s space</strong>) of the vocal cords. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aetiological factors:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Misuse of voice, Heavy smoking, Chronic sinusitis, Laryngopharyngeal reflux, Myxoedema.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hoarseness</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a common symptom. </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On indirect laryngoscopy, vocal cords appear as <strong>fusiform swellings </strong>with a <strong>pale translucent look</strong>. </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bands may appear <strong>hyperaemic</strong> and <strong>hypertrophic</strong> and may hide the view of the true cords.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment: </span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decortications</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of the vocal cords, i.e. <strong>removal</strong> of <strong>strip</strong> of epithelium, is done first on one side and <strong>3&ndash;4 weeks</strong> <strong>later</strong> on the other. </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Voice rest</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></span></li>\r\n\t\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speech therapy</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> for proper <strong>voice production</strong>.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-123932.JPG\" style=\"height:250px; width:300px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Vocal cord nodules</strong> are also known as <strong>singer&#39;s nodules</strong> and are typically found in individuals who <strong>strain</strong> their <strong>voices</strong>. They present as <strong>bilateral growths</strong> on the <strong>vocal cords</strong> but do not usually result in the swollen appearance seen in this patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-123943.JPG\" style=\"height:219px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Laryngeal papillomatosis</strong> is characterized by <strong>Multiple Papillomas (warts)</strong> on the <strong>vocal cords</strong> and is caused by <strong>HPV infection</strong>. It is less likely in this patient given the clinical presentation and risk factors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-123954.JPG\" style=\"height:165px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Laryngeal carcinoma.</strong> While smoking is a <strong>risk factor for</strong> <strong>laryngeal carcinoma</strong>, the <strong>bilateral</strong>, <strong>non-tender nature</strong> of the <strong>lesions</strong> and the absence of other symptoms like pain, dysphagia, or weight loss make this diagnosis less likely.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-124008.JPG\" style=\"height:197px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnose Reinke&#39;s edema based on the clinical presentation of a <strong>hoarse voice</strong> in a <strong>long-term smoker</strong> and <strong>distinguish it</strong> from other conditions <strong>affecting</strong> the <strong>vocal cords</strong> by <strong>recognizing</strong> its <strong>characteristic appearance</strong> on <strong>laryngoscopy</strong>.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38821,
      "choices": [
        {
          "id": 155023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perthes disease</span></span></span></span></p>"
        },
        {
          "id": 155024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Slipped capital femoral epiphysis (SCFE)</span></span></span></span></p>"
        },
        {
          "id": 155025,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Observation hip</span></span></span></span></p>"
        },
        {
          "id": 155026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis of the hip</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 11-year-old child weighing 70 kg presents to the pediatric orthopedic clinic with complaints of difficulty in moving his hip sideways and rotating it inward. Upon examination, there is notable tenderness in the region of Scarpa&#39;s triangle, and when the hip is flexed, the limb assumes an externally rotated position. The child&#39;s weight is significantly above average for his age, which is an important consideration in the clinical assessment. Based on the presenting symptoms and physical examination findings, the clinician is evaluating the most likely diagnosis. Which of the following is the most likely diagnosis for this patient?</span></span></span></span></p>",
      "unique_key": "Q5506342",
      "question_audio": null,
      "question_video": null,
      "map_id": 3784355,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Slipped capital femoral epiphysis (SCFE)</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Slipped capital femoral epiphysis (SCFE) is a condition where the femoral head slips posteriorly and inferiorly with respect to the femoral neck due to weakness at the growth plate. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is more common in overweight or obese children, especially during the pubertal growth spurt. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation often includes pain in the hip or knee, a limp, and restricted hip movements, particularly limited abduction and internal rotation. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The external rotation of the limb upon flexing the hip is a classic sign of SCFE. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s age, weight, and clinical findings strongly suggest SCFE.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Perthes disease.</strong> Perthes disease involves avascular necrosis of the femoral head and typically presents in children aged 4-8 years. It can cause hip pain and limping but the presentation and age group are less consistent with this patient&#39;s profile.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Observation hip.</strong> &quot;Observation hip&quot; is not a recognized medical condition or diagnosis. This option does not correspond to any specific hip pathology.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tuberculosis of the hip.</strong> Tuberculosis (TB) of the hip is an infectious condition that can lead to chronic hip pain, stiffness, and swelling. While TB hip can cause limited range of motion, the clinical presentation and epidemiology are less consistent with this patient&#39;s symptoms and the typical presentation of TB hip.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective of this question is to diagnose slipped capital femoral epiphysis (SCFE) based on the classic presentation of hip pain, limited abduction and internal rotation, and external rotation of the limb upon hip flexion in an overweight or obese adolescent. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing the signs and risk factors of SCFE is crucial for early diagnosis and management to prevent further slippage and potential complications.</span></span></li>\r\n</ul>",
      "correct_choice_id": 155024,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38534,
      "choices": [
        {
          "id": 153879,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amphibole</span></span></span></p>"
        },
        {
          "id": 153880,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chrysotile</span></span></span></p>"
        },
        {
          "id": 153881,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amesite</span></span></span></p>"
        },
        {
          "id": 153882,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tremolite</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old male with a history of working in the construction industry for over 30 years presents to the clinic with shortness of breath, chest pain, and a persistent cough. Imaging studies reveal pleural thickening and the presence of pleural plaques. Given the patient&#39;s occupational history and clinical presentation, there is a concern for mesothelioma, a type of cancer often associated with asbestos exposure. There are several types of asbestos fibres, with varying degrees of association with mesothelioma. Which of the following asbestos types is least likely to be associated with the development of mesothelioma?</span></span></span></p>",
      "unique_key": "Q5572641",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734393,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Chrysotile</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chrysotile, also known as <strong>white asbestos</strong>, is the most common form of asbestos and is part of the serpentine family of minerals. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While all forms of asbestos are hazardous and can potentially cause mesothelioma, chrysotile fibres are less potent in inducing mesothelioma compared to amphibole forms of asbestos. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is due to the physical and biological properties of chrysotile fibres, which are more likely to be cleared from the lung and pleural spaces. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, it is important to note that no form of asbestos is considered safe, and all can potentially lead to mesothelioma, though the risk associated with chrysotile is relatively lower compared to the amphibole types.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Amphibole.</span></strong><span style=\"font-size:14.0pt\"> This category includes several types of asbestos, such as amosite and crocidolite, which are more strongly associated with mesothelioma than chrysotile due to their physical shape and biopersistence in the lung tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Amosite.</span></strong><span style=\"font-size:14.0pt\"> This amosite is a type of amphibole asbestos. Also known as <strong>brown</strong> <strong>asbestos</strong>, it is highly associated with mesothelioma due to its amphibole fibres, which are straight and needle-like, making them more hazardous than chrysotile.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Tremolite</span></strong><span style=\"font-size:14.0pt\">. Tremolite is another type of amphibole asbestos, not used as widely as chrysotile or amosite but present as a contaminant in some chrysotile deposits and other minerals. It is also associated with a higher risk of mesothelioma due to its amphibole nature.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When considering the risk of mesothelioma related to asbestos exposure, it&#39;s important to understand the different types of asbestos fibres. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chrysotile, or white asbestos, has the lowest association with mesothelioma compared to amphibole forms such as amosite, crocidolite, and tremolite, due to its physical and biological properties that allow for greater clearance from lung tissues. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, all forms of asbestos exposure are hazardous and can potentially lead to mesothelioma, underscoring the need for protective measures in industries where asbestos exposure is a risk.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153880,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38559,
      "choices": [
        {
          "id": 153979,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fasciola gigantica</span></span></span></p>"
        },
        {
          "id": 153980,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gastrodiscoides hominis</span></span></span></p>"
        },
        {
          "id": 153981,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ancylostoma caninum</span></span></span></p>"
        },
        {
          "id": 153982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Opisthorchis viverrini</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old girl residing in a suburban area is brought to a healthcare facility by her parents due to persistent diarrhea and occasional abdominal cramps that have lasted for several months. The family owns a small farm where they grow various crops and have some livestock. The patient has been involved in farming activities but has no notable travel history outside her local region. Her diet is typical for her community, without any recent changes. A detailed investigation, including a stool analysis, reveals the presence of large ova, each measuring more than 100 microns in size. The identification of the causative organism is essential for initiating appropriate treatment. Based on the size of the ova found in the stool sample, which of the following organisms is the most likely cause of her symptoms?</span></span></p>",
      "unique_key": "Q9587357",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736169,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A)</span></strong><strong><span style=\"font-size:14.0pt\"> Fasciola gigantica</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fasciola gigantica is a trematode (fluke) that causes fascioliasis, typically associated with the ingestion of contaminated water plants like watercress or drinking water contaminated with the encysted larvae. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ova of Fasciola gigantica are large, measuring up to 150 microns, and are passed in the feces of infected individuals. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of such large ova in the stool sample is characteristic of an infection with Fasciola gigantica.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Gastrodiscoides hominis</span></strong><span style=\"font-size:14.0pt\">. This trematode is less well-known and causes a mild infection; its eggs are smaller than those of Fasciola gigantica and not commonly encountered.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Ancylostoma caninum</span></strong><span style=\"font-size:14.0pt\">. This is a hookworm species that typically infects dogs, and its eggs are significantly smaller than 100 microns. It can cause cutaneous larva migrans in humans but is not associated with the presence of large eggs in stool.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Opisthorchis viverrini</span></strong><span style=\"font-size:14.0pt\">. This is a liver fluke associated with the consumption of raw or undercooked fish, primarily found in Southeast Asia. Its eggs are also smaller than those of Fasciola gigantica.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-120018.JPG\" style=\"height:338px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 153979,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38464,
      "choices": [
        {
          "id": 153607,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The depth and location of the fatal wounds</span></span></span></p>"
        },
        {
          "id": 153608,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of defensive wounds on the hands and arms</span></span></span></p>"
        },
        {
          "id": 153609,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The pattern of blood splatter in the room</span></span></span></p>"
        },
        {
          "id": 153610,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The degree of bruising around the superficial wounds</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 40-year-old man is found dead in his apartment with multiple stab wounds. Forensic analysis reveals that some wounds are superficial while others are deep and fatal. The presence of bruising around the deeper wounds indicates they were inflicted while the victim was still alive. During the medicolegal investigation, it is crucial to determine the sequence of injuries. Which of the following findings would most likely indicate the initial phase of the assault?</span></span></span></p>",
      "unique_key": "Q8493880",
      "question_audio": null,
      "question_video": null,
      "map_id": 3720275,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) The presence of defensive wounds on the hands and arms</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Defensive wounds, typically found on the hands and arms, suggest that the victim was conscious and attempting to defend themselves at the beginning of the attack. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These wounds are often seen in the initial phase of an assault, providing valuable information about the sequence of events.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. The depth and location of the fatal wounds</span></strong><span style=\"font-size:14.0pt\">. While important, they do not necessarily indicate the sequence of the assault.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The pattern of blood splatter in the room</span></strong><span style=\"font-size:14.0pt\">. This can help reconstruct the event but does not specifically indicate the initial phase of the assault.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. The degree of bruising around the superficial wounds</span></strong><span style=\"font-size:14.0pt\">. This can indicate whether the wounds were inflicted pre- or post-mortem but does not directly indicate the start of the assault.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">The significance of defensive wounds</span></strong><span style=\"font-size:14.0pt\">: These injuries are critical for reconstructing the sequence of events in a violent assault. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing and interpreting such findings is essential in medicolegal investigations, particularly in cases involving criminal acts, to provide a detailed and accurate account of the incident.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38726,
      "choices": [
        {
          "id": 154647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triceps</span></span></span></span></p>"
        },
        {
          "id": 154648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biceps</span></span></span></span></p>"
        },
        {
          "id": 154649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sartorius</span></span></span></span></p>"
        },
        {
          "id": 154650,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brachioradialis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mr. Shetty recently underwent surgery to remove a parathyroid gland due to hyperparathyroidism. The surgeon informed the patient that one or more of the parathyroid glands may be transferred to another location during the surgery to protect them or due to their location. The parathyroid is commonly transferred to:</span></span></span></span></p>",
      "unique_key": "Q1526222",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756712,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Brachioradialis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common site for relocation of the parathyroid gland(s) is in the forearm muscle (non-dominant side Brachioradialis). </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transplantation to this location provides several advantages. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One key advantage is that it is easy to access if future surgical interventions are necessary. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moreover, the forearm location allows for easy monitoring of parathyroid function using simple clinical tests.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The transferred gland(s) will continue to function and produce parathyroid hormone as normal in their new location, helping to regulate calcium levels in the body.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This also facilitates easy removal if there is disease recurrence after surgery.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;A total of 12 to 14 pieces are transplanted. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a type of heterotopic transplant.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Triceps, Option B. Biceps</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and <strong>Option C. Sartorius</strong> are not preferred for parathyroid transplantation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common site for relocation of the parathyroid gland(s) is in the forearm muscle (non-dominant side Brachioradialis). </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38322,
      "choices": [
        {
          "id": 153047,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cellulose</span></span></p>"
        },
        {
          "id": 153048,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pectin</span></span></p>"
        },
        {
          "id": 153049,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Psyllium</span></span></p>"
        },
        {
          "id": 153050,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inulin</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 58-year-old man with a history of type 2 diabetes mellitus and chronic constipation presents to his primary care physician seeking advice on dietary modifications to improve his glycemic control and bowel habits. He reports trying various fibre supplements and medications with limited success. The physician recommends incorporating a specific type of dietary fibre found in fruits such as apples and oranges, which has been shown to slow glucose absorption and improve bowel movements by increasing stool bulk. Which of the following is the most appropriate dietary fibre to recommend to this patient?</span></span></span></p>",
      "unique_key": "Q4426945",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715373,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Pectin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pectin is a soluble dietary fibre found in high concentrations in fruits such as apples and oranges. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It has the ability to form a gel-like matrix in the presence of water, which can slow the passage of food through the GI tract, thereby slowing glucose absorption and improving glycemic control. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, pectin increases stool bulk and water content, which can alleviate constipation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This makes pectin an ideal dietary supplement for patients with type 2 diabetes and chronic constipation, like the patient described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Cellulose.</strong> Cellulose is an insoluble fibre that increases fecal bulk and speeds up the passage of stool through the digestive tract. While it can help with constipation, it does not have the same impact on glucose absorption as pectin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Psyllium.</strong> Psyllium is a soluble fibre that can improve both constipation and glycemic control, but it is not specifically found in fruits and may not be as effective as pectin in forming gel-like matrices that slow glucose absorption.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Inulin.</strong> Inulin is a type of soluble fibre found in chicory root and other vegetables. It acts as a prebiotic, promoting gut health, but does not have the same direct impact on glucose absorption or stool bulk as pectin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the examinee&#39;s knowledge of dietary fibres, specifically pectin, and their effects on glycemic control and bowel habits. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pectin, a soluble fibre found in certain fruits, can slow glucose absorption and improve constipation, making it suitable for patients with diabetes and chronic constipation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the properties and sources of different dietary fibres is crucial for recommending dietary modifications in clinical practice.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153048,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38539,
      "choices": [
        {
          "id": 153899,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Burkitt lymphoma</span></span></span></p>"
        },
        {
          "id": 153900,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hodgkin lymphoma</span></span></span></p>"
        },
        {
          "id": 153901,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cat scratch disease</span></span></span></p>"
        },
        {
          "id": 153902,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mycosis fungoides</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 33-year-old woman has experienced low grade fevers, night sweats, and generalized malaise for the past 2 months. On physical examination, she has non-tender cervical and supraclavicular lymphadenopathy. A cervical lymph node biopsy is performed. On microscopic examination at high magnification, there are occasional CD15+ and CD30+ cells with owl eye inclusions along with large and small lymphocytes and bands of fibrosis. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q6554411",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734838,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Hodgkin lymphoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of low-grade fevers, night sweats, generalized malaise, and non-tender cervical and supraclavicular lymphadenopathy, in conjunction with the presence of CD15+ and CD30+ Reed-Sternberg cells on lymph node biopsy, is indicative of Hodgkin lymphoma. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reed-Sternberg cells are the pathognomonic cells for Hodgkin lymphoma and are typically present in a background of reactive large and small lymphocytes and often with fibrosis, as described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Burkitt lymphoma.</span></strong><span style=\"font-size:14.0pt\"> This aggressive lymphoma is characterized by a very high mitotic index and is associated with the c-myc oncogene translocation. It does not have Reed-Sternberg cells and is typically CD10+, BCL6+, and BCL2- on immunophenotyping.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cat scratch disease.</span></strong><span style=\"font-size:14.0pt\"> This is an infectious disease caused by Bartonella henselae and would more commonly present with a history of cat exposure and a scratch or bite. The microscopic examination typically shows granulomatous inflammation, not Reed-Sternberg cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Mycosis fungoides.</span></strong><span style=\"font-size:14.0pt\"> This is a form of cutaneous T-cell lymphoma and would present with skin lesions, such as patches, plaques, or tumors. The diagnosis is made through skin biopsy, which would show atypical T-cells with cerebriform nuclei infiltrating the epidermis (epidermotropism).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The diagnosis of Hodgkin lymphoma is supported by the characteristic presence of CD15+ and CD30+ Reed-Sternberg cells on lymph node biopsy, along with associated clinical symptoms such as fevers, night sweats, malaise, and lymphadenopathy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the immunophenotypic markers and the classic presentation helps to distinguish Hodgkin lymphoma from other lymphoid neoplasms and reactive conditions.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38702,
      "choices": [
        {
          "id": 154551,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serum Folate</span></span></span></p>"
        },
        {
          "id": 154552,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serum Homocysteine Levels</span></span></span></p>"
        },
        {
          "id": 154553,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Red Cell Folate Assay</span></span></span></p>"
        },
        {
          "id": 154554,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serum Methylmalonate Levels</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old male with a history of alcohol abuse, presenting with fatigue, difficulty concentrating, shortness of breath, pale conjunctiva, glossitis, and macrocytic anemia, is suspected of having a folate deficiency. Considering his dietary habits and clinical presentation, which test is most appropriate to assess his body folate stores?</span></span></p>",
      "unique_key": "Q8091614",
      "question_audio": null,
      "question_video": null,
      "map_id": 3754668,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Red Cell Folate Assay</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Red Cell Folate Assay is the most accurate indicator of long-term folate status in the body. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unlike serum folate, which can fluctuate based on recent dietary intake and reflects only short-term folate status, red cell folate is a better measure of tissue stores and long-term nutritional status. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This test measures the folate concentration within erythrocytes, which is less likely to be influenced by short-term dietary changes and provides a more reliable assessment of folate sufficiency or deficiency.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Serum Folate.</strong> Measures the concentration of folate in the blood serum, providing a snapshot of recent folate intake rather than long-term stores. Serum levels can quickly change with dietary intake and may not accurately reflect the body&#39;s folate status over time.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Serum Homocysteine Levels.</strong> While elevated homocysteine levels can suggest folate deficiency (as folate is involved in homocysteine metabolism), they are not specific and can also be elevated in vitamin B12 deficiency and other conditions. Thus, it is not a direct measure of folate stores.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Serum Methylmalonate Levels.</strong> This test is primarily used to diagnose vitamin B12 deficiency, as methylmalonate levels rise when vitamin B12 is deficient. It is not useful for assessing folate status.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Red Cell Folate Assay is the most reliable indicator of long-term folate status, as it measures folate levels within red blood cells, which are less influenced by recent dietary intake and reflect the folate available for erythropoiesis and other cellular processes over time. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154553,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38697,
      "choices": [
        {
          "id": 154531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Nifedipine</span></span></span></p>"
        },
        {
          "id": 154532,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Ambrisentan</span></span></span></p>"
        },
        {
          "id": 154533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Epoprostenol</span></span></span></p>"
        },
        {
          "id": 154534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Iloprost</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">A 36-year-old female with class II pulmonary hypertension was found to have positive vasoreactivity testing on right heart catheterisation. Which of the following drugs are recommended in the management of this patient?</span></span></span></p>",
      "unique_key": "Q4456896",
      "question_audio": null,
      "question_video": null,
      "map_id": 3754533,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Nifedipine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with pulmonary hypertension (PH), particularly those with class II pulmonary arterial hypertension (PAH) who demonstrate positive vasoreactivity during right heart catheterization, calcium channel blockers such as nifedipine can be effective for long-term management. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Positive vasoreactivity is defined by a decrease in mean pulmonary artery pressure by at least 10 mmHg to a value of 40 mmHg or less, with an increased or unchanged cardiac output. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nifedipine, a calcium channel blocker, helps to relax and widen the blood vessels, reducing the pressure in the pulmonary arteries. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Its use is specifically recommended for patients who have shown a favourable response to acute vasoreactivity testing, as it can improve symptoms, exercise tolerance, and possibly prognosis in these selected individuals.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Ambrisentan</span></strong><span style=\"font-size:14.0pt\"> is an endothelin receptor antagonist used in the treatment of PAH. While it is effective for many patients with PAH, it is not the first-line treatment for those with demonstrated vasoreactivity, where calcium channel blockers are preferred due to their efficacy in this specific subgroup.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Epoprostenol</span></strong><span style=\"font-size:14.0pt\"> is a prostacyclin analogue that is a potent vasodilator and inhibitor of platelet aggregation. It is used in the management of severe PAH, particularly in patients who do not respond to oral therapies. It is not typically the first choice in patients with positive vasoreactivity who may respond well to oral calcium channel blockers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Iloprost</span></strong><span style=\"font-size:14.0pt\"> is another prostacyclin analogue used in the treatment of PAH. Like epoprostenol, it is more commonly reserved for more severe cases or for patients who have not responded adequately to oral therapies and is not the initial treatment choice for patients with positive vasoreactivity to calcium channel blockers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcium channel blockers such as nifedipine are recommended for this specific patient population due to their efficacy in reducing pulmonary arterial pressure in vasoreactive patients. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154531,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38315,
      "choices": [
        {
          "id": 153019,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sino-atrial node</span></span></span></p>"
        },
        {
          "id": 153020,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Bundle of His</span></span></span></p>"
        },
        {
          "id": 153021,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Atrial pathways</span></span></span></p>"
        },
        {
          "id": 153022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Purkinje fibres</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 58-year-old male with a history of hypertension and diabetes mellitus presents to the clinic complaining of palpitations and episodes of dizziness for the past week. Physical examination reveals an irregularly irregular heartbeat. An electrocardiogram (EKG) is performed, showing evidence of atrial fibrillation. Given the patient&#39;s arrhythmia, the physician decides to discuss the cardiac conduction system to explain how electrical impulses travel through the heart, leading to the coordination of heart muscle contractions. Which of the following components of the cardiac conduction system is responsible for the fastest conduction velocity, which is critical in the rapid transmission of electrical impulses to the ventricles?</span></span></span></p>",
      "unique_key": "Q9312433",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715186,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Purkinje fibres</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Purkinje fibres have the fastest conduction velocity in the cardiac conduction system, which allows for the rapid and coordinated transmission of electrical impulses to the ventricular myocardium. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This rapid conduction ensures that the ventricles contract efficiently and in a synchronized manner, which is crucial for maintaining an effective cardiac output. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The high speed of conduction is due to the unique properties of Purkinje fibres, including their large diameter and the presence of abundant gap junctions that facilitate the quick passage of ions between cells.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Sino-atrial node.</span></strong><span style=\"font-size:14.0pt\"> The SA node is the primary pacemaker of the heart, located in the right atrium. It initiates the heart&#39;s electrical impulse, but its conduction velocity is slower compared to Purkinje fibres. Its primary role is in the initiation of the cardiac cycle, not in rapid impulse conduction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Bundle of His.</span></strong><span style=\"font-size:14.0pt\"> The Bundle of His conducts impulses from the atria to the ventricles but does so at a slower velocity than Purkinje fibres. It serves as a pathway for impulses to travel from the atrioventricular node to the ventricles.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Atrial pathways.</span></strong><span style=\"font-size:14.0pt\"> These pathways conduct impulses through the atria. They facilitate the spread of the electrical impulse from the SA node throughout the atria but do not have the fastest conduction velocity compared to Purkinje fibres.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question tests the understanding of the cardiac conduction system and the recognition that Purkinje fibres have the fastest conduction velocity, which is essential for the rapid and coordinated contraction of the ventricles. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding the role and characteristics of different components of the cardiac conduction system is crucial for diagnosing and managing cardiac arrhythmias.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38399,
      "choices": [
        {
          "id": 153351,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pulmonary embolism</span></span></span></p>"
        },
        {
          "id": 153352,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pulmonary hypertension</span></span></span></p>"
        },
        {
          "id": 153353,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pulmonary edema</span></span></span></p>"
        },
        {
          "id": 153354,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pulmonary infarction</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A 36-year-old male presents with progressive shortness of breath and fatigue, particularly with physical activity. A loud pulmonic component of the second heart sound is heard on examination. The patient also notices swelling and tightness of the skin in the fingers, hands, and face, joint pain and stiffness, and difficulty swallowing. Chest X-Ray is shown here. What is the likely diagnosis? </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-183833.JPG\" style=\"height:283px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6543366",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718052,
      "difficulty_level": "intermediate",
      "subjects_id": [
        17
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) Pulmonary hypertension </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation of progressive shortness of breath and fatigue, especially with exertion, along with a loud pulmonic component of the second heart sound, are classic signs of pulmonary hypertension. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary hypertension leads to increased pressure in the pulmonary arteries, causing the right side of the heart to work harder, which can manifest as a loud P2 (pulmonic component of the second heart sound). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The symptoms of swelling and tightness in the fingers, hands, and face, joint pain and stiffness, and difficulty swallowing may suggest a connective tissue disease like scleroderma, which can be associated with pulmonary hypertension.</span> </span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Peripheral pruning is the tapering of the peripheral arterial branches which a characteristic radiologic feature of Pulmonary artery hypertension. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The plain radiograph findings in pulmonary artery hypertension include:</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Elevated cardiac apex due to right ventricular hypertrophy</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Enlarged right atrium</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Prominent pulmonary outflow tract</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Enlarged pulmonary arteries</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pruning of peripheral pulmonary vessels</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option</span></strong> <strong><span style=\"font-size:14.0pt\">A. Pulmonary embolism.</span></strong><span style=\"font-size:14.0pt\"> While pulmonary embolism can cause shortness of breath and chest pain, the progressive nature of the symptoms and the presence of skin and joint symptoms are less typical. Pulmonary embolism usually presents acutely.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option</span></strong> <strong><span style=\"font-size:14.0pt\">C. Pulmonary edema.</span></strong><span style=\"font-size:14.0pt\"> Pulmonary edema typically presents with acute shortness of breath, often with a history of heart failure or acute cardiac event. The skin and joint symptoms described do not fit with pulmonary edema.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option</span></strong> <strong><span style=\"font-size:14.0pt\">D. Pulmonary infarction.</span></strong><span style=\"font-size:14.0pt\"> A pulmonary infarction could cause shortness of breath and pain, but it is less likely to present with the chronic, progressive symptoms and systemic features such as skin tightness and joint pain described in the scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question aims to assess the ability to recognize the signs and symptoms of pulmonary hypertension and distinguish them from other pulmonary conditions. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary hypertension&#39;s hallmark features include progressive shortness of breath, fatigue with exertion, and a loud pulmonic component of the second heart sound, along with potential systemic manifestations related to underlying causes such as connective tissue diseases. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the clinical presentation of pulmonary embolism, pulmonary edema, and pulmonary infarction is essential for differential diagnosis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153352,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38729,
      "choices": [
        {
          "id": 154659,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GI tract</span></span></span></span></p>"
        },
        {
          "id": 154660,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lungs</span></span></span></span></p>"
        },
        {
          "id": 154661,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver</span></span></span></span></p>"
        },
        {
          "id": 154662,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ear drum</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A team of emergency responders has been called to the scene of a bomb blast in a crowded city center. Upon arrival, they find multiple casualties with various injuries, including blast injuries. In a blast injury, which of the following organs is least vulnerable to the blast wave?</span></span></span></span></p>",
      "unique_key": "Q6099182",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756825,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Liver </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The liver, being a solid and dense organ, is least vulnerable to the direct effects of a blast wave. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, this does not mean that it is immune to blast injuries altogether. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary or tertiary mechanisms, like being struck by flying debris or crushed against another object, can still cause liver injuries. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. GI tract. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The gastrointestinal (GI) tract, particularly the hollow parts like the stomach and intestines, is susceptible to blast injuries due to the presence of air within these structures. Typical injuries include subserosal hemorrhage, cecal and ileal perforation. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lungs. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lungs are among the most vulnerable organs to a blast injury. Being air-filled and highly delicate, they can sustain significant injury from the sudden pressure wave generated by an explosion. Pulmonary barotrauma can lead to potentially life-threatening conditions like pneumothorax (collapsed lung), hemothorax (blood in the pleural cavity), and pulmonary contusion (bruising of the lung tissue).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ear drum. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The eardrum, or tympanic membrane, is particularly sensitive to sudden pressure changes and the most commonly injured organ. It&#39;s a thin membrane separating the external ear from the middle ear. The eardrum can easily rupture from the pressure wave of a blast, making it a common injury in explosion scenarios. A ruptured eardrum can cause hearing loss and pain.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While all the organs listed can be injured during an explosion, the liver, being a solid organ, is least vulnerable to the primary blast wave compared to the air-filled structures like the lungs and GI tract or the delicate eardrum.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154661,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38724,
      "choices": [
        {
          "id": 154639,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1.6 </span></span></span></span></p>"
        },
        {
          "id": 154640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3.6 </span></span></span></span></p>"
        },
        {
          "id": 154641,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2.2 </span></span></span></span></p>"
        },
        {
          "id": 154642,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2.6</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-day-old baby has been diagnosed with asymmetrical intrauterine growth restriction (IUGR). Given the baby&#39;s weight of 2 kg and length of 50 cm, what is the neonate&#39;s ponderal index?</span></span></p>",
      "unique_key": "Q6961154",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1.6</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ponderal index (PI) is calculated using the formula</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formula = weight in grams / length in cm (cube) Multiply by 100</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The answer is 1.6</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PI &gt; 2</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: symmetrical IUGR </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PI &lt;2</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: asymmetrical IUGR </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The calculated ponderal index (PI) is 1.6. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A PI less than 2 is indicative of asymmetrical IUGR, where the weight is more affected than the length, often seen with late gestation insults.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 3.6</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. A PI of 3.6 would be abnormally high and is not typically associated with IUGR.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 2.2</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. A PI of 2.2 would be closer to normal but is still not correct for this neonate.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 2.6</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. A PI of 2.6 would also be considered within the normal range and not indicative of IUGR.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ponderal index for this neonate is 1.6, which supports the diagnosis of asymmetrical IUGR, a condition where the baby&#39;s weight is disproportionately low compared to their length. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154639,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38411,
      "choices": [
        {
          "id": 153399,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immediate caesarean section</span></span></span></p>"
        },
        {
          "id": 153400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Forceps delivery</span></span></span></p>"
        },
        {
          "id": 153401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Repeat scalp blood pH within 30 mins</span></span></span></p>"
        },
        {
          "id": 153402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrate the patient and start O2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A 24-year primigravida is in labor. At 5 cm dilatation, a CTG taken shows late decelerations. A fetal scalp blood sample reveals a pH of 7.19. What is the next best step in management?</span></span></span></p>",
      "unique_key": "Q4455178",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718800,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Immediate caesarean section</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In this scenario, immediate cesarean section is indicated due to the presence of late decelerations on the CTG, which are a sign of fetal hypoxia or distress. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The fetal scalp blood pH of 7.19, while close to the lower limit of the normal range, in the context of ongoing late decelerations, suggests that the fetus may not be tolerating labor well. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In such cases, the priority is to prevent potential fetal compromise or neurological injury, and an immediate cesarean section is warranted to deliver the fetus promptly.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Forceps delivery</span></strong><span style=\"font-size:14.0pt\">. This option is not appropriate at 5 cm dilation, as forceps delivery requires full cervical dilation. Moreover, without addressing the underlying cause of fetal distress, instrumental delivery could potentially exacerbate fetal compromise.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Repeat scalp blood pH within 30 mins.</span></strong><span style=\"font-size:14.0pt\"> While repeating the scalp pH could provide additional information, the presence of ongoing late decelerations suggests a need for more immediate action to prevent fetal harm.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hydrate the patient and start O2</span></strong><span style=\"font-size:14.0pt\">. These conservative measures might be considered as initial steps in cases of mild or uncertain fetal distress. However, in the presence of clear signs of distress such as late decelerations and a borderline fetal scalp blood pH, they are not sufficient to address the immediate risk to the fetus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question emphasizes the critical nature of interpreting CTG findings and fetal scalp blood pH in the context of labor management. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Late decelerations are a serious sign of fetal distress, often indicating inadequate fetal oxygenation. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In such cases, especially when accompanied by a concerning fetal scalp blood pH, prompt delivery via cesarean section is essential to prevent fetal harm. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The decision for an immediate caesarean section is based on the need to swiftly address potential fetal compromise.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38466,
      "choices": [
        {
          "id": 153615,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Executive magistrate</span></span></span></p>"
        },
        {
          "id": 153616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Jail superintendent</span></span></span></p>"
        },
        {
          "id": 153617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Judicial magistrate</span></span></span></p>"
        },
        {
          "id": 153618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sub-Inspector</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a recent incident at a local Police station, a man who was detained overnight was found unresponsive in his cell the following morning. The circumstances surrounding his death were unclear, leading to concerns regarding the handling of detainees and the conditions within the station. Given the legal and procedural implications of a death occurring under legal custody, it is crucial to determine which official is specifically designated to lead the investigation into such matters to ensure accountability and transparency. Which official is tasked with the investigation of deaths occurring under legal custody?</span></span></span></p>",
      "unique_key": "Q7570575",
      "question_audio": null,
      "question_video": null,
      "map_id": 3720337,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Judicial magistrate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The judicial magistrate is responsible for investigating deaths that occur under legal custody. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This role is crucial in maintaining an impartial and thorough inquiry into the circumstances leading to the death, ensuring that any procedural or criminal issues are appropriately addressed.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Executive magistrate</span></strong><span style=\"font-size:14.0pt\">. The executive magistrate is responsible for inquests in <strong>two conditions:&nbsp;</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Dowry death&nbsp;</span></strong><span style=\"font-size:14.0pt\">(Death within 7 years of marriage, and death was unnatural and related to dowry) - 304B IPC- Executive magistrate</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Exhumation &ndash;&nbsp; </span></strong><span style=\"font-size:14.0pt\">digging&nbsp; out&nbsp; of buried bodies. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Jail superintendent</span></strong><span style=\"font-size:14.0pt\">. The jail superintendent manages the administrative functions of the prison but does not conduct legal inquests into custodial deaths.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Sub-inspector</span></strong><span style=\"font-size:14.0pt\">. The sub-inspector may be involved in the preliminary response but is not authorized to conduct the official inquest into a custodial death.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:&nbsp;</span></strong></span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In India, inquests are classified as Police Inquests, conducted by police officers of at least Head Constable rank, and Magistrate Inquests, divided into Executive Magistrate Inquests for dowry deaths and exhumation, and Judicial Magistrate Inquests for custodial deaths.</span></span></p>",
      "correct_choice_id": 153617,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38443,
      "choices": [
        {
          "id": 153523,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To reapply the patch with another adhesive</span></span></span></p>"
        },
        {
          "id": 153524,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To apply a new patch</span></span></span></p>"
        },
        {
          "id": 153525,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To apply a new patch and use a condom for 1 week</span></span></span></p>"
        },
        {
          "id": 153526,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To remove the patch and use a condom until her next menstrual period</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 23-year-old woman, who has been using the transdermal contraceptive patch as her primary method of contraception, presents to the outpatient department. She reports that her contraceptive patch was partially detached for more than 24 hours. Considering the potential compromise in the patch&#39;s effectiveness due to this incident, what would be the most appropriate advice for her to ensure continuous contraceptive protection?</span></span></span></p>",
      "unique_key": "Q5910919",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719868,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) To apply a new patch and use a condom for 1 week</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The correct advice would be to apply a new patch immediately and use a backup method of contraception, such as a condom, for the next 7 days. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When a transdermal contraceptive patch is detached for more than 24 hours, its effectiveness can be compromised, and there is a risk of reduced contraceptive protection. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Applying a new patch restores contraceptive coverage, but the backup method is necessary to ensure protection while the hormone levels from the new patch reach effective concentrations.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. To reapply the patch with another adhesive</span></strong><span style=\"font-size:14.0pt\">. This is not recommended because the patch&#39;s ability to deliver hormones at the correct rate may be compromised if it has been detached, especially for an extended period.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. To apply a new patch</span></strong><span style=\"font-size:14.0pt\">. While applying a new patch is part of the correct action, this option alone does not address the need for a backup contraceptive method during the period when the hormone levels may not yet be fully effective.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. To remove the patch and use a condom until her next menstrual period</span></strong><span style=\"font-size:14.0pt\">. This option might provide immediate contraceptive protection through the use of condoms, but it does not take into account the immediate re-establishment of hormonal contraception, which the woman may prefer for ongoing contraceptive coverage.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective is to understand the importance of maintaining continuous and effective contraceptive protection with the transdermal patch. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In instances where the patch has been detached for an extended period, applying a new patch and using a backup contraceptive method, such as condoms, for the next 7 days is crucial to ensure ongoing contraceptive efficacy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This approach addresses both the immediate need for contraception and the potential gap in hormonal coverage due to the detachment.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153525,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38370,
      "choices": [
        {
          "id": 153235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Desmopressin</span></span></span></p>"
        },
        {
          "id": 153236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leuprolide</span></span></span></p>"
        },
        {
          "id": 153237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thiazide diuretics</span></span></span></p>"
        },
        {
          "id": 153238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Insulin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old woman presents to the endocrinology clinic with complaints of excessive thirst and frequent urination, which she has been experiencing for the past few months. She reports that she drinks several litres of water each day but still feels dehydrated. Laboratory tests reveal low urine osmolality and high serum osmolality. After further evaluation, she is diagnosed with central diabetes insipidus. Considering the need to replace ADH and reduce her symptoms, which of the following medications is the drug of choice for the management of central diabetes insipidus in this patient?</span></span></span></p>",
      "unique_key": "Q6080240",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716896,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Desmopressin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Desmopressin is a synthetic analog of antidiuretic hormone (ADH), also known as <strong>vasopressin</strong>, and is the drug of choice for the treatment of central diabetes insipidus. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It acts on the kidneys to increase water reabsorption, thereby reducing polyuria (excessive urination) and polydipsia (excessive thirst). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Desmopressin can be administered orally, intranasally, or parenterally, making it a versatile option for managing central diabetes insipidus.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Leuprolide</span></strong><span style=\"font-size:14.0pt\"> is a gonadotropin-releasing hormone (GnRH) analog used in the treatment of hormone-responsive cancers such as prostate cancer and in conditions like endometriosis and uterine fibroids, not for diabetes insipidus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Thiazide</span></strong><span style=\"font-size:14.0pt\"> <strong>diuretics</strong> are used in the management of nephrogenic diabetes insipidus, not central diabetes insipidus, by inducing mild volume depletion and increasing proximal tubule water reabsorption.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Insulin</span></strong><span style=\"font-size:14.0pt\"> is used in the treatment of diabetes mellitus to control blood glucose levels, not in the management of diabetes insipidus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the appropriate pharmacological management of central diabetes insipidus, focusing on the role of desmopressin as a synthetic analog of ADH. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of distinguishing between central and nephrogenic diabetes insipidus and selecting the correct treatment based on the underlying pathophysiology.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38616,
      "choices": [
        {
          "id": 154207,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">Type 1 Hypersensitivity Reaction </span></span></span></span></p>"
        },
        {
          "id": 154208,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">Type 2 Hypersensitivity Reaction </span></span></span></span></p>"
        },
        {
          "id": 154209,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">Type 3 Hypersensitivity Reaction </span></span></span></span></p>"
        },
        {
          "id": 154210,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">Type 4 Hypersensitivity Reaction</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\">A 12-year-old boy presents to the ophthalmology clinic with complaints of itching, redness, and mucous discharge from both eyes, particularly during the spring and summer months. On examination, you observe the presence of giant papillae on the upper tarsal conjunctiva. What type of immunologic reaction is most likely involved in the pathogenesis of this condition?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-163228.JPG\" style=\"height:170px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2327373",
      "question_audio": null,
      "question_video": null,
      "map_id": 3740195,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Type 1 Hypersensitivity Reaction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is an <strong>immediate hypersensitivity reaction</strong> mediated by <strong>IgE antibodies</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In conditions like <strong>VKC</strong>, exposure to specific <strong>allergens triggers</strong> the <strong>IgE-mediated activation</strong> of <strong>mast cells</strong>, leading to the <strong>release</strong> of <strong>histamine</strong> and other inflammatory mediators. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This results in symptoms such as <strong>itching</strong>, <strong>redness</strong>, and <strong>mucous discharge</strong>, which are characteristic of allergic reactions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Type 2 Hypersensitivity Reaction</span></strong><span style=\"font-size:14.0pt\"> involves antibodies (<strong>IgG or IgM</strong>) directed against <strong>cell surface</strong> or <strong>tissue antigens</strong>, <strong>leading</strong> to <strong>cell damage</strong>. This mechanism is typically <strong>involved</strong> in <strong>diseases</strong> where there is a reaction <strong>against self-antigens</strong> or <strong>modified host cells</strong>, and it is not associated with VKC.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Type 3 Hypersensitivity Reaction</span></strong><span style=\"font-size:14.0pt\"> involves the <strong>formation</strong> of <strong>immune complexes</strong> (<strong>antigen-antibody complexes</strong>) that <strong>deposit</strong> in <strong>tissues</strong> and cause <strong>inflammation</strong>. Commonly seen in conditions like <strong>systemic lupus erythematosus</strong> and <strong>serum sickness</strong>, it is not the mechanism involved in VKC.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Type 4 Hypersensitivity Reaction</span></strong><span style=\"font-size:14.0pt\">, also known as <strong>delayed-type hypersensitivity</strong>, this reaction is <strong>cell-mediated</strong>, primarily involving <strong>T cells</strong>. It is the mechanism behind conditions such as <strong>contact dermatitis</strong> and <strong>tuberculosis skin tests</strong>, but not VKC.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>symptoms</strong> and <strong>signs</strong> of <strong>Vernal Keratoconjunctivitis,</strong> such as <strong>itching</strong>, <strong>redness</strong>, <strong>mucous discharge</strong>, and <strong>giant papillae</strong> on the <strong>upper tarsal conjunctiva</strong>, are <strong>indicative</strong> of a <strong>Type 1 hypersensitivity</strong> <strong>reaction</strong>, where <strong>IgE</strong>-<strong>mediated immune</strong> responses play a <strong>central role</strong> in the <strong>pathogenesis</strong> of the <strong>condition</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154207,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38527,
      "choices": [
        {
          "id": 153851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Apoptosis</span></span></span></p>"
        },
        {
          "id": 153852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Necrosis</span></span></span></p>"
        },
        {
          "id": 153853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ferroptosis</span></span></span></p>"
        },
        {
          "id": 153854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Autophagy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old man with a history of chronic pancreatitis and diabetes mellitus type 2 presents to the clinic with complaints of progressive weakness, fatigue, and a recent unintentional weight loss of 10 kg over the past 6 months. He denies any fever, night sweats, or changes in bowel habits. His medications include pancreatic enzyme replacement, insulin, and a multivitamin supplement. Physical examination is unremarkable except for mild pallor. Laboratory studies show anemia with low serum iron levels, normal total iron-binding capacity, and elevated ferritin levels. A subsequent examination revealed that cellular death can be prevented by reducing iron levels. The patient&#39;s condition is most likely a result of which of the following cellular processes?</span></span></span></p>",
      "unique_key": "Q2422052",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734046,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Ferroptosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s clinical presentation and laboratory findings suggest a condition related to abnormal iron metabolism, leading to iron overload in the absence of inflammation, infection, or malignancy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ferroptosis is a form of regulated cell death characterized by the accumulation of lipid peroxides and is distinct from apoptosis, necrosis, and autophagy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is driven by iron-dependent lipid peroxidation, leading to cell death. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Conditions associated with iron overload, such as the patient&#39;s chronic pancreatitis and potential for malnutrition or malabsorption syndromes, could predispose to alterations in iron metabolism and subsequent ferroptosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An important hint to this being the answer can be found in the fact that the cellular death can be prevented by reducing iron levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. </span></strong><strong><span style=\"font-size:14.0pt\">Apoptosis</span></strong><span style=\"font-size:14.0pt\"> is a process of programmed cell death involving cell shrinkage, nuclear fragmentation, and chromatin condensation, which is not directly related to iron metabolism or the patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. </span></strong><strong><span style=\"font-size:14.0pt\">Necrosis</span></strong><span style=\"font-size:14.0pt\"> is an unregulated form of cell death caused by external factors such as trauma or infection, leading to cell swelling, membrane rupture, and inflammation, which does not fit the patient&#39;s clinical picture.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. </span></strong><strong><span style=\"font-size:14.0pt\">Autophagy</span></strong><span style=\"font-size:14.0pt\"> is a regulated process that involves the degradation and recycling of cellular components in response to stress or nutrient deprivation, which is not directly implicated in the patient&#39;s condition related to iron overload.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question aims to assess the understanding of ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of recognizing the role of iron metabolism in various pathophysiological conditions and distinguishing ferroptosis from other forms of cell death such as apoptosis, necrosis, and autophagy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding these processes is crucial in the diagnosis and management of conditions associated with abnormal iron metabolism.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153853,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38720,
      "choices": [
        {
          "id": 154623,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">William&rsquo;s syndrome </span></span></span></span></p>"
        },
        {
          "id": 154624,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DiGeorge syndrome </span></span></span></span></p>"
        },
        {
          "id": 154625,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prader-Willi syndrome </span></span></span></span></p>"
        },
        {
          "id": 154626,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angelman syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child with coarse facial features, hypercalcemia, and a heart murmur indicative of supravalvular aortic stenosis most likely has which of the following syndromes?</span></span></span></span></p>",
      "unique_key": "Q2800678",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756216,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) William&rsquo;s syndrome</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">William&rsquo;s syndrome is characterized by distinctive &ldquo;elfin&rdquo; facial features, cardiovascular disease such as supravalvular aortic stenosis, hypercalcemia, developmental delays, and a unique personality profile that often includes being overly friendly.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. DiGeorge syndrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, also known as <strong>22q11.2 deletion syndrome</strong>, includes features such as conotruncal congenital heart defects, hypocalcemia due to hypoparathyroidism, immune deficiencies, and other phenotypic features, but not typically the combination of features described in the question.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Prader-Willi syndrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is associated with hypotonia, obesity, hypogonadism, and mild to moderate intellectual disability. Coarse facial features, hypercalcemia, and supravalvular aortic stenosis are not typical of this syndrome.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Angelman syndrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by severe intellectual disability, seizures, ataxic gait, and frequent laughter or smiling, but it is not associated with the specific constellation of symptoms described.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">William&rsquo;s syndrome is the most likely diagnosis in a child presenting with coarse facial features, hypercalcemia, and a cardiac murmur indicative of supravalvular aortic stenosis. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other key features of Williams syndrome include a broad smile, outgoing personality, and stellate iris pattern.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154623,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38721,
      "choices": [
        {
          "id": 154627,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toxic shock syndrome </span></span></span></span></p>"
        },
        {
          "id": 154628,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scarlet fever </span></span></span></span></p>"
        },
        {
          "id": 154629,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kawasaki disease </span></span></span></span></p>"
        },
        {
          "id": 154630,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stevens-Johnson syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with a five-day history of fever, conjunctivitis without pus, cervical lymphadenopathy larger than 1.5 cm, erythematous skin with desquamation, and inflammation of the oral mucosa including a strawberry tongue. What is the most likely diagnosis?</span></span></span></span></p>",
      "unique_key": "Q6439092",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756307,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Kawasaki disease </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kawasaki disease is a medium vessel vasculitis that typically affects children. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation can include fever for at least five days, non-exudative conjunctivitis, erythema and desquamation of the extremities, oral mucosal changes including &quot;strawberry tongue,&quot; and cervical lymphadenopathy, which fits the presentation described.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Toxic shock syndrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is associated with fever, rash, and multisystem involvement, typically in association with toxin-producing bacterial infections. It is often accompanied by hypotension and organ dysfunction, which are not described in the question.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Scarlet fever</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is associated with fever, a fine sandpaper-like rash, and &quot;strawberry tongue.&quot; However, it does not typically present with unilateral cervical lymphadenopathy or the systemic vasculitis seen in the condition described.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Stevens-Johnson syndrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a serious systemic reaction with extensive mucosal involvement and epidermal detachment, but it is not typically characterized by prolonged fever or unilateral cervical lymphadenopathy, as described.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kawasaki disease is characterized by a constellation of symptoms, including fever for at least five days, non-purulent conjunctivitis, rash, edema of the hands and feet, changes in the oral mucosa, and cervical lymphadenopathy.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154629,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38714,
      "choices": [
        {
          "id": 154599,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Herpes Simplex Virus Type 1 (HSV-1) </span></span></span></p>"
        },
        {
          "id": 154600,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Coxsackievirus A</span></span></span></p>"
        },
        {
          "id": 154601,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Epstein-Barr Virus (EBV)</span></span></span></p>"
        },
        {
          "id": 154602,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Human Immunodeficiency Virus (HIV)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 5-year-old boy is brought to the pediatric clinic by his mother, who reports that he has had a fever, sore throat, and difficulty swallowing for the past two days. On examination, the child appears irritable and has multiple small vesicular lesions with erythematous bases on his soft palate and tonsillar pillars. No skin rash is noted. His immunizations are up to date, and there is no significant past medical history. Which of the following is the most likely causative agent of this child&#39;s condition?</span></span></span></p>",
      "unique_key": "Q9414525",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755870,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Coxsackievirus A</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coxsackievirus A is the <strong>most common cause</strong> of <strong>herpangina</strong>, an illness characterized by <strong>fever, sore throat</strong>, and <strong>vesicular lesions</strong> on the <strong>oropharynx</strong>, particularly the <strong>soft palate</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It typically <strong>affects young children</strong> and is more common in the <strong>summer</strong> and <strong>fall</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To begin with, <strong>multiple small vesicles</strong> appear on the <strong>faucial pillars</strong>, <strong>tonsils</strong>, <strong>soft palate</strong> and <strong>uvula</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They rupture to form <strong>ulcers</strong> which are usually <strong>2&ndash;4 mm in size</strong>, had a <strong>yellow base</strong> and <strong>red areola</strong> around them. They seldom persist <strong>beyond 1 week</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. </span></strong><strong><span style=\"font-size:14.0pt\">Herpes Simplex Virus Type 1 (HSV-1).</span></strong><span style=\"font-size:14.0pt\"> HSV-1 typically causes <strong>oral herpes</strong>, characterized by <strong>cold sores</strong> or <strong>fever blisters</strong> around the mouth. While it can cause <strong>pharyngitis</strong>, the presentation is <strong>usually different</strong> from that of herpangina.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Epstein-Barr Virus (EBV).</strong> EBV is the <strong>causative agent</strong> of <strong>infectious mononucleosis</strong>. It can cause <strong>pharyngitis</strong>, <strong>fever</strong>, and <strong>lymphadenopathy</strong>, but the presence of palatal vesicles is not characteristic of EBV infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\">&nbsp; <strong>Human Immunodeficiency Virus (HIV).</strong> Acute HIV infection can present with <strong>pharyngitis</strong>, but it is not typically associated with the vesicular lesions seen in herpangina. Moreover, the <strong>epidemiology</strong> (<strong>a young</strong>, otherwise healthy child) makes this a less likely option.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify Coxsackievirus A as the most common causative agent of <strong>herpangina</strong>, which presents with <strong>fever, sore throat</strong>, and <strong>vesicular lesions</strong> on the <strong>oropharynx</strong>, especially in young children.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154600,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38705,
      "choices": [
        {
          "id": 154563,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unexplained hepatomegaly</span></span></span></p>"
        },
        {
          "id": 154564,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unexplained splenomegaly</span></span></span></p>"
        },
        {
          "id": 154565,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unexplained massive ascites</span></span></span></p>"
        },
        {
          "id": 154566,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fever of unknown origin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old male with significant hepatomegaly, inconclusive liver function tests, and no clear etiology on imaging is considered for further diagnostic evaluation. Among the following options, which is NOT a typical reason for performing a percutaneous liver biopsy in this case?</span></span></span></p>",
      "unique_key": "Q7375264",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755211,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Unexplained massive ascites</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unexplained massive ascites is not a typical indication for a percutaneous liver biopsy primarily due to the increased risk of complications such as bleeding and leakage of ascitic fluid through the biopsy site. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Percutaneous liver biopsy in the presence of significant ascites is generally avoided or approached with caution, and alternative diagnostic methods or different biopsy approaches (e.g., transjugular liver biopsy) might be considered to minimize risks.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Unexplained hepatomegaly.</strong> This is a common indication for liver biopsy when the cause of liver enlargement cannot be determined through non-invasive means. A biopsy can help diagnose conditions like fatty liver disease, chronic hepatitis, or infiltrative diseases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Unexplained splenomegaly.</strong> While splenomegaly itself may not directly indicate a liver biopsy, it often accompanies liver diseases such as cirrhosis, suggesting an underlying condition affecting the liver that may warrant a biopsy for diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Fever of unknown origin.</strong> In certain contexts, especially when liver involvement is suspected in systemic diseases or infections that could contribute to a prolonged fever, a liver biopsy might be indicated to aid in the diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unexplained hepatomegaly and potential liver involvement in systemic diseases may warrant a liver biopsy for diagnostic purposes, massive ascites represents a relative contraindication due to increased procedural risks. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38719,
      "choices": [
        {
          "id": 154619,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harlequin icthyosis</span></span></p>"
        },
        {
          "id": 154620,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harlequin colour change </span></span></span></span></p>"
        },
        {
          "id": 154621,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mongolion spot </span></span></span></span></p>"
        },
        {
          "id": 154622,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newborn is observed with tight, translucent skin resembling plastic wrap, which is suggestive of a collodion membrane. The infant&rsquo;s skin barrier function is impaired, which of the following diagnoses is most consistent with this presentation?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-125432.JPG\" style=\"height:170px; width:300px\" /></span></span></p>",
      "unique_key": "Q2569482",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756195,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong></span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harlequin icthyosis</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Picture is a case of </span></span></span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harlequin icthyosis</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> / colloidon baby</span></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harlequin icthyosis</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, especially when referred to in the neonatal period as a &quot;collodion baby,&quot; is characterized by a tight, shiny, translucent membrane that covers the skin and then peels off. It is associated with defects in skin barrier function and lipid transport and is typically inherited in an autosomal recessive pattern.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Harlequin colour change&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a condition often seen in newborns characterized by temporary colour changes, where half of the skin turns red while the other half turns pale. It is not associated with the collodion membrane.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mongolian spots&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are congenital dermal melanocytosis, presenting as blue or greyish pigmentation, commonly found on the back or buttocks of infants. It does not present with the membrane-like skin changes.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The newborn in the picture is most likely a &quot;</span></span></span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harlequin icthyosis</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">,&quot; a term used for neonates born with ichthyosis vulgaris, characterized by a tight, shiny membrane that covers the skin and results from defects in skin development and lipid transport. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is typically inherited in an autosomal recessive manner.</span></span></li>\r\n</ul>",
      "correct_choice_id": 154619,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38820,
      "choices": [
        {
          "id": 155019,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule H drugs</span></span></span></span></p>"
        },
        {
          "id": 155020,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule X drugs</span></span></span></span></p>"
        },
        {
          "id": 155021,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule J drugs</span></span></span></span></p>"
        },
        {
          "id": 155022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule Y drugs</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old woman visits your clinic for a consultation regarding her chronic pain management. She has a history of rheumatoid arthritis and has tried various over-the-counter medications, but with little relief. You consider prescribing a more potent medication that falls under a specific drug schedule, which mandates that it should only be dispensed with a prescription from a registered medical practitioner due to its potential for adverse effects and necessity for medical supervision. Which of the following drug schedules includes medications that should only be sold on the prescription of a registered medical practitioner?</span></span></span></span></p>",
      "unique_key": "Q3802725",
      "question_audio": null,
      "question_video": null,
      "map_id": 3784254,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A) Schedule H drugs</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule H drugs are a category of prescription drugs in some countries&#39; drug regulation systems that are not to be sold without a prescription from a registered medical practitioner. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These drugs include those that can cause significant potential harm if used without adequate medical supervision, have a high potential for abuse, or are used to treat serious medical conditions. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The regulation helps ensure that these medications are used safely and effectively, minimizing the risk of adverse effects and misuse.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Schedule X drugs</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> also require a prescription and are under even stricter control due to their high potential for abuse. However, the question specifically asks for the category that broadly encompasses prescription-only medications, making Schedule H a more fitting choice.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Schedule J drugs</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically include substances that are not to be used as ingredients in pharmaceuticals and are not relevant to the context of prescription-only medications.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Schedule Y drugs</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are related to the clinical trial and regulatory approval process of drugs in some countries, not to the prescription requirements for dispensing existing medications.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The question is designed to test the understanding of drug scheduling systems and their implications for clinical practice, particularly regarding which medications require a prescription from a registered medical practitioner. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It emphasizes the importance of adhering to legal and regulatory frameworks in prescribing medications, ensuring patient safety, and the effective use of pharmacological interventions in treatment plans.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 155019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38355,
      "choices": [
        {
          "id": 153175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ceftriaxone</span></span></span></p>"
        },
        {
          "id": 153176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ceftazidime</span></span></span></p>"
        },
        {
          "id": 153177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cefuroxime</span></span></span></p>"
        },
        {
          "id": 153178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ceftobiprole</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 58-year-old man with a history of diabetes mellitus presents to the emergency department with a swollen, red, and painful right lower leg. He mentions a minor abrasion he sustained while gardening a week ago. On examination, the area is warm to the touch, and there are purulent drainage and surrounding cellulitis. His temperature is 38.7&deg;C (101.7&deg;F). Given the clinical presentation and the increasing prevalence of antibiotic-resistant organisms, you suspect a methicillin-resistant Staphylococcus aureus (MRSA) infection. You decide to initiate antibiotic therapy and recall that one of the following cephalosporins has activity against MRSA. Which cephalosporin would be most appropriate for this suspected infection?</span></span></span></p>",
      "unique_key": "Q3911525",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716289,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Ceftobiprole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ceftobiprole is a broad-spectrum cephalosporin with activity against MRSA. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is one of the few cephalosporins that can target MRSA effectively due to its ability to bind to modified penicillin-binding proteins (PBPs) that are present in MRSA strains. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This makes it a suitable choice for treating infections suspected to be caused by MRSA, in settings where this antibiotic is available and its use is indicated.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Ceftriaxone</span></strong><span style=\"font-size:14.0pt\"> is a third-generation cephalosporin widely used for various bacterial infections, but it lacks efficacy against MRSA.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Ceftazidime</span></strong><span style=\"font-size:14.0pt\"> is a third-generation cephalosporin that has excellent activity against Pseudomonas aeruginosa but does not have activity against MRSA.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cefuroxime</span></strong><span style=\"font-size:14.0pt\"> is a second-generation cephalosporin with a broader spectrum of activity than first-generation cephalosporins but is not effective against MRSA.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question is designed to test knowledge of antibiotic selection, specifically within the class of cephalosporins, for infections caused by resistant bacteria such as MRSA. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the spectrum of activity of different cephalosporins is crucial for effective and appropriate antibiotic therapy, especially in the context of increasing antibiotic resistance.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38393,
      "choices": [
        {
          "id": 153327,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior cruciate ligament (ACL)</span></p>"
        },
        {
          "id": 153328,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior cruciate ligament (PCL)</span></p>"
        },
        {
          "id": 153329,
          "text": "<p><span style=\"font-size:14.0pt;\">Medial meniscus</span></p>"
        },
        {
          "id": 153330,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral meniscus</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 25-year-old basketball player presents to the clinic after experiencing a painful \"pop\" in his knee during a game, followed by swelling and instability. Physical examination reveals a positive pivot shift test. The physician considers the structures that might be injured to account for this clinical finding. A positive pivot shift test in the knee is indicative of an injury to which of the following structures?</span></p>",
      "unique_key": "Q7180303",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Anterior cruciate ligament (ACL)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Painful \"pop\" in knee during sports is a classic symptom of a ligamentous rupture, particularly the ACL.</span></li><li><span style=\"font-size:14.0pt;\">Swelling and instability are also common signs of acute ligamentous injury.</span></li><li><span style=\"font-size:14.0pt;\">The pivot shift test is a specific physical examination manoeuvre used to assess the integrity of the anterior cruciate ligament (ACL) in the knee.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It evaluates the amount of anterolateral rotatory instability.</span></li><li><span style=\"font-size:14.0pt;\">It<strong>&nbsp;</strong>is the <strong>most specific and sensitive clinical test for an ACL rupture</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A positive pivot shift test, which indicates a momentary subluxation of the tibia on the femur followed by a reduction, is highly suggestive of an ACL tear.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The ACL is crucial for maintaining the stability of the knee, especially in rotational and anterior-posterior movements.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">An injury to the ACL can lead to a sensation of instability or giving way, especially during activities that involve pivoting or sudden changes in direction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Posterior cruciate ligament (PCL).</strong>PCL injuries typically result in posterior instability. Injuries to the PCL typically present with a positive posterior drawer test or posterior sag sign, not a positive pivot shift test. The PCL is responsible for preventing posterior displacement of the tibia relative to the femur.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Medial meniscus.</strong> While meniscal injuries can contribute to knee pain and instability, a positive pivot shift test is not indicative of a meniscal injury. Meniscus tears can cause pain, swelling, and mechanical symptoms like locking or clicking, but they do not primarily cause the type of rotatory instability. Meniscal injuries are more likely to be identified with the McMurray test or joint line tenderness.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Lateral meniscus.</strong> Similar to the medial meniscus, lateral meniscus injuries do not typically present with a positive pivot shift test. The presentation and diagnosis of lateral meniscal injuries involve other clinical findings and tests.&nbsp;A lateral meniscus tear can sometimes accompany an ACL tear, but it is not the primary structure assessed by the pivot shift.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A positive pivot shift test is the <strong>most specific and sensitive clinical test for an ACL rupture</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It directly demonstrates the anterolateral rotatory instability caused by an incompetent ACL.</span></li></ul>",
      "correct_choice_id": 153327,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38693,
      "choices": [
        {
          "id": 154515,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient can present with diabetic ketoacidosis.</span></span></span></p>"
        },
        {
          "id": 154516,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The condition can be treated with oral glucose-lowering agents once the patient is stabilized.</span></span></span></p>"
        },
        {
          "id": 154517,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Positive autoimmune markers are typically present in this type of diabetes.</span></span></span></p>"
        },
        {
          "id": 154518,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Autoimmune markers are typically absent in this type of diabetes.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old recently diagnosed diabetic male presents with diabetic ketoacidosis (DKA), showing high blood glucose and urinary ketones. With a BMI of 29 kg/m&sup2; and no autoimmune history, which statement about ketosis-prone type 2 DM is incorrect in this context?</span></span></span></p>",
      "unique_key": "Q7851587",
      "question_audio": null,
      "question_video": null,
      "map_id": 3752659,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Positive autoimmune markers are typically present in this type of diabetes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ketosis-prone type 2 diabetes mellitus, also known as <strong>Flatbush diabetes</strong>, is characterized by the acute onset of diabetic ketoacidosis (DKA) in individuals who may not have a prior history of diabetes. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unlike type 1 diabetes, which involves autoimmune destruction of insulin-producing beta cells and is often associated with positive autoimmune markers (such as anti-GAD antibodies), ketosis-prone type 2 diabetes typically does not have these autoimmune markers. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients with ketosis-prone type 2 diabetes often have features of type 2 diabetes, such as obesity or a strong family history of diabetes, and may not require lifelong insulin therapy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They can often be managed with oral glucose-lowering agents after the initial episode of DKA is resolved.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. The patient can present with diabetic ketoacidosis</span></strong><span style=\"font-size:14.0pt\">. Patients with ketosis-prone type 2 DM can indeed present with DKA, which might be their first manifestation of diabetes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. The condition can be treated with oral glucose-lowering agents once the patient is stabilized</span></strong><span style=\"font-size:14.0pt\">. After the acute episode of DKA is treated, patients with ketosis-prone type 2 DM can often be managed with oral glucose-lowering agents, reflecting their type 2 diabetes pathophysiology.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Autoimmune markers are typically absent in this type of diabetes</span></strong><span style=\"font-size:14.0pt\">. The statement that autoimmune markers are typically absent in ketosis-prone type 2 DM is correct. This distinguishes it from type 1 diabetes, where autoimmune markers are usually present.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective of this question is to understand the characteristics of ketosis-prone type 2 diabetes mellitus, particularly distinguishing it from type 1 diabetes. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It emphasizes that ketosis-prone type 2 diabetes can present with DKA, similar to type 1 diabetes, but lacks autoimmune markers and can often be managed with oral glucose-lowering agents after stabilization from the acute episode, reflecting its type 2 diabetes pathophysiology.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38304,
      "choices": [
        {
          "id": 152975,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Keratinized stratified squamous epithelium</span></span></span></p>"
        },
        {
          "id": 152976,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-keratinized stratified squamous epithelium</span></span></span></p>"
        },
        {
          "id": 152977,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transitional epithelium</span></span></span></p>"
        },
        {
          "id": 152978,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Simple columnar epithelium</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old male patient presents to the clinic with complaints of difficulty swallowing and a sensation of food getting stuck in his throat. Upon further examination, a biopsy is taken from the affected area of the oesophagus, revealing changes in the epithelial tissue. Histological examination of the biopsy shows a type of epithelium that is multilayered but lacks keratinization, typically found in areas requiring a protective barrier that remains moist. Based on the histological findings, which type of epithelium is most likely affected in this patient?</span></span></span></p>",
      "unique_key": "Q7828828",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714445,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Non-keratinized stratified squamous epithelium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-keratinized stratified squamous epithelium is found in areas that need protection from mechanical abrasion but must also remain moist, such as the oral cavity, pharynx, oesophagus, and the anal canal. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This type of epithelium is multilayered, which helps in protection, but does not have a layer of keratin on its surface, allowing it to stay moist. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s symptoms and the histological findings of the oesophagus biopsy suggest that the affected epithelium is non-keratinized stratified squamous epithelium, which is consistent with the location and the nature of the epithelium involved in the pathology.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Keratinized stratified squamous epithelium</span></strong><span style=\"font-size:14.0pt\">. This type of epithelium has a layer of keratin on its surface and is found in areas exposed to the external environment, such as the skin. The keratin layer provides a waterproof barrier, which is not needed in the internal cavities like the esophagus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Transitional epithelium.</span></strong><span style=\"font-size:14.0pt\"> Also known as <strong>urothelium</strong>, this type of epithelium lines the urinary bladder, ureters, and part of the urethra. It is specialized to stretch and accommodate fluctuations in volume in the urinary tract, which is not relevant to the esophagus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Simple columnar epithelium.</span></strong><span style=\"font-size:14.0pt\"> This type of epithelium is typically found in areas of absorption or secretion, such as the stomach, small intestines, and some parts of the colon. It consists of a single layer of column-shaped cells, which does not match the description of the biopsy from the patient&#39;s esophagus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question assesses the learner&#39;s ability to identify non-keratinized stratified squamous epithelium based on its location and functional requirements. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The correct answer, <strong>non-keratinized stratified squamous epithelium</strong>, is found in the esophagus and is adapted to provide protection without a keratin layer, allowing the tissue to remain moist, which is essential for its function in the esophagus. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the differences between various types of epithelial tissues, such as keratinized vs non-keratinized and their locations and functions in the body, is crucial for diagnosing and managing esophageal and other epithelial-related diseases.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 152976,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38396,
      "choices": [
        {
          "id": 153339,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased osteoblastic activity</span></span></span></p>"
        },
        {
          "id": 153340,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-functional osteoclast</span></span></span></p>"
        },
        {
          "id": 153341,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Defective osteoclastic resorption of uncalcified osteoid and cartilage</span></span></span></p>"
        },
        {
          "id": 153342,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Defective proliferation of physis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A pediatrician is reviewing a case of a child with bowing of the legs, delayed growth, and a history of prolonged nutritional deficiencies. The child&#39;s laboratory tests reveal low levels of vitamin D, calcium, and phosphate. Based on the clinical presentation and laboratory findings, the pediatrician considers a diagnosis that involves a fundamental defect in bone metabolism. Understanding the underlying pathology of this condition is crucial for initiating the appropriate treatment. The basic pathological defect in rickets is:</span></span></span></p>",
      "unique_key": "Q2252690",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717919,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Defective osteoclastic resorption of uncalcified osteoid and cartilage</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rickets is primarily characterized by a defect in the mineralization of bone due to inadequate levels of calcium, phosphate, or vitamin D. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This results in an accumulation of unmineralized bone matrix (osteoid) and cartilage, particularly at the growth plates (physes) of long bones, leading to softening and deformation of bones. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The key pathological process in rickets involves defective mineralization, rather than a specific dysfunction of osteoblasts or osteoclasts. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The osteoclasts are involved in the resorption of bone tissue, and while their function may be indirectly affected in rickets, the core issue lies with the failure to properly mineralize new osteoid and cartilage, not with the resorption process itself.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A</span></strong><span style=\"font-size:14.0pt\">. <strong>Decreased osteoblastic activity. </strong>While osteoblastic activity may be altered in rickets, the primary issue is not a decrease in their activity but rather a failure in the mineralization process of the osteoid they produce.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Non-functional osteoclast. </strong>Non-functional osteoclasts are not the primary defect in rickets. Osteoclasts are responsible for bone resorption, and their dysfunction would lead to different clinical manifestations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Defective proliferation of physis. </strong>Although the growth plates are affected in rickets, leading to abnormalities such as bowing of the legs, the fundamental defect is in the mineralization process, not merely in the proliferation of the physis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective of this question is to identify the fundamental pathological defect in rickets as the defective mineralization of osteoid and cartilage, leading to an accumulation of uncalcified bone matrix. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This understanding is crucial for diagnosing and treating rickets, which typically involves supplementation with vitamin D, calcium, and phosphate to address the underlying deficiencies and correct bone mineralization.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38311,
      "choices": [
        {
          "id": 153003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Celiac trunk</span></span></span></p>"
        },
        {
          "id": 153004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Superior mesenteric artery</span></span></span></p>"
        },
        {
          "id": 153005,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inferior mesenteric artery</span></span></span></p>"
        },
        {
          "id": 153006,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Renal artery</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old man is brought to the emergency department with sudden onset of severe abdominal pain. The pain is described as sharp, periumbilical, and radiating to the back. He has a past medical history of atrial fibrillation for which he is on anticoagulation therapy. His vital signs are stable upon examination, but his abdomen is tender in the periumbilical area with some guarding. An urgent CT angiogram of the abdomen is performed, which reveals occlusion of a major abdominal artery. Based on the patient&#39;s presentation and imaging findings, which artery is most likely occluded?</span></span></span></p>",
      "unique_key": "Q8622698",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714982,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Superior mesenteric artery</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The superior mesenteric artery (SMA) is the most likely artery to be occluded in this patient, given the sudden onset of severe, sharp periumbilical pain radiating to the back. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The SMA supplies blood to the midgut, which includes the lower duodenum, jejunum, ileum, cecum, ascending colon, and most of the transverse colon. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute occlusion, possibly due to an embolism (especially in a patient with a history of atrial fibrillation), can lead to ischemia of these regions, causing severe abdominal pain. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The location of the pain corresponds to the distribution of the SMA, and the patient&#39;s anticoagulation therapy may have been insufficient to prevent such an embolic event.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Celiac trunk.</span></strong><span style=\"font-size:14.0pt\"> Occlusion of the celiac trunk would predominantly affect the foregut, leading to pain in the upper abdomen. The presentation would likely include the stomach, duodenum, liver, and spleen, not the periumbilical region.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Inferior mesenteric artery.</span></strong><span style=\"font-size:14.0pt\"> This artery supplies the hindgut, including the distal transverse colon, descending colon, sigmoid colon, and rectum. Occlusion would typically cause pain in the lower abdomen and might be associated with changes in bowel habits or blood in the stool, not the acute presentation described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Renal artery.</span></strong><span style=\"font-size:14.0pt\"> Occlusion of the renal artery would primarily affect the kidneys, potentially leading to flank pain, hematuria, or acute kidney injury. It would not typically cause periumbilical pain or the gastrointestinal symptoms seen in this patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The objective of this question is to identify the clinical presentation and implications of acute superior mesenteric artery (SMA) occlusion. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the anatomical distribution of the SMA and recognizing the typical symptoms of its occlusion, such as severe periumbilical pain radiating to the back, are crucial for prompt diagnosis and treatment. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This knowledge aids in distinguishing SMA occlusion from other vascular events affecting different abdominal organs, ensuring appropriate and targeted therapeutic interventions.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153004,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38602,
      "choices": [
        {
          "id": 154151,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sensitivity of fever for appendicitis is 21/49</span></span></span></p>"
        },
        {
          "id": 154152,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Specificity of fever for appendicitis is 42/70</span></span></span></p>"
        },
        {
          "id": 154153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Positive predictive value of fever for appendicitis is 21/30</span></span></span></p>"
        },
        {
          "id": 154154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Specificity of fever for appendicitis varies with prevalence</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an emergency department, a study is conducted on patients presenting with abdominal pain to determine the diagnostic utility of fever (&gt;37.5&deg;C) for acute appendicitis. It is found that 30% have acute appendicitis, 70% of those with appendicitis have a fever, and 40% of those without appendicitis also have a fever. Based on this information, which of the following is true about using fever as a diagnostic marker for appendicitis?</span></span></p>",
      "unique_key": "Q2995850",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739621,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Specificity of fever for appendicitis is 42/70</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Specificity is calculated as the number of true negatives (those without the condition and test negative) divided by the total number of actual negatives. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Here, 60% of the 70 patients without appendicitis do not have a fever, resulting in 42 true negatives out of 70, giving a specificity of 42/70.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Sensitivity of fever for appendicitis is 21/49</span></strong><span style=\"font-size:14.0pt\">. Incorrect because sensitivity is the true positives divided by the total with the condition, which isn&#39;t represented by 21/49.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Positive Predictive Value (PPV) of fever for appendicitis is 21/30.</span></strong><span style=\"font-size:14.0pt\"> Incorrect as PPV is the true positives divided by all positive tests (true positives + false positives), not 21/30.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Specificity of fever for appendicitis varies with prevalence</span></strong><span style=\"font-size:14.0pt\">. Incorrect because specificity is a characteristic of the test and does not vary with disease prevalence.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Specificity of a screening test is the ability of a test to detect</span></strong><span style=\"font-size:14.0pt\">: True negatives</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Sensitivity of a screening test is the ability of a test to detect</span></strong><span style=\"font-size:14.0pt\">: True positives</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Usefulness of a screening test is given by</span></strong><span style=\"font-size:14.0pt\">: Sensitivity</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statistical index of diagnostic accuracy</span></strong><span style=\"font-size:14.0pt\">: Sensitivity</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Out of those shown positive by a screening test in a population, those who actually have the disease, this is</span></strong><span style=\"font-size:14.0pt\">: PPV of a screening test</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Out of those shown negative by a screening test in a population, those who actually don&rsquo;t have the disease, this is</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: NPV of a screening test</span></span></li>\r\n</ul>",
      "correct_choice_id": 154152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38712,
      "choices": [
        {
          "id": 154591,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type I Thyroplasty</span></span></span></p>"
        },
        {
          "id": 154592,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kashima&rsquo;s Surgery</span></span></span></p>"
        },
        {
          "id": 154593,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Woodman&rsquo;s Surgery</span></span></span></p>"
        },
        {
          "id": 154594,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Total Laryngectomy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Which of these surgeries may be beneficial in unilateral vocal cord palsy?</span></span></span></p>",
      "unique_key": "Q8317419",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Type I Thyroplasty</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unilateral adductor palsy</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of the <strong>vocal cord</strong> can lead to a <strong>gap </strong>between the <strong>vocal cords</strong> during <strong>phonation</strong>, resulting in <strong>voice difficulties</strong> (<strong>breathy voice</strong>). </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I thyroplasty</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>surgical procedure</strong> that involves the <strong>insertion</strong> of an <strong>implant</strong> to <strong>medialize</strong> (<strong>move closer</strong> to the <strong>midline</strong>) the <strong>affected vocal cord</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This medialization helps <strong>improve vocal cords</strong> <strong>approximation</strong> and <strong>voice quality</strong> in individuals with <strong>unilateral vocal cord palsy</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Kashima&rsquo;s surgery</strong> (<strong>Posterior transverse cordotomy</strong>) is a well-known surgical procedure for addressing <strong>bilateral vocal cord palsy</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Woodman&rsquo;s surgery</strong> is not a recognized surgical procedure for addressing this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Total laryngectomy</strong> is a surgical procedure that involves the <strong>removal</strong> of the <strong>entire larynx</strong>. It is <strong>typically performed</strong> for more <strong>severe laryngeal conditions</strong>, such as <strong>advanced laryngeal cancer</strong>, and is not a treatment for unilateral adductor palsy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I thyroplasty may be beneficial in <strong>addressing unilateral vocal cord palsy</strong> by <strong>improving phonation</strong>.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154591,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38734,
      "choices": [
        {
          "id": 154679,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreaticoduodenectomy</span></span></span></span></p>"
        },
        {
          "id": 154680,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Longitudinal pancreaticojejunostomy</span></span></span></span></p>"
        },
        {
          "id": 154681,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ERCP and sphincterotomy</span></span></span></span></p>"
        },
        {
          "id": 154682,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coring of pancreas head</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An alcoholic patient presented with features of chronic pancreatitis with recurrent attacks and has a 10 mm dilatation of the pancreatic duct with intraductal calculi present. Which of the following is the surgery of choice?</span></span></span></span></p>",
      "unique_key": "Q4160914",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757130,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Longitudinal pancreaticojejunostomy</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the given scenario of dilated pancreatic duct with stones, a drainage procedure in the form of longitudinal pancreatico-jejunostomy (Peusthow) is preferred. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A and D.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pancreaticoduodenectomy (Whipple&rsquo;s) and Coring of pancreas head</strong> may be if inflammation is limited to head of pancreas alone.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>ERCP and sphincterotomy</strong>. ERCP may aid removal of pancreatic calculi but is not a long term solution.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CHRONIC PANCREATITIS</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Irreversible damage to architecture of pancreas</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132516.JPG\" style=\"height:785px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a case of<strong> </strong></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dilated pancreatic duct with stones, a drainage procedure in the form of longitudinal pancreatico-jejunostomy (Peusthow) is preferred. </span></span></li>\r\n</ul>",
      "correct_choice_id": 154680,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38533,
      "choices": [
        {
          "id": 153875,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mallory-Weiss tears</span></span></span></p>"
        },
        {
          "id": 153876,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Zenker&rsquo;s diverticulum</span></span></span></p>"
        },
        {
          "id": 153877,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Schatzki rings</span></span></span></p>"
        },
        {
          "id": 153878,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Traction diverticula</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 65-year-old male presents to his primary care physician with complaints of discomfort and mild pain in the upper part of his neck when swallowing. He reports that this has been ongoing for several months and seems to be worsening. The patient also notes that he occasionally regurgitates undigested food shortly after eating, which is particularly distressing during social meals. He denies any significant weight loss, changes in appetite, or gastrointestinal bleeding. His past medical history is unremarkable, and he is not on any regular medications. Physical examination, including a neck examination, is unremarkable. Based on the patient&#39;s history and clinical presentation, which of the following is the most likely etiology of his symptoms?</span></span></span></p>",
      "unique_key": "Q4179757",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734372,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Zenker&rsquo;s diverticulum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Zenker&#39;s diverticulum is an outpouching of the pharyngeal mucosa that occurs at the junction of the oropharynx and esophagus (Killian&#39;s triangle). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is more common in older adults and can lead to symptoms such as dysphagia, regurgitation of undigested food, coughing, and neck pain, particularly during swallowing. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The regurgitation of undigested food, as described by the patient, is a hallmark of this condition, as the diverticulum can collect food particles that are later expelled. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The diagnosis is often confirmed through a barium swallow study or esophagoscopy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Mallory-Weiss Tears.</span></strong><span style=\"font-size:14.0pt\"> These are longitudinal lacerations at the gastroesophageal junction, usually caused by forceful or prolonged vomiting. Patients typically present with hematemesis (vomiting blood) rather than regurgitation of undigested food.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Schatzki Rings.</span></strong><span style=\"font-size:14.0pt\"> A Schatzki ring is a narrowing of the lower esophagus that can cause intermittent dysphagia, especially for solid foods. Patients usually do not experience regurgitation of undigested food shortly after eating, which distinguishes this from Zenker&rsquo;s diverticulum.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Traction Diverticula.</span></strong><span style=\"font-size:14.0pt\"> These are typically mid-esophageal diverticula caused by external traction from fibrotic mediastinal lymph nodes. They are less common and usually asymptomatic or cause vague esophageal symptoms, not specifically regurgitation of undigested food soon after eating.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When a patient presents with symptoms of dysphagia and regurgitation of undigested food without associated vomiting, Zenker&rsquo;s diverticulum should be high on the differential diagnosis list. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is characterized by the formation of a diverticulum at the pharyngoesophageal junction, which can trap food and lead to regurgitation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other conditions, such as Mallory-Weiss tears, Schatzki rings, and traction diverticula, affect the esophagus differently and present with distinct clinical features that help differentiate them from Zenker&rsquo;s diverticulum.</span></span></li>\r\n</ul>",
      "correct_choice_id": 153876,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38365,
      "choices": [
        {
          "id": 153215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Promethazine</span></span></span></p>"
        },
        {
          "id": 153216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Meclizine</span></span></span></p>"
        },
        {
          "id": 153217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Cinnarizine</span></span></span></p>"
        },
        {
          "id": 153218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Fexofenadine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 35-year-old male software developer presents to your clinic complaining of seasonal allergic rhinitis symptoms, including sneezing, nasal congestion, and itchy eyes. He reports that these symptoms significantly impact his work performance, especially during the spring. The patient is seeking a medication that can alleviate his symptoms without causing drowsiness or impairing his cognitive function, as his job requires high levels of concentration and attention to detail. Considering his need for a non-sedating antihistamine, which of the following medications would be most appropriate for this patient?</span></span></span></p>",
      "unique_key": "Q8458341",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716734,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Fexofenadine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fexofenadine is a second-generation antihistamine known for its minimal or no CNS depressant activity. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unlike first-generation antihistamines, which readily cross the blood-brain barrier and can cause significant sedation and drowsiness, fexofenadine has a lower affinity for the central H1 receptors, making it an ideal choice for patients who require relief from allergic symptoms without the sedative effects.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Promethazine</span></strong><span style=\"font-size:14.0pt\"> is a first-generation antihistamine with significant sedative effects, making it unsuitable for patients who need to maintain alertness and cognitive function.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Meclizine</span></strong><span style=\"font-size:14.0pt\"> is another first-generation antihistamine primarily used to treat nausea and motion sickness, and it also has sedative properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cinnarizine</span></strong><span style=\"font-size:14.0pt\">, also a first-generation antihistamine, is used for its anti-vertigo and antiemetic properties but can cause sedation and impair cognitive function.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to test the knowledge of the side effect profiles of different generations of antihistamines, specifically their potential for CNS depressant activity. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the pharmacologic differences between first- and second-generation antihistamines is crucial for selecting the appropriate medication based on the patient&#39;s needs, especially when avoiding sedation is a priority.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153218,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38334,
      "choices": [
        {
          "id": 153095,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Myeloperoxidase</span></span></span></p>"
        },
        {
          "id": 153096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">NADPH oxidase</span></span></span></p>"
        },
        {
          "id": 153097,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Catalase</span></span></span></p>"
        },
        {
          "id": 153098,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Superoxide dismutase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old boy is brought to the pediatrician by his parents, who are concerned about his frequent and severe bacterial infections. His medical history is notable for multiple hospital admissions due to bacterial infections that required intravenous antibiotics for resolution. A detailed workup indicates a defect in the patient&#39;s ability to generate reactive oxygen species within phagocytes. Which of the following components is most likely deficient or dysfunctional in this patient&#39;s phagocytes?</span></span></p>",
      "unique_key": "Q2029950",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715662,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">B) NADPH oxidase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">NADPH oxidase plays a crucial role in the innate immune system&#39;s ability to combat pathogens. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is responsible for generating superoxide radicals by transferring electrons from NADPH inside the phagocyte to oxygen, creating a superoxide anion, a precursor to other reactive oxygen species (ROS). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These ROS are essential for the oxidative burst that phagocytes use to kill ingested pathogens. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A deficiency or dysfunction in NADPH oxidase leads to a condition known as <strong>Chronic Granulomatous Disease (CGD)</strong>, characterized by recurrent, severe infections with bacteria and fungi due to the inability of phagocytes to produce ROS necessary for killing pathogens. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of frequent and severe bacterial infections in this young patient strongly suggests a diagnosis of CGD, likely due to NADPH oxidase deficiency.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>A. Myeloperoxidase.</strong> This enzyme is involved in the conversion of hydrogen peroxide to hypochlorous acid within phagocytes. While myeloperoxidase deficiency can lead to increased susceptibility to infections, it typically does not result in the same severity of recurrent infections as seen in CGD.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>C. Catalase.</strong> Catalase breaks down hydrogen peroxide into water and oxygen. Its deficiency is not typically associated with an increased risk of severe bacterial infections. Pathogens that produce their own catalase can pose a problem in CGD because they neutralize the less effective ROS, but catalase deficiency in human cells is not the primary issue in this context.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>D. Superoxide dismutase.</strong> This enzyme converts superoxide radicals into hydrogen peroxide and is not directly involved in the oxidative burst mechanism of killing pathogens. Deficiencies are more associated with neurological conditions than with increased susceptibility to infections.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to highlight the importance of NADPH oxidase in the immune response, particularly in the oxidative burst mechanism of phagocytes that is crucial for killing pathogens. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It underscores the clinical presentation and implications of NADPH oxidase deficiency, leading to Chronic Granulomatous Disease, which is characterized by recurrent, severe infections. Understanding the role of various components in the immune system&#39;s response to pathogens is essential for diagnosing and managing immune deficiencies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38338,
      "choices": [
        {
          "id": 153111,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibition of bacterial cell wall synthesis</span></span></span></p>"
        },
        {
          "id": 153112,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibition of dihydrofolate reductase</span></span></span></p>"
        },
        {
          "id": 153113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disruption of bacterial protein synthesis</span></span></span></p>"
        },
        {
          "id": 153114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibition of DNA gyrase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 32-year-old woman with no significant past medical history presents to the clinic with complaints of fever, dysuria, and increased frequency of urination for the past two days. On examination, her temperature is 101.3&deg;F, and her physical examination is unremarkable except for mild suprapubic tenderness. Urinalysis reveals pyuria and bacteriuria. A urine culture is obtained, and empirical antibiotic therapy is initiated. Given the patient&#39;s symptoms and initial urinalysis findings, Cotrimoxazole (TMP-SMX) is chosen as the empirical treatment. Which of the following is the most likely mechanism of action of Cotrimoxazole in treating this patient&#39;s condition?</span></span></span></p>",
      "unique_key": "Q9347964",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Inhibition of dihydrofolate reductase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cotrimoxazole, also known as <strong>Trimethoprim-Sulfamethoxazole (TMP-SMX)</strong>, acts by inhibiting two consecutive steps in the bacterial synthesis of tetrahydrofolic acid, which is essential for the synthesis of purines and hence for the synthesis of DNA. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sulfamethoxazole inhibits dihydropteroate synthase, while Trimethoprim inhibits dihydrofolate reductase, effectively halting the production of tetrahydrofolic acid. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This dual blockade is what makes Cotrimoxazole an effective bacteriostatic agent.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Inhibition of bacterial cell wall synthesis</span></strong><span style=\"font-size:14.0pt\"> is the mechanism of action of antibiotics such as penicillins and cephalosporins, not Cotrimoxazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Disruption of bacterial protein synthesis</span></strong><span style=\"font-size:14.0pt\"> is characteristic of antibiotics like tetracyclines and aminoglycosides.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Inhibition of DNA gyrase</span></strong><span style=\"font-size:14.0pt\"> is the mechanism of action of fluoroquinolones, not Cotrimoxazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to test the understanding of the mechanism of action of Cotrimoxazole (Trimethoprim-Sulfamethoxazole), a commonly used antibiotic for urinary tract infections. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cotrimoxazole works by inhibiting two consecutive steps in the bacterial synthesis of tetrahydrofolic acid, essential for DNA synthesis, making it an effective treatment for bacterial infections. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the specific actions of antibiotics is crucial for their effective and appropriate use in clinical practice.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38548,
      "choices": [
        {
          "id": 153935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recombinant DNA vaccine</span></span></span></p>"
        },
        {
          "id": 153936,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Edible vaccine</span></span></span></p>"
        },
        {
          "id": 153937,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nuclear transformation</span></span></span></p>"
        },
        {
          "id": 153938,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RNA vaccine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During a medical school immunology course, a student is tasked with presenting on various vaccination strategies used to prevent infectious diseases. One segment of the presentation focuses on the prevention of Hepatitis B, a significant global health concern due to its potential to cause chronic liver disease and hepatocellular carcinoma. The student explores the development, mechanism, and efficacy of the Hepatitis B vaccine. Based on current vaccination technology and the nature of the Hepatitis B vaccine, which of the following descriptions best characterizes the Hepatitis B vaccine?</span></span></span></p>",
      "unique_key": "Q9247305",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736075,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Recombinant DNA vaccine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Hepatitis B vaccine is a recombinant DNA vaccine, which means it is produced through recombinant DNA technology. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This technology involves inserting the gene for the hepatitis B surface antigen (HBsAg) into yeast cells, which then produce the antigen. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The antigen is purified and used as the active component of the vaccine, stimulating the immune system to produce protective antibodies against Hepatitis B virus (HBV) without causing the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Edible vaccine</span></strong><span style=\"font-size:14.0pt\">. Edible vaccines are a research area involving the introduction of selected genes into plants, allowing the edible parts to produce the antigenic proteins. This concept is not applicable to the current Hepatitis B vaccine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Nuclear transformation</span></strong><span style=\"font-size:14.0pt\">. This term does not specifically apply to vaccine technology. In the context of genetics, transformation refers to the alteration of a cell&#39;s genetic material through the uptake of foreign DNA.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. RNA vaccine</span></strong><span style=\"font-size:14.0pt\">. RNA vaccines, such as some COVID-19 vaccines, use messenger RNA (mRNA) to instruct cells to produce a viral protein that elicits an immune response. The Hepatitis B vaccine does not utilize RNA technology; instead, it is based on recombinant DNA technology.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatitis B vaccine is a recombinant DNA vaccine, the first of its kind approved for human use.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153935,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38308,
      "choices": [
        {
          "id": 152991,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It begins as a continuation of sigmoid sinus </span></span></span></p>"
        },
        {
          "id": 152992,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Superior bulb lodges in the jugular fossa of temporal bone</span></span></span></p>"
        },
        {
          "id": 152993,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inferior bulb lies beneath the suprasternal space</span></span></span></p>"
        },
        {
          "id": 152994,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Common carotid artery lies medial to it</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Identify the incorrect statement about the pointed structure in the below image.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-161441.JPG\" style=\"height:298px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5795316",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714889,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C)</span></strong><span style=\"font-size:14.0pt\"> <strong>Inferior bulb lies beneath the suprasternal space</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The statement about the inferior bulb lying beneath the suprasternal space is incorrect because the inferior bulb of the internal jugular vein is located at the root of the neck and does not extend down into the suprasternal space. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The inferior bulb is typically found at the level where the internal jugular vein joins with the subclavian vein to form the brachiocephalic vein, which is above the suprasternal space.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. It begins as a continuation of sigmoid sinus.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> This statement is correct. The internal jugular vein begins at the base of the skull as a direct continuation of the sigmoid sinus, one of the dural venous sinuses that drain blood from the brain.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B. Superior bulb lodges in the jugular fossa of temporal bone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. This is also correct. The superior bulb of the internal jugular vein is located at the jugular foramen, where it exits the skull. The jugular fossa is part of the temporal bone that accommodates the jugular foramen.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Common carotid artery lies medial to it.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> This statement is accurate. In the neck, the common carotid artery is typically located medial to the internal jugular vein. This anatomical relationship is a key landmark in surgical procedures and medical imaging.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The question aims to assess the understanding of the anatomy of the internal jugular vein, particularly its relationship with surrounding structures and its anatomical course. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It emphasizes the importance of recognizing the correct anatomical landmarks and relationships, such as the origin of the internal jugular vein, the location of its bulbs, and its spatial relationship with the common carotid artery, which are crucial for accurate diagnosis, surgical planning, and interventions involving the neck and head regions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ref: IB Singh, Textbook of Anatomy, vol. 3, Head and Neck, Neuroanatomy, 7<sup>th</sup> edition, page no. 341</span></strong></span></span></p>",
      "correct_choice_id": 152993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38546,
      "choices": [
        {
          "id": 153927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Herpes Simplex Virus (HSV)</span></span></span></p>"
        },
        {
          "id": 153928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rubella</span></span></span></p>"
        },
        {
          "id": 153929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cytomegalovirus (CMV)</span></span></span></p>"
        },
        {
          "id": 153930,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fetal varicella syndrome</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A neonatologist evaluates a newborn with notable physical findings including limb hypoplasia, scarring on the hands, and chorioretinitis. The mother recalls experiencing a vesicular rash during the second trimester of her pregnancy. These clinical manifestations in the neonate are concerning for an intrauterine infection acquired from the mother. Given the maternal history and the neonate&#39;s clinical presentation, which of the following intrauterine infections is most likely responsible for these findings?</span></span></span></p>",
      "unique_key": "Q8646220",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736024,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Fetal varicella syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fetal varicella syndrome, caused by maternal infection with the varicella-zoster virus (VZV) during pregnancy, can lead to a range of congenital abnormalities in the neonate. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The characteristic features include limb hypoplasia, cicatricial skin lesions (scarring), ocular abnormalities such as chorioretinitis, and neurological disorders. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mother&#39;s history of a vesicular rash during pregnancy, consistent with varicella (chickenpox), strongly suggests fetal varicella syndrome as the cause of the neonate&#39;s condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Herpes Simplex Virus (HSV)</span></strong><span style=\"font-size:14.0pt\">. Neonatal HSV infection typically results from exposure to HSV during delivery, rather than intrauterine infection. It can cause severe neonatal illness, including encephalitis and disseminated disease, but it does not typically present with limb hypoplasia and cicatricial skin lesions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Rubella</span></strong><span style=\"font-size:14.0pt\">. Congenital rubella syndrome can result in cataracts, cardiac defects, and hearing impairment, among other findings. While it can lead to ocular issues, the specific combination of limb hypoplasia, cicatricial lesions, and maternal vesicular rash is not characteristic of rubella.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cytomegalovirus (CMV)</span></strong><span style=\"font-size:14.0pt\">. CMV is the most common congenital viral infection and can cause a wide range of clinical manifestations, including hearing loss, microcephaly, and chorioretinitis. However, the presence of limb hypoplasia and cicatricial lesions, along with a maternal history of a vesicular rash, is more indicative of fetal varicella syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fetal varicella syndrome, resulting from maternal VZV infection during pregnancy, especially in the first or early second trimester, leads to developmental abnormalities like limb hypoplasia and chorioretinitis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is distinct from the effects of other infections during pregnancy, such as HSV, Rubella, or CMV, each causing different types of congenital abnormalities.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153930,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38397,
      "choices": [
        {
          "id": 153343,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sign of recovery from spinal shock</span></span></span></p>"
        },
        {
          "id": 153344,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Partial lesion of the spinal cord</span></span></span></p>"
        },
        {
          "id": 153345,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Complete transection of the spinal cord</span></span></span></p>"
        },
        {
          "id": 153346,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Incomplete transection of the spinal cord</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with a recent spinal cord injury is being monitored for neurological signs to assess the extent of the injury and potential for recovery. Initially, the patient exhibited signs of spinal shock, characterized by a complete loss of reflexes, motor, sensory, and autonomic function below the level of injury. Over time, the medical team observes the return of the bulbocavernosus reflex, which involves a contraction of the anal sphincter in response to squeezing the glans penis or clitoris. The team considers the significance of this finding in the context of the patient&#39;s spinal cord injury. The return of the bulbocavernosus reflex in a patient with spinal shock indicates:</span></span></p>",
      "unique_key": "Q1177276",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717920,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Sign of recovery from spinal shock</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The return of the bulbocavernosus reflex is a significant clinical sign indicating the resolution of spinal shock. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spinal shock is a temporary condition that occurs following a spinal cord injury, characterized by flaccid paralysis, loss of reflex activity, and autonomic dysfunction below the level of injury. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The resolution of spinal shock is marked by the return of reflexes, starting with the bulbocavernosus reflex, which is one of the earliest reflexes to return. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This does not necessarily provide information about the completeness or incompleteness of the spinal cord lesion but rather indicates the transition out of the spinal shock phase and the potential for further neurological recovery or assessment.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Partial lesion of the spinal cord. </strong>While the return of reflexes may suggest some level of preservation of neural pathways, the return of the bulbocavernosus reflex alone does not specifically indicate a partial lesion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C</span></strong><span style=\"font-size:14.0pt\">. <strong>Complete transection of the spinal cord. </strong>The return of reflexes such as the bulbocavernosus reflex does not indicate the completeness or incompleteness of the transection. Complete transection might be suggested by other clinical findings and imaging.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Incomplete transection of the spinal cord. </strong>Similarly, while incomplete lesions may allow for more significant recovery of function, the return of the bulbocavernosus reflex specifically indicates the resolution of spinal shock rather than the degree of spinal cord injury.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective of this question is to understand that the return of the bulbocavernosus reflex is a clinical sign indicating the resolution of spinal shock following a spinal cord injury. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This finding is important for clinicians as it marks the end of the spinal shock phase, after which a more accurate neurological assessment can be made, and the extent of permanent injury can begin to be evaluated.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38728,
      "choices": [
        {
          "id": 154655,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ampulla of Vater</span></span></span></span></p>"
        },
        {
          "id": 154656,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ligament of Treitz</span></span></span></span></p>"
        },
        {
          "id": 154657,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superior duodenal flexure</span></span></span></span></p>"
        },
        {
          "id": 154658,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ileocecal junction</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man came with complaints of dark-colored stools to the OPD. After undergoing endoscopy, the patient was diagnosed with an upper GI bleed. Which of the following structures is used as a demarcation point to differentiate it from a lower GI bleed?</span></span></span></span></p>",
      "unique_key": "Q6323587",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756714,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Ligament of Treitz</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ligament of Treitz is used as the demarcation point to differentiate between upper gastrointestinal bleeding and lower gastrointestinal bleeding. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a part of the duodenojejunal junction.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upper GI bleeding refers to bleeding proximal to the ligament of Treitz, and lower GI bleeding refers to bleeding distal to the ligament of Treitz.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Ampulla of Vater. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ampulla of Vater is the point where the pancreatic duct and common bile duct converge and enter the second part of the duodenum. It is an essential structure for the drainage of both bile and pancreatic enzymes into the duodenum. It is not used as a demarcation point for differentiating between upper and lower gastrointestinal bleeding.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Superior duodenal flexure. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The superior duodenal flexure is the bend in the duodenum as it transitions from the first part (horizontal) to the second part (descending). </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ileocecal junction. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ileocecal junction is the point where the ileum meets the cecum. The ileocecal valve is present here, preventing the reflux of colonic contents into the ileum. While it&#39;s an important anatomical landmark in the gastrointestinal tract, it&#39;s not used as the demarcation point for differentiating between upper and lower gastrointestinal bleeding.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ligament of Treitz is used as the demarcation point to differentiate between upper gastrointestinal bleeding and lower gastrointestinal bleeding</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132340.JPG\" style=\"height:543px; width:500px\" /></span></span></span></span></p>",
      "correct_choice_id": 154656,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38607,
      "choices": [
        {
          "id": 154171,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A healthy 30-year-old man needing an inguinal hernia repair</span></span></span></p>"
        },
        {
          "id": 154172,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A 45-year-old woman with well-controlled diabetes requiring a laparoscopic cholecystectomy</span></span></span></p>"
        },
        {
          "id": 154173,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">An elderly woman needing a cataract operation who lives with a mentally challenged caretaker</span></span></span></p>"
        },
        {
          "id": 154174,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A 25-year-old woman requiring diagnostic laparoscopy for endometriosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Which of the following patients would NOT be typically considered as an ideal candidate for day care surgery?</span></span></span></p>",
      "unique_key": "Q9908757",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739856,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) An elderly woman needing a cataract operation who lives with a mentally challenged caretaker</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This patient may not be an ideal candidate for day care surgery because, even though the procedure is typically done as a day surgery, her <strong>postoperative care</strong> could be <strong>compromised</strong> due to <strong>her caretaker&#39;s inability</strong> to <strong>adequately provide</strong> for her needs at home after the procedure.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. <strong>A healthy 30-year-old man needing an</strong> <strong>inguinal hernia repair.</strong> This patient would be an <strong>ideal candidate for day care surgery</strong> as he is young, healthy, and the procedure he needs is commonly performed as an outpatient procedure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. <strong>A 45-year-old woman with well-controlled diabetes requiring a laparoscopic cholecystectomy.</strong> While she has diabetes, it is well-controlled, and she is otherwise healthy. The procedure she requires is often performed on an outpatient basis, making her a suitable candidate for day care surgery.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. <strong>A 25-year-old woman requiring diagnostic laparoscopy for endometriosis</strong>. This is a common outpatient procedure and she is young and presumably healthy, making her a good candidate for day care surgery.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ideal candidates for <strong>day care surgery</strong>, also known as <strong>outpatient surgery</strong>, are typically individuals who are in <strong>good general health</strong>, have <strong>stable medical conditions</strong>, and <strong>meet specific criteria</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">These candidates should be <strong>mentally and emotionally stable</strong>, have a <strong>responsible adult</strong> to accompany them home, and <strong>follow preoperative instructions</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">They should undergo relatively <strong>straightforward</strong> and <strong>low-risk elective procedures</strong>, with realistic expectations about surgery and recovery. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Individualized assessments by the surgical team, including the surgeon and anesthesiologist, prioritize patient safety and minimize risks.</span></span></li>\r\n</ul>",
      "correct_choice_id": 154173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38310,
      "choices": [
        {
          "id": 152999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Superior Pulmonary Vein</span></span></span></p>"
        },
        {
          "id": 153000,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Inferior Pulmonary Vein</span></span></span></p>"
        },
        {
          "id": 153001,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pulmonary Artery</span></span></span></p>"
        },
        {
          "id": 153002,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Azygos Vein</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient presents to the emergency department with acute shortness of breath and chest pain. A CT angiogram of the chest is ordered to rule out a pulmonary embolism. The radiologist notes an anomaly in the vascular structures of the lungs and points out an enlarged vein draining into the left atrium. This vein is primarily responsible for carrying oxygenated blood from the lower lobes of the lungs back to the heart. Which of the following veins is most likely being described?</span></span></p>",
      "unique_key": "Q2728686",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714981,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Inferior Pulmonary Vein</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The inferior pulmonary vein is responsible for draining oxygenated blood from the lower lobes of the lungs back to the left atrium of the heart. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Each lung has an inferior pulmonary vein, and these veins are crucial for the pulmonary circulation, ensuring the return of oxygenated blood to the heart for systemic distribution. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The enlargement or anomaly of the inferior pulmonary vein could be indicative of various pulmonary or cardiac conditions, and its identification is key in diagnosing and managing respiratory and cardiovascular diseases.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Superior Pulmonary Vein.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> This vein drains oxygenated blood from the upper lobes of the lungs to the left atrium. While it also plays a crucial role in pulmonary circulation, the question specifically mentions the vein responsible for draining the lower lobes, which points to the inferior pulmonary vein.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Pulmonary Artery</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">. The pulmonary artery carries deoxygenated blood from the right ventricle of the heart to the lungs for oxygenation. It is not involved in draining blood from the lungs back to the heart, thus not the correct answer in this context.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Azygos Vein.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> The azygos vein is part of the systemic venous system, draining deoxygenated blood from the posterior walls of the thorax and abdomen into the superior vena cava. It is not directly involved in pulmonary circulation and does not drain blood from the lungs to the heart.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question aims to assess the learner&#39;s understanding of the pulmonary venous system, particularly the role of the inferior pulmonary vein in draining oxygenated blood from the lower lobes of the lungs to the left atrium. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Recognizing the anatomy and function of the pulmonary veins is essential in the diagnosis and treatment of pulmonary and cardiovascular conditions, as anomalies in these veins can have significant clinical implications. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding these vascular structures also aids in the accurate interpretation of imaging studies, such as CT angiograms, which are pivotal in diagnosing conditions like pulmonary embolism.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38405,
      "choices": [
        {
          "id": 153375,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Maternal obesity</span></span></span></p>"
        },
        {
          "id": 153376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Multiple pregnancy</span></span></span></p>"
        },
        {
          "id": 153377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anterior placenta</span></span></span></p>"
        },
        {
          "id": 153378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fetal demise</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 21-year-old primigravida is at her 21-week prenatal visit, expressing concern about not having felt fetal movements, often referred to as &quot;quickening.&quot; Quickening is typically perceived by first-time mothers around 18-22 weeks of gestation. She is anxious, seeking reassurance and understanding of potential reasons for this delay. Consider the following potential reasons for her not perceiving fetal movements yet, and identify which one is not a plausible cause.</span></span></span></p>",
      "unique_key": "Q1451911",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718447,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Multiple pregnancy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Multiple pregnancies are usually associated with more noticeable fetal movements earlier in the pregnancy due to the presence of more than one fetus. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Therefore, multiple pregnancy would not be a reason for a woman not to perceive quickening by 21 weeks. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In fact, women with multiple pregnancies might perceive fetal movements earlier than those with a singleton pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Maternal obesity</span></strong><span style=\"font-size:14.0pt\">. Increased maternal adipose tissue can dampen the sensation of fetal movements, making it more difficult for an obese mother to perceive quickening as early as a mother with less body fat.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Anterior placenta</span></strong><span style=\"font-size:14.0pt\">. When the placenta is positioned at the front of the uterus (anteriorly), it can act as a cushion between the fetus and the abdominal wall. This placement can reduce the intensity of fetal movements felt by the mother, potentially delaying the perception of quickening.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Fetal demise</span></strong><span style=\"font-size:14.0pt\">. Absence of fetal movements can be an indicator of fetal demise. If the fetus has passed away, there would be no movements for the mother to perceive. This is a serious condition that requires immediate medical attention.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question assesses the understanding of factors that can influence the perception of fetal movements or &quot;quickening&quot; in pregnancy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It&#39;s important to recognize that while maternal obesity and an anterior placenta can delay the perception of fetal movements, and fetal demise can altogether stop them, a multiple pregnancy typically results in earlier and possibly more pronounced fetal movements. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding these factors is crucial for assessing fetal well-being and providing appropriate reassurance and care to pregnant women.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38327,
      "choices": [
        {
          "id": 153067,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acyl-CoA dehydrogenase</span></span></span></p>"
        },
        {
          "id": 153068,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Citrate synthase</span></span></span></p>"
        },
        {
          "id": 153069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hexokinase</span></span></span></p>"
        },
        {
          "id": 153070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pyruvate carboxylase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 6-month-old infant is brought to the pediatrician due to episodes of hypoglycemia, especially during periods of fasting. Laboratory tests reveal low blood sugar levels and elevated levels of dicarboxylic acids in the urine. The child appears lethargic and irritable during these episodes but recovers quickly after being fed. The pediatrician suspects a disorder in fatty acid metabolism. Which of the following enzymatic deficiencies is most likely responsible for this patient&#39;s condition?</span></span></span></p>",
      "unique_key": "Q1682171",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Acyl-CoA dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The correct answer is <strong>Option A) Acyl-CoA dehydrogenase</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s symptoms of hypoglycemia during fasting and the presence of elevated dicarboxylic acids in the urine suggest a deficiency in fatty acid oxidation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acyl-CoA dehydrogenase is crucial in the &beta;-oxidation pathway of fatty acid metabolism. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A deficiency in this enzyme can lead to an inability to break down fatty acids into acetyl-CoA, leading to hypoglycemia during fasting when the body relies on fatty acids for energy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The accumulation of partially oxidized fatty acids results in elevated dicarboxylic acids in the urine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>B. Citrate synthase.</strong> This enzyme is involved in the citric acid cycle, not directly in fatty acid oxidation. A deficiency would affect the energy production from all acetyl-CoA sources, not specifically during fasting.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>C. Hexokinase.</strong> This enzyme catalyses the phosphorylation of glucose to glucose-6-phosphate, the first step of glycolysis. A deficiency would impair glucose utilization but is not related to the symptoms of fasting hypoglycemia and elevated dicarboxylic acids indicative of a fatty acid oxidation disorder.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>D. Pyruvate carboxylase.</strong> This enzyme is involved in gluconeogenesis. While a deficiency can lead to hypoglycemia, it would not explain the elevated levels of dicarboxylic acids in the urine, which are indicative of a block in fatty acid oxidation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question aims to assess the understanding of fatty acid oxidation disorders, specifically focusing on the role of acyl-CoA dehydrogenase in &beta;-oxidation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The correct diagnosis is based on recognizing the clinical presentation of hypoglycemia during fasting, elevated urine dicarboxylic acids, and connecting these findings to an enzymatic deficiency in the fatty acid oxidation pathway. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the roles of other enzymes listed as options helps distinguish between different metabolic pathways and their contributions to energy production and metabolic homeostasis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38621,
      "choices": [
        {
          "id": 154227,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Intorsion</span></span></span></p>"
        },
        {
          "id": 154228,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Depression</span></span></span></p>"
        },
        {
          "id": 154229,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adduction</span></span></span></p>"
        },
        {
          "id": 154230,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A patient is diagnosed with left oculomotor nerve palsy. Which of the following movements is spared?</span></span></span></p>",
      "unique_key": "Q6540793",
      "question_audio": null,
      "question_video": null,
      "map_id": 3740270,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Intorsion</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">This movement is primarily controlled by the superior oblique muscle</span></strong><span style=\"font-size:14.0pt\">, which is innervated by the <strong>trochlear nerve</strong> (Cranial Nerve IV), <strong>not the oculomotor nerve</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, <strong>intorsion is spared in oculomotor nerve palsy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Depression.</strong> The <strong>primary muscle for depression of the eye is the inferior rectus</strong>, which is <strong>innervated by the oculomotor nerve</strong>. This movement would be affected in oculomotor nerve palsy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>C</strong>. <strong>Adduction.</strong> This <strong>movement is controlled by the medial rectus muscle</strong>, which is also <strong>innervated by the oculomotor nerve</strong>. Thus, adduction is impaired in oculomotor nerve palsy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Elevation.</strong> The <strong>superior rectus</strong>, which is responsible for <strong>elevation of the eye, is innervated by the oculomotor nerve.</strong> This movement would be compromised in oculomotor nerve palsy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In <strong>oculomotor nerve palsy, intorsion,</strong> controlled by the <strong>superior oblique muscle</strong> and <strong>innervated by the trochlear nerve</strong>, is the movement that is spared. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38739,
      "choices": [
        {
          "id": 154699,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic cholecystectomy</span></span></span></span></p>"
        },
        {
          "id": 154700,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conservative management</span></span></span></span></p>"
        },
        {
          "id": 154701,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical dissolution therapy</span></span></span></span></p>"
        },
        {
          "id": 154702,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ERCP and stone removal</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman was undergoing a routine check-up when the radiologist noticed gallstones on USG. However, the patient says that there have been no complaints so far and she is asymptomatic. The stone measures 4cms. What will be your treatment of choice?</span></span></span></span></p>",
      "unique_key": "Q5877797",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Laparoscopic cholecystectomy</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic gallstones do not need intervention however prophylactic cholecystectomy may be performed for asymptomatic cholelithiasis in the <strong>following situations</strong>:</span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large (&gt;3 cm) gallstones;</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choledocholithiasis;</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic haemolytic conditions (sickle cell disease, hereditary spherocytosis);</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gallbladder polyps &gt;1 cm in diameter;</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suspicion/risk of malignancy (anomalous pancreatic ductal drainage);</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcification of the wall (porcelain gallbladder);</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some ethnic groups or subjects living in areas with a high prevalence of gallbladder cancer associated with gallstones (some parts of northern India, Native Americans, Mexican Americans, Colombia, Chile, Bolivia);</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transplant patients (during transplantation);</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bariatric surgery.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While asymptomatic gallstones generally do not require treatment, prophylactic laparoscopic cholecystectomy is recommended for stones larger than 3 cm due to the increased risk of gallbladder cancer and other complications.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Conservative management</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the standard treatment for asymptomatic gallstones that do not meet criteria for cholecystectomy. However, given the size of the stone in this patient, conservative management is not the best choice.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Medical dissolution therapy</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is typically reserved for patients who refuse or are not candidates for surgery due to comorbidities. The effectiveness is variable and less likely to be successful with larger stones.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. ERCP</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Endoscopic Retrograde Cholangiopancreatography) <strong>and stone removal</strong> are used for stones in the common bile duct, not for gallstones in the gallbladder itself.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylactic cholecystectomy may be performed in asymptomatic patients with risk factors that predispose them to complications, such as having large gallstones greater than 3 cm, which is the case with this patient. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This approach is aimed at preventing future gallstone-related complications.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Bailey, 28<sup>th</sup> Edition, Page no. 1244</span></span></strong></span></span></p>",
      "correct_choice_id": 154699,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38605,
      "choices": [
        {
          "id": 154163,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RRR 11%, ARR 11%</span></span></span></p>"
        },
        {
          "id": 154164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RRR 11%, ARR 1%</span></span></span></p>"
        },
        {
          "id": 154165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RRR 1%, ARR 11%</span></span></span></p>"
        },
        {
          "id": 154166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RRR 1%, ARR 1%</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinical trial comparing a new drug &#39;A&#39; to a placebo &#39;B&#39; reveals differing rates of adverse outcomes. With 15,225 patients in each group, the new drug &#39;A&#39; had 1,605 adverse outcomes, whereas the placebo &#39;B&#39; had 1,804. To evaluate the efficacy of drug &#39;A&#39;, what are the Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR)?</span></span></p>",
      "unique_key": "Q6134909",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739684,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) RRR 11%, ARR 1%</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-132420.JPG\" style=\"height:287px; width:708px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the given question,</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Event rate Drug = 1605/15225 &times; 100 = 10.5% (0.105)</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Event rate Placebo = 1804/15225 &times; 100 = 11.8% (0.118)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hence,</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Relative risk of Event rate = Event rate drug/Event rate Placebo = 0.105/0.118 = 0.9</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Relative risk reduction (RRR) = (Event rate Placebo &ndash; Event rate drug)/Event rate placebo = (0.118)&ndash; 0.105)/0.118 = 0.11 = 11%</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Absolute risk reduction = Event rate Drug &ndash; Event rate Placebo = 0.105 &ndash; 0.118 = &ndash; 0.013 = &ndash; 1.3%</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Relative risk reduction (RRR)</span></strong><span style=\"font-size:14.0pt\">: Percentage reduction in one outcome (E.g. Death or Adverse outcome) comparing one group (New drug) with another group (Older drug or Placebo)</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absolute risk reduction (ARR)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Reduction in outcome (E.g. Death or Adverse outcome) comparing one group (New drug) with another group (Older drug or Placebo)</span></span></li>\r\n</ul>",
      "correct_choice_id": 154164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38703,
      "choices": [
        {
          "id": 154555,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Follicular Lymphoma</span></span></span></p>"
        },
        {
          "id": 154556,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Marginal Zone Lymphoma</span></span></span></p>"
        },
        {
          "id": 154557,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mantle Cell Lymphoma</span></span></span></p>"
        },
        {
          "id": 154558,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic Lymphocytic Leukemia (CLL)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 60-year-old man with generalized lymphadenopathy, fatigue, weight loss, and biopsy showing small to medium lymphocytes with irregular nuclei and Cyclin D1 positivity is likely facing which condition?</span></span></span></p>",
      "unique_key": "Q1533665",
      "question_audio": null,
      "question_video": null,
      "map_id": 3754689,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Mantle Cell Lymphoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mantle Cell Lymphoma (MCL) is characterized by the overexpression of Cyclin D1, which is a key regulator of the cell cycle. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The translocation t(11;14) (q13;q32) is commonly found in MCL, leading to the overexpression of Cyclin D1. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This protein promotes the progression from the G1 phase to the S phase of the cell cycle, contributing to the uncontrolled growth of the lymphoma cells. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of Cyclin D1 positivity on immunohistochemistry is a hallmark feature of MCL and aids in its distinction from other types of lymphomas.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Follicular Lymphoma.</strong> This type of lymphoma is typically characterized by the translocation t(14;18) (q32;q21), leading to the overexpression of the BCL-2 protein, not Cyclin D1. It usually presents with a nodular or follicular pattern on histology.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Marginal Zone Lymphoma.</strong> Marginal zone lymphomas, including MALT lymphomas, are usually negative for Cyclin D1. They are associated with chronic inflammation or autoimmune diseases and have distinct morphological and immunophenotypic features.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Chronic Lymphocytic Leukemia (CLL).</strong> CLL is characterized by the proliferation of small, mature-appearing lymphocytes in the peripheral blood, bone marrow, and lymphoid tissues. Cyclin D1 is not typically overexpressed in CLL, making it an unlikely diagnosis when Cyclin D1 positivity is observed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Mantle Cell Lymphoma is marked by Cyclin D1 positivity due to a characteristic genetic translocation helps distinguish it from other lymphoma types such as Follicular Lymphoma, Marginal Zone Lymphoma, and CLL, which have different genetic and immunophenotypic profiles. </span></span></li>\r\n</ul>",
      "correct_choice_id": 154557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38595,
      "choices": [
        {
          "id": 154123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A physiotherapist focusing on rehabilitation</span></span></span></p>"
        },
        {
          "id": 154124,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A counsellor aiding in coping strategies and family dynamics</span></span></span></p>"
        },
        {
          "id": 154125,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A vocational advisor helping disabled individuals find employment</span></span></span></p>"
        },
        {
          "id": 154126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A clinician primarily treating physical ailments</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A community health centre in India is looking to expand its team to better address the psychosocial needs of its patients. Which of the following professionals would be most suited to fulfil the role of a social worker within this healthcare setting?</span></span></p>",
      "unique_key": "Q1594387",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739324,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) A counsellor aiding in coping strategies and family dynamics</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The role of a social worker in a healthcare setting is primarily to address the psychosocial aspects of patient care, which includes providing support for mental health, facilitating coping strategies, and assisting with interpersonal and family dynamics. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This aligns with the role of a counsellor described in <strong>option B).</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. A physiotherapist focusing on rehabilitation</span></strong><span style=\"font-size:14.0pt\">. Focuses on physical rehabilitation, which does not encompass the full scope of social work.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. A vocational advisor helping disabled individuals find employment</span></strong><span style=\"font-size:14.0pt\">. While important, this role is more specialized and does not cover the broader psychosocial support offered by social workers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. A clinician primarily treating physical ailments</span></strong><span style=\"font-size:14.0pt\">. Concentrates on the medical treatment of physical conditions, differing from the psychosocial support role of social workers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The importance of addressing psychosocial needs in healthcare, highlighting the role of social workers in providing comprehensive patient care through support in coping strategies, mental health, and family dynamics.</span></span></li>\r\n</ul>",
      "correct_choice_id": 154124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38695,
      "choices": [
        {
          "id": 154523,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Putamen</span></span></span></p>"
        },
        {
          "id": 154524,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thalamus</span></span></span></p>"
        },
        {
          "id": 154525,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brainstem</span></span></span></p>"
        },
        {
          "id": 154526,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Globus pallidus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 50-year-old male with episodic dizziness and headaches has an MRI showing brain capillary telangiectasias. Considering the common bleeding sites for these malformations, which brain site is most likely affected?</span></span></span></p>",
      "unique_key": "Q1064934",
      "question_audio": null,
      "question_video": null,
      "map_id": 3752801,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Brainstem</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Capillary telangiectasias are small, dilated blood vessels in the brain that are often found incidentally on imaging and are usually asymptomatic. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When symptomatic, they can present with headaches, seizures, or focal neurological deficits depending on their location. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The brainstem is the most frequent site of clinically significant bleeding from capillary telangiectasias, given its critical function and the density of critical structures within a small area. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bleeding in this region, although rare, can lead to significant neurological impairments.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Putamen</span></strong><span style=\"font-size:14.0pt\">. The putamen is a common site for hypertensive hemorrhages but is not the most frequent site of bleeding associated with capillary telangiectasias.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Thalamus</span></strong><span style=\"font-size:14.0pt\">. The thalamus is another site where hypertensive and deep brain hemorrhages commonly occur but is not specifically associated with a higher risk of bleeding from capillary telangiectasias compared to the brainstem.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Globus pallidus</span></strong><span style=\"font-size:14.0pt\">. The globus pallidus is involved in movement regulation and is also a site for hypertensive hemorrhages, but it is not the most common site for bleeding from capillary telangiectasias.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The brainstem is the most common site of clinically significant bleeding from capillary telangiectasias. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154525,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38571,
      "choices": [
        {
          "id": 154027,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Peptidoglycan</span></span></span></p>"
        },
        {
          "id": 154028,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lipopolysaccharides</span></span></span></p>"
        },
        {
          "id": 154029,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lipids</span></span></span></p>"
        },
        {
          "id": 154030,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Teichoic acid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a microbiology laboratory session focused on diagnostic techniques, medical students are presented with a case study involving a patient with a bacterial infection. As part of the diagnostic process, a Gram stain is performed on a sample obtained from the patient, revealing that the causative organism stains pink/red under the microscope. The instructor asks the students to identify the characteristic components of the cell wall of the organism based on the Gram staining result. Given that the organism appears pink/red, indicating it is Gram-negative, which component(s) are characteristic of the cell wall of this organism?</span></span></span></p>",
      "unique_key": "Q2051207",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736434,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Lipopolysaccharides</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The pink/red coloration observed in the Gram stain indicates that the organism is Gram-negative. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A key characteristic of the cell wall of Gram-negative bacteria is the presence of lipopolysaccharides (LPS) in the outer membrane. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">LPS is a complex molecule consisting of lipids and polysaccharides, which contributes to the structural integrity of the cell wall and can elicit a strong immune response in the host.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Peptidoglycan</span></strong><span style=\"font-size:14.0pt\">. While peptidoglycan is a component of the cell walls of both Gram-positive and Gram-negative bacteria, it is not the defining characteristic of Gram-negative bacteria in the context of a Gram stain. Gram-negative bacteria have a thinner layer of peptidoglycan than Gram-positive bacteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Lipids</span></strong><span style=\"font-size:14.0pt\">. While lipids are present in the cell walls of Gram-negative bacteria, particularly in the outer membrane, the specific component that is characteristic and unique to Gram-negative bacteria in the context of Gram staining is lipopolysaccharides (LPS).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Teichoic acid</span></strong><span style=\"font-size:14.0pt\">. Teichoic acids are found in the cell walls of Gram-positive bacteria, not Gram-negative bacteria, and are involved in the regulation of cell wall autolysis and ion movement.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-120538.JPG\" style=\"height:389px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 154028,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38593,
      "choices": [
        {
          "id": 154115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">120 grams</span></span></span></p>"
        },
        {
          "id": 154116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">160 grams</span></span></span></p>"
        },
        {
          "id": 154117,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">200 grams</span></span></span></p>"
        },
        {
          "id": 154118,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">360 grams</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A public health officer is tasked with assessing and ensuring the safety of community well water in a rural village in India. During a routine inspection, the officer uses Horrock&#39;s apparatus to test the chlorine demand of the water. The test indicates that the third cup turns blue, signalling a specific chlorine demand to effectively disinfect the water. Considering the volume of the community well is approximately 9100 litres, the officer must calculate the precise amount of bleaching powder required to ensure the water is safe for consumption. Based on the results from Horrock&#39;s apparatus, what is the correct amount of bleaching powder needed for the disinfection of 9100 litres of water?</span></span></p>",
      "unique_key": "Q3374972",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739302,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) 120 grams </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dose of bleaching powder required (Chlorine demand): n &times; 2 gm to disinfect 455 litres of water (where n = no. of first cup which shows distinct blue colour in Horrock&rsquo;s apparatus)</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the given question, 3rd cup shows blue colour so 3 &times; 2 grams (6 grams) will disinfect 455 litres of water.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hence, 9100 litres will require 6/455 &times; 9100 = 120 grams bleaching powder.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The application of Horrock&#39;s apparatus is in determining the chlorine demand for water disinfection and to calculate the required amount of bleaching powder based on the volume of water and the desired chlorine concentration. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38718,
      "choices": [
        {
          "id": 154615,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Henoch schonlein purpura (HSP)</span></span></span></span></p>"
        },
        {
          "id": 154616,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune thrombocytopenia (ITP)</span></span></span></span></p>"
        },
        {
          "id": 154617,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dengue</span></span></span></span></p>"
        },
        {
          "id": 154618,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal change disease (MCD)</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with palpable blanching purpura predominantly on the lower limbs, abdominal pain, arthritis predominantly affecting the knee joint, and renal involvement as evidenced by hematuria and proteinuria. What is the most likely diagnosis?</span></span></span></span></p>",
      "unique_key": "Q2524257",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756194,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Henoch schonlein purpura (HSP)</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Henoch Schonlein Purpura (HSP) is a small vessel vasculitis associated with IgA deposition and is characterized by the classic tetrad of palpable purpura (often on the lower limbs), abdominal pain, renal involvement (hematuria and proteinuria), and arthritis. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This constellation of symptoms fits with the clinical presentation described.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Immune thrombocytopenia (ITP)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. ITP is a hematological disorder characterized by thrombocytopenia and purpura but is not typically associated with abdominal pain, arthritis, or renal involvement.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dengue</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> fever can cause purpura due to thrombocytopenia and may lead to joint pains, but it does not typically present with the renal involvement described here or the palpable purpura specific to HSP.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Minimal change disease (MCD)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. MCD is a nephrotic syndrome primarily presenting with proteinuria and hypoalbuminemia and does not typically present with purpura or joint pain.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Henoch-Sch&ouml;nlein purpura (HSP) is a small vessel vasculitis that presents with a <strong>tetrad of symptoms</strong>: palpable purpura, abdominal pain, renal involvement (hematuria and proteinuria), and arthritis, particularly affecting the lower limbs.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38420,
      "choices": [
        {
          "id": 153435,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cordocentesis &amp; Intrauterine transfusion (if necessary)</span></span></span></p>"
        },
        {
          "id": 153436,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Repeat ICT after 2 weeks</span></span></span></p>"
        },
        {
          "id": 153437,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Give maternal steroid and deliver</span></span></span></p>"
        },
        {
          "id": 153438,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Repeat MCA-PSV after 2 weeks</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A 32-year-old G3A2, Rh Negative, pregnant lady presents at 31 weeks&rsquo; pregnancy with an Indirect Coomb&rsquo;s Test (ICT) titer of 1:64. Ultrasound assessment shows MCA PSV more than 1.5 MOM. What is the next step in management?</span></span></span></p>",
      "unique_key": "Q1241079",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719283,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Cordocentesis &amp; Intrauterine transfusion (if necessary)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The correct management step for a Rh-negative pregnant woman at 31 weeks with an Indirect Coomb&rsquo;s Test (ICT) titer of 1:64 and an ultrasound assessment showing middle cerebral artery peak systolic velocity (MCA PSV) more than 1.5 multiples of the median (MOM) is to proceed with cordocentesis and, if necessary, intrauterine transfusion. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This scenario suggests fetal anemia, potentially due to Rh alloimmunization, where antibodies in the mother&rsquo;s blood are attacking the fetal red blood cells. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The MCA PSV is a non-invasive ultrasound marker for fetal anemia, and values above 1.5 MOM are indicative of moderate to severe anemia, warranting immediate intervention to prevent hydrops fetalis or fetal death.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Repeat ICT after 2 weeks</span></strong><span style=\"font-size:14.0pt\">. This approach would delay necessary intervention. Given the current ICT titer and the ultrasound findings indicating fetal anemia, waiting another 2 weeks could result in worsening of the fetal condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Give maternal steroid and deliver</span></strong><span style=\"font-size:14.0pt\">. Administering maternal steroids and considering delivery at 31 weeks would be premature without attempting to directly treat the fetal anemia and improve the fetal condition. Steroids could be considered for fetal lung maturity, but only in the context of an imminent delivery after optimal fetal treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Repeat MCA-PSV after 2 weeks</span></strong><span style=\"font-size:14.0pt\">. Repeating the MCA-PSV after 2 weeks could delay necessary treatment. The current finding of MCA PSV more than 1.5 MOM already indicates significant fetal anemia, necessitating immediate intervention rather than a watchful waiting approach.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The management of a Rh-negative pregnant woman with a significant ICT titer and ultrasound findings suggestive of fetal anemia (MCA PSV &gt; 1.5 MOM) involves immediate assessment and intervention, typically via cordocentesis and intrauterine transfusion if necessary. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This approach aims to directly address fetal anemia and prevent complications such as hydrops fetalis or fetal demise. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Delaying intervention by repeating tests or considering premature delivery without addressing the underlying anemia is not appropriate in this context.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38403,
      "choices": [
        {
          "id": 153367,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Urethral obstruction</span></span></span></p>"
        },
        {
          "id": 153368,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fetal growth restriction</span></span></span></p>"
        },
        {
          "id": 153369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Uteroplacental insufficiency</span></span></span></p>"
        },
        {
          "id": 153370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Maternal administration of frusemide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 26-year-old woman in her second trimester undergoes a routine antenatal checkup. During the ultrasound examination, the obstetrician notes the amniotic fluid volume and assesses fetal well-being. The doctor explains to the patient that fetal urine plays a significant role in the volume of amniotic fluid, which is crucial for fetal development. Considering factors that can influence fetal urine production, which of the following condition or intervention is most likely to increase fetal urine production?</span></span></span></p>",
      "unique_key": "Q2606976",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718346,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Maternal administration of frusemide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Frusemide (furosemide) is a loop diuretic that acts on the ascending limb of the loop of Henle in the kidneys, inhibiting the reabsorption of sodium and chloride, which leads to an increase in urine production. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">When administered to the mother, frusemide can cross the placenta and exert a diuretic effect on the fetus, thereby increasing fetal urine production. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fetal urine is a significant component of amniotic fluid, especially in the second half of pregnancy, so an increase in fetal urine production can lead to an increase in amniotic fluid volume.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Urethral obstruction</span></strong><span style=\"font-size:14.0pt\"> in the fetus can lead to a decrease in the amount of urine expelled into the amniotic cavity, potentially resulting in oligohydramnios (reduced amniotic fluid volume), not an increase in urine production.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Fetal growth restriction (FGR)</span></strong><span style=\"font-size:14.0pt\"> is often associated with placental insufficiency, which can lead to reduced fetal renal perfusion and urine output, not an increase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Uteroplacental insufficiency</span></strong><span style=\"font-size:14.0pt\"> reduces blood flow to the fetus, which can compromise renal function and decrease urine output, contrary to increasing it.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The educational objective of this question is to understand the factors influencing fetal urine production and their impact on amniotic fluid volume. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Specifically, it highlights that maternal administration of diuretics like frusemide can increase fetal urine production, potentially affecting amniotic fluid volume, which is crucial for fetal development.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38542,
      "choices": [
        {
          "id": 153911,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Escherichia coli</span></span></span></p>"
        },
        {
          "id": 153912,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Klebsiella pneumonia</span></span></span></p>"
        },
        {
          "id": 153913,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Legionella pneumophila</span></span></span></p>"
        },
        {
          "id": 153914,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pseudomonas aeruginosa</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 24-year-old patient with cystic fibrosis comes in for a routine clinic visit. Over the past few months, he reports an increased cough frequency accompanied by purulent sputum production. He also notes a gradual worsening in his breathing capacity, which has significantly impacted his daily activities. Recent pulmonary function tests indicate a decline in both forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). Given the patient&#39;s underlying condition and the described clinical progression, a sputum culture is planned to identify the responsible pathogen. Which of the following Gram-negative organisms is most commonly associated with pulmonary infections in patients with cystic fibrosis and is likely to be identified in this patient&#39;s sputum culture?</span></span></span></p>",
      "unique_key": "Q2212040",
      "question_audio": null,
      "question_video": null,
      "map_id": 3735981,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Pseudomonas aeruginosa</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pseudomonas aeruginosa is a common Gram-negative bacterium associated with chronic lung infections in patients with cystic fibrosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is known for its role in the progressive decline in pulmonary function seen in these patients. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The organism&#39;s ability to form biofilms and its intrinsic resistance to many antibiotics make it a particularly challenging pathogen to eradicate once colonization and infection are established in the cystic fibrosis lung.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Escherichia coli</span></strong><span style=\"font-size:14.0pt\">. While E. coli is a common Gram-negative bacterium, it is not typically associated with lung infections in cystic fibrosis patients.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Klebsiella pneumonia</span></strong><span style=\"font-size:14.0pt\">. Klebsiella pneumoniae can cause severe lung infections, particularly in hospitalized or immunocompromised individuals, but it is not as commonly associated with cystic fibrosis lung disease as Pseudomonas aeruginosa.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Legionella pneumophila</span></strong><span style=\"font-size:14.0pt\">. Legionella pneumophila is the causative agent of Legionnaires&#39; disease, a type of pneumonia. However, it is not commonly associated with chronic lung infections in patients with cystic fibrosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pseudomonas aeruginosa as the most common Gram-negative organism causing chronic lung infections in patients with cystic fibrosis.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Types of pigments</span></strong><span style=\"font-size:14.0pt\"> it produces: </span></span></span>\r\n\t<ol>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pyocyanin (blue-green)</span></span></span></li>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pyoverdin or Fluorescein (greenish-yellow)</span></span></span></li>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pyorubin (Red color)</span></span></span></li>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pyomelanin (Brown-black)</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 153914,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38435,
      "choices": [
        {
          "id": 153491,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cervicopexy</span></span></span></p>"
        },
        {
          "id": 153492,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cervical cerclage</span></span></span></p>"
        },
        {
          "id": 153493,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ring pessary</span></span></span></p>"
        },
        {
          "id": 153494,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vaginal packing</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 30-year-old woman, G5P4L4, presents at 10 weeks of gestation with a third-degree uterine prolapse. She reports discomfort and the sensation of a bulge in her vagina, which has worsened since her last pregnancy. Considering her current pregnancy and the degree of prolapse, what would be the most appropriate management option for her condition at this time?</span></span></span></p>",
      "unique_key": "Q6602381",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719646,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Ring pessary</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most appropriate management for a pregnant woman with third-degree uterine prolapse is the use of a ring pessary. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A pessary is a device inserted into the vagina to support the uterus or vaginal walls, and it is particularly useful in the case of uterine prolapse. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ring pessary can accommodate the growing uterus during pregnancy and alleviate the symptoms associated with prolapse without requiring surgery, which is generally avoided during pregnancy unless absolutely necessary.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Cervicopexy</span></strong><span style=\"font-size:14.0pt\">. This surgical procedure involves the suspension of the cervix to correct uterine prolapse. However, it is not typically indicated during pregnancy due to the risks associated with surgery in this patient population.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Cervical cerclage</span></strong><span style=\"font-size:14.0pt\">. This procedure involves placing a stitch around the cervix to prevent its premature dilation. It is used in the management of cervical incompetence, not uterine prolapse, and therefore is not appropriate in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Vaginal packing</span></strong><span style=\"font-size:14.0pt\">. This involves placing gauze or another material in the vagina to apply pressure and support. It is a temporary measure, often used for bleeding, and is not suitable for the management of uterine prolapse, especially in a pregnant woman.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective is to understand that a ring pessary is a suitable and non-invasive option for managing uterine prolapse in pregnant women. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It provides the necessary support to the prolapsed uterus without the risks associated with surgical interventions during pregnancy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the appropriate indications and management options for uterine prolapse, especially in the context of pregnancy, is crucial for providing safe and effective care.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38694,
      "choices": [
        {
          "id": 154519,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cushing&#39;s syndrome</span></span></span></p>"
        },
        {
          "id": 154520,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Addison&#39;s disease</span></span></span></p>"
        },
        {
          "id": 154521,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperparathyroidism</span></span></span></p>"
        },
        {
          "id": 154522,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypothyroidism</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 32-year-old female with progressive weight gain, central obesity, easy bruising, hypertension, irregular menstruation, skin myxomas, and a relevant family history is suspected of having Carney Complex. What is the most common endocrine manifestation in this condition?</span></span></span></p>",
      "unique_key": "Q3285036",
      "question_audio": null,
      "question_video": null,
      "map_id": 3752780,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Cushing&#39;s syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carney Complex is a rare autosomal dominant syndrome characterized by spotty skin pigmentation, cardiac myxomas, endocrine overactivity, and schwannomas. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most common endocrine manifestation of Carney Complex is Cushing&#39;s syndrome, which is due to primary pigmented nodular adrenocortical disease (PPNAD). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PPNAD leads to the overproduction of cortisol, causing symptoms such as central obesity, moon facies, hypertension, and menstrual irregularities, which are consistent with the patient&#39;s presentation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Addison&#39;s disease</span></strong><span style=\"font-size:14.0pt\"> is characterized by adrenal insufficiency, which presents with symptoms such as fatigue, weight loss, hypotension, and hyperpigmentation, which are not consistent with the patient&#39;s presentation or the typical manifestations of Carney Complex.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hyperparathyroidism</span></strong><span style=\"font-size:14.0pt\"> could present with hypercalcemia symptoms, but it is not the most common endocrine abnormality associated with Carney Complex. Carney Complex may involve multiple endocrine glands, but hyperparathyroidism is less frequently observed than Cushing&#39;s syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hypothyroidism</span></strong><span style=\"font-size:14.0pt\">, characterized by symptoms such as weight gain, fatigue, and cold intolerance, is not a typical endocrine manifestation of Carney Complex. While endocrine abnormalities are common in Carney Complex, hypothyroidism is not among the most frequently observed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most common endocrine manifestation of Carney Complex, is Cushing&#39;s syndrome, due to primary pigmented nodular adrenocortical disease (PPNAD). </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38371,
      "choices": [
        {
          "id": 153239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Furosemide</span></span></span></p>"
        },
        {
          "id": 153240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrochlorothiazide</span></span></span></p>"
        },
        {
          "id": 153241,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spironolactone</span></span></span></p>"
        },
        {
          "id": 153242,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Triamterene</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old man with a history of recurrent calcium oxalate kidney stones is seen in the clinic for follow-up. As part of his management plan to reduce the risk of stone formation, he was started on a diuretic known to decrease urinary calcium excretion. However, he returns to the clinic complaining of sudden onset of severe pain, redness, and swelling in his right big toe. His serum uric acid level is found to be elevated. Based on the clinical presentation, it appears that the diuretic therapy may have precipitated an attack of gout. Which of the following diuretics was this patient most likely taking?</span></span></span></p>",
      "unique_key": "Q8128702",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716967,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Hydrochlorothiazide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrochlorothiazide, a thiazide diuretic, is known to decrease urinary calcium excretion and is often used in patients with recurrent calcium-containing kidney stones to reduce stone formation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, one of the side effects of thiazide diuretics is hyperuricemia, as they can reduce the renal clearance of uric acid, leading to elevated serum uric acid levels and potentially precipitating gout attacks in susceptible individuals.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Furosemide</span></strong><span style=\"font-size:14.0pt\"> is a loop diuretic that can actually increase calcium excretion and is less likely to be used in the management of calcium kidney stones. While it can cause hyperuricemia, it is less commonly associated with gout attacks compared to thiazide diuretics.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Spironolactone</span></strong><span style=\"font-size:14.0pt\"> is a potassium-sparing diuretic that has no significant effect on calcium excretion or uric acid levels and is unlikely to precipitate gout.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Triamterene</span></strong><span style=\"font-size:14.0pt\"> is another potassium-sparing diuretic that does not significantly affect calcium excretion or uric acid levels and is unlikely to be the cause of gout in this scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the side effects associated with different classes of diuretics, specifically the relationship between thiazide diuretics, hyperuricemia, and gout. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of considering potential adverse effects when choosing a diuretic for the management of conditions such as recurrent kidney stones.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153240,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38817,
      "choices": [
        {
          "id": 155007,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Department for International Development (DFID) </span></span></span></span></p>"
        },
        {
          "id": 155008,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">World Bank</span></span></span></span></p>"
        },
        {
          "id": 155009,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">United Nations Development Programme (UNDP)</span></span></span></span></p>"
        },
        {
          "id": 155010,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">United Nations Programme on HIV/AIDS (UNAIDS)</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician working with an international health organization is tasked with identifying the organization&#39;s logo in a documentation audit. Based on the logo shown, which international organization does the physician identify?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/16/screenshot-2024-03-14-131214.JPG\" style=\"height:291px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q1211702",
      "question_audio": null,
      "question_video": null,
      "map_id": 3776083,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) World Bank</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image provided depicts a logo with a simple, stylized globe, which is recognized as the logo of the World Bank. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The World Bank&#39;s emblem is well-known in international circles, especially those involving global development and finance, and consists of a world globe design.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. DFID</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The Department for International Development (DFID) was a UK government department responsible for administering overseas aid. Its logo did not feature a globe.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. UNDP</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The United Nations Development Programme (UNDP) has a different logo that typically includes both the name and a design element that does not solely focus on a stylized globe.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. UNAIDS</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The Joint United Nations Programme on HIV/AIDS (UNAIDS) logo usually incorporates the red ribbon symbol which is widely recognized as a symbol of AIDS awareness.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WORLD BANK (WB)</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An international financial institution that provides loans to developing countries for capital programs.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A component of the World Bank Group, which is part of the United Nations system.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Comprises two institutions:</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">International Bank for Reconstruction and Development (IBRD)</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">International Development Association (IDA)</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Official goal is the reduction of poverty.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Commitment</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Promotion of foreign investment and international trade and facilitation of Capital investment.</span></span></li>\r\n</ul>",
      "correct_choice_id": 155008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38340,
      "choices": [
        {
          "id": 153119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Suppression of gastric acid secretion</span></span></span></p>"
        },
        {
          "id": 153120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enhancement of intestinal fluid and nutrient absorption</span></span></span></p>"
        },
        {
          "id": 153121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stimulation of appetite via hypothalamic receptors</span></span></span></p>"
        },
        {
          "id": 153122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibition of pancreatic exocrine secretion</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old man with a history of Crohn&#39;s disease presents to the gastroenterology clinic for a follow-up visit. He has had multiple bowel resections in the past and now has short bowel syndrome with dependence on parenteral nutrition. He expresses concern about the inconvenience and complications associated with long-term parenteral nutrition. After evaluating his condition, you decide to initiate teduglutide as part of his treatment plan. What is the primary mechanism of action of teduglutide that benefits patients with short bowel syndrome?</span></span></span></p>",
      "unique_key": "Q2914205",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716044,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Enhancement of intestinal fluid and nutrient absorption</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Teduglutide is a glucagon-like peptide-2 (GLP-2) analog that acts primarily by promoting the growth of the intestinal mucosa and enhancing the absorptive capacity of the intestine. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with short bowel syndrome, where the absorptive surface of the intestine is significantly reduced due to surgical resection, teduglutide helps to increase the surface area for nutrient and fluid absorption, thereby reducing the dependency on parenteral nutrition. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This effect is achieved through its action on the proliferation of enterocytes, improvement in the function of existing enterocytes, and potentially promoting the formation of new blood vessels in the intestinal mucosa.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Suppression of gastric acid secretion</span></strong><span style=\"font-size:14.0pt\"> is the action of proton pump inhibitors (PPIs) and not related to teduglutide&#39;s mechanism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Stimulation of appetite via hypothalamic receptors</span></strong><span style=\"font-size:14.0pt\"> is more related to medications like ghrelin agonists, not teduglutide.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Inhibition of pancreatic exocrine secretion</span></strong><span style=\"font-size:14.0pt\"> is not a known effect of teduglutide and is more characteristic of medications used to treat pancreatitis or to reduce pancreatic stimulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question assesses the understanding of the mechanism of action of teduglutide, a GLP-2 analog used in the management of short bowel syndrome. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Teduglutide works by promoting the growth of the intestinal mucosa and enhancing the intestine&#39;s capacity to absorb fluids and nutrients, which is crucial for patients with short bowel syndrome to reduce their dependency on parenteral nutrition. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing the specific actions of gastrointestinal drugs is essential for their effective use in clinical practice, particularly in managing complex conditions like short bowel syndrome.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38706,
      "choices": [
        {
          "id": 154567,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lynch Syndrome</span></span></span></p>"
        },
        {
          "id": 154568,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Familial Adenomatous Polyposis</span></span></span></p>"
        },
        {
          "id": 154569,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serrated Polyposis Syndrome (SPS)</span></span></span></p>"
        },
        {
          "id": 154570,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hereditary Nonpolyposis Colorectal Cancer (HNPCC)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given the family history of early-onset colon cancer in the child&#39;s father and uncle, initiating colonoscopy screening at 10 years of age would be most appropriate if the family history suggests which condition?</span></span></p>",
      "unique_key": "Q4923746",
      "question_audio": null,
      "question_video": null,
      "map_id": 3755212,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Familial Adenomatous Polyposis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Familial Adenomatous Polyposis (FAP) is a hereditary condition characterized by the early onset of hundreds to thousands of polyps in the colon and rectum during adolescence or young adulthood, which if left untreated, almost inevitably leads to colorectal cancer, often at a young age. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Screening guidelines recommend that children at risk of FAP undergo an initial screening colonoscopy at the age of 10-12 years to look for the presence of polyps, which are a hallmark of the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Lynch Syndrome.</strong> Screening for Lynch syndrome typically begins in early adulthood, not childhood. Lynch syndrome is associated with an increased risk of several types of cancer, including colorectal cancer, but the onset is typically later than in FAP.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Serrated Polyposis Syndrome (SPS).</strong> SPS is characterized by the development of multiple serrated polyps in the colon, but the recommended age for initial screening is not as early as 10 years old. Screening recommendations may vary based on family history and other risk factors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Hereditary Nonpolyposis Colorectal Cancer (HNPCC),</strong> also known as <strong>Lynch</strong> <strong>Syndrome</strong>, does not typically necessitate screening as early as 10 years of age. Screening generally starts in the early 20s or 2-5 years earlier than the youngest case in the family if diagnosed before age 25.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Screening guidelines recommend that children at risk of FAP undergo an initial screening colonoscopy at the age of 10-12 years to look for the presence of polyps, which are a hallmark of the disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154568,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38463,
      "choices": [
        {
          "id": 153603,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Obsessive-compulsive disorder (OCD)</span></span></span></p>"
        },
        {
          "id": 153604,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hoarding disorder</span></span></span></p>"
        },
        {
          "id": 153605,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Major depressive disorder</span></span></span></p>"
        },
        {
          "id": 153606,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Generalized anxiety disorder (GAD)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 63-year-old woman presents to her primary care physician accompanied by her adult daughter. The daughter expresses concern about her mother&#39;s living conditions, describing them as cluttered and unsafe due to an excessive accumulation of items such as newspapers, old clothing, and miscellaneous objects. The patient admits to difficulty discarding items, feeling that they may be needed in the future, leading to significant distress and impairment in daily functioning. The clutter in her home has made some rooms unusable and poses a safety risk. There is no significant history of obsessive-compulsive behaviour, substance use, or cognitive impairment. The patient appears anxious when discussing the possibility of removing any items from her home. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q7508953",
      "question_audio": null,
      "question_video": null,
      "map_id": 3720194,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Hoarding disorder</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hoarding disorder is characterized by persistent difficulty discarding or parting with possessions, regardless of their actual value. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This difficulty is due to a perceived need to save the items and distress associated with discarding them. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The hoarding results in clutter that disrupts living spaces and significantly impairs social, occupational, or other important areas of functioning. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unlike in OCD, where hoarding may be a symptom driven by obsessive thoughts, in hoarding disorder, the behaviour is not exclusively attributed to obsessions or compulsions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Obsessive-compulsive disorder (OCD).</span></strong><span style=\"font-size:14.0pt\"> In OCD, hoarding behaviour can be a symptom, but it is typically accompanied by specific obsessions (intrusive, unwanted thoughts) and compulsions (repetitive behaviours or mental acts performed to reduce anxiety related to the obsessions). The key difference is the presence of other OCD symptoms and the nature of the hoarding behaviour.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Major depressive disorder.</span></strong><span style=\"font-size:14.0pt\"> While individuals with major depressive disorder may exhibit a lack of energy to clean or organize, leading to clutter, the primary features of this disorder are persistent sad, anxious, or &quot;empty&quot; mood, feelings of hopelessness, and loss of interest in activities. Hoarding behaviour is not a core feature of depression.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Generalized anxiety disorder (GAD).</span></strong><span style=\"font-size:14.0pt\"> GAD is characterized by excessive anxiety and worry about various topics, events, or activities. It is not specifically associated with hoarding behaviour. While individuals with GAD may worry excessively about many things, the hoarding seen in hoarding disorder is specifically related to difficulty parting with possessions due to a perceived need to save them.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hoarding disorder is characterized by persistent difficulty discarding or parting with possessions, regardless of their actual value.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38426,
      "choices": [
        {
          "id": 153459,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA) syndrome</span></span></span></p>"
        },
        {
          "id": 153460,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mayer-Rokitansky-K&uuml;ster-Hauser syndrome (MRKH) syndrome</span></span></span></p>"
        },
        {
          "id": 153461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Accessory and Cavitated Uterine Mass (ACUM)</span></span></span></p>"
        },
        {
          "id": 153462,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Robert&rsquo;s uterus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 17-year-old woman comes to the outpatient department complaining of painful menstruation. Physical examination reveals normal development of secondary sexual characteristics. A vaginal examination discloses a patent vagina with a noticeable bulge on the right side near the cervix. During a rectal examination, a bulge is palpable approximately 4 cm from the anal verge, predominantly on the left side. Ultrasound imaging reveals hematocolpos and the absence of the left kidney. Based on these findings, what is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q1107932",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719601,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA) syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">OHVIRA syndrome, also known as <strong>Herlyn-Werner-Wunderlich syndrome</strong>, is characterized by the triad of Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA), along with uterine didelphys. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation of painful menstruation due to hematocolpos, a bulge in the vagina indicating an obstructed hemivagina, and the absence of one kidney on ultrasound are classic signs of OHVIRA syndrome.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. MRKH syndrome (Mayer-Rokitansky-K&uuml;ster-Hauser syndrome).</span></strong><span style=\"font-size:14.0pt\"> This syndrome involves congenital aplasia of the uterus and the upper part of the vagina in females, leading to primary amenorrhea in patients with normal secondary sexual characteristics. However, the presence of hematocolpos suggests that there is vaginal and uterine tissue, which contradicts the typical findings of MRKH syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. ACUM (Accessory and Cavitated Uterine Mass).</span></strong><span style=\"font-size:14.0pt\"> This condition involves a non-communicating, cavitated uterine mass that is distinct from the normal uterus and cervix. Patients may present with dysmenorrhea and pelvic pain. However, the absence of a kidney and the specific findings on examination and ultrasound are more consistent with OHVIRA syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Robert&rsquo;s uterus</span></strong><span style=\"font-size:14.0pt\">. This is a rare congenital malformation of the uterus where there is a septum dividing the uterine cavity, potentially leading to unilateral hematometra. However, the presence of a renal anomaly and the specific clinical and ultrasound findings strongly support OHVIRA syndrome over Robert&#39;s uterus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective is to recognize the clinical and diagnostic features of OHVIRA syndrome, which include painful menstruation due to hematocolpos, the presence of a vaginal bulge indicative of an obstructed hemivagina, and a unilateral renal anomaly. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the distinguishing features of similar syndromes such as MRKH syndrome, ACUM, and Robert&rsquo;s uterus is crucial for accurate diagnosis and management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153459,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38305,
      "choices": [
        {
          "id": 152979,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Synovial Joints</span></span></span></p>"
        },
        {
          "id": 152980,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cartilaginous Joints</span></span></span></p>"
        },
        {
          "id": 152981,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sutural (Synarthrodial) Joints</span></span></span></p>"
        },
        {
          "id": 152982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gomphosis Joints</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 30-year-old neurosurgeon is reviewing cranial anatomy in preparation for an upcoming complex cranial surgery. While examining a 3D model of the skull, the surgeon pays particular attention to the fibrous joints that connect the bony plates of the skull. These joints are crucial for the surgery as they provide a natural guideline for certain surgical approaches. The surgeon notes that these joints are characterized by their immovable nature and the fibrous tissue that connects the skull bones. Which of the following types of joints is the surgeon focusing on?</span></span></span></p>",
      "unique_key": "Q3765618",
      "question_audio": null,
      "question_video": null,
      "map_id": 3714516,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Sutural (Synarthrodial) Joints</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sutural (Synarthrodial) Joints, also known as <strong>sutures</strong>, are found only in the skull. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are immovable (synarthrodial) joints characterized by a thin layer of fibrous tissue connecting the bones. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These joints are critical in cranial anatomy as they allow for the growth of the skull during childhood and become less movable in adulthood. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The surgeon&#39;s focus on these joints for surgical guidelines is due to their immovable nature and their role in connecting the bony plates of the skull, providing a natural map for surgical navigation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Synovial Joints.</span></strong><span style=\"font-size:14.0pt\"> These are the most movable type of joint found in the body, characterized by a joint cavity filled with synovial fluid. Common examples include the knee, hip, and shoulder joints. Unlike sutural joints, synovial joints allow for significant movement and are not involved in the fibrous connection of skull bones.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Cartilaginous Joints.</span></strong><span style=\"font-size:14.0pt\"> These joints are partially movable and are connected by cartilage. Examples include the intervertebral discs in the spine and the pubic symphysis in the pelvis. They provide more movement than sutural joints but are not found in the skull.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Gomphosis Joints.</span></strong><span style=\"font-size:14.0pt\"> A type of fibrous joint where a conical process fits into a socket, held in place by a ligament. The most common example is the attachment of a tooth to its socket. While this joint is similar to sutural joints in being fibrous, it is specific to teeth and not applicable to the cranial sutures.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question aims to assess the learner&#39;s understanding of the different types of joints in the human body, with a particular focus on sutural (synarthrodial) joints found in the skull. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of recognizing the unique characteristics of sutural joints, such as their immovable nature and their role in connecting the bony plates of the skull, which is crucial for neurosurgeons and other medical professionals dealing with cranial anatomy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the distinctions between sutural, synovial, cartilaginous, and gomphosis joints is essential for accurate diagnosis and surgical planning in medical practice.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 152981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38457,
      "choices": [
        {
          "id": 153579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disulfiram</span></span></span></p>"
        },
        {
          "id": 153580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acamprosate</span></span></span></p>"
        },
        {
          "id": 153581,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Naltrexone</span></span></span></p>"
        },
        {
          "id": 153582,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methadone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old male with a history of alcohol dependence, currently in a rehabilitation program, is being evaluated for an adjunctive medication to decrease the risk of relapse. He has been sober for three months and attends regular counselling sessions. He is motivated to maintain sobriety and is interested in additional treatment options to help prevent relapse. The patient has no known allergies and no significant comorbid conditions. After discussing various options, the healthcare provider suggests a medication that can reduce the craving for alcohol and decrease the pleasurable effects of alcohol. Which of the following medications is most appropriate for this patient?</span></span></span></p>",
      "unique_key": "Q2330557",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719949,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Naltrexone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Naltrexone is an opioid antagonist that is used to reduce cravings and the rewarding effects of alcohol in patients with alcohol dependence, thereby helping to maintain sobriety. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It can be administered orally or as a monthly intramuscular injection. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Naltrexone is also used to prevent relapse in opioid dependence. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works by blocking the euphoric and sedative effects of opioids and can decrease the desire to take alcohol by modulating the dopaminergic mesolimbic pathway, which is implicated in the rewarding effects of alcohol consumption.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Disulfiram.</span></strong><span style=\"font-size:14.0pt\"> Disulfiram is an alcohol aversion therapy that inhibits aldehyde dehydrogenase, leading to the accumulation of acetaldehyde when alcohol is consumed, which causes unpleasant effects such as flushing, nausea, and palpitations. It is more suitable for highly motivated patients who are aware of the consequences of alcohol consumption while on the medication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Acamprosate.</span></strong><span style=\"font-size:14.0pt\"> Acamprosate modulates glutamatergic neurotransmission and is thought to restore the balance between excitatory and inhibitory neurotransmission in alcohol dependence. It is used to maintain abstinence in patients who have stopped drinking alcohol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Methadone.</span></strong><span style=\"font-size:14.0pt\"> Methadone is a long-acting opioid agonist used primarily in the treatment of opioid dependence. It is not indicated for alcohol dependence treatment and is used to prevent withdrawal symptoms in patients addicted to opiates.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Naltrexone is an opioid antagonist that reduces the craving for alcohol and the pleasurable effects of alcohol consumption, making it a suitable option for preventing relapse in alcohol-dependent patients. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38614,
      "choices": [
        {
          "id": 154199,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Also called as Lattice Theory</span></span></span></p>"
        },
        {
          "id": 154200,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Scattered light is destroyed by mutual interference</span></span></span></p>"
        },
        {
          "id": 154201,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Loss of transparency results if lattice arrangement is altered</span></span></span></p>"
        },
        {
          "id": 154202,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">All the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is/are true about MAURICE theory?</span></span></p>",
      "unique_key": "Q7529393",
      "question_audio": null,
      "question_video": null,
      "map_id": 3740143,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) All the above</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">MAURICE or LATTICE THEORY</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-163022.JPG\" style=\"height:530px; width:700px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Arrangement is altered by <strong>stromal edema</strong> &amp; <strong>mechanical stress</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If the distance between collagen fibrils <strong>increases</strong>, it leads to <strong>bullae formation</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Corneal transparency</span></strong><span style=\"font-size:14.0pt\"> is maintained by </span></span></span>\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Dehydrated state</span></strong><span style=\"font-size:14.0pt\"> (hydration leads to loss of transparency) </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Avascularity </span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Regular arrangement of <strong>corneal lamellae</strong> </span></span></span></li>\r\n\t\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unmyelinated nerve fibres</span></span></strong></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 154202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38323,
      "choices": [
        {
          "id": 153051,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hexokinase</span></span></span></p>"
        },
        {
          "id": 153052,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phosphofructokinase</span></span></span></p>"
        },
        {
          "id": 153053,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pyruvate kinase</span></span></span></p>"
        },
        {
          "id": 153054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lactate dehydrogenase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 22-year-old male, long-distance runner presents to the clinic with complaints of unusual fatigue and muscle cramps after intense exercise. Laboratory findings reveal no electrolyte imbalances. His dietary history is significant for a high carbohydrate intake. Given the patient&#39;s symptoms and diet, a deficiency in a key regulatory enzyme of glycolysis is suspected that could lead to inadequate ATP production during anaerobic conditions. Which of the following enzymes is most likely deficient in this patient?</span></span></span></p>",
      "unique_key": "Q1803033",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715394,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Phosphofructokinase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phosphofructokinase (PFK) is a key regulatory enzyme in the glycolytic pathway, catalysing the phosphorylation of fructose-6-phosphate to fructose-1, 6-bisphosphate. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a rate-limiting step in glycolysis and is highly regulated by ATP and AMP levels, as well as by other factors. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A deficiency in PFK can lead to a reduced rate of glycolysis, impairing ATP production during anaerobic conditions such as intense exercise. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This can cause symptoms like muscle fatigue and cramps, as seen in the patient. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s high carbohydrate diet would typically support glycolysis, further suggesting that the issue lies with the glycolytic pathway itself, particularly at a regulatory step like that catalysed by PFK.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Hexokinase.</strong> Hexokinase catalyses the first step of glycolysis, the phosphorylation of glucose to glucose-6-phosphate. While important, it is not as significant a regulatory step as that catalysed by phosphofructokinase, and deficiencies are less likely to produce the acute exercise-related symptoms described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Pyruvate kinase.</strong> Pyruvate kinase catalyses the last step of glycolysis, converting phosphoenolpyruvate to pyruvate. Deficiencies can affect ATP production but are more commonly associated with hemolytic anemia rather than exercise-induced muscle cramps.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Lactate dehydrogenase.</strong> Lactate dehydrogenase is involved in converting pyruvate to lactate during anaerobic glycolysis. A deficiency here would likely lead to decreased lactate production, which might present differently and is less directly related to a block in the glycolytic pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This question aims to evaluate the examinee&#39;s understanding of the glycolytic pathway, particularly the role of phosphofructokinase as a key regulatory enzyme. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the clinical implications of a deficiency in this enzyme, including exercise-induced muscle fatigue and cramps, reinforcing the importance of metabolic pathways in diagnosing and understanding patient symptoms.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153052,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38402,
      "choices": [
        {
          "id": 153363,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Apparent diffusion coefficient (ADC) map</span></span></span></p>"
        },
        {
          "id": 153364,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diffusion weighted image (DWI)</span></span></span></p>"
        },
        {
          "id": 153365,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Susceptibility weighted image (SWI)</span></span></span></p>"
        },
        {
          "id": 153366,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Proton density weighted image (PDWI)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 62-year-old male with a history of hypertension and atrial fibrillation presents to the emergency room with acute onset of left-sided weakness and slurred speech. An MRI of the brain is ordered to evaluate for possible stroke. The image provided shows a brain MRI sequence. Identifying the correct MRI sequence is crucial for appropriate diagnosis and management. Based on the appearance of the lesions seen in the image provided, which of the following MRI sequences is being shown?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-183906.JPG\" style=\"height:396px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3345045",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718145,
      "difficulty_level": "intermediate",
      "subjects_id": [
        17
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Susceptibility weighted image (SWI)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The MRI sequence provided appears to be a Susceptibility Weighted Image (SWI). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SWI is a high-resolution MRI sequence that is sensitive to differences in the magnetic susceptibility of various tissues, particularly blood, iron, and calcium. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image shows multiple small dark spots throughout the brain, which could represent microhemorrhages or calcium deposits, commonly highlighted on SWI due to their paramagnetic or diamagnetic properties.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>A. Apparent diffusion coefficient (ADC) map.</strong> ADC maps are typically used to characterize diffusion restriction on DWI, showing areas of decreased diffusion as dark, which contrasts with the bright signals of restricted diffusion on DWI.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>B. Diffusion weighted image (DWI).</strong> DWI detects acute ischemia by highlighting areas of restricted diffusion as bright signals. The dark signals in the provided image are not characteristic of DWI findings in acute stroke.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option</span></strong><span style=\"font-size:14.0pt\"> <strong>D. Proton density weighted image (PDWI).</strong> PDWI images have a long repetition time (TR) and a short echo time (TE), which results in high signal from fluids and good contrast between different soft tissues. The lesions in the provided image do not have the appearance typical of PDWI.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective here is to identify and understand the clinical applications of SWI in neuroimaging. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SWI is particularly useful for detecting small vascular lesions, microbleeds, and calcifications that are not as evident on other MRI sequences. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing the characteristic appearance of these lesions on SWI is important in the context of diagnosing conditions that may involve microvascular changes, such as cerebral amyloid angiopathy, hypertension-related microbleeds, or traumatic brain injury.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38586,
      "choices": [
        {
          "id": 154087,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">There is no agreement between the two groups.</span></span></span></p>"
        },
        {
          "id": 154088,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The two groups have a constant relationship with a variation of 3%.</span></span></span></p>"
        },
        {
          "id": 154089,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">There is no association between the two groups.</span></span></span></p>"
        },
        {
          "id": 154090,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The curve shows a regression line which means there is a correlation.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A study is conducted to compare the oxygen saturation (SpO2) readings obtained through a micropore tape (a transparent, breathable adhesive tape used in medical settings) with those obtained directly in a pediatric population. The scatter plot graph provided represents the relationship between the SpO2 readings obtained directly and those obtained through the micropore tape. Based on the scatter plot provided, which of the following statements is true regarding the agreement between the two groups?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-131133.JPG\" style=\"height:240px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7509713",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739025,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) The curve shows a regression line which means there is a correlation.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The scatter plot shows a clear linear relationship between the SpO2 readings obtained directly and those obtained through the micropore. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The data points are closely aligned along a straight line, which suggests a strong positive correlation between the two sets of measurements. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This means that as the directly measured SpO2 increases, the SpO2 measured through the micropore also increases, indicating agreement and correlation between the two methods.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">Option A.</span></span></strong><strong><span style=\"font-size:14.0pt\"> There is no agreement between the two groups</span></strong><span style=\"font-size:14.0pt\">. This option is incorrect because the scatterplot clearly shows a pattern indicating agreement between the two sets of measurements.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">Option B.</span></span></strong><strong><span style=\"font-size:14.0pt\"> The two groups have a constant relationship with a variation of 3%.</span></strong><span style=\"font-size:14.0pt\"> This statement is imprecise without more information, such as a line of best fit or confidence intervals that could substantiate the exact variation percentage.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"color:black\">Option C.</span></span></strong><strong><span style=\"font-size:14.0pt\"> There is no association between the two groups</span></strong><span style=\"font-size:14.0pt\">. This option is incorrect as the graph demonstrates a linear relationship, suggesting an association.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Interpretation of Bland-Altman Plot:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Perfect correlation if the points lie perfectly along any straight line</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Regression line indicates Correlation:</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-131146.JPG\" style=\"height:195px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Perfect agreement only if they lie perfectly along the line of equality</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Line of equality does not indicate perfect agreement:</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-131159.JPG\" style=\"height:197px; width:300px\" /></span></strong></span></span></p>",
      "correct_choice_id": 154090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38540,
      "choices": [
        {
          "id": 153903,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leukemoid reaction</span></span></span></p>"
        },
        {
          "id": 153904,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute myelogenous leukemia</span></span></span></p>"
        },
        {
          "id": 153905,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic lymphocytic leukemia</span></span></span></p>"
        },
        {
          "id": 153906,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lymphoblastic leukemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 30-year-old man has had a progressively worsening productive cough for one month. On physical examination, a few small non-tender lymph nodes are palpable in the axillae, and the tip of the spleen is palpable. Laboratory studies show Hgb 10.2 g/dL, Hct 31.1%, MCV 90 fL, WBC count 67,000/microliter, and platelet count 36,000/microliter. Microscopic examination of his peripheral blood smear shows many blasts with Auer rods. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q9374608",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734879,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Acute myelogenous leukemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation with a productive cough, splenomegaly, anemia (Hgb 10.2 g/dL, Hct 31.1%), thrombocytopenia (platelet count 36,000/microliter), and an elevated white blood cell count with many blasts containing Auer rods on peripheral blood smear is highly indicative of acute myelogenous leukemia (AML). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Auer rods are needle-shaped azurophilic granular bodies found in the cytoplasm of myeloblasts and are a diagnostic feature of AML.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Leukemoid reaction.</span></strong><span style=\"font-size:14.0pt\"> This is a reactive process that can cause a marked increase in the white blood cell count, often in response to severe infections or stressors. However, it does not typically present with blasts containing Auer rods, which are specific for myeloid lineage malignancies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Chronic lymphocytic leukemia (CLL).</span></strong><span style=\"font-size:14.0pt\"> CLL typically presents with a lymphocytosis of mature-looking lymphocytes and is more common in older adults. It does not feature blasts with Auer rods.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Lymphoblastic leukemia.</span></strong><span style=\"font-size:14.0pt\"> While this leukemia presents with blasts, these blasts are of lymphoid origin and do not contain Auer rods. Lymphoblastic leukemia would also usually present with a different immunophenotype on flow cytometry.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The diagnosis of acute myelogenous leukemia is supported by clinical findings such as anemia, thrombocytopenia, splenomegaly, and a high white blood cell count with the presence of myeloblasts containing Auer rods on a peripheral blood smear. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Auer rods are pathognomonic for a myeloid lineage malignancy, specifically AML.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153904,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38314,
      "choices": [
        {
          "id": 153015,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Beta fibres</span></span></span></p>"
        },
        {
          "id": 153016,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Alpha fibres</span></span></span></p>"
        },
        {
          "id": 153017,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Delta fibres</span></span></span></p>"
        },
        {
          "id": 153018,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Gamma fibres</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 45-year-old male presents to the clinic with complaints of muscle weakness and decreased sensitivity in his left arm. On examination, you note that his reflexes are diminished in the affected arm. You recall that muscle spindles play a critical role in proprioception and reflex regulation. Muscle spindles contain intrafusal fibres that are essential for sensing changes in muscle length and initiating reflexive responses to maintain muscle tone and posture. Given the importance of muscle spindles in proprioception and reflex regulation, which of the following nerve fibres is primarily responsible for the motor supply to the intrafusal muscle fibres within these spindles?</span></span></span></p>",
      "unique_key": "Q9754325",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715165,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Gamma fibres</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Gamma motor neurons innervate the intrafusal muscle fibres within the muscle spindle. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Their activation adjusts the sensitivity of the spindle to changes in muscle length, thereby modulating the stretch reflex to prevent muscle injury. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">By adjusting the tension in the intrafusal fibres, gamma motor neurons ensure that the muscle spindle is appropriately responsive to stretch, even when the muscle itself is contracted. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This mechanism is essential for maintaining muscle tone and coordinating fine motor movements.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Alpha fibres</span></strong><span style=\"font-size:14.0pt\">: Alpha motor neurons innervate the extrafusal muscle fibres, which are responsible for the contraction of the muscle and generating force, not directly involved in adjusting the sensitivity of muscle spindles.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Beta fibres</span></strong><span style=\"font-size:14.0pt\">: Beta motor neurons have a dual role, innervating both intrafusal and extrafusal muscle fibres, but they are less involved in the precise modulation of muscle spindle sensitivity compared to gamma motor neurons.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Delta fibres</span></strong><span style=\"font-size:14.0pt\">: Delta fibres are primarily involved in the transmission of pain and temperature sensations and are not directly involved in motor supply to muscle fibres.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The primary objective of this question is to understand the role of gamma motor neurons in proprioception and reflex regulation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Gamma motor neurons innervate the intrafusal muscle fibres within muscle spindles, adjusting their sensitivity to changes in muscle length and thereby modulating the stretch reflex. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is crucial for maintaining muscle tone and posture. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Alpha motor neurons control the contraction of extrafusal muscle fibres, while beta motor neurons have a less specific role, innervating both intrafusal and extrafusal fibres. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Delta fibres are sensory and not involved in motor control of muscle spindles.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38819,
      "choices": [
        {
          "id": 155015,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose</span></span></p>"
        },
        {
          "id": 155016,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl-CoA</span></span></p>"
        },
        {
          "id": 155017,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinyl-CoA</span></span></p>"
        },
        {
          "id": 155018,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male with a history of alcohol abuse presents to the emergency department with severe abdominal pain radiating to his back, nausea, and vomiting. His blood tests reveal elevated amylase and lipase levels. Abdominal imaging is suggestive of acute pancreatitis. In the context of this patient&#39;s condition, the metabolism of which of the following substances is most likely to be disrupted?</span></span></span></span></p>",
      "unique_key": "Q5721829",
      "question_audio": null,
      "question_video": null,
      "map_id": 3784153,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Succinyl-CoA</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinyl-CoA plays a critical role in the tricarboxylic acid (TCA) cycle, an essential pathway for energy production in the mitochondria. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In conditions of acute pancreatitis, especially in the context of alcohol abuse, mitochondrial dysfunction is a common pathological finding. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The disruption in mitochondrial function can lead to impaired energy production due to the inefficient functioning of the TCA cycle, where Succinyl-CoA is converted into Succinate. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This step is crucial for the synthesis of ATP via substrate-level phosphorylation, and its impairment can significantly affect the cell&#39;s energy status, particularly in metabolically active tissues like the pancreas.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>A. Glucose.</strong> While glucose metabolism may be altered due to changes in insulin sensitivity and secretion secondary to pancreatitis, it is not directly impacted by mitochondrial dysfunction in the context of the TCA cycle.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>B. Acetyl-CoA.</strong> Although Acetyl-CoA is an essential substrate for the TCA cycle, its metabolism is less likely to be directly disrupted in acute pancreatitis compared to Succinyl-CoA, as Acetyl-CoA has multiple metabolic fates and can be diverted to other pathways such as ketogenesis, especially in the setting of alcohol abuse.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>D. Glycerol.</strong> Glycerol metabolism, involved in triglyceride synthesis and breakdown, may be affected due to alterations in lipid metabolism in acute pancreatitis. However, it does not directly relate to the mitochondrial dysfunction affecting the TCA cycle as Succinyl-CoA does.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The question aims to assess the understanding of metabolic pathways affected in acute conditions like pancreatitis, with a focus on the TCA cycle&#39;s role in energy production. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct answer, <strong>Succinyl-CoA</strong>, highlights the importance of mitochondrial function in energy metabolism and the potential impact of acute illnesses on crucial metabolic pathways.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 155017,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38530,
      "choices": [
        {
          "id": 153863,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rheumatoid arthritis </span></span></span></p>"
        },
        {
          "id": 153864,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tuberculosis </span></span></span></p>"
        },
        {
          "id": 153865,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Systemic lupus erythematosus </span></span></span></p>"
        },
        {
          "id": 153866,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multiple myeloma </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old previously healthy man has developed progressive renal failure for the past 5 years along with back pain. Microscopic examination of a renal biopsy shows extensive glomerular and vascular deposition of pink amorphous material on H&amp;E staining. This material demonstrates apple-green birefringence under polarized light after Congo red staining. Immunohistochemical staining of these deposits is positive for lambda light chains. Which of the following conditions is most likely to be present in this man? </span></span></span></p>",
      "unique_key": "Q8608897",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734249,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Multiple myeloma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The renal biopsy findings of pink amorphous material showing apple-green birefringence under polarized light after Congo red staining are characteristic of amyloidosis, which is often associated with multiple myeloma. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The immunohistochemical positivity for lambda light chains suggests the presence of light chain amyloidosis (AL amyloidosis), which is commonly seen in multiple myeloma. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of plasma cells that produce monoclonal light chains, which can deposit in various organs, including the kidneys, leading to organ dysfunction. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s progressive renal failure and back pain (possibly due to lytic lesions or osteoporosis secondary to plasma cell infiltration) further support the diagnosis of multiple myeloma.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. </span></strong><strong><span style=\"font-size:14.0pt\">Rheumatoid arthritis </span></strong><span style=\"font-size:14.0pt\">can have renal involvement due to secondary amyloidosis (AA amyloidosis); however, this is typically associated with chronic inflammation and would not typically present with lambda light chain deposition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. </span></strong><strong><span style=\"font-size:14.0pt\">Tuberculosis </span></strong><span style=\"font-size:14.0pt\">can cause granulomatous inflammation in the kidneys but does not cause the deposition of amyloid material that exhibits apple-green birefringence.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. </span></strong><strong><span style=\"font-size:14.0pt\">Systemic lupus erythematosus </span></strong><span style=\"font-size:14.0pt\">can lead to a variety of renal pathologies, including lupus nephritis, which does not typically show the described staining characteristics of amyloidosis with Congo red staining and would show immune complex deposition on immunofluorescence.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The objective of this question is to recognize the clinical and pathological features of amyloidosis associated with multiple myeloma. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It emphasizes the importance of identifying characteristic Congo red staining with apple-green birefringence and the presence of monoclonal light chain deposition, which are indicative of light chain amyloidosis frequently associated with plasma cell dyscrasias such as multiple myeloma. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the associations between hematologic malignancies and renal pathology is critical for the diagnosis and management of these conditions.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153866,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38373,
      "choices": [
        {
          "id": 153247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">30% Amorphous + 70% Crystalline insulin</span></span></span></p>"
        },
        {
          "id": 153248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">30% Crystalline + 70% Amorphous insulin</span></span></span></p>"
        },
        {
          "id": 153249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Same as Neutral Protamine Hagedorn (NPH) insulin</span></span></span></p>"
        },
        {
          "id": 153250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Only 70% amorphous insulin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 65-year-old woman with a 20-year history of type 2 diabetes mellitus is being reviewed in the clinic for her glycemic control. She has been on various insulin regimens over the years and is currently interested in learning about different types of insulin formulations and their pharmacokinetic profiles, as she seeks better control over her blood glucose levels. During the discussion, Lente insulin, an intermediate-acting insulin, is brought up. She is curious about the composition of Lente insulin and how it differs from other insulin formulations she has used in the past. Which of the following best describes the composition of Lente insulin?</span></span></span></p>",
      "unique_key": "Q4097235",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716968,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) 30% Amorphous + 70% Crystalline insulin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lente insulin is an intermediate-acting insulin composed of 30% semi-lente (amorphous) insulin and 70% ultra-lente (crystalline) insulin. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The combination of amorphous and crystalline forms allows for a biphasic onset of action, with the amorphous component providing an initial peak and the crystalline component extending the duration of action. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This composition is distinct from other insulin formulations, such as NPH (Neutral Protamine Hagedorn) insulin, which has a different mechanism for prolonging insulin action.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. 30% Crystalline + 70% Amorphous insulin</span></strong><span style=\"font-size:14.0pt\">. The reverse composition (30% crystalline + 70% amorphous insulin) does not accurately describe any commonly used insulin formulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Same as Neutral Protamine Hagedorn (NPH) insulin</span></strong><span style=\"font-size:14.0pt\">. NPH insulin contains insulin combined with protamine, which differs from the amorphous and crystalline mixture in Lente insulin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Only 70% amorphous insulin</span></strong><span style=\"font-size:14.0pt\">. No insulin formulation consists of only 70% amorphous insulin. The specific mixture of amorphous and crystalline insulin in Lente insulin is what defines its pharmacokinetic profile.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to assess the understanding of the composition and pharmacokinetic profiles of different insulin formulations, specifically Lente insulin. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of knowing the characteristics of various insulin types to optimize diabetes management based on individual patient needs and preferences.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153247,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38535,
      "choices": [
        {
          "id": 153883,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyponatremia</span></span></span></p>"
        },
        {
          "id": 153884,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypergammaglobulinemia</span></span></span></p>"
        },
        {
          "id": 153885,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperbilirubinemia</span></span></span></p>"
        },
        {
          "id": 153886,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypercalcemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 60-year-old woman has been a cigarette smoker since the age of 18, averaging a pack a day of unfiltered cigarettes. She works as a dispatcher for a trucking company. She has had several episodes of hemoptysis in the past two weeks along with fatigue, headache, nausea, and anorexia. On physical examination, her sensorium is clouded. A chest radiograph shows an ill-defined hilar mass. A transbronchial lung biopsy is performed and the microscopic appearance is shown here. Which of the following laboratory test findings is most likely to be present in this woman?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-110338.JPG\" style=\"height:205px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2683684",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734414,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Hyponatremia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These neoplastic cells have a small overall size, and the nuclei are markedly hyperchromatic and there is scant cytoplasm (high N/C ratio). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Their appearance is most characteristic for small cell anaplastic (&#39;oat cell&#39;) carcinoma of the lung, which is a neuroendocrine carcinoma often associated with paraneoplastic syndromes such as the syndrome of inappropriate ADH (SIADH).</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given the patient&#39;s history of chronic smoking, episodes of hemoptysis, and the presence of an ill-defined hilar mass on chest radiograph, a likely diagnosis is lung cancer, particularly small cell lung cancer (SCLC) due to the central location of the mass and the patient&#39;s heavy smoking history. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SCLC is known for its association with paraneoplastic syndromes, including the syndrome of inappropriate antidiuretic hormone secretion (SIADH). </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SIADH leads to water retention and hyponatremia, which can explain the patient&#39;s symptoms of fatigue, headache, nausea, and clouded sensorium, as these are common manifestations of hyponatremia. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, hyponatremia is the most likely laboratory test finding in this woman.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hypergammaglobulinemia.</span></strong><span style=\"font-size:14.0pt\"> This is more commonly associated with chronic inflammatory conditions, autoimmune diseases, or chronic infections rather than with lung cancer. Therefore, it is less likely to be found in this patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hyperbilirubinemia.</span></strong><span style=\"font-size:14.0pt\"> This condition indicates liver dysfunction or hemolysis and is not directly associated with lung cancer unless there is extensive liver involvement by metastatic disease, which is not indicated by the current clinical scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hypercalcemia.</span></strong><span style=\"font-size:14.0pt\"> While hypercalcemia can be seen in patients with cancer, it is more commonly associated with squamous cell carcinoma of the lung due to parathyroid hormone-related peptide (PTHrP) production, rather than with SCLC. Therefore, it is less likely than hyponatremia to be present in this patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with small cell lung cancer, the syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common paraneoplastic syndrome that can lead to hyponatremia. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of hyponatremia includes fatigue, headache, nausea, and altered mental status, which align with the symptoms described by the patient. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the association between specific lung cancer types and their paraneoplastic syndromes is crucial for diagnosis and management.</span></span></li>\r\n</ul>",
      "correct_choice_id": 153883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38538,
      "choices": [
        {
          "id": 153895,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic adenomas</span></span></span></p>"
        },
        {
          "id": 153896,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Metastatic adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 153897,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multifocal biliary tract dysplasia</span></span></span></p>"
        },
        {
          "id": 153898,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatocellular carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old woman has been feeling fatigued for the past 6 weeks. She has had a 6 kg weight loss in the past 3 months. She has nausea, but no vomiting, hemoptysis, or hematemesis. She does not have a cough. On physical examination, she is afebrile. A stool sample is positive for occult blood. Her serum carcinoembryonic antigen (CEA) is elevated but her alpha-fetoprotein (AFP) is not. The representative gross appearance of her liver is depicted here. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-110410.JPG\" style=\"height:208px; width:300px\" /></span></span></p>",
      "unique_key": "Q3940077",
      "question_audio": null,
      "question_video": null,
      "map_id": 3734837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Metastatic adenocarcinoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The liver gross appearance shown in the image, with multiple nodular lesions of varying sizes, is highly suggestive of metastatic disease to the liver, particularly given the patient&#39;s clinical presentation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of fatigue, weight loss, occult blood in the stool, and an elevated carcinoembryonic antigen (CEA) are findings that are commonly associated with colorectal cancer, which frequently metastasizes to the liver. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The fact that the alpha-fetoprotein (AFP) is not elevated makes a primary hepatocellular carcinoma less likely, as AFP is often elevated in that condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Hepatic adenomas.</span></strong><span style=\"font-size:14.0pt\"> These are benign liver tumors that are generally solitary and not associated with the systemic symptoms of weight loss and fatigue, nor would they typically cause an elevated CEA level.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Multifocal biliary tract dysplasia.</span></strong><span style=\"font-size:14.0pt\"> Dysplasia in the biliary tract does not present as multiple nodular lesions throughout the liver and is not associated with an elevated CEA.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hepatocellular carcinoma.</span></strong><span style=\"font-size:14.0pt\"> While hepatocellular carcinoma can present with a multifocal pattern in the liver, it is usually associated with an elevated AFP, which is not the case here. Additionally, hepatocellular carcinoma is less likely to present with occult blood in the stool.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When evaluating a liver with multiple nodular lesions, metastatic adenocarcinoma should be high on the differential diagnosis list, particularly in the setting of systemic symptoms such as weight loss, occult gastrointestinal bleeding, and elevated CEA levels. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic metastases are more common than primary liver tumors in adults.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38439,
      "choices": [
        {
          "id": 153507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Clinical history of passage of clear vesicles</span></span></span></p>"
        },
        {
          "id": 153508,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Histological features showing hydropic changes in villi/trophoblastic proliferation</span></span></span></p>"
        },
        {
          "id": 153509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased beta hCG levels</span></span></span></p>"
        },
        {
          "id": 153510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ultrasound feature of snowstorm appearance</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A woman presents to the emergency department with a history of amenorrhea, vaginal bleeding, and the passage of clear vesicles. Following a suction evacuation procedure, the medical team is considering the diagnosis of a molar pregnancy, which is a type of gestational trophoblastic disease. Based on the clinical presentation and initial management, which of the following would provide the definitive diagnosis of a molar pregnancy?</span></span></span></p>",
      "unique_key": "Q9414294",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719767,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Histological features showing hydropic changes in villi/trophoblastic proliferation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The definitive diagnosis of a molar pregnancy is made by histological examination of the evacuated tissue, which reveals characteristic features such as hydropic changes in the chorionic villi and trophoblastic proliferation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These pathological changes are distinctive for molar pregnancies, differentiating them from other types of pregnancy-related issues.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Clinical history of passage of clear vesicles</span></strong><span style=\"font-size:14.0pt\">. While the passage of clear vesicles is suggestive of a molar pregnancy, it is not definitive without histological confirmation, as other conditions can present with similar symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Increased beta hCG levels</span></strong><span style=\"font-size:14.0pt\">. Elevated beta hCG levels are commonly associated with molar pregnancies due to the abnormal proliferation of trophoblastic tissue. However, increased hCG levels alone cannot confirm the diagnosis, as they can also be seen in normal pregnancies, multiple pregnancies, and other types of gestational trophoblastic diseases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ultrasound feature of snowstorm appearance</span></strong><span style=\"font-size:14.0pt\">. The &quot;snowstorm&quot; appearance on ultrasound is indicative of a molar pregnancy, but it is not definitive. This ultrasound finding represents the extensive trophoblastic proliferation and hydropic villi but must be confirmed with histological examination for a definitive diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective is to understand that the definitive diagnosis of a molar pregnancy is established through histological examination of evacuated tissue, showing characteristic hydropic changes in the chorionic villi and trophoblastic proliferation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While clinical history, elevated beta hCG levels, and ultrasound findings are important for the initial suspicion and diagnosis, histopathological confirmation is essential for definitive diagnosis and appropriate management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38699,
      "choices": [
        {
          "id": 154539,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Contrast-induced acute kidney injury (AKI)</span></span></span></p>"
        },
        {
          "id": 154540,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Atheroembolic renal disease</span></span></span></p>"
        },
        {
          "id": 154541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rhabdomyolysis</span></span></span></p>"
        },
        {
          "id": 154542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute interstitial nephritis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old male with a history of hypertension, hyperlipidemia, and recent endovascular aortic aneurysm repair presents one-week post-procedure with a purple discoloration of his right great toe, a lacy non-blanching rash, peripheral eosinophilia, and acute kidney injury. No new medications or allergies are reported. What is the most likely diagnosis given his clinical presentation and recent medical history?</span></span></p>",
      "unique_key": "Q3633475",
      "question_audio": null,
      "question_video": null,
      "map_id": 3754585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Atheroembolic renal disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Atheroembolic renal disease, also known as <strong>cholesterol crystal embolism</strong>, is a condition where cholesterol crystals dislodge from atherosclerotic plaques and embolize to distant organs, including the kidneys, skin, and gastrointestinal tract. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It can occur spontaneously or, more commonly, after procedures such as angiography, vascular surgery, or anticoagulation therapy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The classic triad of presentation includes <strong>livedo reticularis</strong> (a lacy, non-blanching rash), <strong>eosinophilia</strong>, and <strong>acute kidney injury</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The purple discoloration of the toe (<strong>blue toe syndrome</strong>) is also a characteristic finding, indicating embolization to the small vessels of the extremities.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Contrast-induced AKI</span></strong><span style=\"font-size:14.0pt\"> is caused by nephrotoxic effects of iodinated contrast agents used during imaging studies or procedures. While it can lead to acute kidney injury, it does not typically present with skin manifestations or peripheral eosinophilia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Rhabdomyolysis</span></strong><span style=\"font-size:14.0pt\"> is characterized by the breakdown of muscle tissue leading to the release of muscle fiber contents into the bloodstream, which can lead to kidney injury. The classic triad includes muscle pain, weakness, and dark urine (myoglobinuria), not typically associated with skin changes or eosinophilia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Acute interstitial nephritis</span></strong><span style=\"font-size:14.0pt\"> is an inflammatory condition affecting the kidney&#39;s interstitium, often due to allergic drug reactions, leading to acute kidney injury. While it may present with peripheral eosinophilia, it is less likely to cause skin changes like livedo reticularis or blue toe syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atheroembolic renal disease is a complication following vascular procedures, characterized by the triad of livedo reticularis, peripheral eosinophilia, and acute kidney injury, along with the potential for blue toe syndrome. </span></span></li>\r\n</ul>",
      "correct_choice_id": 154540,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38353,
      "choices": [
        {
          "id": 153171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Lubiprostone</span></span></span></p>"
        },
        {
          "id": 153172,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Linaclotide</span></span></span></p>"
        },
        {
          "id": 153173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Tegaserod</span></span></span></p>"
        },
        {
          "id": 153174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methylnaltrexone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old woman presents to the clinic with a 6-month history of abdominal pain, bloating, and altered bowel habits. Her symptoms include periods of diarrhea interspersed with constipation. She reports that her symptoms are significantly affecting her quality of life. She has tried dietary modifications and over-the-counter medications with minimal relief. After a thorough evaluation, you diagnose her with irritable bowel syndrome (IBS) and decide to initiate pharmacotherapy. Considering her symptoms, you contemplate prescribing a Guanylate Cyclase-C agonist to improve her bowel habits and alleviate her discomfort. Which of the following medications would be most appropriate for this purpose?</span></span></p>",
      "unique_key": "Q5292748",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716248,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Linaclotide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Linaclotide is a Guanylate Cyclase-C (GC-C) agonist that is used in the management of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It works by increasing the concentration of cyclic guanosine monophosphate (cGMP), which, in turn, leads to an increase in chloride and bicarbonate secretion into the intestinal lumen. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This increased secretion enhances bowel movements and alleviates the symptoms associated with IBS-C.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Lubiprostone</span></strong><span style=\"font-size:14.0pt\"> is a chloride channel activator used to treat chronic idiopathic constipation and IBS-C, but it does not work through the Guanylate Cyclase-C pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Tegaserod</span></strong><span style=\"font-size:14.0pt\"> is a serotonin receptor agonist that was used to treat IBS with constipation, particularly in women, but its use is limited due to cardiovascular concerns and it does not act as a Guanylate Cyclase-C agonist.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Methylnaltrexone</span></strong><span style=\"font-size:14.0pt\"> is a peripheral opioid receptor antagonist used to treat opioid-induced constipation and does not act on the Guanylate Cyclase-C receptor.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to test the understanding of the pharmacological management of irritable bowel syndrome with constipation (IBS-C), focusing on the mechanism of action of Guanylate Cyclase-C agonists like Linaclotide. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It highlights the importance of selecting medication based on the underlying pathophysiology of the condition and the specific symptoms presented by the patient.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38735,
      "choices": [
        {
          "id": 154683,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mallory-Weiss tear</span></span></span></span></p>"
        },
        {
          "id": 154684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophagitis</span></span></span></span></p>"
        },
        {
          "id": 154685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peptic ulcer</span></span></span></span></p>"
        },
        {
          "id": 154686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal varices</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents in emergency department with sudden hematemesis. He has been taking aspirin for his arthritis and drinks alcohol occasionally. He gives a history of occasional abdominal pain. On examination, there is no abdominal mass or tenderness. What is the likely diagnosis?</span></span></p>",
      "unique_key": "Q7954830",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757181,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Peptic ulcer</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient most likely has a bleeding peptic ulcer.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peptic ulcer disease (PUD) are of <strong>two types</strong>: Gastric and Duodenal. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastric ulcer has an etiology of Helicobacter pylori and NSAIDs.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NSAIDs like aspirin interferes with the protective role of Prostaglandins on gastric and duodenal mucosa from acid and pepsin and increase the risk of peptic ulcer formation in the stomach and the duodenum.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They present with Pain in epigastrium, bleeding, vomiting.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sequelae: </span></span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bleed (Duodenal &gt; Gastric ulcer) &ndash; MC complication of peptic ulcer</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\">Perforation </span><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Times New Roman&quot;,serif; font-size:14pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;peritonitis (duodenal &gt; gastric)</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stricture </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> gastric outlet obstruction</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> only in gastric ulcers</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Mallory-Weiss tears</strong> occur following repeated vomiting/ retching &ndash; alcoholic binge. Self-limiting, no profuse hematemesis. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Esophagitis</strong> results in chronic blood loss and commonly presents as anemia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Esophageal varices</strong> commonly occur in portal hypertension patients with cirrhosis. There is no splenomegaly or ascites seen in the given patient, which is a typical finding in portal hypertension.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient&#39;s use of aspirin, an NSAID, increases the risk of peptic ulcer disease, which can present with sudden hematemesis in the absence of other symptoms suggestive of esophageal varices, Mallory-Weiss tear, or esophagitis.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154685,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38410,
      "choices": [
        {
          "id": 153395,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Biophysical profile</span></span></span></p>"
        },
        {
          "id": 153396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Daily fetal movement count</span></span></span></p>"
        },
        {
          "id": 153397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Non-stress test</span></span></span></p>"
        },
        {
          "id": 153398,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ultrasound for biometry</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 24-year-old primigravida is seen for a routine prenatal visit at 36 weeks of gestation. On examination, the uterus appears smaller than expected for gestational age, with the symphysio-fundal height measuring 31 cm, suggesting the uterus corresponds to approximately 32 weeks of gestation rather than 36. The fetus is in a cephalic presentation, and the fetal heart rate is recorded at 140 beats per minute. Given these findings, which of the following would be the most appropriate next step in management to assess fetal well-being and growth?</span></span></span></p>",
      "unique_key": "Q4455914",
      "question_audio": null,
      "question_video": null,
      "map_id": 3718799,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Ultrasound for biometry</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">An ultrasound for biometry is the most appropriate next step in this scenario. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The discrepancy between the gestational age and the symphysio-fundal height (a difference of 4 weeks or more) warrants an ultrasound to assess fetal growth, amniotic fluid volume, and overall fetal well-being. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Biometry measurements such as the biparietal diameter, head circumference, abdominal circumference, and femur length can help determine if the fetus is experiencing intrauterine growth restriction (IUGR) or if the dates were initially miscalculated.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Biophysical profile</span></strong><span style=\"font-size:14.0pt\">. While a biophysical profile (BPP) is a comprehensive assessment that includes fetal heart rate, movement, tone, breathing movements, and amniotic fluid volume, it might be more appropriate after confirming fetal growth status with biometry. The BPP is typically used in high-risk pregnancies to monitor fetal well-being more closely.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Daily fetal movement count</span></strong><span style=\"font-size:14.0pt\">. Monitoring daily fetal movements is a non-invasive method to assess fetal well-being. However, it would not provide information about fetal growth or the cause of the discrepancy in symphysio-fundal height, making it less appropriate as the next immediate step.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Non-stress test</span></strong><span style=\"font-size:14.0pt\">. A non-stress test (NST) assesses fetal heart rate patterns in response to fetal movements, indicating fetal well-being. While useful, it does not address the need to evaluate the cause of the reduced symphysio-fundal height measurement, such as potential growth restrictions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question underscores the importance of evaluating fetal growth in the presence of a significant discrepancy between gestational age and symphysio-fundal height measurements. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">An ultrasound for biometry is the most appropriate next step to assess fetal size, growth pattern, and amniotic fluid volume, which are crucial for managing potential complications such as intrauterine growth restriction. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other options like biophysical profile, daily fetal movement count, and non-stress test are valuable for ongoing fetal surveillance but are not the primary tools for initially assessing fetal growth discrepancies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153398,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38545,
      "choices": [
        {
          "id": 153923,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Retroviruses</span></span></span></p>"
        },
        {
          "id": 153924,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Reoviruses</span></span></span></p>"
        },
        {
          "id": 153925,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Coronaviruses</span></span></span></p>"
        },
        {
          "id": 153926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Robo Viruses</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a clinical pathology lecture, a medical student presents a case study of a patient diagnosed with Burkitt&#39;s lymphoma. The discussion focuses on the viral etiology of certain cancers, particularly how some viruses can alter cellular DNA, leading to uncontrolled cell growth. The student explores various RNA viruses and their potential role in oncogenesis. Which RNA virus family, known for its ability to integrate into the host genome and potentially induce oncogenic transformation, is most relevant to the topic of virus-associated cancers?</span></span></span></p>",
      "unique_key": "Q9973851",
      "question_audio": null,
      "question_video": null,
      "map_id": 3736003,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Retroviruses</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Retroviruses are characterized by their ability to convert their RNA genome into DNA, which can then integrate into the host cell&#39;s genome. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This integration can lead to the activation of oncogenes or the inactivation of tumor suppressor genes, contributing to the development of cancer. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For example, Human T-lymphotropic virus type 1 (HTLV-1), a retrovirus, is associated with adult T-cell leukemia/lymphoma, illustrating the oncogenic potential of retroviruses.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B) Reoviruses</span></strong><span style=\"font-size:14.0pt\">. These are double-stranded RNA viruses that typically do not cause cancer in humans. They are known to infect the gastrointestinal and respiratory tracts, leading to mild diseases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C) Coronaviruses</span></strong><span style=\"font-size:14.0pt\">. These single-stranded RNA viruses are known for causing illnesses ranging from the common cold to severe diseases like COVID-19. There is no established link between coronaviruses and the direct induction of cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D) Robo Viruses</span></strong><span style=\"font-size:14.0pt\">. This term does not correspond to a recognized category of viruses in the field of virology and may represent a typographical or fictional virus name. It is not associated with any known RNA virus group that has oncogenic properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Carcinogenic Organism: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-122304.JPG\" style=\"height:561px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 153923,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38594,
      "choices": [
        {
          "id": 154119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cyclopropagative: Agent changes form and number</span></span></span></p>"
        },
        {
          "id": 154120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Propagative: Agent multiplies without changing form</span></span></span></p>"
        },
        {
          "id": 154121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cyclodevelopmental: Agent develops without multiplying</span></span></span></p>"
        },
        {
          "id": 154122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transovarial: Agent transmitted from nymph to adult</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A public health report in India highlights confusion regarding vector transmission mechanisms. Specifically, it mislabels transovarial transmission as occurring from nymph to adult vector. Which of the following pairings is incorrectly matched?</span></span></span></p>",
      "unique_key": "Q7007110",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Transovarial: Agent transmitted from nymph to adult</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transovarial transmission involves the passage of pathogens from the female vector to its offspring via the eggs, not from nymph to adult vector as described.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Cyclopropagative</span></strong><span style=\"font-size:14.0pt\">: Correctly describes a transmission where the agent changes form and number within the vector.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Propagative</span></strong><span style=\"font-size:14.0pt\">: Accurately refers to the multiplication of the agent in the vector without a change in form.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cyclodevelopmental</span></strong><span style=\"font-size:14.0pt\">: Correctly denotes the developmental change of the agent in the vector without multiplication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Trans-stadial transmission</span></strong><span style=\"font-size:14.0pt\">: Agent transmitted from nymph to adult vector &ndash; Borrelia burgdorferi in ticks</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trans-ovarial transmission (vertical transmission)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Female vector passes the infectious agent through her eggs to the next generation &ndash; Rickettsia rickettsii in ticks.</span></span></li>\r\n</ul>",
      "correct_choice_id": 154122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38391,
      "choices": [
        {
          "id": 153319,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical steroids</span></span></span></span></p>"
        },
        {
          "id": 153320,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interferons</span></span></span></span></p>"
        },
        {
          "id": 153321,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PUVA</span></span></span></span></p>"
        },
        {
          "id": 153322,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old female presents with subtle, fine, reticulate lacy white pattern in the buccal mucosa, flat-topped purple papules on vulva, cicatricial alopecia of scalp &amp; the following cutaneous finding. Most appropriate treatment strategy would be:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-181123.JPG\" style=\"height:283px; width:200px\" /></span></span></p>",
      "unique_key": "Q2408228",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717826,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>A) Topical steroids</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s age and the presence of <strong><em>purple, polygonal flat-topped papules</em></strong>, and <strong><em>plaques </em></strong>on the <strong><em>dorsum of the hand</em></strong> and similar lesions on the <strong><em>vulva</em></strong> in the image all point to a diagnosis of <strong><em>lichen planus. </em></strong></span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical steroids are the <strong><em>first-line treatment</em></strong> for lichen planus, particularly for <strong><em>symptomatic</em></strong> relief of <strong><em>cutaneous and mucosal</em></strong> lesions and persistent lichen planus.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They help <strong><em>reduce inflammation</em></strong> and <strong><em>immune response</em></strong>, alleviating symptoms.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic steroids, retinoids, and PUVA</span></span></em></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are used as <strong><em>second-line treatments</em></strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Interferons</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are used in some <strong><em>chronic viral</em></strong> infections and certain <strong><em>malignancies</em></strong> but are not the first-line treatment for lichen planus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>PUVA</strong> <strong>(psoralen and ultraviolet A)</strong> therapy may be used in <strong><em>severe cases</em></strong> of lichen planus that are not responsive to topical therapies, but it is not typically first-line due to its side effects and the <strong><em>intensive</em></strong> nature of the treatment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Methotrexate</strong> is a <strong><em>systemic immunosuppressant</em></strong> that might be used in <strong><em>severe, widespread</em></strong>, or <strong><em>refractory lichen planus</em></strong>, but it is not usually the first step in treatment due to potential side effects and the need for monitoring.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-181230.JPG\" style=\"height:799px; width:876px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient presenting with lichen planus affecting <strong><em>mucosal and cutaneous</em></strong> surfaces, <strong>topical steroids</strong> represent the cornerstone of initial treatment for their <strong><em>anti-inflammatory</em></strong> and <strong><em>immunosuppressive effects</em></strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Rook&rsquo;s textbook of dermatology, 9th Edition, Chapter 37, page no. 37.16</span></span></strong></span></span></p>",
      "correct_choice_id": 153319,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38460,
      "choices": [
        {
          "id": 153591,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Classical conditioning</span></span></span></p>"
        },
        {
          "id": 153592,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Operant conditioning</span></span></span></p>"
        },
        {
          "id": 153593,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Social learning theory</span></span></span></p>"
        },
        {
          "id": 153594,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Observational learning</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 30-year-old teacher is implementing a new strategy to improve student behaviour and enhance learning in her classroom. She decides to apply a psychological principle that involves modifying behaviour through the use of consequences. Specifically, she introduces a system where students receive &quot;good behaviour tickets&quot; for positive behaviours, which can be exchanged for extra recess time or small prizes at the end of the week. Negative behaviours result in a loss of these tickets. Over time, the teacher notices a significant improvement in the students&#39; behaviour and an increase in class participation. Which of the following psychological principles is the teacher applying?</span></span></span></p>",
      "unique_key": "Q5454175",
      "question_audio": null,
      "question_video": null,
      "map_id": 3720031,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Operant conditioning</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Operant conditioning is a learning process through which the strength of a behaviour is modified by reinforcement or punishment. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this scenario, the teacher is using positive reinforcement by giving &quot;good behaviour tickets&quot; for desired behaviours, which increases the likelihood of these behaviours being repeated. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The possibility of losing tickets for negative behaviours can be seen as negative punishment, which decreases the likelihood of these behaviours being repeated. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Operant conditioning involves actively modifying behaviour through the management of consequences.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Classical conditioning.</span></strong><span style=\"font-size:14.0pt\"> This involves learning through association and is famously demonstrated by Pavlov&#39;s dogs, where a neutral stimulus (bell) becomes associated with an unconditioned stimulus (food), leading to a conditioned response (salivation). It does not involve consequences for behaviour but rather the association of two stimuli.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Social learning theory.</span></strong><span style=\"font-size:14.0pt\"> This theory, proposed by Albert Bandura, suggests that people learn from one another through observation, imitation, and modelling. While the students might learn behaviours from observing others, the scenario primarily emphasizes the modification of behaviour through reinforcement and punishment, which is characteristic of operant conditioning.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Observational learning.</span></strong><span style=\"font-size:14.0pt\"> This is a part of social learning theory, where learning occurs by watching others and then imitating their actions. Although students might learn by observing their peers receiving rewards or punishments, the scenario specifically highlights the systematic approach of reinforcing desired behaviours and punishing undesired ones, which is a hallmark of operant conditioning.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Operant conditioning is a psychological principle used to modify behaviour through the use of reinforcement and punishment. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38432,
      "choices": [
        {
          "id": 153483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Tenderness to lower abdominal palpation</span></span></span></p>"
        },
        {
          "id": 153484,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Endocervical polyp during speculum examination</span></span></span></p>"
        },
        {
          "id": 153485,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Powder burn lesions on the cervix during speculum examination</span></span></span></p>"
        },
        {
          "id": 153486,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Uterosacral ligament nodularity during bimanual examination</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Which of the following manifestations is most likely encountered during the physical examination of a patient with endometriosis?</span></span></span></p>",
      "unique_key": "Q6098827",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719625,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Uterosacral ligament nodularity during bimanual examination</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uterosacral ligament nodularity is a characteristic finding during the bimanual examination of patients with endometriosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Endometriosis involves the presence of endometrial-like tissue outside the uterus, which can lead to the formation of nodules or lesions, particularly in areas such as the uterosacral ligaments.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These nodules can cause significant pain and tenderness, especially during pelvic examinations, and are indicative of deep infiltrating endometriosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Tenderness to lower abdominal palpation</span></strong><span style=\"font-size:14.0pt\">. While patients with endometriosis may experience abdominal pain and tenderness, this is a nonspecific finding and can be present in many other conditions. It does not directly indicate endometriosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Endocervical polyp during speculum examination</span></strong><span style=\"font-size:14.0pt\">. Endocervical polyps are benign growths from the cervical canal and are not directly associated with endometriosis. Their presence does not indicate endometriosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Powder burn lesions on the cervix during speculum examination</span></strong><span style=\"font-size:14.0pt\">. Powder burn lesions are more commonly seen on the peritoneal surfaces during laparoscopy, not on the cervix during a speculum examination. These lesions are characteristic of endometriosis but are not typically visualized without surgical intervention.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The educational objective is to recognize uterosacral ligament nodularity during a bimanual examination as a significant physical examination finding indicative of endometriosis. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This finding can suggest the presence of deep infiltrating endometriosis, which is associated with more severe disease and symptoms. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the typical and atypical presentations of endometriosis aids in the timely diagnosis and management of this condition.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153486,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38541,
      "choices": [
        {
          "id": 153907,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Coxiella burnetii</span></span></span></p>"
        },
        {
          "id": 153908,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ehrlichia chaffeensis</span></span></span></p>"
        },
        {
          "id": 153909,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bartonella henselae</span></span></span></p>"
        },
        {
          "id": 153910,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tropheryma whipplei</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 58-year-old male farmer presents to the clinic with persistent fever, night sweats, and a new heart murmur. His medical history is significant for prolonged exposure to livestock and farm animals. Blood cultures remain negative, prompting further investigation into atypical causes of endocarditis. Given the patient&#39;s occupational history and the clinical presentation of a culture-negative endocarditis, which of the following pathogens, known for its obligate intracellular nature and potential for causing chronic infection, is most likely responsible for this patient&#39;s condition?</span></span></span></p>",
      "unique_key": "Q3915862",
      "question_audio": null,
      "question_video": null,
      "map_id": 3735840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Coxiella burnetii</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Coxiella burnetii, the causative agent of Q fever, is an obligate intracellular bacterium that can cause chronic infections, including endocarditis, especially in individuals with a history of exposure to farm animals and livestock. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C. burnetii endocarditis is notable for being a culture-negative endocarditis, as the organism is not readily cultured by standard blood culture techniques. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s occupational exposure and the presentation of a febrile illness with endocarditis symptoms strongly suggest C. burnetii as the causative pathogen.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Ehrlichia chaffeensis</span></strong><span style=\"font-size:14.0pt\">. This bacterium causes human monocytic ehrlichiosis, transmitted by ticks. It primarily presents with fever, malaise, and leukopenia and is less commonly associated with endocarditis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Bartonella henselae</span></strong><span style=\"font-size:14.0pt\">. While B. henselae, the agent of cat scratch disease, can cause culture-negative endocarditis, it is more commonly associated with contact with cats rather than livestock.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Tropheryma whipplei</span></strong><span style=\"font-size:14.0pt\">. This organism causes Whipple&#39;s disease, which can involve various systems including the gastrointestinal tract, heart, and central nervous system. However, it is not typically associated with acute presentations of endocarditis and lacks a direct link to farm animal exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Coxiella burnetii as the causative agent of chronic Q fever, which can present as endocarditis in individuals with a history of exposure to farm animals. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An understanding of the pathogen&#39;s obligate intracellular nature and potential for chronic infection is key for diagnosis and management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153907,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38415,
      "choices": [
        {
          "id": 153415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">High dose monotherapy</span></span></span></p>"
        },
        {
          "id": 153416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hyperemesis gravidarum</span></span></span></p>"
        },
        {
          "id": 153417,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Multiple seizure types</span></span></span></p>"
        },
        {
          "id": 153418,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sleep deprivation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During pregnancy, managing epilepsy poses unique challenges, and several factors can contribute to poor seizure control. Among the following options, which one is NOT typically considered a contributing factor to poor seizure control in pregnancy?</span></span></span></p>",
      "unique_key": "Q6599265",
      "question_audio": null,
      "question_video": null,
      "map_id": 3719128,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) High dose monotherapy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">High dose monotherapy is generally not considered a factor contributing to poor seizure control in pregnancy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In fact, monotherapy, even at higher doses, is often preferred over polytherapy to minimize fetal exposure to antiepileptic drugs while still maintaining seizure control. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The goal is to use the lowest effective dose of a single medication to reduce the risk of teratogenic effects.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hyperemesis gravidarum</span></strong><span style=\"font-size:14.0pt\">. This condition involves severe nausea and vomiting, which can lead to dehydration and electrolyte imbalances, potentially worsening seizure control. Additionally, vomiting can impair the absorption of antiepileptic drugs, leading to subtherapeutic levels and poor seizure control.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Multiple seizure types</span></strong><span style=\"font-size:14.0pt\">. Having multiple types of seizures can complicate the management of epilepsy, making it harder to achieve good seizure control. Different seizure types may require different therapeutic approaches, increasing the complexity of management during pregnancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Sleep deprivation</span></strong><span style=\"font-size:14.0pt\">. Sleep deprivation is a well-known trigger for seizures. Pregnancy-related sleep disturbances can exacerbate this issue, contributing to poor seizure control.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This question aims to identify factors that can affect seizure control in pregnant women with epilepsy. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding these factors is crucial for managing epilepsy during pregnancy effectively. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">High dose monotherapy is actually a strategy to minimize fetal exposure to antiepileptic drugs while maintaining seizure control, whereas hyperemesis gravidarum, multiple seizure types, and sleep deprivation are recognized as potential contributors to poor seizure control during pregnancy.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153415,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38698,
      "choices": [
        {
          "id": 154535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD)</span></span></span></p>"
        },
        {
          "id": 154536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Desquamative interstitial pneumonia (DIP)</span></span></span></p>"
        },
        {
          "id": 154537,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Langerhans cell histiocytosis (LCH)</span></span></span></p>"
        },
        {
          "id": 154538,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Usual interstitial pneumonia (UIP)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 54-year-old male smoker with progressive dyspnea, a non-productive cough, and HRCT showing interstitial lung disease (ILD) is evaluated for smoking-related lung diseases. Which interstitial lung disease is least likely linked to his smoking history?</span></span></span></p>",
      "unique_key": "Q2141193",
      "question_audio": null,
      "question_video": null,
      "map_id": 3754534,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Usual Interstitial Pneumonia (UIP)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Usual Interstitial Pneumonia (UIP) is a form of interstitial lung disease characterized by a pattern of lung injury that includes honeycombing, fibrosis with architectural distortion, and temporal heterogeneity. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">UIP is most commonly associated with idiopathic pulmonary fibrosis (IPF) and is not specifically related to smoking. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While smoking can increase the risk of developing various forms of lung disease, including ILD, the characteristic UIP pattern on imaging and histopathology is not considered a direct consequence of smoking.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD)</span></strong><span style=\"font-size:14.0pt\"> is seen almost exclusively in smokers and is characterized by respiratory bronchiolitis with interstitial lung involvement.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Desquamative interstitial pneumonia (DIP)</span></strong><span style=\"font-size:14.0pt\"> is strongly associated with smoking and is characterized by the accumulation of macrophages in the alveolar spaces, along with interstitial inflammation and fibrosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Langerhans cell histiocytosis (LCH)</span></strong><span style=\"font-size:14.0pt\">, previously known as <strong>pulmonary</strong> <strong>histiocytosis</strong> <strong>X</strong>, is predominantly seen in young adult smokers and is characterized by the proliferation of Langerhans cells, creating nodules that can cavitate.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usual Interstitial Pneumonia (UIP) is most commonly associated with idiopathic pulmonary fibrosis (IPF) and is not specifically related to smoking.</span></span></li>\r\n</ul>",
      "correct_choice_id": 154538,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38598,
      "choices": [
        {
          "id": 154135,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">500 Kcal + 20 grams proteins</span></span></span></p>"
        },
        {
          "id": 154136,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">600 Kcal + 20 grams proteins</span></span></span></p>"
        },
        {
          "id": 154137,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">550 Kcal + 18 grams proteins</span></span></span></p>"
        },
        {
          "id": 154138,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">600 Kcal + 10 grams proteins</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the Integrated Child Development Services (ICDS) scheme, aimed at providing nutritional support to vulnerable sections of the population in India, specific dietary recommendations are made for pregnant women to ensure maternal and fetal health. Among the options below, which one correctly outlines the dietary supplementation provided to pregnant women under the ICDS program?</span></span></span></p>",
      "unique_key": "Q1243386",
      "question_audio": null,
      "question_video": null,
      "map_id": 3739547,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 600 Kcal + 20 grams proteins</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ICDS scheme, recognizing the increased nutritional needs during pregnancy, recommends a dietary supplementation of 600 Kcal and 20 grams of proteins for pregnant women. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is designed to support the health of both the mother and the developing fetus by ensuring adequate energy and protein intake.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Revised norms for free food supplementation under ICDS:</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/14/screenshot-2024-03-14-132146.JPG\" style=\"height:278px; width:700px\" /></span></strong></span></span></p>",
      "correct_choice_id": 154136,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38723,
      "choices": [
        {
          "id": 154635,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administration of intravenous immunoglobulin (IVIG) </span></span></span></span></p>"
        },
        {
          "id": 154636,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Use of insulin for hyperglycemia </span></span></span></span></p>"
        },
        {
          "id": 154637,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Avoiding aminoglycoside exposure for more than 7 days </span></span></span></span></p>"
        },
        {
          "id": 154638,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Use of antenatal steroids</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which intervention is strongly recommended to reduce mortality and prevent future neurodevelopmental impairment in a preterm neonate?</span></span></span></span></p>",
      "unique_key": "Q4659768",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756449,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Use of antenatal steroids </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antenatal steroids are given to the mother when she pregnant and expecting a preterm labor. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is given for baby&rsquo;s lung maturity. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inj. betamethasone 12 mg for 2 doses 24 hrs. apart.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inj. dexamethasone 6 mg 4 doses 12 hours apart.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The use of antenatal steroids is recommended to accelerate fetal lung maturity and reduce the risks of respiratory distress syndrome, intraventricular hemorrhage, and necrotizing enterocolitis in preterm infants, all of which can impact mortality and neurodevelopmental outcomes.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Administration of intravenous immunoglobulin (IVIG)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. IVIG administration is sometimes used in neonates, but it is not a standard recommendation for the reduction of mortality and neurodevelopmental impairment in preterm infants without a specific indication.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Use of insulin for hyperglycemia</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. While managing hyperglycemia is important, the routine use of insulin for this purpose in preterm neonates is not a standard recommendation to reduce mortality and neurodevelopmental impairment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Avoiding aminoglycoside exposure for more than 7 days</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Avoiding prolonged exposure to aminoglycosides can be important due to the risk of nephrotoxicity and ototoxicity, but it is not the primary intervention for reducing mortality and neurodevelopmental impairment in preterm neonates.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The administration of antenatal steroids to mothers at risk of preterm delivery is strongly recommended to reduce mortality and prevent future neurodevelopmental impairment in preterm neonates by enhancing lung maturity.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38700,
      "choices": [
        {
          "id": 154543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diabetic nephropathy</span></span></span></p>"
        },
        {
          "id": 154544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amyloidosis</span></span></span></p>"
        },
        {
          "id": 154545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Focal segmental glomerulosclerosis (FSGS)</span></span></span></p>"
        },
        {
          "id": 154546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HIV-associated nephropathy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old male with poorly controlled diabetes and chronic kidney disease (CKD) shows gradually declining renal function and enlarged kidneys on ultrasound. Considering the etiologies of CKD, which condition is least likely to present with large kidneys in its advanced stages?</span></span></p>",
      "unique_key": "Q1218453",
      "question_audio": null,
      "question_video": null,
      "map_id": 3754586,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Focal segmental glomerulosclerosis (FSGS)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">FSGS is a cause of nephrotic syndrome and CKD characterized by scarring in some of the glomeruli. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the advanced stages of the disease, kidneys often become scarred and shrink over time, leading to smaller, not larger, kidney sizes on imaging studies such as ultrasound. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This contrasts with other conditions listed, which can present with larger kidneys even in later stages due to different pathophysiological mechanisms.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Diabetic nephropathy</span></strong><span style=\"font-size:14.0pt\"> often leads to enlarged kidneys in the early and sometimes later stages due to hyperfiltration and hypertrophy of the nephrons, a common finding in patients with diabetes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Amyloidosis</span></strong><span style=\"font-size:14.0pt\"> can lead to enlarged kidneys due to amyloid deposition in the renal parenchyma, which can occur even as the renal function declines.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. HIV-associated nephropathy (HIVAN)</span></strong><span style=\"font-size:14.0pt\"> is typically associated with large kidneys on ultrasound due to collapsing FSGS and associated tubular hypertrophy, especially in the early and middle stages, and can persist into the later stages of the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the advanced stages of CKD, most conditions lead to reduced kidney size due to scarring and loss of nephron mass. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154545,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38368,
      "choices": [
        {
          "id": 153227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Epirubicin</span></span></span></p>"
        },
        {
          "id": 153228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Irinotecan</span></span></span></p>"
        },
        {
          "id": 153229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cyclophosphamide</span></span></span></p>"
        },
        {
          "id": 153230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methotrexate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 55-year-old female patient consults an oncologist due to a recently discovered breast lump. After undergoing a thorough examination and necessary diagnostic tests, she is diagnosed with breast cancer. An echocardiogram reveals her ejection fraction to be at 25%. Considering the patient&#39;s cardiac condition, which of the following chemotherapeutic agents should be avoided to prevent exacerbation of her cardiac dysfunction?</span></span></span></p>",
      "unique_key": "Q9722462",
      "question_audio": null,
      "question_video": null,
      "map_id": 3716755,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Epirubicin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Epirubicin is an anthracycline chemotherapeutic agent known for its potential cardiotoxic effects, especially in patients with pre-existing cardiac conditions. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The drug can lead to cardiomyopathy and congestive heart failure, which are particularly concerning in patients with a low ejection fraction, such as the 25% observed in this patient. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, Epirubicin should be avoided to prevent further cardiac damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Irinotecan.</strong> This drug is primarily associated with gastrointestinal side effects, such as diarrhea and neutropenia, but not with significant cardiotoxicity. Therefore, it would not be contraindicated based on the patient&#39;s low ejection fraction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Cyclophosphamide.</strong> While cyclophosphamide can have cardiotoxic effects, particularly at high doses, its risk profile is generally considered lower than that of anthracyclines like Epirubicin. However, careful consideration and monitoring are still required in patients with compromised cardiac function.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Methotrexate.</strong> Methotrexate is associated with hepatotoxicity, mucositis, and myelosuppression but has minimal cardiotoxic effects. It would not be contraindicated in a patient with a low ejection fraction based on its side effect profile.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The key educational point in this question is to recognize the cardiotoxic potential of certain chemotherapeutic agents, particularly anthracyclines like Epirubicin, in patients with pre-existing cardiac conditions such as a reduced ejection fraction. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is crucial to consider the cardiac risk profile of chemotherapeutic agents when treating cancer patients with underlying cardiac dysfunction to avoid exacerbating their condition.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38737,
      "choices": [
        {
          "id": 154691,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostate</span></span></span></span></p>"
        },
        {
          "id": 154692,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penile</span></span></span></span></p>"
        },
        {
          "id": 154693,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bulbar</span></span></span></span></p>"
        },
        {
          "id": 154694,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which part of urethra would be injured in the pictures given below?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132630.JPG\" style=\"height:166px; width:500px\" /></span></span></p>",
      "unique_key": "Q9035217",
      "question_audio": null,
      "question_video": null,
      "map_id": 3757563,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Bulbar</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Straddle injuries lead to rupture of bulbous urethra. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This can occur with a sharp blow to the perineum.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis is made by retrograde urethrography.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suprapubic cystostomy is performed.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delayed urethroplasty (2-3 months later) is the surgical treatment of choice.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presentation: </span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood at urethral meatus</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not being able to pass urine</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine building up in the bladder (distension)</span></span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Butterfly-shaped perineal hematoma</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Straddle injuries lead to rupture of bulbous urethra.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Bailey and Love&rsquo;s short practice of surgery, 28<sup>th</sup> edition, page no. 1540-1541</span></span></strong></span></span></p>",
      "correct_choice_id": 154693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38319,
      "choices": [
        {
          "id": 153035,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES-TRAD\" style=\"font-size:14.0pt\">ATP-Sensitive K+ Channels</span></span></span></p>"
        },
        {
          "id": 153036,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">cAMP </span></span></span></p>"
        },
        {
          "id": 153037,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES-TRAD\" style=\"font-size:14.0pt\">Carrier Modulators</span></span></span></p>"
        },
        {
          "id": 153038,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Receptor Phosphorylation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The process of insulin release in response to elevated blood glucose levels represents a finely tuned physiological mechanism critical for maintaining metabolic equilibrium. The phenomena of Glucose-mediated insulin release involves:</span></span></span></p>",
      "unique_key": "Q5038163",
      "question_audio": null,
      "question_video": null,
      "map_id": 3715330,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) ATP-Sensitive K+ Channels&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Glucose-mediated insulin release</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> involves the <strong>closure</strong> of <strong>ATP-sensitive</strong> <strong>K+ channels</strong> in <strong>beta cells</strong> of the <strong>pancreas</strong>, leading to <strong>cell depolarization</strong> and <strong>subsequent insulin secretion</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option </span></strong><strong><span style=\"font-size:14.0pt\">B</span></strong><span style=\"font-size:14.0pt\">. <strong>cAMP (Cyclic adenosine monophosphate).</strong> While cAMP plays a <strong>role</strong> in other <strong>hormonal pathways</strong>, it is not directly involved in the mechanism of glucose-mediated insulin release from pancreatic beta cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option </span></strong><strong><span style=\"font-size:14.0pt\">C</span></strong><span style=\"font-size:14.0pt\">. <strong>Carrier Modulators</strong>. This term is <strong>broad</strong> and <strong>not specifically</strong> related to the mechanism of insulin release in response to glucose levels; hence, it <strong>does not directly</strong> participate in this physiological process.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Receptor Phosphorylation.</strong> While receptor phosphorylation is a <strong>common cellular</strong> <strong>signalling mechanism</strong>, it is not directly associated with glucose-mediated <strong>insulin release</strong> from <strong>pancreatic beta cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding the role of <strong>ATP-sensitive K+ channels</strong> in <strong>glucose-mediated insulin</strong> release provides <strong>insight</strong> into the <strong>intricate mechanisms</strong> regulating <strong>pancreatic beta cell function</strong>, essential for <strong>maintaining glucose</strong> <strong>homeostasis</strong> in the <strong>body</strong>.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Mechanism of insulin secretion by the K+ channel in pancreatic &beta;-cells:</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-164653.JPG\" style=\"height:481px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Glucose</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> enters the <strong>B cells</strong> via <strong>GLUT 2</strong> <strong>transporters</strong> and is <strong>phosphorylated</strong> by <strong>Glucokinase</strong> then metabolized to <strong>pyruvate</strong> in the cytoplasm </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> in mitochondria, the <strong>formation</strong> of <strong>ATP</strong> by <strong>oxidative phosphorylation</strong> occurs. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The <strong>ATP inhibits</strong> <strong>ATP-sensitive K+ channels</strong>, <strong>reducing K+ efflux </strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>depolarization</strong> and <strong>opening</strong> of <strong>voltage-gated Ca<sup>2+</sup> channels</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The <strong>Ca<sup>2+</sup> influx</strong> causes <strong>exocytosis</strong> of a readily releasable <strong>pool</strong> of <strong>insulin-containing</strong> <strong>secretory granules</strong>, producing the <strong>initial spike</strong> of <strong>insulin secretion</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Ganong&#39;s Review of Medical Physiology, 26th Edition, Page no. 326</span></span></strong></p>",
      "correct_choice_id": 153035,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38377,
      "choices": [
        {
          "id": 153263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Levetiracetam </span></span></span></p>"
        },
        {
          "id": 153264,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phenytoin </span></span></span></p>"
        },
        {
          "id": 153265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vigabatrin </span></span></span></p>"
        },
        {
          "id": 153266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ethosuximide </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 25-year-old male patient with a history of seizures presents to the clinic. He has been taking anticonvulsants for the last few years, and he reports experiencing visual disturbances, including a narrowing of his visual field. He is concerned about the possibility of permanent vision loss. Which of these anticonvulsants causes contraction of visual field? </span></span></span></p>",
      "unique_key": "Q3364172",
      "question_audio": null,
      "question_video": null,
      "map_id": 3717040,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C</span></strong><strong><span style=\"font-size:14.0pt\">) Vigabatrin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vigabatrin is an anticonvulsant medication known to cause visual disturbances, including a narrowing of the visual field, which is a characteristic side effect of this drug. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vigabatrin&#39;s mechanism of action involves the irreversible inhibition of gamma-aminobutyric acid transaminase (GABA-T), leading to increased levels of gamma-aminobutyric acid (GABA) in the brain, which helps control seizures. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, one of the serious adverse effects of vigabatrin is its potential to cause permanent vision loss, particularly peripheral vision loss or contraction of the visual field. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients on vigabatrin require regular ophthalmologic monitoring to assess for any changes in vision.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Levetiracetam</span></strong><span style=\"font-size:14.0pt\"> works by modulating neurotransmitter release through binding to the synaptic vesicle protein SV2A, and it is not commonly associated with visual disturbances or contraction of the visual field.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Phenytoin</span></strong><span style=\"font-size:14.0pt\">, a sodium channel blocker, can have a variety of side effects, but contraction of the visual field is not a characteristic adverse effect. Phenytoin&#39;s more common side effects include nystagmus, ataxia, and gingival hyperplasia, among others.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ethosuximide</span></strong><span style=\"font-size:14.0pt\">, which is primarily used in the treatment of absence seizures, acts by inhibiting T-type calcium channels. It is not typically associated with visual field defects as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The question aims to highlight the importance of recognizing the potential ocular side effects of anticonvulsant medications, specifically the risk of visual field contraction associated with vigabatrin use. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It underscores the need for regular ophthalmologic evaluations in patients taking vigabatrin to monitor for this serious adverse effect and illustrates the diverse side effect profiles of anticonvulsant drugs.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 153265,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38727,
      "choices": [
        {
          "id": 154651,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pedicled TRAM based on superior epigastric artery</span></span></span></span></p>"
        },
        {
          "id": 154652,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Free TRAM based on inferior epigastric artery</span></span></span></span></p>"
        },
        {
          "id": 154653,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DIEP based on deep inferior epigastric artery</span></span></span></span></p>"
        },
        {
          "id": 154654,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DIEP is a myocutaneous flap</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the false statement about the flaps used in breast reconstruction. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132310.JPG\" style=\"height:378px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q6475007",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756713,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) DIEP is a myocutaneous flap</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image provided depicts a deep inferior epigastric artery perforator flap (DIEP).</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The DIEP flap is derived from the deep inferior epigastric artery and is a muscle sparing flap.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A myocutaneous flap, by definition, includes muscle. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The DIEP flap is differentiated from the TRAM flap by the fact that it spares the rectus abdominis muscle and uses only the skin, fat, and blood vessels for breast reconstruction.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-132321.JPG\" style=\"height:300px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pedicled TRAM based on superior epigastric artery. </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TRAM stands for Transverse Rectus Abdominis Myocutaneous. The pedicled TRAM flap relies primarily on the superior epigastric artery, which remains attached (or &quot;pedicled&quot;) to its original blood supply. The flap is tunneled under the skin to the chest and used to reconstruct the breast.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Free TRAM based on inferior epigastric artery. </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The free TRAM flap involves removing a section of the abdominal tissue (including the rectus muscle) and its associated blood vessels (inferior epigastric arteries). This flap is then transplanted to the chest and connected to the chest&#39;s blood vessels using microsurgical techniques. It utilizes both the superior and inferior epigastric arteries.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. DIEP based on deep inferior epigastric artery. </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The DIEP (Deep Inferior Epigastric Perforator) flap is similar to the free TRAM flap but does not involve the removal of the rectus muscle. Instead, only the blood vessels (or &quot;perforators&quot;) and the skin and fat are removed. It is based solely on the deep inferior epigastric artery. The DIEP flap reduces post-operative abdominal weakness and complications because it spares the abdominal muscles.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The DIEP flap is derived from the deep inferior epigastric artery and is a muscle sparing flap.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154654,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38725,
      "choices": [
        {
          "id": 154643,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The surgeon must use chromic catgut.</span></span></span></span></p>"
        },
        {
          "id": 154644,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The surgeon must not include the submucosa in the sutures.</span></span></span></span></p>"
        },
        {
          "id": 154645,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The surgeon must use the single layer, extramucosal suture technique.</span></span></span></span></p>"
        },
        {
          "id": 154646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The surgeon must use the single layer, seromuscular suture technique.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old boy is brought to the hospital with symptoms of an inguinal hernia. During the operation, the surgeon observes a segment of necrotic bowel in the hernial sac. What is the appropriate course of action for resection and anastomosis of a necrotic bowel seen during surgery?</span></span></span></span></p>",
      "unique_key": "Q7751082",
      "question_audio": null,
      "question_video": null,
      "map_id": 3756711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) The surgeon must use the single layer, extramucosal suture technique.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The single-layer, extramucosal suture technique of Halstead involves using a single layer of sutures to join the two ends of the bowel together, while avoiding the mucosal layer. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This technique is less time-consuming than the double-layer technique and reduces the risk of complications such as bleeding, stricture formation, and anastomotic leak. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is one of the preferred techniques in small bowel anastomosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. The surgeon must use chromic catgut. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromic catgut is a type of absorbable suture that is made from the collagen found in sheep or goat intestine. Chromic catgut has a relatively short duration of tensile strength, and so it is not recommended for use in areas of high tension or stress, including intestinal anastomosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. The surgeon must not include the submucosa in the sutures. </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The submucosa is a layer of tissue beneath the mucosal lining of the bowel. It should be included in sutures as it is the toughest layer of the bowel.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The surgeon must use the single layer, seromuscular suture technique</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The single-layer seromuscular suture technique involves suturing the seromuscular layer of the bowel to join the two ends together. This technique is quick and easy to perform but may not be suitable for all cases as it can increase the risk of anastomotic leakage and stenosis. Therefore, it is important to assess each case individually and choose the appropriate technique based on the specific circumstances.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For resection and anastomosis of a necrotic bowel seen during surgery,<strong> </strong>the surgeon must use the single layer, extramucosal suture technique.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 154645,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38870,
      "choices": [
        {
          "id": 155219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases the secretion of enkephalin</span></span></span></span></p>"
        },
        {
          "id": 155220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases the secretion of enkephalin</span></span></span></span></p>"
        },
        {
          "id": 155221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No effect on the secretion of enkephalin</span></span></span></span></p>"
        },
        {
          "id": 155222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Negligible effect on enkephalin secretion</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman with a history of chronic pain syndrome is being evaluated in a pain management clinic. Her treatment regimen includes medications that modulate neurotransmitter levels to manage her pain. One of the medical students shadowing in the clinic is curious about the role of various neurotransmitters in pain modulation and their effects on pain-modulating peptides such as enkephalins. The attending physician decides to use this opportunity to test the student&#39;s understanding of the interaction between neurotransmitters and neuropeptides involved in pain modulation. What will be the effect of serotonin on the secretion of enkephalin?</span></span></p>",
      "unique_key": "Q5621170",
      "question_audio": null,
      "question_video": null,
      "map_id": 3786168,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A) Increases the secretion of enkephalin</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin, a neurotransmitter known for its role in mood regulation, also plays a significant role in the modulation of pain. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of pain pathways, serotonin released in the spinal cord can increase the secretion of enkephalin, a type of endogenous opioid peptide. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enkephalins bind to opioid receptors in the central nervous system, inhibiting pain signals and thereby exerting an analgesic effect. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The increase in enkephalin secretion by serotonin contributes to the descending pain modulation pathway, where the brain influences the perception of pain by sending inhibitory signals to the spinal cord.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreases the secretion of enkephalin.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect as serotonin generally has a facilitatory effect on the secretion of enkephalins, contributing to pain inhibition rather than decreasing their secretion.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. No effect on the secretion of enkephalin.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect because serotonin does influence enkephalin secretion as part of the body&#39;s complex pain modulation mechanisms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Negligible effect on enkephalin secretion.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is also incorrect. While the effect of serotonin on enkephalin secretion may vary depending on the physiological context, it is generally considered significant in the modulation of pain pathways.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to understand the role of neurotransmitters like serotonin in modulating pain through their effects on neuropeptides such as enkephalins. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing the interplay between neurotransmitters and neuropeptides is crucial for comprehending the complex mechanisms of pain modulation and for the effective management of pain in clinical practice.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 155219,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38871,
      "choices": [
        {
          "id": 155223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P. falciparum</span></span></span></span></p>"
        },
        {
          "id": 155224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P. vivax</span></span></span></span></p>"
        },
        {
          "id": 155225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P. ovale</span></span></span></span></p>"
        },
        {
          "id": 155226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P. malariae</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man visits the clinic with a history of recurring fevers. He reports that the fever episodes have been occurring like clockwork, every 72 hours for the past several weeks. He recently returned from a trip to sub-Saharan Africa, where he spent significant time outdoors in rural areas. The patient did not take any prophylactic antimalarial medication. Given the periodicity of the fever, which Plasmodium species is most likely responsible for the patient&#39;s malaria infection, considering the classic fever patterns associated with different species?</span></span></span></span></p>",
      "unique_key": "Q5043249",
      "question_audio": null,
      "question_video": null,
      "map_id": 3786389,
      "difficulty_level": "difficult",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> P. malariae</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P. malariae is known for its quartan fever pattern, which occurs every 72 hours. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is due to the parasite&#39;s 72-hour erythrocytic cycle. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s reported pattern of recurring fever matches the quartan cycle associated with P. malariae infection, making it the most likely cause of his malaria.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. P. falciparum</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Typically causes a more irregular fever pattern, often with more severe and life-threatening symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. P. vivax</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and <strong>Option C. P. ovale</strong>. Both of these species can cause tertian fever patterns, with fevers typically recurring every 48 hours.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other differences between the species of Plasmodium:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/16/screenshot-2024-03-16-202333.JPG\" style=\"height:625px; width:1000px\" /></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "correct_choice_id": 155226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38872,
      "choices": [
        {
          "id": 155227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biophysical profile</span></span></span></span></p>"
        },
        {
          "id": 155228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal blood sampling</span></span></span></span></p>"
        },
        {
          "id": 155229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniospectrometry</span></span></span></span></p>"
        },
        {
          "id": 155230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCA (Middle cerebral artery) doppler peak systolic velocity</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In modern obstetrics, which of the following investigations is used for monitoring the fetus of an Rh-negative sensitized mother?</span></span></span></span></p>",
      "unique_key": "Q8196638",
      "question_audio": null,
      "question_video": null,
      "map_id": 3786460,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) MCA (Middle cerebral artery) doppler peak systolic velocity </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Doppler of the middle cerebral artery indirectly gives evidence of fetal anemia.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An anemic fetus (For e.g. due to fetal red cell destruction in an Rh iso-immunized mother) will re-direct blood flow to more important organs like the brain. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is reflected by an increased flow in the middle cerebral artery which can be measured by doing a Doppler of the MCA.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Rh immunized mothers, when indirect Coomb&rsquo;s Test (ICT) titers rise above the critical titer of 1:16, then MCA doppler peak systolic velocity (PSV) is used for monitoring fetal anemia and development of hydrops in these babies. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCA-PSV has replaced amniocentesis as it is a non-invasive test.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Biophysical Profile</strong> is a test of antepartum fetal assessment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fetal blood sampling or Cordocentesis</strong>. This is done only when the fetal MCA doppler shows a peak systolic velocity of &gt; 1.5 MoMs.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Amnio-spectrometry</strong>. This is no longer done as it is an invasive method of measuring the amount of bilirubin in the amniotic fluid to determine the level of fetal anemia. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Doppler of the middle cerebral artery indirectly gives evidence of fetal anemia.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An anemic fetus (For e.g. due to fetal red cell destruction in an Rh iso-immunized mother) will re-direct blood flow to more important organs like the brain. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is reflected by an increased flow in the middle cerebral artery which can be measured by doing a Doppler of the MCA.</span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Rh immunized mothers, when indirect Coomb&rsquo;s Test (ICT) titers rise above the critical titer of 1:16, then MCA doppler peak systolic velocity (PSV) is used for monitoring fetal anemia and development of hydrops in these babies. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCA-PSV has replaced amniocentesis as it is a non-invasive test.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s Obstetrics, 26<sup>th</sup> edition, Page no. 931</span></span></strong></p>",
      "correct_choice_id": 155230,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38873,
      "choices": [
        {
          "id": 155231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoebiasis </span></span></span></span></p>"
        },
        {
          "id": 155232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiodysplasia</span></span></span></span></p>"
        },
        {
          "id": 155233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crohn&#39;s disease </span></span></span></span></p>"
        },
        {
          "id": 155234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudomembranous colitis </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 54-year-old man is being treated for a pulmonary abscess. He has received broad spectrum antibiotic therapy with nafcillin, cephalosporins, and gentamicin for the past 14 days. He has developed abdominal pain, fever, and diarrhea over the past 3 days. The gross appearance of his colonic mucosa is shown here. Which of the following is the most likely diagnosis? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/16/screenshot-2024-03-14-110306.JPG\" style=\"height:195px; width:300px\" /></span></span></p>",
      "unique_key": "Q8108942",
      "question_audio": null,
      "question_video": null,
      "map_id": 3786721,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pseudomembranous colitis</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical history of broad-spectrum antibiotic therapy, especially including cepahlosporins, followed by abdominal pain, fever, and diarrhea, is highly suggestive of pseudomembranous colitis. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The colonic mucosa&#39;s gross appearance, characterized by yellowish plaques or pseudomembrane, is pathognomonic for pseudomembranous colitis, which results from overgrowth of <em>Clostridium difficile</em>. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This bacterium releases toxins that cause mucosal inflammation, leading to the formation of pseudomembrane.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoebiasis</span></span></strong><strong> </strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">could present with diarrhea and abdominal pain but typically has a different endoscopic appearance, often with flask-shaped ulcers rather than pseudomembrane, and would not be expected after broad-spectrum antibiotic use.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiodysplasia </span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a vascular abnormality that can cause bleeding in the gastrointestinal tract, typically presenting with painless bleeding rather than diarrhea and is not associated with recent antibiotic use.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. </span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crohn&#39;s disease</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a chronic inflammatory bowel disease that can cause abdominal pain, diarrhea, and fever. However, the endoscopic appearance often shows deep longitudinal ulcers and a cobblestone pattern, which are not seen in this image.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This question tests the ability to recognize pseudomembranous colitis&#39;s clinical presentation and characteristic endoscopic findings. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It&#39;s crucial to identify this condition given its association with recent antibiotic use and the potential for severe complications. </span></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the differences in presentation and endoscopic findings among various colitides is important for accurate diagnosis and appropriate treatment.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 155234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}